data_2ddi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ddi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.306 0 CA-C-O 118.805 -0.617 . . . . 1.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.58 -26.92 68.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.624 1.102 . . . . 1.0 111.449 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.17 -25.76 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.331 1.052 . . . . 1.0 109.936 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.7 tp -76.47 130.19 77.68 Favored Pre-proline 0 C--O 1.226 -0.137 0 C-N-CA 127.065 2.146 . . . . 1.0 112.944 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.37 153.33 13.63 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.954 2.436 . . . . 1.0 111.51 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.66 13.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.031 0.532 . . . . 1.0 110.16 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.66 148.6 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 125.119 1.368 . . . . 1.0 107.514 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.49 -56.77 4.32 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.622 1.169 . . . . 1.0 110.937 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.62 174.73 19.88 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.061 1.315 . . . . 1.0 109.971 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.19 -6.41 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.065 2.51 . . . . 1.0 113.505 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -73.32 175.62 6.72 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 122.364 1.078 . . . . 1.0 112.593 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.4 3.51 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.479 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.4 153.82 21.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 103.511 -3.836 . . . . 1.0 103.511 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -126.63 106.14 9.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.109 1.455 . . . . 1.0 109.52 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -102.12 113.83 65.71 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 128.748 2.819 . . . . 1.0 107.07 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.36 126.51 13.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.276 2.651 . . . . 1.0 110.284 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -132.37 -179.86 5.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.222 1.009 . . . . 1.0 109.005 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 48.2 m95 -119.55 143.87 47.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.667 1.187 . . . . 1.0 108.217 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.2 39.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -80.84 138.57 36.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.922 0.868 . . . . 1.0 108.976 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m -117.29 113.7 38.88 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.242 -1.361 . . . . 1.0 108.177 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.6 -33.61 21.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.788 1.659 . . . . 1.0 110.371 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -63.25 -20.54 65.54 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.0 112.711 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -108.24 -5.34 16.89 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.518 1.127 . . . . 1.0 110.769 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.63 37.93 3.64 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.543 2.737 . . . . 1.0 109.997 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -162.76 168.06 22.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.93 150.65 21.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.24 1.019 . . . . 1.0 112.156 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -140.74 154.61 69.07 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.944 -1.025 . . . . 1.0 111.28 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.59 162.71 35.78 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.178 1.918 . . . . 1.0 109.0 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.98 163.19 36.68 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.395 0.998 . . . . 1.0 108.575 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.97 127.13 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.39 -1.707 . . . . 1.0 106.39 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -119.2 168.9 10.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.848 2.059 . . . . 1.0 105.533 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.88 1.35 15.13 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 120.692 -1.255 . . . . 1.0 116.106 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.65 -7.24 58.96 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.277 1.538 . . . . 1.0 115.058 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 32.0 p -118.73 -172.75 2.34 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.723 2.409 . . . . 1.0 108.128 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.6 0.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.679 1.992 . . . . 1.0 112.853 -173.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.79 -176.76 38.1 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.555 -2.218 . . . . 1.0 107.555 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -93.5 174.93 6.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.179 0.989 . . . . 1.0 108.616 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.8 -11.76 85.11 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.228 -0.896 . . . . 1.0 112.93 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -78.02 74.17 4.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.435 1.118 . . . . 1.0 108.199 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.53 113.08 6.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -121.12 161.02 22.5 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.82 1.248 . . . . 1.0 108.624 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -93.27 -15.05 26.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.981 -1.463 . . . . 1.0 112.336 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -166.54 171.11 12.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.402 0.681 . . . . 1.0 109.295 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.9 tpt180 -62.29 -47.3 84.91 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -66.93 0.31 Allowed 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 128.466 2.706 . . . . 1.0 111.261 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -54.93 -33.17 61.94 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.0 t -72.04 -50.72 26.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.821 0.848 . . . . 1.0 112.899 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.348 76.2 mt-10 -67.29 -33.13 74.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 118.432 -0.795 . . . . 1.0 109.948 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.35 -38.9 85.26 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.376 0.989 . . . . 1.0 109.007 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 -43.66 72.84 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.33 0.968 . . . . 1.0 112.781 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.237 0.418 0 C-N-CA 123.662 0.785 . . . . 1.0 109.856 178.404 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.3 p -47.58 -28.45 2.31 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.588 -1.32 . . . . 1.0 113.603 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.55 -28.29 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 119.56 1.073 . . . . 1.0 112.301 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.46 156.14 85.36 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 127.929 2.491 . . . . 1.0 109.594 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.5 168.54 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.825 1.684 . . . . 1.0 111.856 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 113.54 8.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.931 -1.137 . . . . 1.0 107.931 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.2 t -91.94 124.14 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -80.07 -33.07 39.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.693 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.17 173.32 42.03 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.409 -1.077 . . . . 1.0 110.409 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.54 -8.16 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.261 2.641 . . . . 1.0 114.409 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -73.6 -179.05 3.36 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 3.86 5.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.66 1.584 . . . . 1.0 113.105 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.17 155.18 26.04 Favored Glycine 0 CA--C 1.533 1.161 1 N-CA-C 101.157 -4.777 . . . . 1.0 101.157 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -132.58 120.32 21.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.931 2.366 . . . . 1.0 108.829 -173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.95 113.79 28.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 129.377 3.071 . . . . 1.0 107.801 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.32 125.23 12.62 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.441 2.76 . . . . 1.0 111.214 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -131.81 178.31 6.86 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.295 1.038 . . . . 1.0 109.729 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 68.6 m95 -113.2 143.34 44.56 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.1 144.02 42.85 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.773 1.17 . . . . 1.0 108.243 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -79.5 139.21 37.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.808 0.813 . . . . 1.0 109.43 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -117.17 113.86 39.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.274 1.83 . . . . 1.0 107.806 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.79 -34.34 24.65 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.946 1.764 . . . . 1.0 111.06 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.59 -13.99 55.75 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.369 1.067 . . . . 1.0 112.754 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -115.9 -4.0 12.11 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.963 1.305 . . . . 1.0 110.723 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.65 37.97 1.76 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.893 2.877 . . . . 1.0 109.974 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.67 169.32 23.08 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.9 m -106.78 136.0 47.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.573 0.749 . . . . 1.0 110.681 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -122.89 159.48 53.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.295 1.038 . . . . 1.0 109.325 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -71.12 164.81 34.46 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 120.233 1.119 . . . . 1.0 109.588 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.22 168.89 25.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.09 113.7 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -99.46 162.08 13.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.02 55.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 116.185 1.234 . . . . 1.0 116.185 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.96 2.05 57.11 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 118.943 1.371 . . . . 1.0 115.062 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 p -125.46 -172.64 2.64 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.263 2.625 . . . . 1.0 107.846 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -33.3 133.64 0.15 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.801 2.04 . . . . 1.0 112.514 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.93 174.68 43.49 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.169 -1.973 . . . . 1.0 108.169 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.62 -174.76 3.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.195 0.997 . . . . 1.0 108.603 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.77 -4.26 82.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 126.983 2.23 . . . . 1.0 113.934 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -80.07 65.7 5.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.929 2.864 . . . . 1.0 107.107 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -144.04 112.9 6.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -115.27 161.25 18.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.399 -1.704 . . . . 1.0 106.399 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.294 6.4 m80 -92.75 -20.68 20.52 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.614 -2.539 . . . . 1.0 108.477 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -170.47 165.52 8.54 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.906 0.882 . . . . 1.0 108.641 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 14.9 ttp85 -65.75 -42.3 91.11 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.678 -1.23 . . . . 1.0 107.678 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -46.55 -66.1 0.46 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.369 2.268 . . . . 1.0 110.276 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 p -57.77 -34.28 69.4 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.689 0.618 . . . . 1.0 111.954 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.1 t -71.66 -48.52 47.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.285 1.034 . . . . 1.0 112.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.09 -33.53 73.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.53 0.681 . . . . 1.0 109.733 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.64 -23.36 39.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.13 -62.78 1.48 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.935 0.789 . . . . 1.0 111.847 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -173.114 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 p -49.3 -33.38 13.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.422 1.465 . . . . 1.0 112.766 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -76.63 -21.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 O-C-N 120.788 -1.195 . . . . 1.0 111.076 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -73.72 131.03 82.52 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 127.313 2.245 . . . . 1.0 112.193 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.76 154.22 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.227 2.618 . . . . 1.0 112.825 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.51 161.52 24.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.017 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.8 t -137.89 145.47 28.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 105.74 -1.948 . . . . 1.0 105.74 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -96.48 -23.99 16.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.668 0.787 . . . . 1.0 112.086 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.34 170.43 46.24 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.587 1.565 . . . . 1.0 111.307 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.13 -3.39 13.73 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.388 3.392 . . . . 1.0 114.691 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.3 176.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.655 1.582 . . . . 1.0 112.984 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 3.65 3.82 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.411 1.485 . . . . 1.0 112.946 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.15 153.44 20.27 Favored Glycine 0 CA--C 1.528 0.896 1 N-CA-C 101.63 -4.588 . . . . 1.0 101.63 172.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -128.69 104.68 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.974 1.387 . . . . 1.0 110.889 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -94.16 113.67 61.3 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.138 2.975 . . . . 1.0 106.992 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.21 127.75 14.66 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.37 2.714 . . . . 1.0 110.478 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.52 179.4 5.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.82 0.848 . . . . 1.0 108.935 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.2 m95 -119.74 136.31 54.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.883 -1.525 . . . . 1.0 106.883 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.62 143.51 48.66 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -77.45 139.18 39.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.705 0.764 . . . . 1.0 110.299 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -117.15 113.57 39.22 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 117.064 -1.446 . . . . 1.0 107.537 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.09 -33.38 31.88 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.09 1.86 . . . . 1.0 110.601 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.04 -16.88 63.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.568 1.147 . . . . 1.0 112.804 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -111.56 -4.35 14.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.38 1.472 . . . . 1.0 110.557 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 51.99 20.2 1.19 Allowed 'General case' 0 N--CA 1.431 -1.421 1 C-N-CA 132.35 4.26 . . . . 1.0 110.324 -173.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -157.72 167.98 28.52 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.416 -1.427 . . . . 1.0 108.988 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.8 m -84.23 152.89 23.92 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -138.43 156.05 73.58 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.933 -1.485 . . . . 1.0 109.527 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.57 160.27 32.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.135 1.89 . . . . 1.0 109.666 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -156.75 163.83 38.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.39 0.995 . . . . 1.0 108.603 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.0 t -87.2 122.85 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -124.08 173.27 8.39 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.899 1.68 . . . . 1.0 106.637 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.32 -7.66 5.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 116.414 1.326 . . . . 1.0 116.414 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.86 -28.76 8.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 119.472 1.636 . . . . 1.0 111.586 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -75.11 -173.26 1.92 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.979 1.712 . . . . 1.0 109.331 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -34.41 134.2 0.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.759 2.824 . . . . 1.0 112.764 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.77 178.71 39.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.965 -2.054 . . . . 1.0 107.965 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -93.61 178.59 5.64 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.3 -18.51 71.46 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.582 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.54 70.97 1.82 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.996 0.919 . . . . 1.0 108.797 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.14 112.71 7.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.78 -1.563 . . . . 1.0 106.78 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.34 162.96 16.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.513 1.525 . . . . 1.0 107.072 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -106.55 -9.39 16.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.341 -1.299 . . . . 1.0 114.459 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 p -162.45 161.76 27.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.396 0.617 . . . . 1.0 109.964 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 23.0 tpt85 -60.95 -40.35 92.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.528 0.731 . . . . 1.0 110.464 174.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -66.8 0.41 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.932 2.493 . . . . 1.0 110.655 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 p -56.54 -33.87 66.51 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.647 0.592 . . . . 1.0 111.702 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.81 -51.92 23.79 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.281 13.9 mt-10 -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 116.052 -2.259 . . . . 1.0 112.825 173.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.258 8.2 t70 -65.95 -23.17 66.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 118.986 -1.086 . . . . 1.0 109.004 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.11 2.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.152 -1.593 . . . . 1.0 106.855 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.7 m . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.604 . . . . 1.0 110.901 -178.834 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 119.213 -0.422 . . . . 1.0 110.283 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -23.84 67.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.186 0.903 . . . . 1.0 112.696 -174.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.31 -30.93 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.147 0.979 . . . . 1.0 109.87 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.07 130.69 94.38 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 125.256 1.423 . . . . 1.0 112.732 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 153.62 5.88 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.499 2.799 . . . . 1.0 113.183 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.72 143.73 29.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.846 -1.07 . . . . 1.0 108.663 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.93 147.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -78.04 -53.42 7.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.259 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 176.49 15.7 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.085 1.326 . . . . 1.0 110.095 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.71 -35.24 4.72 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.923 2.415 . . . . 1.0 111.865 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.0 m -71.93 160.91 31.73 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 121.901 0.858 . . . . 1.0 111.006 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.94 3.77 19.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.854 1.662 . . . . 1.0 114.218 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.64 157.21 53.52 Favored Glycine 0 CA--C 1.538 1.476 1 N-CA-C 102.347 -4.301 . . . . 1.0 102.347 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -130.3 125.59 35.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.315 2.557 . . . . 1.0 108.742 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.515 ' CD ' HH12 ' A' ' 25' ' ' ARG . 5.7 tp10 -131.33 113.99 15.85 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 129.187 2.995 . . . . 1.0 107.076 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.62 133.59 32.51 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.734 2.956 . . . . 1.0 110.502 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.515 HH12 ' CD ' ' A' ' 23' ' ' GLU . 86.8 mmt-85 -133.09 177.29 7.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.608 -1.178 . . . . 1.0 108.85 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.4 m95 -126.11 143.48 51.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.526 2.33 . . . . 1.0 105.591 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.74 144.08 41.5 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.722 1.209 . . . . 1.0 107.838 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -81.24 137.59 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.78 0.8 . . . . 1.0 109.14 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 m -117.44 113.66 38.62 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 126.136 1.774 . . . . 1.0 107.578 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.86 -33.7 19.71 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.888 1.725 . . . . 1.0 110.88 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.78 -14.38 58.78 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.725 1.21 . . . . 1.0 112.348 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -113.4 -4.31 13.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.978 1.311 . . . . 1.0 110.549 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.09 36.83 2.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.163 2.585 . . . . 1.0 110.043 -173.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.68 172.13 14.68 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.373 -0.829 . . . . 1.0 108.918 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -104.94 143.01 33.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.4 0.68 . . . . 1.0 110.111 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -123.77 153.72 66.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.727 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -70.74 168.65 22.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.525 1.483 . . . . 1.0 110.027 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -163.11 163.91 25.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.66 113.5 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.927 -1.879 . . . . 1.0 105.927 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -99.85 163.22 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.622 1.969 . . . . 1.0 106.829 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.17 4.5 52.04 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.326 0.89 . . . . 1.0 115.326 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.59 -36.86 2.05 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.597 1.57 . . . . 1.0 113.832 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.7 p -87.99 -172.87 4.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.716 1.606 . . . . 1.0 107.927 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.62 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.649 2.38 . . . . 1.0 113.158 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.71 29.74 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.918 -2.073 . . . . 1.0 107.918 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.37 174.66 7.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.336 1.068 . . . . 1.0 109.712 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 -15.69 80.51 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.55 1.071 . . . . 1.0 114.179 -173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -78.41 70.24 4.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -138.1 113.12 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.616 1.166 . . . . 1.0 108.306 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.24 151.94 48.68 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.682 1.193 . . . . 1.0 108.28 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -93.15 -7.94 43.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.408 -0.807 . . . . 1.0 110.026 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -158.71 162.61 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.889 0.768 . . . . 1.0 111.108 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 26.1 ttp85 -65.26 -49.43 69.61 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.391 -0.822 . . . . 1.0 112.256 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -58.95 -48.27 82.13 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.56 0.537 . . . . 1.0 110.718 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 p -51.1 -38.85 54.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.7 t -73.99 -48.43 30.37 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.88 1.272 . . . . 1.0 110.067 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.34 -33.47 71.19 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.16 -31.69 62.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.385 -1.447 . . . . 1.0 109.407 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.89 -59.15 3.51 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.971 0.794 . . . . 1.0 110.658 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 1.0 108.397 175.447 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 119.265 -0.398 . . . . 1.0 111.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 p -48.53 -29.76 4.54 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.256 0.935 . . . . 1.0 113.479 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.08 -27.06 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.178 0.899 . . . . 1.0 111.332 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.51 152.91 61.3 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 127.682 2.393 . . . . 1.0 110.938 -176.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.83 161.31 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.721 2.947 . . . . 1.0 113.158 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.99 113.61 11.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.01 115.15 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 107.436 -1.32 . . . . 1.0 107.436 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.74 -24.44 44.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.951 -1.477 . . . . 1.0 110.952 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.55 173.96 50.06 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.201 0.905 . . . . 1.0 111.263 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.06 -5.94 7.55 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.396 2.731 . . . . 1.0 114.631 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.3 m -73.74 -178.21 3.08 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 3.7 4.65 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.827 1.651 . . . . 1.0 113.423 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.88 154.32 22.46 Favored Glycine 0 CA--C 1.533 1.184 1 N-CA-C 100.652 -4.979 . . . . 1.0 100.652 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -132.55 122.59 25.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 120.968 2.384 . . . . 1.0 108.795 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -125.14 113.82 26.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.908 3.283 . . . . 1.0 106.847 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.13 126.82 14.95 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.521 2.814 . . . . 1.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -131.72 178.4 6.78 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.036 0.934 . . . . 1.0 109.361 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.522 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -117.59 144.43 45.15 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.443 1.097 . . . . 1.0 108.144 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.12 148.04 37.69 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.079 -0.711 . . . . 1.0 109.079 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -82.83 139.38 33.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 174.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m -117.11 113.42 39.37 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 117.213 -1.375 . . . . 1.0 107.619 173.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.43 -32.26 25.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.75 1.634 . . . . 1.0 110.239 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.3 -15.01 59.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.923 1.289 . . . . 1.0 112.471 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 mt -115.23 -4.2 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.094 1.358 . . . . 1.0 110.805 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.0 35.44 3.35 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.388 2.675 . . . . 1.0 110.042 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -162.51 168.68 21.54 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.563 -0.71 . . . . 1.0 109.707 -173.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -95.6 149.58 21.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.963 0.887 . . . . 1.0 112.114 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -139.85 154.5 70.82 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.624 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -69.78 161.82 44.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 107.971 -1.588 . . . . 1.0 107.971 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -159.04 170.7 21.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.081 0.855 . . . . 1.0 109.031 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.43 113.8 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 106.609 -1.626 . . . . 1.0 106.609 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.63 158.02 16.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.43 0.39 58.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 116.677 1.431 . . . . 1.0 116.677 -173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.65 3.41 54.51 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.224 1.512 . . . . 1.0 114.857 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 p -125.11 -172.46 2.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 128.717 2.807 . . . . 1.0 108.073 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -33.37 133.54 0.16 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.533 1.933 . . . . 1.0 113.001 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.26 168.09 40.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.814 -2.114 . . . . 1.0 107.814 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.99 -174.17 3.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.089 0.947 . . . . 1.0 109.06 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.72 -7.04 88.98 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 116.927 -2.041 . . . . 1.0 113.774 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -81.98 66.47 7.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 121.761 2.78 . . . . 1.0 107.607 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -147.08 113.66 6.0 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 130.81 3.644 . . . . 1.0 102.25 -173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -123.71 162.17 23.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.343 1.457 . . . . 1.0 107.747 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -93.07 -14.55 27.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.112 -1.403 . . . . 1.0 111.157 -173.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p -167.72 169.17 11.95 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.76 0.791 . . . . 1.0 109.996 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.0 tpt180 -61.4 -44.75 96.6 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -47.83 -66.51 0.39 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.231 2.612 . . . . 1.0 111.659 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.4 p -59.11 -33.46 70.87 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.046 0.927 . . . . 1.0 112.58 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -71.61 -49.95 35.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.044 0.938 . . . . 1.0 112.491 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.337 27.7 mt-10 -67.19 -32.94 74.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.02 -47.27 78.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 1.0 106.107 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.87 -58.44 8.59 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 118.686 0.675 . . . . 1.0 111.871 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.452 -0.363 0 O-C-N 123.737 0.648 . . . . 1.0 110.506 -174.649 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 119.036 -0.507 . . . . 1.0 111.1 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -69.02 -15.62 63.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.059 1.3 . . . . 1.0 111.747 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.02 -21.77 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.418 1.087 . . . . 1.0 111.129 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 148.67 88.62 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 127.261 2.224 . . . . 1.0 110.819 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.85 179.04 4.6 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.266 1.977 . . . . 1.0 111.034 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -120.41 161.6 20.94 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.14 152.97 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.653 1.181 . . . . 1.0 109.217 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -88.04 -31.47 19.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.343 1.457 . . . . 1.0 113.201 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 176.94 51.44 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.199 0.904 . . . . 1.0 112.404 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.88 -25.47 27.98 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.293 2.662 . . . . 1.0 112.842 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.56 158.85 25.98 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.206 -0.934 . . . . 1.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 3.53 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.685 1.594 . . . . 1.0 112.985 173.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.42 153.23 38.79 Favored Glycine 0 CA--C 1.531 1.044 1 N-CA-C 102.123 -4.391 . . . . 1.0 102.123 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.91 105.37 8.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.621 1.711 . . . . 1.0 111.022 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.02 114.01 62.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.426 2.29 . . . . 1.0 105.629 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 114.1 3.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.536 2.824 . . . . 1.0 109.747 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -114.78 176.94 4.83 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.361 0.664 . . . . 1.0 109.372 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 63.1 m95 -114.19 145.37 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.34 144.91 40.56 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.24 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.717 0.807 . . . . 1.0 110.009 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -117.43 113.36 38.78 Favored Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 120.684 -1.26 . . . . 1.0 108.034 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.09 -34.36 6.38 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.573 1.515 . . . . 1.0 109.665 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -65.03 -20.57 66.56 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 124.324 1.05 . . . . 1.0 112.355 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.34 -6.02 23.54 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.405 0.682 . . . . 1.0 110.223 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.88 38.47 6.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.278 2.631 . . . . 1.0 108.412 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.7 166.82 28.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.2 148.8 24.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.324 1.059 . . . . 1.0 110.699 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -132.35 152.18 79.61 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.592 -1.186 . . . . 1.0 109.577 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -68.9 166.31 26.91 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -155.59 164.09 39.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.15 123.81 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.455 -1.683 . . . . 1.0 106.455 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -122.49 168.84 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.409 1.884 . . . . 1.0 106.331 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.63 8.11 6.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.899 -0.945 . . . . 1.0 115.027 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.97 -48.31 4.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.29 1.545 . . . . 1.0 110.289 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 p -69.05 -173.39 0.5 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.635 1.174 . . . . 1.0 109.4 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -34.77 133.57 0.27 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.697 1.999 . . . . 1.0 114.261 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.7 173.49 39.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.756 -2.538 . . . . 1.0 106.756 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -93.65 171.24 9.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.63 -6.82 63.58 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.44 1.019 . . . . 1.0 114.356 -173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -80.13 68.15 6.18 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -135.96 113.05 10.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.152 -1.796 . . . . 1.0 106.152 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.34 161.5 18.42 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 123.211 1.482 . . . . 1.0 108.382 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.1 -21.03 19.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.016 -2.356 . . . . 1.0 109.732 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -164.51 165.23 21.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.624 0.726 . . . . 1.0 109.117 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.56 -49.22 78.4 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.839 -1.073 . . . . 1.0 108.833 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.89 -66.85 0.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 128.004 2.521 . . . . 1.0 111.638 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -57.13 -33.27 67.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 t -67.51 -53.61 27.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.99 0.916 . . . . 1.0 112.908 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -33.27 75.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.526 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.84 -24.2 55.78 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.259 -0.877 . . . . 1.0 110.692 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.96 70.15 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 120.564 1.529 . . . . 1.0 111.634 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.239 0.541 0 CA-C-N 118.702 0.683 . . . . 1.0 112.8 173.708 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 119.194 -0.432 . . . . 1.0 110.205 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 p -62.81 -28.93 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.476 0.711 . . . . 1.0 111.924 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.32 -28.08 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.2 tp -69.2 125.43 91.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 126.946 2.098 . . . . 1.0 112.412 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.91 154.71 4.83 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.579 2.852 . . . . 1.0 112.764 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.71 160.98 27.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.844 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -135.01 148.78 28.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 126.307 1.843 . . . . 1.0 106.226 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -74.0 -56.39 4.99 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.08 171.7 15.44 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.891 2.186 . . . . 1.0 108.682 -173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.11 -35.69 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.425 2.083 . . . . 1.0 111.375 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.5 158.64 23.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.952 0.882 . . . . 1.0 110.788 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 3.94 22.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.807 2.043 . . . . 1.0 113.701 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.7 154.13 50.96 Favored Glycine 0 CA--C 1.535 1.331 1 N-CA-C 102.85 -4.1 . . . . 1.0 102.85 172.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -125.2 104.86 8.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 120.526 2.163 . . . . 1.0 110.864 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -99.27 119.21 61.04 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 127.468 2.307 . . . . 1.0 107.168 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.59 125.65 10.24 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.11 2.54 . . . . 1.0 109.933 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -130.27 177.11 7.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.36 -0.837 . . . . 1.0 109.533 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.53 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -112.66 141.2 46.72 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.93 0.892 . . . . 1.0 108.619 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.37 147.52 45.57 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.07 133.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.792 0.682 . . . . 1.0 110.145 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -117.59 113.42 38.45 Favored Pre-proline 0 N--CA 1.445 -0.702 0 O-C-N 119.854 -1.779 . . . . 1.0 109.075 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.14 -35.11 20.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.752 1.635 . . . . 1.0 109.982 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.83 -19.71 65.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.62 1.168 . . . . 1.0 112.151 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -103.04 -4.15 24.98 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.364 1.066 . . . . 1.0 110.078 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.63 29.98 8.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.493 2.717 . . . . 1.0 110.749 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -165.04 166.66 19.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.96 0.8 . . . . 1.0 109.861 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.01 147.36 22.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.029 0.918 . . . . 1.0 109.459 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -142.7 153.74 61.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.625 0.77 . . . . 1.0 111.132 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.43 160.08 44.5 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.815 1.677 . . . . 1.0 108.534 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -153.59 160.34 42.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.622 1.101 . . . . 1.0 108.776 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.12 113.62 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.942 -1.874 . . . . 1.0 105.942 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -107.63 167.68 9.78 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.229 2.212 . . . . 1.0 106.457 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.77 9.39 10.59 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.15 0.82 . . . . 1.0 115.15 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.26 -39.66 2.3 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.276 1.417 . . . . 1.0 113.241 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.17 -172.98 3.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.584 1.154 . . . . 1.0 108.41 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.7 mp0 -33.99 133.94 0.19 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.047 2.539 . . . . 1.0 112.838 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.23 -167.22 23.33 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 107.453 -2.259 . . . . 1.0 107.453 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.31 173.56 7.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.462 1.131 . . . . 1.0 108.172 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.87 -15.19 81.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.359 -0.837 . . . . 1.0 112.547 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -74.92 79.73 2.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.872 0.869 . . . . 1.0 108.675 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -146.57 113.09 5.96 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.915 -1.883 . . . . 1.0 105.915 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.32 162.33 19.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.499 1.52 . . . . 1.0 108.351 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -93.49 -19.43 21.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.145 -1.388 . . . . 1.0 112.381 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 p -162.73 169.34 20.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 1.0 109.561 -173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.7 tpt180 -61.81 -49.32 76.77 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.06 -0.973 . . . . 1.0 108.507 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.12 -66.61 0.38 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.508 2.723 . . . . 1.0 112.123 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 p -60.35 -33.25 72.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.734 0.646 . . . . 1.0 112.229 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.41 -51.84 39.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 112.694 0.627 . . . . 1.0 112.694 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.286 71.5 mt-10 -69.76 -33.28 72.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.144 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.06 -35.28 80.1 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.48 -50.74 34.83 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 120.164 1.347 . . . . 1.0 111.674 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 116.087 1.884 . . . . 1.0 116.087 -173.136 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.521 0 N-CA-C 112.283 0.475 . . . . 1.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -46.86 -25.44 0.77 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.874 -1.141 . . . . 1.0 113.482 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.85 -33.0 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 119.403 1.002 . . . . 1.0 111.916 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 152.87 93.12 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 128.406 2.682 . . . . 1.0 109.013 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.06 173.15 10.76 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.742 . . . . 1.0 111.598 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.31 113.58 7.61 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.627 -1.249 . . . . 1.0 107.627 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.69 123.94 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.008 -1.479 . . . . 1.0 107.008 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -79.33 -33.41 43.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.257 -1.338 . . . . 1.0 110.737 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.84 172.66 42.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.74 -8.55 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.024 2.483 . . . . 1.0 114.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.55 -179.5 5.29 Favored 'General case' 0 N--CA 1.461 0.095 0 O-C-N 120.952 -1.093 . . . . 1.0 113.57 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.27 3.81 4.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.307 1.443 . . . . 1.0 113.576 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.79 157.12 29.48 Favored Glycine 0 CA--C 1.533 1.214 1 N-CA-C 101.301 -4.72 . . . . 1.0 101.301 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -131.44 117.88 19.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 121.333 2.567 . . . . 1.0 108.869 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.16 113.94 29.46 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 129.323 3.049 . . . . 1.0 107.77 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.55 125.44 13.33 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.559 2.839 . . . . 1.0 111.203 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -131.56 -179.99 5.7 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.403 1.081 . . . . 1.0 109.846 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 55.1 m95 -117.35 141.4 48.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.797 0.839 . . . . 1.0 108.751 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.86 148.44 48.64 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.87 143.69 29.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.666 0.746 . . . . 1.0 109.01 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 113.28 39.35 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 105.498 -2.038 . . . . 1.0 105.498 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.41 -32.41 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.747 1.631 . . . . 1.0 110.656 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.01 -17.1 64.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.793 0.837 . . . . 1.0 112.299 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.96 -4.29 16.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 1.0 110.546 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.78 35.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.64 3.176 . . . . 1.0 108.45 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -162.75 170.88 17.64 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 121.139 -0.976 . . . . 1.0 110.185 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -100.85 145.08 29.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.938 1.695 . . . . 1.0 111.738 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -138.48 153.6 72.77 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.887 0.875 . . . . 1.0 110.689 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.48 163.32 24.29 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.492 2.128 . . . . 1.0 110.483 173.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.0 168.26 27.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.19 113.72 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -99.36 163.82 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.561 1.944 . . . . 1.0 105.809 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.77 1.48 41.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 116.459 1.344 . . . . 1.0 116.459 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.5 1.96 67.13 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 118.963 1.382 . . . . 1.0 115.456 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.2 p -125.53 -172.65 2.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.699 2.4 . . . . 1.0 108.074 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -33.26 133.52 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.827 2.051 . . . . 1.0 112.839 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.2 42.27 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -93.81 -174.11 3.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.172 0.987 . . . . 1.0 109.773 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.4 -7.61 88.09 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 127.764 2.602 . . . . 1.0 113.591 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -86.3 53.16 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.442 2.121 . . . . 1.0 106.911 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -131.47 112.73 12.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 101.902 -3.37 . . . . 1.0 101.902 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -108.85 156.15 19.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.12 -13.46 28.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.461 -2.154 . . . . 1.0 112.137 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -166.48 169.33 13.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.694 1.198 . . . . 1.0 109.131 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -64.5 -42.93 95.54 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -48.97 -66.34 0.42 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.689 2.796 . . . . 1.0 111.318 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.8 p -58.47 -36.07 73.14 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.95 0.781 . . . . 1.0 111.495 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 39.1 t -66.61 -52.99 39.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.5 0.72 . . . . 1.0 112.35 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.39 -33.41 72.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.471 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.42 -29.48 61.52 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.663 1.119 . . . . 1.0 111.563 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -61.64 1.69 Allowed 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.372 0.987 . . . . 1.0 110.15 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 124.693 1.197 . . . . 1.0 108.336 177.655 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 118.258 -0.877 . . . . 1.0 111.774 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -21.0 66.01 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.302 1.41 . . . . 1.0 111.566 -174.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.3 t -74.2 -36.71 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.931 -1.105 . . . . 1.0 110.252 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 tp -70.29 129.98 89.89 Favored Pre-proline 0 N--CA 1.455 -0.176 0 C-N-CA 127.229 2.212 . . . . 1.0 113.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.01 153.73 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.008 2.472 . . . . 1.0 111.403 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.97 166.82 16.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.315 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.93 146.3 30.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.403 -2.073 . . . . 1.0 105.403 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -97.53 -24.37 15.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.259 1.024 . . . . 1.0 112.242 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.08 45.82 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.999 1.761 . . . . 1.0 112.014 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.81 -3.43 13.85 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.609 3.539 . . . . 1.0 115.032 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.3 m -61.05 178.56 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.712 1.605 . . . . 1.0 113.298 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 3.65 3.98 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.233 1.413 . . . . 1.0 113.201 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.04 153.39 20.55 Favored Glycine 0 CA--C 1.529 0.945 1 N-CA-C 101.974 -4.45 . . . . 1.0 101.974 172.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -130.06 105.79 8.19 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.245 1.523 . . . . 1.0 111.324 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.01 114.84 64.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 129.153 2.981 . . . . 1.0 106.638 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.73 122.18 8.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.395 2.73 . . . . 1.0 109.549 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -123.28 179.57 4.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.593 0.757 . . . . 1.0 108.976 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -125.13 144.35 50.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.506 1.122 . . . . 1.0 108.436 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.57 141.33 35.22 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -77.14 137.73 39.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -117.3 113.66 38.89 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 117.463 -1.256 . . . . 1.0 108.006 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.26 -33.72 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.953 1.769 . . . . 1.0 110.805 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.66 -20.32 66.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.048 0.939 . . . . 1.0 112.37 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.66 -4.06 22.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.842 1.257 . . . . 1.0 110.479 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.65 16.85 2.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 128.416 2.686 . . . . 1.0 111.721 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -164.13 172.17 14.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.979 1.263 . . . . 1.0 110.525 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -87.75 148.82 24.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -133.9 155.9 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.989 1.316 . . . . 1.0 109.953 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.38 165.88 31.06 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.982 1.788 . . . . 1.0 109.237 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -158.6 165.69 33.87 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.7 t -89.05 129.96 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.793 -1.558 . . . . 1.0 106.793 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -132.46 170.13 15.57 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.492 1.517 . . . . 1.0 107.163 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.26 -3.18 8.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.946 1.538 . . . . 1.0 116.946 -173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.56 -29.92 6.42 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.826 1.813 . . . . 1.0 111.838 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -73.34 -173.2 1.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.383 1.873 . . . . 1.0 109.649 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -34.14 134.04 0.2 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.52 2.728 . . . . 1.0 112.983 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.93 175.86 41.44 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.271 -1.932 . . . . 1.0 108.271 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -93.62 177.55 5.98 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.89 76.15 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.511 -0.768 . . . . 1.0 112.825 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -78.99 70.2 5.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.372 1.086 . . . . 1.0 108.4 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -144.42 113.07 6.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -119.76 162.03 19.75 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.227 1.411 . . . . 1.0 108.785 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -93.33 -14.16 27.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.591 -1.186 . . . . 1.0 112.032 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -166.24 170.7 12.97 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.54 0.686 . . . . 1.0 109.222 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -62.81 -46.32 88.49 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -66.87 0.32 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 128.796 2.838 . . . . 1.0 111.079 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -54.57 -33.26 59.94 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.7 t -72.62 -49.42 32.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.448 -0.782 . . . . 1.0 112.793 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.19 -33.74 76.48 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 118.515 -0.755 . . . . 1.0 109.883 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.87 -41.41 97.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.813 0.845 . . . . 1.0 110.113 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.25 -42.01 76.18 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 118.709 0.686 . . . . 1.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.238 0.477 0 C-N-CA 123.619 0.768 . . . . 1.0 110.855 174.659 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 118.63 -0.7 . . . . 1.0 111.813 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -22.67 61.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.528 1.513 . . . . 1.0 112.746 -173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.47 -37.87 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.11 0.868 . . . . 1.0 110.754 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 147.09 87.03 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.746 2.018 . . . . 1.0 112.832 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.09 158.08 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.063 3.175 . . . . 1.0 113.019 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.89 113.39 13.32 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.343 -1.473 . . . . 1.0 108.053 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.88 129.35 44.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -79.12 -35.12 42.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.938 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.51 171.98 37.95 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.95 -40.72 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.259 1.973 . . . . 1.0 112.849 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.5 m -68.12 159.32 31.2 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 121.34 -0.85 . . . . 1.0 111.877 -174.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 3.92 24.84 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.978 2.111 . . . . 1.0 114.279 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.41 165.48 46.8 Favored Glycine 0 CA--C 1.544 1.901 1 N-CA-C 102.49 -4.244 . . . . 1.0 102.49 172.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -136.95 135.88 38.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 123.444 3.622 . . . . 1.0 110.943 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -135.91 121.05 13.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 131.221 3.808 . . . . 1.0 107.237 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 128.15 16.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.377 2.718 . . . . 1.0 109.582 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -130.67 -179.01 5.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.428 1.091 . . . . 1.0 108.506 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.524 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.0 m95 -129.83 145.31 51.58 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 127.29 2.236 . . . . 1.0 106.613 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.08 145.64 30.62 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -80.72 138.48 36.33 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.548 0.689 . . . . 1.0 109.628 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -117.31 113.68 38.85 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 116.723 -1.608 . . . . 1.0 106.798 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.67 -33.28 28.44 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.855 1.704 . . . . 1.0 110.077 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.82 -15.62 62.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.761 1.224 . . . . 1.0 112.568 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.2 mt -112.35 -4.0 14.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.414 1.486 . . . . 1.0 110.498 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.64 26.94 2.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.333 3.053 . . . . 1.0 111.843 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -164.85 167.89 18.29 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.05 -1.031 . . . . 1.0 110.134 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.4 m -84.39 144.95 28.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.751 0.786 . . . . 1.0 112.396 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.46 155.12 81.9 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.058 1.343 . . . . 1.0 109.62 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.92 167.37 27.5 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.745 1.63 . . . . 1.0 108.739 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -161.84 166.32 26.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.36 113.47 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.239 -2.134 . . . . 1.0 105.239 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.441 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 14.0 t80 -98.9 156.33 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.559 1.944 . . . . 1.0 107.005 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.19 1.27 73.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 115.351 0.9 . . . . 1.0 115.351 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.441 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 80.44 -38.22 2.26 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.51 1.529 . . . . 1.0 114.21 174.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.6 p -80.91 -173.2 4.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 1.0 109.432 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.82 133.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.317 2.647 . . . . 1.0 113.261 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.88 -179.68 39.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.881 -1.688 . . . . 1.0 108.881 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.64 -175.05 3.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.711 0.767 . . . . 1.0 110.486 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.22 -19.76 79.47 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.742 -1.588 . . . . 1.0 115.498 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -79.99 70.87 6.65 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.605 2.203 . . . . 1.0 108.227 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -149.4 113.3 5.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 -173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -125.53 156.07 39.61 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.127 1.771 . . . . 1.0 107.689 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -93.58 -10.12 35.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 1.0 111.969 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.76 158.09 43.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 120.162 1.346 . . . . 1.0 111.319 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -61.72 -45.99 91.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.39 -1.277 . . . . 1.0 109.426 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.36 -66.57 0.38 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.042 2.537 . . . . 1.0 112.369 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.4 p -57.99 -41.27 82.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.011 0.819 . . . . 1.0 110.861 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.55 -48.32 72.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.946 0.898 . . . . 1.0 112.137 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.52 -34.04 77.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 117.503 -1.237 . . . . 1.0 110.886 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.76 -29.75 70.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.406 1.912 . . . . 1.0 111.1 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -63.5 1.05 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-N 119.49 1.041 . . . . 1.0 108.398 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 1.0 110.216 -178.079 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.419 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.15 68.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.976 0.807 . . . . 1.0 112.291 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.08 -34.55 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.039 0.936 . . . . 1.0 109.843 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.68 129.24 94.23 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 125.672 1.589 . . . . 1.0 113.169 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.6 159.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.597 2.865 . . . . 1.0 111.859 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.17 113.72 25.76 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.118 -0.989 . . . . 1.0 109.599 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.77 145.88 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.3 -23.96 18.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.066 1.347 . . . . 1.0 111.59 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.12 168.86 34.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.085 1.326 . . . . 1.0 115.189 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.17 -28.23 2.05 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.844 3.029 . . . . 1.0 113.221 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 m -72.7 165.38 24.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.035 0.834 . . . . 1.0 110.728 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.85 3.78 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.11 1.152 . . . . 1.0 114.11 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 154.27 37.47 Favored Glycine 0 CA--C 1.534 1.25 1 N-CA-C 101.892 -4.483 . . . . 1.0 101.892 172.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -136.16 129.77 32.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.711 2.255 . . . . 1.0 108.379 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' CD ' HH12 ' A' ' 25' ' ' ARG . 5.7 tp10 -131.08 113.98 16.16 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 129.679 3.192 . . . . 1.0 105.744 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.93 129.34 20.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.287 2.658 . . . . 1.0 109.925 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.413 HH12 ' CD ' ' A' ' 23' ' ' GLU . 87.3 mmt-85 -130.46 176.19 8.35 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.736 -1.12 . . . . 1.0 108.639 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.569 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 62.8 m95 -129.83 139.15 51.27 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.972 -1.862 . . . . 1.0 105.972 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.91 145.31 41.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -81.69 139.09 35.12 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.728 0.775 . . . . 1.0 110.811 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -117.44 113.59 38.64 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.114 -1.422 . . . . 1.0 107.328 172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.82 -34.33 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.977 1.785 . . . . 1.0 110.832 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.6 -20.67 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.142 0.977 . . . . 1.0 112.42 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -103.1 -5.39 23.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.731 1.212 . . . . 1.0 110.61 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 48.95 29.88 2.54 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 130.74 3.616 . . . . 1.0 110.065 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -165.47 168.33 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.378 -0.826 . . . . 1.0 109.187 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.5 m -90.79 147.72 23.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -126.43 156.06 73.39 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.743 1.217 . . . . 1.0 109.47 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -72.85 168.67 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.589 1.526 . . . . 1.0 109.252 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -159.54 165.34 33.13 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.64 113.93 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.053 -2.202 . . . . 1.0 105.053 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -106.55 145.92 31.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.458 -1.682 . . . . 1.0 106.458 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.07 3.31 85.75 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.109 -0.828 . . . . 1.0 114.667 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.99 -49.08 3.43 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.983 1.278 . . . . 1.0 110.058 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.6 p -72.58 -172.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.396 1.478 . . . . 1.0 108.44 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -33.05 133.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.269 2.228 . . . . 1.0 114.46 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.21 177.58 44.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 128.299 2.857 . . . . 1.0 106.861 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -93.73 177.02 6.14 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.276 1.038 . . . . 1.0 109.906 -174.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.22 82.43 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.845 -1.071 . . . . 1.0 113.504 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.34 72.11 3.07 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -135.37 112.95 10.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.94 149.69 43.93 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.51 -8.52 41.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 118.531 -0.747 . . . . 1.0 110.76 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -155.34 158.94 39.51 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.083 0.856 . . . . 1.0 112.249 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.569 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -57.19 -56.98 14.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.839 1.656 . . . . 1.0 111.661 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.16 -47.53 82.28 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.057 0.848 . . . . 1.0 111.72 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.7 p -53.68 -35.3 60.92 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.83 -48.43 21.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.55 -34.02 73.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.397 -0.811 . . . . 1.0 111.346 174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.96 -27.07 49.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.217 1.371 . . . . 1.0 110.665 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.03 1.14 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.986 1.267 . . . . 1.0 109.174 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 124.967 1.307 . . . . 1.0 107.894 176.418 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.375 0 N-CA-C 110.634 -0.136 . . . . 1.0 110.634 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -66.61 -14.97 63.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.934 0.893 . . . . 1.0 113.38 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.18 -28.94 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.265 1.026 . . . . 1.0 109.517 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -71.05 131.8 86.94 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.227 2.211 . . . . 1.0 113.013 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.51 157.73 4.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.646 2.897 . . . . 1.0 113.139 173.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.22 164.46 24.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.663 0.785 . . . . 1.0 110.433 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.35 151.43 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.036 1.734 . . . . 1.0 106.405 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -99.38 -27.55 13.7 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.001 0.92 . . . . 1.0 113.442 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.6 171.05 46.83 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.989 -1.645 . . . . 1.0 108.989 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.85 -27.01 37.73 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.734 2.289 . . . . 1.0 112.504 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.72 155.37 38.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.085 0.954 . . . . 1.0 109.562 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.09 3.97 19.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.487 1.915 . . . . 1.0 113.962 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.03 157.48 48.85 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 103.639 -3.785 . . . . 1.0 103.639 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -132.76 108.36 8.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 121.541 2.671 . . . . 1.0 115.102 -173.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' CD ' ' HE ' ' A' ' 25' ' ' ARG . 75.7 tt0 -106.04 126.21 31.18 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -71.09 113.72 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.404 2.069 . . . . 1.0 108.142 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.495 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 25.6 mmt85 -107.92 178.87 4.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.691 -1.225 . . . . 1.0 107.691 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.503 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -133.22 143.61 49.25 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.825 1.65 . . . . 1.0 107.724 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.32 149.36 37.67 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.82 0.848 . . . . 1.0 109.063 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -83.63 141.47 31.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.195 0.998 . . . . 1.0 110.818 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.2 m -117.34 113.29 38.98 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 106.08 -1.822 . . . . 1.0 106.08 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.14 -32.18 21.71 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.631 1.554 . . . . 1.0 110.219 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.65 -15.34 61.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 1.0 112.367 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 mt -112.7 -4.57 14.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.823 1.249 . . . . 1.0 110.521 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.93 36.66 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.276 2.63 . . . . 1.0 109.821 -173.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -164.85 169.01 17.13 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.738 -0.601 . . . . 1.0 109.576 -173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -95.31 150.84 19.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.498 1.142 . . . . 1.0 112.883 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -135.04 155.66 78.94 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.725 1.21 . . . . 1.0 109.682 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.59 169.51 21.67 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.938 1.759 . . . . 1.0 110.229 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -162.56 175.22 11.66 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.538 1.935 . . . . 1.0 106.722 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.1 126.58 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.021 -1.474 . . . . 1.0 107.021 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.77 160.1 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.033 2.533 . . . . 1.0 110.015 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.72 19.32 11.37 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 118.104 2.002 . . . . 1.0 118.104 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 -46.81 3.34 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 119.807 1.803 . . . . 1.0 112.321 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 p -65.9 -173.14 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.686 1.595 . . . . 1.0 110.541 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.3 mp0 -33.54 133.85 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 129.394 3.078 . . . . 1.0 114.365 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.81 174.85 35.17 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.159 -1.976 . . . . 1.0 108.159 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.59 -177.62 4.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 -23.72 76.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.333 0.492 . . . . 1.0 112.341 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.71 69.08 4.83 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.032 0.916 . . . . 1.0 108.81 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -152.14 113.14 4.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.07 156.72 42.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.5 1.52 . . . . 1.0 109.206 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -93.46 -8.21 42.26 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.424 -0.798 . . . . 1.0 110.68 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 p -157.14 166.07 34.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.025 0.829 . . . . 1.0 109.897 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.9 tpt180 -60.28 -47.38 86.27 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 173.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -44.66 -66.56 0.38 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 128.284 2.634 . . . . 1.0 112.474 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 p -60.65 -36.04 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.626 0.579 . . . . 1.0 111.91 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.39 -47.71 63.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.283 0.633 . . . . 1.0 111.715 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.57 -32.91 74.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.176 0.991 . . . . 1.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.58 -40.18 70.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 117.737 -1.125 . . . . 1.0 110.001 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -59.18 5.09 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.819 1.19 . . . . 1.0 110.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 125.087 1.355 . . . . 1.0 108.307 173.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 117.945 -1.026 . . . . 1.0 112.417 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 p -55.22 -31.51 61.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.174 1.352 . . . . 1.0 112.518 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.79 -34.3 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.307 -0.87 . . . . 1.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.7 129.14 91.2 Favored Pre-proline 0 CA--C 1.522 -0.124 0 C-N-CA 125.276 1.43 . . . . 1.0 113.045 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.93 151.36 8.58 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.316 2.678 . . . . 1.0 112.164 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.5 23.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.576 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.48 139.98 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 104.689 -2.337 . . . . 1.0 104.689 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.61 -58.29 3.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.28 171.66 12.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.729 1.633 . . . . 1.0 109.979 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.9 -12.22 14.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.973 2.449 . . . . 1.0 112.802 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.66 176.21 6.43 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 122.34 1.067 . . . . 1.0 112.373 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.26 3.69 8.5 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.603 -1.18 . . . . 1.0 112.479 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.29 154.28 21.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 103.176 -3.97 . . . . 1.0 103.176 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -132.19 119.9 21.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.478 1.639 . . . . 1.0 108.377 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -120.2 113.75 33.82 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 129.551 3.14 . . . . 1.0 106.584 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.04 124.28 11.22 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.183 2.589 . . . . 1.0 110.835 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -129.4 178.32 6.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.958 0.903 . . . . 1.0 109.34 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.7 m95 -120.07 141.17 50.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.554 1.142 . . . . 1.0 107.994 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.25 146.7 51.67 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -84.56 136.14 33.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.6 m -117.23 113.94 38.89 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 120.35 -1.469 . . . . 1.0 109.11 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.72 -36.52 18.68 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.208 1.939 . . . . 1.0 110.634 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 mt -61.98 -23.32 66.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.793 1.237 . . . . 1.0 113.083 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 mt -102.85 -4.36 24.97 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.165 0.986 . . . . 1.0 110.801 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.08 36.13 1.91 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.985 2.914 . . . . 1.0 109.995 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.16 169.88 17.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.352 -0.842 . . . . 1.0 109.074 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.2 m -98.77 146.32 26.03 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.88 -0.512 . . . . 1.0 111.164 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -132.73 154.09 81.33 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.253 1.021 . . . . 1.0 110.194 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.17 165.9 30.94 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.482 -1.391 . . . . 1.0 108.482 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -157.68 161.59 38.58 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.366 -0.975 . . . . 1.0 108.366 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 t -86.24 113.82 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.579 -2.008 . . . . 1.0 105.579 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.41 159.06 15.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.223 -2.14 . . . . 1.0 105.223 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.44 1.25 49.83 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.854 -1.154 . . . . 1.0 115.611 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 -8.47 13.24 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.776 1.288 . . . . 1.0 115.06 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.23 -172.53 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.076 2.95 . . . . 1.0 107.252 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -33.47 133.64 0.16 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.741 2.017 . . . . 1.0 112.809 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -174.84 38.78 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.185 -2.366 . . . . 1.0 107.185 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -93.41 174.92 6.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.784 1.292 . . . . 1.0 108.883 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.07 84.83 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 114.574 -1.193 . . . . 1.0 112.644 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -76.54 73.12 3.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.648 -1.241 . . . . 1.0 107.648 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -138.23 112.92 8.94 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.128 -1.804 . . . . 1.0 106.128 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.06 158.26 24.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 123.618 1.675 . . . . 1.0 107.132 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -93.3 -16.47 24.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.754 -2.021 . . . . 1.0 111.602 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -166.05 164.44 18.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.976 0.893 . . . . 1.0 109.145 -173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.1 tpt180 -60.27 -47.94 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.476 -1.238 . . . . 1.0 108.54 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.46 -66.27 0.43 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.612 2.365 . . . . 1.0 111.362 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 p -57.76 -33.4 68.46 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 123.997 0.811 . . . . 1.0 112.423 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.5 t -68.15 -54.05 20.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.146 0.978 . . . . 1.0 112.789 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.48 -33.18 75.29 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.8 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.12 -24.32 51.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.898 -1.048 . . . . 1.0 111.054 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.82 -65.03 0.73 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 120.839 1.654 . . . . 1.0 109.497 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.119 0.414 . . . . 1.0 112.119 -173.77 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.627 -0.702 . . . . 1.0 111.089 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -47.11 -34.6 6.19 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.184 1.356 . . . . 1.0 114.154 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.95 -25.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 120.683 -1.261 . . . . 1.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.24 127.57 93.51 Favored Pre-proline 0 CA--C 1.519 -0.243 0 C-N-CA 126.21 1.804 . . . . 1.0 112.033 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.9 152.24 7.45 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.993 2.462 . . . . 1.0 112.205 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.51 158.17 27.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.215 -0.902 . . . . 1.0 109.827 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -139.49 148.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.28 -69.77 0.38 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.98 175.9 14.06 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.77 -19.64 18.24 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.652 2.235 . . . . 1.0 112.651 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.38 177.85 4.95 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.059 0.944 . . . . 1.0 112.276 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.75 3.44 11.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.378 1.471 . . . . 1.0 112.1 174.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.47 153.9 32.29 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 103.704 -3.758 . . . . 1.0 103.704 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -133.62 125.79 29.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.279 1.54 . . . . 1.0 107.401 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.32 113.88 23.5 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 129.153 2.981 . . . . 1.0 106.633 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.43 129.78 15.27 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.203 2.602 . . . . 1.0 110.711 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -134.43 178.23 7.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.083 0.953 . . . . 1.0 109.614 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.3 m95 -110.84 141.71 43.85 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.191 -1.041 . . . . 1.0 108.191 174.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.5 41.76 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 118.855 0.752 . . . . 1.0 109.515 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -81.78 136.54 35.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -117.39 113.88 38.61 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 116.379 -1.772 . . . . 1.0 110.685 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.69 -34.26 32.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.726 1.618 . . . . 1.0 109.793 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.1 mt -64.78 -10.85 30.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.687 1.595 . . . . 1.0 112.716 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -120.63 -4.22 9.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.191 1.396 . . . . 1.0 110.51 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.22 36.16 6.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.746 2.418 . . . . 1.0 109.767 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.84 166.43 19.7 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.294 -0.879 . . . . 1.0 110.016 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.9 m -94.63 145.85 24.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.013 0.911 . . . . 1.0 110.607 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.37 156.46 63.96 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 118.514 -0.755 . . . . 1.0 111.304 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.63 157.28 56.41 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.12 1.88 . . . . 1.0 108.832 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -153.49 161.36 42.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.786 1.176 . . . . 1.0 108.833 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -85.76 124.41 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -116.05 163.82 15.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.98 -0.78 48.5 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.558 -1.339 . . . . 1.0 115.131 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.83 -37.07 1.04 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.41 1.481 . . . . 1.0 112.881 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.06 -172.74 4.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.211 1.804 . . . . 1.0 107.759 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.84 133.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.871 2.068 . . . . 1.0 112.88 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 -167.83 30.59 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 107.596 -2.201 . . . . 1.0 107.596 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -93.34 174.89 6.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.224 1.012 . . . . 1.0 108.827 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.02 -10.93 82.17 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.819 -1.082 . . . . 1.0 112.755 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -73.17 81.39 1.3 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.51 112.95 6.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.81 160.77 21.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 123.468 1.604 . . . . 1.0 107.894 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -93.42 -20.81 19.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 112.542 -2.117 . . . . 1.0 112.492 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -165.14 167.62 18.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -60.9 -51.31 69.84 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -45.1 -66.6 0.38 Allowed 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 128.202 2.601 . . . . 1.0 112.075 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -60.83 -33.39 72.96 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.67 0.606 . . . . 1.0 112.304 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.94 -52.23 38.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -69.92 -33.24 71.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.466 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.46 -28.14 61.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 117.902 -1.519 . . . . 1.0 110.448 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.2 -48.61 41.81 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-N 120.543 1.519 . . . . 1.0 110.483 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.446 -0.632 0 C-N-CA 123.868 0.867 . . . . 1.0 113.328 -174.261 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 118.585 -0.721 . . . . 1.0 111.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 p -52.84 -30.64 34.8 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.137 1.335 . . . . 1.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 t -78.19 -27.11 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.437 -0.789 . . . . 1.0 110.444 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.48 130.16 90.95 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 126.391 1.876 . . . . 1.0 112.178 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.77 154.42 9.65 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.922 2.415 . . . . 1.0 111.579 173.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.39 160.27 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.383 0.673 . . . . 1.0 109.636 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.69 150.06 20.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 126.002 1.721 . . . . 1.0 106.567 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -72.61 -68.7 0.46 Allowed 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.75 171.36 12.82 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.441 1.496 . . . . 1.0 109.8 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.79 -12.16 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.074 2.516 . . . . 1.0 113.358 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.3 m -72.69 -174.99 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.574 1.15 . . . . 1.0 112.201 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.65 3.61 5.51 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.064 0.945 . . . . 1.0 113.167 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.83 153.61 25.97 Favored Glycine 0 CA--C 1.528 0.89 1 N-CA-C 102.292 -4.323 . . . . 1.0 102.292 172.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -134.21 123.34 24.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.482 1.641 . . . . 1.0 108.277 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.59 113.7 34.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 129.732 3.213 . . . . 1.0 106.56 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.9 130.47 14.53 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.68 . . . . 1.0 110.486 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -134.41 177.34 7.84 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.724 0.81 . . . . 1.0 109.353 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.52 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.4 m95 -111.1 141.06 45.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.27 47.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -82.68 141.35 32.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.777 0.799 . . . . 1.0 109.398 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -117.31 113.14 39.11 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 105.818 -1.919 . . . . 1.0 105.818 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -33.65 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.68 1.587 . . . . 1.0 109.584 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.29 -15.86 62.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.145 1.378 . . . . 1.0 112.601 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.6 mt -112.12 -5.32 14.25 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.262 1.025 . . . . 1.0 110.493 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.74 37.47 7.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.324 2.25 . . . . 1.0 109.47 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -160.88 166.2 28.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.2 149.57 23.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.981 0.896 . . . . 1.0 111.744 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -140.8 154.26 68.56 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.804 . . . . 1.0 110.832 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.79 162.08 33.41 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.147 1.898 . . . . 1.0 109.084 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -156.03 157.57 36.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.352 0.978 . . . . 1.0 108.416 173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.35 130.76 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.889 -2.264 . . . . 1.0 104.889 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.76 163.38 22.23 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.26 -0.11 40.83 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.53 -1.15 . . . . 1.0 115.523 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 -34.17 1.07 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.266 1.533 . . . . 1.0 113.116 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -88.85 -172.71 3.81 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.361 2.264 . . . . 1.0 107.748 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -33.8 133.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.795 2.038 . . . . 1.0 112.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.3 -172.28 40.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 107.316 -2.313 . . . . 1.0 107.316 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.55 175.63 6.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.326 1.06 . . . . 1.0 109.355 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.99 -9.75 73.28 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.582 -1.19 . . . . 1.0 113.794 -173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -73.89 81.15 1.65 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.447 -1.686 . . . . 1.0 106.447 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -142.36 113.04 7.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.428 -1.323 . . . . 1.0 107.428 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -118.1 161.3 20.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.009 1.385 . . . . 1.0 108.271 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.21 -19.12 21.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 112.898 -1.955 . . . . 1.0 112.288 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -165.96 168.75 15.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.89 -47.05 88.15 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 173.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -47.59 -66.58 0.38 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.844 2.858 . . . . 1.0 111.947 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 p -60.53 -33.5 72.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.602 0.564 . . . . 1.0 112.093 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.5 t -69.55 -50.7 42.4 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.714 0.806 . . . . 1.0 112.431 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.278 61.7 mt-10 -68.97 -32.9 72.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.997 -0.525 . . . . 1.0 110.085 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.56 -28.94 66.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.424 -1.275 . . . . 1.0 110.805 173.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.77 15.96 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 119.735 1.152 . . . . 1.0 111.039 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.452 -0.34 0 C-N-CA 123.661 0.784 . . . . 1.0 110.359 -179.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.893 -0.575 . . . . 1.0 109.538 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -50.3 -29.5 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.957 1.303 . . . . 1.0 113.115 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.1 t -78.18 -26.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.042 . . . . 1.0 110.674 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.41 131.26 86.69 Favored Pre-proline 0 N--CA 1.453 -0.3 0 C-N-CA 127.185 2.194 . . . . 1.0 112.406 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.74 153.39 11.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.877 2.385 . . . . 1.0 111.59 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.9 160.74 22.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.614 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.61 148.75 21.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 125.479 1.512 . . . . 1.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.83 -68.68 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.312 1.045 . . . . 1.0 109.045 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.73 175.7 14.09 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.139 1.352 . . . . 1.0 109.772 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.92 -15.27 18.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.739 2.293 . . . . 1.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.3 m -72.97 178.85 4.04 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 124.217 1.007 . . . . 1.0 111.808 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.87 3.68 4.46 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.837 1.051 . . . . 1.0 113.837 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.54 153.71 29.01 Favored Glycine 0 CA--C 1.53 1.018 1 N-CA-C 102.037 -4.425 . . . . 1.0 102.037 172.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.18 109.6 11.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.967 1.883 . . . . 1.0 108.9 -173.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.5 113.93 61.23 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 129.021 2.928 . . . . 1.0 107.001 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.46 127.7 14.39 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.14 2.56 . . . . 1.0 110.474 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -132.71 178.7 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.996 0.919 . . . . 1.0 109.312 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.6 m95 -114.3 139.7 49.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.454 1.101 . . . . 1.0 108.177 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.81 145.38 46.43 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.898 0.772 . . . . 1.0 109.109 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -80.97 140.48 35.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.892 0.853 . . . . 1.0 109.095 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 m -117.16 113.38 39.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 106.582 -1.636 . . . . 1.0 106.582 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.78 -33.06 21.81 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.697 1.598 . . . . 1.0 110.208 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.99 -15.12 61.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.935 1.294 . . . . 1.0 112.6 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 mt -113.96 -5.57 13.17 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.533 1.133 . . . . 1.0 110.526 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.74 40.34 8.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.495 2.318 . . . . 1.0 109.072 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -163.85 165.43 22.87 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 -173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.3 148.39 23.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.466 1.127 . . . . 1.0 111.373 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -141.78 155.44 66.26 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 114.869 -1.06 . . . . 1.0 110.942 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 160.18 35.66 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.423 2.082 . . . . 1.0 109.911 173.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.13 161.93 40.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.352 0.978 . . . . 1.0 108.409 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.64 123.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.331 -1.729 . . . . 1.0 106.331 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.4 162.89 16.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 104.857 -2.275 . . . . 1.0 104.857 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.15 4.43 31.67 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.643 -1.286 . . . . 1.0 115.511 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.27 9.8 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 118.657 1.229 . . . . 1.0 115.347 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 p -119.75 -172.63 2.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.401 2.681 . . . . 1.0 107.318 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.73 133.53 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.397 1.879 . . . . 1.0 112.619 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.24 -171.46 34.95 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.651 -2.18 . . . . 1.0 107.651 -174.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -93.44 175.18 6.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.355 1.078 . . . . 1.0 109.047 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -11.78 80.6 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.76 -1.109 . . . . 1.0 113.132 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -76.62 77.39 3.29 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -146.08 113.12 6.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.174 -1.417 . . . . 1.0 107.174 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -120.48 161.03 21.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.208 1.403 . . . . 1.0 108.388 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -93.4 -17.21 23.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.515 -1.675 . . . . 1.0 113.158 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.34 170.09 15.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -61.47 -50.12 74.03 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -66.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 128.506 2.723 . . . . 1.0 111.826 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.4 p -56.76 -33.25 66.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.812 0.671 . . . . 1.0 112.812 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.3 t -70.97 -49.7 42.5 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.637 0.775 . . . . 1.0 112.534 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.366 76.3 mt-10 -67.13 -33.06 74.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.037 -0.506 . . . . 1.0 111.237 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.7 -38.22 90.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.07 68.8 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.946 0.794 . . . . 1.0 111.808 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 125.499 1.519 . . . . 1.0 109.597 179.291 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.356 0 CA-C-O 118.598 -0.715 . . . . 1.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -20.45 65.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.122 1.328 . . . . 1.0 111.544 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -81.79 -30.83 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.48 1.112 . . . . 1.0 110.761 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.27 136.71 91.33 Favored Pre-proline 0 C--O 1.225 -0.209 0 C-N-CA 126.866 2.066 . . . . 1.0 110.185 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.56 166.2 26.64 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.71 1.607 . . . . 1.0 111.711 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.71 156.63 32.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.184 -1.371 . . . . 1.0 109.614 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.54 147.24 22.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 106.901 -1.518 . . . . 1.0 106.901 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -72.0 -67.63 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.402 1.081 . . . . 1.0 109.25 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.39 177.37 14.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.53 -16.77 24.06 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.414 2.076 . . . . 1.0 112.919 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -73.49 -177.58 2.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.417 1.087 . . . . 1.0 112.402 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.91 3.8 4.9 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.895 1.278 . . . . 1.0 113.968 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.94 153.95 40.67 Favored Glycine 0 CA--C 1.531 1.054 1 N-CA-C 102.752 -4.139 . . . . 1.0 102.752 172.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -130.26 123.63 30.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.072 1.936 . . . . 1.0 107.334 -173.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -125.79 114.46 24.68 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 128.679 2.792 . . . . 1.0 107.425 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.0 126.02 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.262 2.641 . . . . 1.0 110.622 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -133.11 -179.37 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.482 1.113 . . . . 1.0 109.056 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.6 m95 -124.71 144.87 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.835 1.254 . . . . 1.0 108.578 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.27 145.61 34.21 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.272 0.629 . . . . 1.0 109.555 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -78.16 139.34 38.99 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 m -116.97 113.43 39.63 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 107.102 -1.444 . . . . 1.0 107.102 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.67 -33.75 20.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.026 1.817 . . . . 1.0 110.329 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.15 -16.28 63.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.725 1.21 . . . . 1.0 112.8 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.35 -4.47 14.28 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.789 1.236 . . . . 1.0 110.669 173.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.86 34.28 3.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.319 2.648 . . . . 1.0 110.381 -173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.34 167.63 23.48 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -94.69 148.91 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.366 1.079 . . . . 1.0 112.274 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -140.61 156.12 69.33 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.892 -1.049 . . . . 1.0 110.972 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -69.72 163.41 38.36 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 1.0 109.509 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -158.71 165.33 34.62 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.273 -0.892 . . . . 1.0 108.721 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.63 116.58 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.784 -1.561 . . . . 1.0 106.784 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.65 162.7 12.85 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.119 -2.178 . . . . 1.0 105.119 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.81 3.48 38.95 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 115.17 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.97 -16.4 4.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.31 1.433 . . . . 1.0 115.425 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.9 p -112.85 -172.78 2.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.644 2.377 . . . . 1.0 108.188 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.76 133.49 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.403 1.881 . . . . 1.0 112.718 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.37 -169.36 31.72 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 108.194 -1.963 . . . . 1.0 108.194 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -93.29 175.4 6.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.161 0.981 . . . . 1.0 109.276 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.91 -14.08 70.58 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 114.46 -1.246 . . . . 1.0 112.575 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -80.33 75.53 7.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.116 -1.809 . . . . 1.0 106.116 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -146.15 113.24 6.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.545 -1.65 . . . . 1.0 106.545 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.02 163.09 19.98 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.272 1.429 . . . . 1.0 108.826 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -93.14 -16.91 24.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.251 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.443 ' HG ' ' CD ' ' A' ' 54' ' ' GLU . 4.0 p -164.77 173.46 11.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -173.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -59.54 -47.4 85.68 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 173.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CD ' ' HG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -44.76 -67.1 0.31 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.975 2.91 . . . . 1.0 112.438 173.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -59.89 -33.14 71.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.534 0.683 . . . . 1.0 112.79 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.5 t -70.1 -50.16 43.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.327 63.2 mt-10 -69.43 -33.34 72.82 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.952 -1.023 . . . . 1.0 108.687 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -36.67 78.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.046 0.839 . . . . 1.0 109.116 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.37 74.62 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.405 1.002 . . . . 1.0 112.875 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.0 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-N 119.32 0.963 . . . . 1.0 113.029 177.09 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 118.373 -0.822 . . . . 1.0 111.607 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 p -57.04 -29.19 63.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.891 1.223 . . . . 1.0 112.633 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.22 -30.77 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.34 -0.85 . . . . 1.0 110.685 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.94 127.73 92.09 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 124.962 1.305 . . . . 1.0 112.23 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.12 154.36 5.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.385 2.724 . . . . 1.0 112.439 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.01 157.25 26.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.65 -0.704 . . . . 1.0 109.499 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 147.47 27.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.371 -2.085 . . . . 1.0 105.371 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.35 -63.26 1.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.55 170.53 12.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 1.0 109.528 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.9 -14.79 15.27 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.709 2.273 . . . . 1.0 113.301 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.8 m -73.85 -177.23 2.73 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.145 -0.972 . . . . 1.0 112.275 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 3.8 6.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.303 1.041 . . . . 1.0 113.125 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.19 154.0 29.81 Favored Glycine 0 CA--C 1.531 1.037 1 N-CA-C 102.344 -4.303 . . . . 1.0 102.344 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -132.52 127.91 36.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.831 1.816 . . . . 1.0 108.289 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' CD ' HH12 ' A' ' 25' ' ' ARG . 6.5 tp10 -125.91 114.32 24.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 130.158 3.383 . . . . 1.0 106.422 -173.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.72 132.03 25.79 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 123.252 2.635 . . . . 1.0 110.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.415 HH12 ' CD ' ' A' ' 23' ' ' GLU . 87.1 mmt-85 -133.98 175.49 9.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.559 173.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.407 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.4 m95 -120.96 143.42 49.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.765 2.026 . . . . 1.0 106.017 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.88 144.04 45.37 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.49 137.99 38.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.744 0.783 . . . . 1.0 109.41 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -117.21 113.53 39.13 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 124.981 1.313 . . . . 1.0 107.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.95 -36.03 24.12 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.125 1.883 . . . . 1.0 110.617 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -66.65 -17.21 64.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.298 1.039 . . . . 1.0 112.562 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.8 mt -106.26 -4.21 20.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.257 1.023 . . . . 1.0 110.293 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.28 32.56 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.172 2.589 . . . . 1.0 110.922 -174.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.23 169.2 14.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.824 0.821 . . . . 1.0 109.249 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.5 m -95.27 149.36 21.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.704 1.202 . . . . 1.0 110.619 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.49 154.31 73.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.898 . . . . 1.0 110.963 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.65 164.82 19.9 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.339 2.026 . . . . 1.0 111.63 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -162.16 164.28 27.97 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.6 t -90.14 113.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.63 159.8 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.214 -1.773 . . . . 1.0 106.214 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.16 0.94 57.39 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.232 -0.917 . . . . 1.0 114.796 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.35 -30.64 1.41 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.579 1.561 . . . . 1.0 113.965 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.89 -172.78 2.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.698 2.399 . . . . 1.0 107.566 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.75 0.17 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.253 2.221 . . . . 1.0 113.042 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.01 -169.72 35.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 107.599 -2.2 . . . . 1.0 107.599 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -93.35 174.35 7.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.491 1.145 . . . . 1.0 109.666 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.92 -11.84 83.36 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 114.694 -1.139 . . . . 1.0 113.419 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.66 74.01 5.2 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.008 -1.849 . . . . 1.0 106.008 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -139.75 113.09 8.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.23 1.012 . . . . 1.0 108.29 -173.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.05 150.96 49.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.703 1.201 . . . . 1.0 108.123 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -93.39 -6.31 47.46 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.05 -0.406 . . . . 1.0 110.709 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.24 170.36 14.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.128 1.371 . . . . 1.0 107.686 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 6.7 ttp180 -70.31 -39.86 74.54 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.324 -1.35 . . . . 1.0 108.535 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -39.62 -65.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.863 2.465 . . . . 1.0 111.006 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 p -57.47 -33.58 68.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.917 0.71 . . . . 1.0 112.917 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.8 t -75.12 -46.7 32.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.864 1.266 . . . . 1.0 112.577 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.12 -33.58 76.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.731 0.813 . . . . 1.0 109.288 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.55 -38.35 84.02 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.68 0.673 . . . . 1.0 109.221 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.31 -60.61 2.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.622 1.101 . . . . 1.0 110.822 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.234 0.285 0 C-N-CA 124.032 0.933 . . . . 1.0 110.678 -177.112 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.343 0 CA-C-O 119.413 -0.327 . . . . 1.0 110.348 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -62.24 -21.2 64.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.5 0.72 . . . . 1.0 112.096 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.36 -33.05 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 O-C-N 120.961 -1.087 . . . . 1.0 110.548 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.03 128.4 86.5 Favored Pre-proline 0 CA--C 1.521 -0.153 0 C-N-CA 127.407 2.283 . . . . 1.0 112.474 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.34 166.18 22.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.957 1.771 . . . . 1.0 111.816 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.89 168.43 11.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.532 1.133 . . . . 1.0 111.109 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -143.1 151.36 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.776 1.631 . . . . 1.0 107.848 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.69 -30.05 15.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.05 1.34 . . . . 1.0 113.463 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.33 177.55 51.8 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.1 -18.81 30.54 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.851 2.368 . . . . 1.0 113.601 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 m -67.83 161.74 25.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.834 -1.167 . . . . 1.0 111.048 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 3.5 15.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.966 1.706 . . . . 1.0 112.653 173.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.67 153.32 31.33 Favored Glycine 0 CA--C 1.528 0.873 1 N-CA-C 102.994 -4.042 . . . . 1.0 102.994 172.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -125.86 103.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.953 1.377 . . . . 1.0 110.461 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -95.13 113.82 62.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 127.872 2.469 . . . . 1.0 106.886 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.48 125.19 11.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.221 2.614 . . . . 1.0 110.319 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -131.26 -177.91 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.146 0.979 . . . . 1.0 108.83 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.3 m95 -125.43 143.28 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.644 1.178 . . . . 1.0 108.472 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.85 145.01 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 56.5 t80 -78.09 137.22 38.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.757 0.789 . . . . 1.0 109.361 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -117.24 113.9 38.9 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 116.801 -1.571 . . . . 1.0 108.461 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -32.25 37.19 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.519 1.479 . . . . 1.0 110.294 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.64 -15.72 61.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.087 1.355 . . . . 1.0 112.562 174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.58 -3.8 13.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 1.0 110.683 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.17 22.84 3.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 129.128 2.971 . . . . 1.0 112.229 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -166.62 170.6 12.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.188 -0.945 . . . . 1.0 110.276 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 86.2 m -84.19 146.82 27.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.101 0.953 . . . . 1.0 113.485 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -136.48 157.19 75.75 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.218 -1.355 . . . . 1.0 109.878 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -69.5 162.14 43.11 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.816 1.677 . . . . 1.0 108.758 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -155.93 163.16 40.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.063 -1.023 . . . . 1.0 108.79 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.19 125.25 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -122.41 175.26 6.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.351 2.261 . . . . 1.0 106.386 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.02 5.72 5.06 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.911 1.124 . . . . 1.0 115.911 -173.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.66 -38.21 2.8 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.842 1.821 . . . . 1.0 112.357 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.2 -173.02 1.87 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.529 1.532 . . . . 1.0 108.892 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -34.13 133.77 0.21 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.867 2.467 . . . . 1.0 113.784 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.7 176.41 41.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -93.72 177.72 5.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.77 0.785 . . . . 1.0 109.187 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.85 79.92 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.519 -0.764 . . . . 1.0 113.343 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -80.11 72.39 6.91 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -143.04 113.18 7.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.929 -1.878 . . . . 1.0 105.929 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -118.42 161.66 19.62 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 125.329 1.452 . . . . 1.0 108.85 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.27 8.2 m80 -93.18 -16.47 24.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.974 -1.466 . . . . 1.0 111.567 -172.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -165.83 172.15 11.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.2 tpt180 -61.49 -48.1 82.61 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 173.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -66.89 0.33 Allowed 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 128.765 2.826 . . . . 1.0 111.719 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -57.24 -33.07 67.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.1 t -71.96 -47.9 48.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.4 -0.812 . . . . 1.0 112.93 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.78 -33.5 76.12 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.85 -0.595 . . . . 1.0 110.248 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -44.87 93.62 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.4 -46.14 70.79 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 121.476 -0.765 . . . . 1.0 112.01 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 125.275 1.43 . . . . 1.0 113.917 -178.409 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.355 0 CA-C-O 119.06 -0.495 . . . . 1.0 109.719 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.23 -28.26 69.91 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.807 0.731 . . . . 1.0 112.579 -173.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -73.16 -37.76 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 tp -62.86 122.14 72.77 Favored Pre-proline 0 N--CA 1.458 -0.07 0 C-N-CA 125.061 1.344 . . . . 1.0 113.301 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.84 152.85 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.717 2.945 . . . . 1.0 113.07 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 153.51 32.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.284 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.82 144.32 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -76.08 -53.48 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.55 175.54 15.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.344 1.45 . . . . 1.0 110.199 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.19 -28.36 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.656 2.237 . . . . 1.0 112.994 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -79.21 159.92 27.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 122.605 1.193 . . . . 1.0 112.539 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.34 3.55 38.1 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.263 1.825 . . . . 1.0 113.546 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.15 155.09 50.25 Favored Glycine 0 CA--C 1.535 1.311 1 N-CA-C 101.555 -4.618 . . . . 1.0 101.555 172.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -136.62 132.62 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 121.319 2.56 . . . . 1.0 108.476 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -135.54 118.8 12.71 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 129.265 3.026 . . . . 1.0 106.514 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.56 124.64 12.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.202 2.601 . . . . 1.0 109.675 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -128.5 179.9 5.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.407 1.083 . . . . 1.0 108.314 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.501 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.6 m95 -130.34 144.58 51.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.163 2.185 . . . . 1.0 106.759 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.95 148.27 38.35 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -82.39 138.54 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.866 0.841 . . . . 1.0 108.893 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -117.23 114.09 38.83 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 125.665 1.586 . . . . 1.0 108.32 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.79 -34.75 23.48 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.017 1.812 . . . . 1.0 110.618 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -62.44 -23.57 66.94 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.561 0.744 . . . . 1.0 112.991 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -102.72 -6.66 22.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 1.0 110.693 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 40.66 2.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.48 3.112 . . . . 1.0 108.452 -173.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.76 168.85 20.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.6 m -98.83 148.27 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.172 0.987 . . . . 1.0 111.795 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -134.62 153.29 78.9 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.315 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.96 168.96 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.971 1.78 . . . . 1.0 109.109 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -163.36 160.1 23.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.3 113.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.653 -2.351 . . . . 1.0 104.653 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 15.6 t80 -96.33 156.85 16.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.969 1.707 . . . . 1.0 106.97 174.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.13 1.95 68.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.939 0.736 . . . . 1.0 114.939 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 78.1 -38.51 1.79 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.87 1.7 . . . . 1.0 113.531 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -85.18 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.107 1.763 . . . . 1.0 108.089 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -33.68 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.575 2.35 . . . . 1.0 113.338 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.96 -167.52 28.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.522 -2.231 . . . . 1.0 107.522 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.35 174.65 7.1 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.545 1.172 . . . . 1.0 108.969 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.02 -15.17 79.5 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.784 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -76.09 78.76 2.92 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.811 -1.922 . . . . 1.0 105.811 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.17 113.17 5.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.775 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -126.12 158.0 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.452 1.901 . . . . 1.0 108.227 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -93.93 -11.02 31.88 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.867 -1.063 . . . . 1.0 112.523 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.82 160.72 42.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.901 1.228 . . . . 1.0 110.71 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.5 tpt180 -60.63 -50.77 72.17 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.519 -1.219 . . . . 1.0 109.087 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -66.75 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.343 2.657 . . . . 1.0 111.8 174.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.8 p -58.31 -33.46 69.5 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.61 -50.43 44.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.444 0.698 . . . . 1.0 112.587 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.92 -33.13 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.525 -0.75 . . . . 1.0 110.262 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.71 -26.65 62.58 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.604 -0.713 . . . . 1.0 110.538 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.28 62.13 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.108 1.322 . . . . 1.0 111.473 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.238 0.484 0 C-N-CA 123.124 0.57 . . . . 1.0 111.693 174.086 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 107.872 -1.159 . . . . 1.0 107.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.41 178.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.402 0.546 . . . . 1.0 109.671 157.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -74.4 -23.56 58.98 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.579 -1.326 . . . . 1.0 110.056 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.62 107.36 15.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.081 -2.562 . . . . 1.0 104.081 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -118.43 -23.89 7.03 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.662 0.785 . . . . 1.0 111.423 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.75 135.12 48.0 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -78.4 93.48 4.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.579 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.91 169.21 16.28 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 104.282 -2.488 . . . . 1.0 104.282 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.29 -34.08 31.55 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 120.729 -1.232 . . . . 1.0 110.535 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.58 -26.92 68.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.624 1.102 . . . . 1.0 111.449 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.17 -25.76 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.331 1.052 . . . . 1.0 109.936 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.7 tp -76.47 130.19 77.68 Favored Pre-proline 0 C--O 1.226 -0.137 0 C-N-CA 127.065 2.146 . . . . 1.0 112.944 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.37 153.33 13.63 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.954 2.436 . . . . 1.0 111.51 173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.66 13.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.031 0.532 . . . . 1.0 110.16 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.66 148.6 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 125.119 1.368 . . . . 1.0 107.514 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.49 -56.77 4.32 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.622 1.169 . . . . 1.0 110.937 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.62 174.73 19.88 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.061 1.315 . . . . 1.0 109.971 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.19 -6.41 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.065 2.51 . . . . 1.0 113.505 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -73.32 175.62 6.72 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 122.364 1.078 . . . . 1.0 112.593 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.4 3.51 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.479 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.4 153.82 21.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 103.511 -3.836 . . . . 1.0 103.511 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -126.63 106.14 9.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.109 1.455 . . . . 1.0 109.52 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -102.12 113.83 65.71 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 128.748 2.819 . . . . 1.0 107.07 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.36 126.51 13.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.276 2.651 . . . . 1.0 110.284 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -132.37 -179.86 5.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.222 1.009 . . . . 1.0 109.005 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 48.2 m95 -119.55 143.87 47.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.667 1.187 . . . . 1.0 108.217 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.2 39.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -80.84 138.57 36.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.922 0.868 . . . . 1.0 108.976 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m -117.29 113.7 38.88 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.242 -1.361 . . . . 1.0 108.177 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.6 -33.61 21.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.788 1.659 . . . . 1.0 110.371 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -63.25 -20.54 65.54 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.0 112.711 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -108.24 -5.34 16.89 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.518 1.127 . . . . 1.0 110.769 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.63 37.93 3.64 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.543 2.737 . . . . 1.0 109.997 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -162.76 168.06 22.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.93 150.65 21.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.24 1.019 . . . . 1.0 112.156 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -140.74 154.61 69.07 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.944 -1.025 . . . . 1.0 111.28 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.59 162.71 35.78 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.178 1.918 . . . . 1.0 109.0 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.98 163.19 36.68 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.395 0.998 . . . . 1.0 108.575 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.97 127.13 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.39 -1.707 . . . . 1.0 106.39 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -119.2 168.9 10.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.848 2.059 . . . . 1.0 105.533 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.88 1.35 15.13 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 120.692 -1.255 . . . . 1.0 116.106 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.65 -7.24 58.96 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.277 1.538 . . . . 1.0 115.058 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 32.0 p -118.73 -172.75 2.34 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.723 2.409 . . . . 1.0 108.128 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.6 0.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.679 1.992 . . . . 1.0 112.853 -173.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.79 -176.76 38.1 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.555 -2.218 . . . . 1.0 107.555 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -93.5 174.93 6.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.179 0.989 . . . . 1.0 108.616 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.8 -11.76 85.11 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.228 -0.896 . . . . 1.0 112.93 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -78.02 74.17 4.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.435 1.118 . . . . 1.0 108.199 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.53 113.08 6.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -121.12 161.02 22.5 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.82 1.248 . . . . 1.0 108.624 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -93.27 -15.05 26.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.981 -1.463 . . . . 1.0 112.336 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -166.54 171.11 12.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.402 0.681 . . . . 1.0 109.295 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.9 tpt180 -62.29 -47.3 84.91 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -66.93 0.31 Allowed 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 128.466 2.706 . . . . 1.0 111.261 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -54.93 -33.17 61.94 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.0 t -72.04 -50.72 26.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.821 0.848 . . . . 1.0 112.899 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.348 76.2 mt-10 -67.29 -33.13 74.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 118.432 -0.795 . . . . 1.0 109.948 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.35 -38.9 85.26 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.376 0.989 . . . . 1.0 109.007 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 -43.66 72.84 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.33 0.968 . . . . 1.0 112.781 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.2 m -128.33 80.43 72.39 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.662 0.785 . . . . 1.0 109.856 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.66 162.43 24.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.749 2.299 . . . . 1.0 112.395 -173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -98.25 140.76 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 103.681 -2.711 . . . . 1.0 103.681 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.2 164.71 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 126.379 1.872 . . . . 1.0 106.664 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.87 139.03 57.01 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.711 -2.329 . . . . 1.0 104.711 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.55 70.81 0.93 Allowed 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.483 1.113 . . . . 1.0 112.947 -173.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -73.07 73.37 1.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 103.232 -2.877 . . . . 1.0 103.232 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -51.35 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.669 1.588 . . . . 1.0 115.239 -173.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -73.11 -31.6 64.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -74.18 168.94 18.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.326 1.85 . . . . 1.0 109.641 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.163 1.785 . . . . 1.0 109.038 173.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.88 160.31 43.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.706 1.139 . . . . 1.0 108.391 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.21 -71.34 0.42 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.495 1.518 . . . . 1.0 107.26 174.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.49 168.09 20.42 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -46.07 -44.22 15.24 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.262 2.225 . . . . 1.0 111.833 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -147.66 93.24 2.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 m -171.65 115.55 0.38 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.429 2.292 . . . . 1.0 104.952 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.01 129.14 37.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.113 -2.18 . . . . 1.0 105.113 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -43.95 -23.8 0.11 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 127.154 2.181 . . . . 1.0 112.642 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.3 p -47.58 -28.45 2.31 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.588 -1.32 . . . . 1.0 113.603 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.55 -28.29 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 119.56 1.073 . . . . 1.0 112.301 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.46 156.14 85.36 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 127.929 2.491 . . . . 1.0 109.594 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -67.5 168.54 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.825 1.684 . . . . 1.0 111.856 175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 113.54 8.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.931 -1.137 . . . . 1.0 107.931 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.2 t -91.94 124.14 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -80.07 -33.07 39.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.693 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.17 173.32 42.03 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.409 -1.077 . . . . 1.0 110.409 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.54 -8.16 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.261 2.641 . . . . 1.0 114.409 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -73.6 -179.05 3.36 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 3.86 5.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.66 1.584 . . . . 1.0 113.105 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.17 155.18 26.04 Favored Glycine 0 CA--C 1.533 1.161 1 N-CA-C 101.157 -4.777 . . . . 1.0 101.157 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -132.58 120.32 21.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.931 2.366 . . . . 1.0 108.829 -173.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.95 113.79 28.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 129.377 3.071 . . . . 1.0 107.801 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.32 125.23 12.62 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.441 2.76 . . . . 1.0 111.214 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -131.81 178.31 6.86 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.295 1.038 . . . . 1.0 109.729 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.498 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 68.6 m95 -113.2 143.34 44.56 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.1 144.02 42.85 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.773 1.17 . . . . 1.0 108.243 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -79.5 139.21 37.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.808 0.813 . . . . 1.0 109.43 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -117.17 113.86 39.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.274 1.83 . . . . 1.0 107.806 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.79 -34.34 24.65 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.946 1.764 . . . . 1.0 111.06 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.59 -13.99 55.75 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.369 1.067 . . . . 1.0 112.754 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -115.9 -4.0 12.11 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.963 1.305 . . . . 1.0 110.723 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.65 37.97 1.76 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.893 2.877 . . . . 1.0 109.974 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.67 169.32 23.08 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.9 m -106.78 136.0 47.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.573 0.749 . . . . 1.0 110.681 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -122.89 159.48 53.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.295 1.038 . . . . 1.0 109.325 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -71.12 164.81 34.46 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 120.233 1.119 . . . . 1.0 109.588 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.22 168.89 25.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.09 113.7 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -99.46 162.08 13.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.02 55.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 116.185 1.234 . . . . 1.0 116.185 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.96 2.05 57.11 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 118.943 1.371 . . . . 1.0 115.062 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 p -125.46 -172.64 2.64 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.263 2.625 . . . . 1.0 107.846 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -33.3 133.64 0.15 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.801 2.04 . . . . 1.0 112.514 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.93 174.68 43.49 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.169 -1.973 . . . . 1.0 108.169 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.62 -174.76 3.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.195 0.997 . . . . 1.0 108.603 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.77 -4.26 82.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 126.983 2.23 . . . . 1.0 113.934 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -80.07 65.7 5.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.929 2.864 . . . . 1.0 107.107 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -144.04 112.9 6.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -115.27 161.25 18.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.399 -1.704 . . . . 1.0 106.399 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.294 6.4 m80 -92.75 -20.68 20.52 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.614 -2.539 . . . . 1.0 108.477 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -170.47 165.52 8.54 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.906 0.882 . . . . 1.0 108.641 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 14.9 ttp85 -65.75 -42.3 91.11 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.678 -1.23 . . . . 1.0 107.678 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -46.55 -66.1 0.46 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.369 2.268 . . . . 1.0 110.276 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 p -57.77 -34.28 69.4 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.689 0.618 . . . . 1.0 111.954 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.1 t -71.66 -48.52 47.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.285 1.034 . . . . 1.0 112.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.09 -33.53 73.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.53 0.681 . . . . 1.0 109.733 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.64 -23.36 39.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -175.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.13 -62.78 1.48 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.935 0.789 . . . . 1.0 111.847 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 20.3 m -99.75 165.92 13.76 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.28 108.72 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.312 2.008 . . . . 1.0 112.086 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG11 ' H ' ' A' ' 63' ' ' VAL . 3.7 t -146.29 -174.72 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 130.695 3.598 . . . . 1.0 102.825 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' HG11 ' A' ' 62' ' ' VAL . 2.4 t -62.28 127.33 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 103.294 -2.854 . . . . 1.0 103.294 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -97.16 135.13 39.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.961 -173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -64.9 -66.8 0.5 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 102.99 -2.967 . . . . 1.0 102.99 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.6 m80 172.93 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 1 C-N-CA 134.224 5.01 . . . . 1.0 102.533 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -34.85 99.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.978 2.111 . . . . 1.0 111.675 -173.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -82.99 44.88 0.96 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.168 1.387 . . . . 1.0 111.989 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -72.22 -170.71 0.65 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.618 1.167 . . . . 1.0 109.966 173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.254 1.324 1 N-CA-C 99.555 -4.239 . . . . 1.0 99.555 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 4.8 tt0 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.33 86.02 0.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 105.775 -1.935 . . . . 1.0 105.775 158.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.64 -24.32 16.62 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.38 92.3 3.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -37.75 -22.71 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.018 3.727 . . . . 1.0 118.327 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -40.63 142.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.907 1.283 . . . . 1.0 112.477 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -68.38 94.5 0.55 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.372 1.469 . . . . 1.0 112.536 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.51 164.51 23.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 1.0 109.915 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -23.96 1.28 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 126.667 1.987 . . . . 1.0 111.272 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 p -49.3 -33.38 13.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.422 1.465 . . . . 1.0 112.766 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -76.63 -21.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 O-C-N 120.788 -1.195 . . . . 1.0 111.076 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -73.72 131.03 82.52 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 127.313 2.245 . . . . 1.0 112.193 174.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -49.76 154.22 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.227 2.618 . . . . 1.0 112.825 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.51 161.52 24.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.017 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.8 t -137.89 145.47 28.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 105.74 -1.948 . . . . 1.0 105.74 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -96.48 -23.99 16.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.668 0.787 . . . . 1.0 112.086 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.34 170.43 46.24 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.587 1.565 . . . . 1.0 111.307 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.13 -3.39 13.73 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.388 3.392 . . . . 1.0 114.691 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.3 176.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.655 1.582 . . . . 1.0 112.984 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 3.65 3.82 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.411 1.485 . . . . 1.0 112.946 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.15 153.44 20.27 Favored Glycine 0 CA--C 1.528 0.896 1 N-CA-C 101.63 -4.588 . . . . 1.0 101.63 172.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -128.69 104.68 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.974 1.387 . . . . 1.0 110.889 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -94.16 113.67 61.3 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.138 2.975 . . . . 1.0 106.992 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.21 127.75 14.66 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.37 2.714 . . . . 1.0 110.478 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.52 179.4 5.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.82 0.848 . . . . 1.0 108.935 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.514 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.2 m95 -119.74 136.31 54.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.883 -1.525 . . . . 1.0 106.883 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.62 143.51 48.66 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -77.45 139.18 39.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.705 0.764 . . . . 1.0 110.299 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -117.15 113.57 39.22 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 117.064 -1.446 . . . . 1.0 107.537 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.09 -33.38 31.88 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.09 1.86 . . . . 1.0 110.601 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.04 -16.88 63.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.568 1.147 . . . . 1.0 112.804 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -111.56 -4.35 14.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.38 1.472 . . . . 1.0 110.557 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 51.99 20.2 1.19 Allowed 'General case' 0 N--CA 1.431 -1.421 1 C-N-CA 132.35 4.26 . . . . 1.0 110.324 -173.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -157.72 167.98 28.52 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.416 -1.427 . . . . 1.0 108.988 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 75.8 m -84.23 152.89 23.92 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -138.43 156.05 73.58 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.933 -1.485 . . . . 1.0 109.527 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.57 160.27 32.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.135 1.89 . . . . 1.0 109.666 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -156.75 163.83 38.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.39 0.995 . . . . 1.0 108.603 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.0 t -87.2 122.85 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -124.08 173.27 8.39 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.899 1.68 . . . . 1.0 106.637 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.32 -7.66 5.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 116.414 1.326 . . . . 1.0 116.414 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.86 -28.76 8.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 119.472 1.636 . . . . 1.0 111.586 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -75.11 -173.26 1.92 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.979 1.712 . . . . 1.0 109.331 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -34.41 134.2 0.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.759 2.824 . . . . 1.0 112.764 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.77 178.71 39.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.965 -2.054 . . . . 1.0 107.965 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -93.61 178.59 5.64 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.3 -18.51 71.46 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.582 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.54 70.97 1.82 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.996 0.919 . . . . 1.0 108.797 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.14 112.71 7.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.78 -1.563 . . . . 1.0 106.78 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.34 162.96 16.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.513 1.525 . . . . 1.0 107.072 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -106.55 -9.39 16.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.341 -1.299 . . . . 1.0 114.459 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 p -162.45 161.76 27.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.396 0.617 . . . . 1.0 109.964 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 23.0 tpt85 -60.95 -40.35 92.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.528 0.731 . . . . 1.0 110.464 174.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -66.8 0.41 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.932 2.493 . . . . 1.0 110.655 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 p -56.54 -33.87 66.51 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.647 0.592 . . . . 1.0 111.702 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.81 -51.92 23.79 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.281 13.9 mt-10 -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 116.052 -2.259 . . . . 1.0 112.825 173.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 1' ' ' GLU 0.258 8.2 t70 -65.95 -23.17 66.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 118.986 -1.086 . . . . 1.0 109.004 175.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.11 2.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.152 -1.593 . . . . 1.0 106.855 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.7 m -140.1 114.4 7.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.604 . . . . 1.0 110.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -98.5 -165.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.742 3.628 . . . . 1.0 113.104 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.504 ' CG1' ' H ' ' A' ' 63' ' ' VAL . 48.0 t -93.17 -157.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 101.003 -3.703 . . . . 1.0 101.003 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.504 ' H ' ' CG1' ' A' ' 62' ' ' VAL . 4.5 t -45.44 138.47 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.197 -1.564 . . . . 1.0 108.858 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -33.65 113.86 0.17 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 131.491 3.916 . . . . 1.0 113.687 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.25 -63.87 1.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.96 1.304 . . . . 1.0 109.437 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -70.76 73.64 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 104.206 -2.516 . . . . 1.0 104.206 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.335 2.2 m-70 -33.72 90.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 117.55 2.426 . . . . 1.0 117.55 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -84.02 -22.72 31.23 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.361 1.865 . . . . 1.0 109.781 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -134.04 -173.95 3.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.93 1.692 . . . . 1.0 108.639 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.248 0.997 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 173.496 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 106.497 -1.668 . . . . 1.0 106.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.03 168.4 26.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.894 0.877 . . . . 1.0 108.967 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.08 -23.93 66.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.03 0.932 . . . . 1.0 110.824 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.92 -2.63 40.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.302 1.441 . . . . 1.0 113.22 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.09 -78.81 0.58 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -163.24 139.1 6.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.521 3.128 . . . . 1.0 105.486 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -157.05 114.61 3.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.985 -1.858 . . . . 1.0 105.985 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.65 159.34 32.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.764 -1.569 . . . . 1.0 106.764 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.89 -46.07 31.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 119.213 -0.422 . . . . 1.0 110.283 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -23.84 67.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.186 0.903 . . . . 1.0 112.696 -174.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.31 -30.93 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.147 0.979 . . . . 1.0 109.87 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 tp -66.07 130.69 94.38 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 125.256 1.423 . . . . 1.0 112.732 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -49.88 153.62 5.88 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.499 2.799 . . . . 1.0 113.183 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.72 143.73 29.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.846 -1.07 . . . . 1.0 108.663 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.93 147.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -78.04 -53.42 7.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.259 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 176.49 15.7 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.085 1.326 . . . . 1.0 110.095 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.71 -35.24 4.72 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.923 2.415 . . . . 1.0 111.865 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.0 m -71.93 160.91 31.73 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 121.901 0.858 . . . . 1.0 111.006 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.94 3.77 19.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.854 1.662 . . . . 1.0 114.218 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.64 157.21 53.52 Favored Glycine 0 CA--C 1.538 1.476 1 N-CA-C 102.347 -4.301 . . . . 1.0 102.347 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -130.3 125.59 35.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.315 2.557 . . . . 1.0 108.742 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.515 ' CD ' HH12 ' A' ' 25' ' ' ARG . 5.7 tp10 -131.33 113.99 15.85 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 129.187 2.995 . . . . 1.0 107.076 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.62 133.59 32.51 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.734 2.956 . . . . 1.0 110.502 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.515 HH12 ' CD ' ' A' ' 23' ' ' GLU . 86.8 mmt-85 -133.09 177.29 7.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.608 -1.178 . . . . 1.0 108.85 173.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.4 m95 -126.11 143.48 51.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.526 2.33 . . . . 1.0 105.591 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.74 144.08 41.5 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.722 1.209 . . . . 1.0 107.838 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -81.24 137.59 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.78 0.8 . . . . 1.0 109.14 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 m -117.44 113.66 38.62 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 126.136 1.774 . . . . 1.0 107.578 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.86 -33.7 19.71 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.888 1.725 . . . . 1.0 110.88 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.78 -14.38 58.78 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.725 1.21 . . . . 1.0 112.348 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -113.4 -4.31 13.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.978 1.311 . . . . 1.0 110.549 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.09 36.83 2.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.163 2.585 . . . . 1.0 110.043 -173.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.68 172.13 14.68 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.373 -0.829 . . . . 1.0 108.918 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -104.94 143.01 33.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.4 0.68 . . . . 1.0 110.111 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -123.77 153.72 66.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.727 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -70.74 168.65 22.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.525 1.483 . . . . 1.0 110.027 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -163.11 163.91 25.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.66 113.5 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.927 -1.879 . . . . 1.0 105.927 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -99.85 163.22 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.622 1.969 . . . . 1.0 106.829 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.17 4.5 52.04 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.326 0.89 . . . . 1.0 115.326 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.59 -36.86 2.05 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.597 1.57 . . . . 1.0 113.832 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.7 p -87.99 -172.87 4.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.716 1.606 . . . . 1.0 107.927 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.62 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.649 2.38 . . . . 1.0 113.158 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.71 29.74 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.918 -2.073 . . . . 1.0 107.918 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.37 174.66 7.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.336 1.068 . . . . 1.0 109.712 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 -15.69 80.51 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.55 1.071 . . . . 1.0 114.179 -173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -78.41 70.24 4.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -138.1 113.12 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.616 1.166 . . . . 1.0 108.306 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.24 151.94 48.68 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.682 1.193 . . . . 1.0 108.28 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -93.15 -7.94 43.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.408 -0.807 . . . . 1.0 110.026 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -158.71 162.61 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.889 0.768 . . . . 1.0 111.108 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 26.1 ttp85 -65.26 -49.43 69.61 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.391 -0.822 . . . . 1.0 112.256 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -58.95 -48.27 82.13 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.56 0.537 . . . . 1.0 110.718 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 p -51.1 -38.85 54.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.7 t -73.99 -48.43 30.37 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.88 1.272 . . . . 1.0 110.067 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.34 -33.47 71.19 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.16 -31.69 62.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.385 -1.447 . . . . 1.0 109.407 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.89 -59.15 3.51 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.971 0.794 . . . . 1.0 110.658 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.4 m -110.11 98.78 36.62 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 1.0 108.397 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.68 176.46 10.01 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.971 2.447 . . . . 1.0 116.399 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 63' ' ' VAL . 3.5 t -131.43 -153.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 2 C-N-CA 135.201 5.4 . . . . 1.0 99.575 173.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' H ' HG13 ' A' ' 62' ' ' VAL . 2.5 t -49.12 131.81 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 105.834 -1.913 . . . . 1.0 105.834 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -56.29 120.69 8.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -49.82 -64.0 0.94 Allowed 'General case' 0 C--N 1.347 0.484 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.254 0.9 OUTLIER 173.05 56.44 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.787 3.235 . . . . 1.0 109.592 173.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -70.28 68.92 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.207 -1.558 . . . . 1.0 108.328 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -144.58 151.41 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.646 -1.284 . . . . 1.0 109.83 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -123.84 -8.26 7.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.04 1.736 . . . . 1.0 108.62 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.256 1.406 2 C-N-CA 141.98 8.112 . . . . 1.0 97.723 173.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.25 168.06 14.62 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.253 1.421 . . . . 1.0 107.768 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.19 -62.98 1.38 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 177.42 4.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.818 1.647 . . . . 1.0 109.713 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -52.61 -32.98 44.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.187 0.995 . . . . 1.0 111.187 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -138.92 92.99 2.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m 173.48 93.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 1 C-N-CA 132.099 4.16 . . . . 1.0 101.248 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.7 120.17 20.72 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 174.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.39 -23.19 1.37 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.15 1.78 . . . . 1.0 111.882 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 p -48.53 -29.76 4.54 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.256 0.935 . . . . 1.0 113.479 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.08 -27.06 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.178 0.899 . . . . 1.0 111.332 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.51 152.91 61.3 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 127.682 2.393 . . . . 1.0 110.938 -176.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.83 161.31 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.721 2.947 . . . . 1.0 113.158 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.99 113.61 11.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.01 115.15 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 107.436 -1.32 . . . . 1.0 107.436 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.74 -24.44 44.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.951 -1.477 . . . . 1.0 110.952 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.55 173.96 50.06 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.201 0.905 . . . . 1.0 111.263 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.06 -5.94 7.55 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.396 2.731 . . . . 1.0 114.631 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.3 m -73.74 -178.21 3.08 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 3.7 4.65 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.827 1.651 . . . . 1.0 113.423 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.88 154.32 22.46 Favored Glycine 0 CA--C 1.533 1.184 1 N-CA-C 100.652 -4.979 . . . . 1.0 100.652 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -132.55 122.59 25.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 120.968 2.384 . . . . 1.0 108.795 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -125.14 113.82 26.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.908 3.283 . . . . 1.0 106.847 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.13 126.82 14.95 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.521 2.814 . . . . 1.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -131.72 178.4 6.78 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.036 0.934 . . . . 1.0 109.361 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.522 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -117.59 144.43 45.15 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.443 1.097 . . . . 1.0 108.144 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.12 148.04 37.69 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.079 -0.711 . . . . 1.0 109.079 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -82.83 139.38 33.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 174.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m -117.11 113.42 39.37 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 117.213 -1.375 . . . . 1.0 107.619 173.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.43 -32.26 25.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.75 1.634 . . . . 1.0 110.239 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.3 -15.01 59.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.923 1.289 . . . . 1.0 112.471 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 mt -115.23 -4.2 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.094 1.358 . . . . 1.0 110.805 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.0 35.44 3.35 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.388 2.675 . . . . 1.0 110.042 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -162.51 168.68 21.54 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.563 -0.71 . . . . 1.0 109.707 -173.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -95.6 149.58 21.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.963 0.887 . . . . 1.0 112.114 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -139.85 154.5 70.82 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.624 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -69.78 161.82 44.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 107.971 -1.588 . . . . 1.0 107.971 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -159.04 170.7 21.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.081 0.855 . . . . 1.0 109.031 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.43 113.8 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 106.609 -1.626 . . . . 1.0 106.609 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.63 158.02 16.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.43 0.39 58.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 116.677 1.431 . . . . 1.0 116.677 -173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.65 3.41 54.51 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.224 1.512 . . . . 1.0 114.857 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 p -125.11 -172.46 2.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 128.717 2.807 . . . . 1.0 108.073 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -33.37 133.54 0.16 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.533 1.933 . . . . 1.0 113.001 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.26 168.09 40.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.814 -2.114 . . . . 1.0 107.814 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.99 -174.17 3.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.089 0.947 . . . . 1.0 109.06 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.72 -7.04 88.98 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 116.927 -2.041 . . . . 1.0 113.774 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -81.98 66.47 7.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 121.761 2.78 . . . . 1.0 107.607 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -147.08 113.66 6.0 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 130.81 3.644 . . . . 1.0 102.25 -173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -123.71 162.17 23.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.343 1.457 . . . . 1.0 107.747 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -93.07 -14.55 27.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.112 -1.403 . . . . 1.0 111.157 -173.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p -167.72 169.17 11.95 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.76 0.791 . . . . 1.0 109.996 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.0 tpt180 -61.4 -44.75 96.6 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -47.83 -66.51 0.39 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.231 2.612 . . . . 1.0 111.659 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.4 p -59.11 -33.46 70.87 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.046 0.927 . . . . 1.0 112.58 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -71.61 -49.95 35.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.044 0.938 . . . . 1.0 112.491 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.337 27.7 mt-10 -67.19 -32.94 74.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.02 -47.27 78.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 1.0 106.107 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.87 -58.44 8.59 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 118.686 0.675 . . . . 1.0 111.871 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 66.9 m -129.27 86.17 57.35 Favored Pre-proline 0 N--CA 1.452 -0.363 0 O-C-N 123.737 0.648 . . . . 1.0 110.506 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -85.31 -177.06 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.642 2.895 . . . . 1.0 110.088 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.54 172.8 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 102.87 -3.011 . . . . 1.0 102.87 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.94 125.38 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 120.339 -1.476 . . . . 1.0 107.579 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -126.39 167.79 15.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.172 1.789 . . . . 1.0 108.633 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -103.06 9.29 38.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.236 3.014 . . . . 1.0 111.803 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.47 -57.79 0.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.614 1.097 . . . . 1.0 111.248 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -65.09 148.5 51.54 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.467 1.107 . . . . 1.0 111.502 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.23 169.05 23.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.008 2.923 . . . . 1.0 105.313 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -138.39 -85.85 0.27 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 102.542 -3.133 . . . . 1.0 102.542 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 . . . . . 0 C--O 1.259 1.56 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 172.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.89 20.99 1.0 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.642 1.977 . . . . 1.0 109.502 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -77.62 -25.33 49.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.013 1.325 . . . . 1.0 111.345 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.57 168.08 10.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.384 1.873 . . . . 1.0 108.115 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.17 -38.81 71.41 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.091 0.957 . . . . 1.0 110.833 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.36 158.2 36.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.094 1.357 . . . . 1.0 108.2 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 m -161.27 110.11 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -73.73 97.78 2.77 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.814 -1.55 . . . . 1.0 106.814 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.7 -35.38 63.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 119.036 -0.507 . . . . 1.0 111.1 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -69.02 -15.62 63.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.059 1.3 . . . . 1.0 111.747 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.02 -21.77 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.418 1.087 . . . . 1.0 111.129 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.32 148.67 88.62 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 127.261 2.224 . . . . 1.0 110.819 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -70.85 179.04 4.6 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.266 1.977 . . . . 1.0 111.034 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -120.41 161.6 20.94 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 174.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.14 152.97 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.653 1.181 . . . . 1.0 109.217 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -88.04 -31.47 19.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.343 1.457 . . . . 1.0 113.201 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 176.94 51.44 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.199 0.904 . . . . 1.0 112.404 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.88 -25.47 27.98 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.293 2.662 . . . . 1.0 112.842 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.56 158.85 25.98 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.206 -0.934 . . . . 1.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 3.53 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.685 1.594 . . . . 1.0 112.985 173.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.42 153.23 38.79 Favored Glycine 0 CA--C 1.531 1.044 1 N-CA-C 102.123 -4.391 . . . . 1.0 102.123 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.91 105.37 8.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.621 1.711 . . . . 1.0 111.022 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.02 114.01 62.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.426 2.29 . . . . 1.0 105.629 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 114.1 3.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.536 2.824 . . . . 1.0 109.747 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -114.78 176.94 4.83 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.361 0.664 . . . . 1.0 109.372 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.515 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 63.1 m95 -114.19 145.37 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.34 144.91 40.56 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.24 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.717 0.807 . . . . 1.0 110.009 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -117.43 113.36 38.78 Favored Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 120.684 -1.26 . . . . 1.0 108.034 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.09 -34.36 6.38 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.573 1.515 . . . . 1.0 109.665 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -65.03 -20.57 66.56 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 124.324 1.05 . . . . 1.0 112.355 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.34 -6.02 23.54 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.405 0.682 . . . . 1.0 110.223 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.88 38.47 6.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.278 2.631 . . . . 1.0 108.412 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.7 166.82 28.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.2 148.8 24.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.324 1.059 . . . . 1.0 110.699 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -132.35 152.18 79.61 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.592 -1.186 . . . . 1.0 109.577 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -68.9 166.31 26.91 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -155.59 164.09 39.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 173.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.15 123.81 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.455 -1.683 . . . . 1.0 106.455 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -122.49 168.84 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.409 1.884 . . . . 1.0 106.331 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.63 8.11 6.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.899 -0.945 . . . . 1.0 115.027 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.97 -48.31 4.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.29 1.545 . . . . 1.0 110.289 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 p -69.05 -173.39 0.5 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.635 1.174 . . . . 1.0 109.4 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -34.77 133.57 0.27 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.697 1.999 . . . . 1.0 114.261 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.7 173.49 39.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.756 -2.538 . . . . 1.0 106.756 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -93.65 171.24 9.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.63 -6.82 63.58 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.44 1.019 . . . . 1.0 114.356 -173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -80.13 68.15 6.18 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -135.96 113.05 10.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.152 -1.796 . . . . 1.0 106.152 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.34 161.5 18.42 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 123.211 1.482 . . . . 1.0 108.382 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.1 -21.03 19.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.016 -2.356 . . . . 1.0 109.732 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -164.51 165.23 21.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.624 0.726 . . . . 1.0 109.117 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.515 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.56 -49.22 78.4 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.839 -1.073 . . . . 1.0 108.833 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.89 -66.85 0.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 128.004 2.521 . . . . 1.0 111.638 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -57.13 -33.27 67.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 t -67.51 -53.61 27.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.99 0.916 . . . . 1.0 112.908 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -33.27 75.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.526 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.84 -24.2 55.78 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.259 -0.877 . . . . 1.0 110.692 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.96 70.15 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 120.564 1.529 . . . . 1.0 111.634 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 m -116.41 75.64 6.61 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 118.702 0.683 . . . . 1.0 112.8 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.87 -178.89 4.11 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.397 2.065 . . . . 1.0 108.237 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.26 178.67 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.643 -1.984 . . . . 1.0 105.643 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.93 137.24 4.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.439 -1.689 . . . . 1.0 106.439 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -43.33 113.1 0.45 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.251 1.024 . . . . 1.0 113.55 -172.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.78 -27.17 60.21 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.309 -0.87 . . . . 1.0 110.276 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -70.98 8.43 0.92 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.517 1.127 . . . . 1.0 111.753 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -33.67 109.99 0.08 Allowed 'General case' 0 C--N 1.347 0.479 0 C-N-CA 127.13 2.172 . . . . 1.0 112.871 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -73.05 30.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.848 1.259 . . . . 1.0 112.473 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -144.58 177.67 8.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.577 1.951 . . . . 1.0 107.473 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.1 m170 . . . . . 0 C--O 1.244 0.796 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 173.646 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.77 -55.53 0.06 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.628 1.171 . . . . 1.0 108.184 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -76.42 -53.41 8.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.937 1.295 . . . . 1.0 107.677 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.73 177.92 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.623 1.569 . . . . 1.0 110.287 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.53 -23.49 26.68 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.174 2.59 . . . . 1.0 113.009 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -145.54 164.65 30.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.095 2.558 . . . . 1.0 105.385 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -122.9 93.7 4.04 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.12 170.65 16.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 105.957 -1.868 . . . . 1.0 105.957 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.62 -42.1 15.69 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 121.195 -0.941 . . . . 1.0 110.205 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 p -62.81 -28.93 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.476 0.711 . . . . 1.0 111.924 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.32 -28.08 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.2 tp -69.2 125.43 91.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 126.946 2.098 . . . . 1.0 112.412 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.91 154.71 4.83 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.579 2.852 . . . . 1.0 112.764 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.71 160.98 27.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.844 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -135.01 148.78 28.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 126.307 1.843 . . . . 1.0 106.226 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -74.0 -56.39 4.99 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.08 171.7 15.44 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.891 2.186 . . . . 1.0 108.682 -173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.11 -35.69 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.425 2.083 . . . . 1.0 111.375 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.5 158.64 23.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.952 0.882 . . . . 1.0 110.788 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 3.94 22.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.807 2.043 . . . . 1.0 113.701 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.7 154.13 50.96 Favored Glycine 0 CA--C 1.535 1.331 1 N-CA-C 102.85 -4.1 . . . . 1.0 102.85 172.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -125.2 104.86 8.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 120.526 2.163 . . . . 1.0 110.864 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -99.27 119.21 61.04 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 127.468 2.307 . . . . 1.0 107.168 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.59 125.65 10.24 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.11 2.54 . . . . 1.0 109.933 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -130.27 177.11 7.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.36 -0.837 . . . . 1.0 109.533 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.53 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -112.66 141.2 46.72 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.93 0.892 . . . . 1.0 108.619 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.37 147.52 45.57 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.07 133.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.792 0.682 . . . . 1.0 110.145 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -117.59 113.42 38.45 Favored Pre-proline 0 N--CA 1.445 -0.702 0 O-C-N 119.854 -1.779 . . . . 1.0 109.075 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.14 -35.11 20.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.752 1.635 . . . . 1.0 109.982 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.83 -19.71 65.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.62 1.168 . . . . 1.0 112.151 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -103.04 -4.15 24.98 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.364 1.066 . . . . 1.0 110.078 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.63 29.98 8.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.493 2.717 . . . . 1.0 110.749 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -165.04 166.66 19.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.96 0.8 . . . . 1.0 109.861 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.01 147.36 22.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.029 0.918 . . . . 1.0 109.459 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -142.7 153.74 61.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.625 0.77 . . . . 1.0 111.132 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.43 160.08 44.5 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.815 1.677 . . . . 1.0 108.534 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -153.59 160.34 42.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.622 1.101 . . . . 1.0 108.776 173.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.12 113.62 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.942 -1.874 . . . . 1.0 105.942 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -107.63 167.68 9.78 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.229 2.212 . . . . 1.0 106.457 173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.77 9.39 10.59 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.15 0.82 . . . . 1.0 115.15 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.26 -39.66 2.3 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.276 1.417 . . . . 1.0 113.241 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.17 -172.98 3.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.584 1.154 . . . . 1.0 108.41 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.7 mp0 -33.99 133.94 0.19 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.047 2.539 . . . . 1.0 112.838 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.23 -167.22 23.33 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 107.453 -2.259 . . . . 1.0 107.453 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.31 173.56 7.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.462 1.131 . . . . 1.0 108.172 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.87 -15.19 81.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.359 -0.837 . . . . 1.0 112.547 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -74.92 79.73 2.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.872 0.869 . . . . 1.0 108.675 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -146.57 113.09 5.96 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.915 -1.883 . . . . 1.0 105.915 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.32 162.33 19.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.499 1.52 . . . . 1.0 108.351 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -93.49 -19.43 21.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.145 -1.388 . . . . 1.0 112.381 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 p -162.73 169.34 20.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 1.0 109.561 -173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.7 tpt180 -61.81 -49.32 76.77 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.06 -0.973 . . . . 1.0 108.507 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.12 -66.61 0.38 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.508 2.723 . . . . 1.0 112.123 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 p -60.35 -33.25 72.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.734 0.646 . . . . 1.0 112.229 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.41 -51.84 39.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 112.694 0.627 . . . . 1.0 112.694 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.286 71.5 mt-10 -69.76 -33.28 72.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.144 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.06 -35.28 80.1 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.48 -50.74 34.83 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 120.164 1.347 . . . . 1.0 111.674 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.79 113.47 20.63 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.087 1.884 . . . . 1.0 116.087 -173.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -78.37 -163.17 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.946 1 C-N-CA 125.453 4.102 . . . . 1.0 109.714 173.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.56 -168.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 104.708 -2.33 . . . . 1.0 104.708 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -46.43 123.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 102.198 -3.26 . . . . 1.0 102.198 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.09 113.27 8.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 117.562 2.43 . . . . 1.0 117.562 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -86.54 79.49 8.92 Favored 'General case' 0 N--CA 1.425 -1.689 1 N-CA-C 97.032 -5.174 . . . . 1.0 97.032 172.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -33.02 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.947 2.899 . . . . 1.0 116.295 -172.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -78.82 96.95 5.77 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 127.187 2.195 . . . . 1.0 107.922 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -62.76 87.75 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.489 0.716 . . . . 1.0 110.055 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.587 ' CG ' ' H ' ' A' ' 70' ' ' HIS . 58.2 t60 173.71 -168.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 136.133 5.773 . . . . 1.0 100.993 -174.056 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.587 ' H ' ' CG ' ' A' ' 69' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.243 0.728 0 N-CA-C 102.093 -3.299 . . . . 1.0 102.093 172.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.39 145.33 54.23 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.598 -0.689 . . . . 1.0 110.915 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.93 -29.68 2.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.098 1.359 . . . . 1.0 110.397 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.45 167.48 11.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.553 1.141 . . . . 1.0 108.226 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.72 -44.22 58.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.324 1.449 . . . . 1.0 111.592 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.35 92.73 2.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.119 -1.437 . . . . 1.0 107.119 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m 173.54 137.26 0.04 OUTLIER 'General case' 0 C--O 1.235 0.317 0 C-N-CA 130.422 3.489 . . . . 1.0 104.979 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.53 146.83 25.39 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.601 -1.629 . . . . 1.0 106.601 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -23.6 0.42 Allowed 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 127.476 2.31 . . . . 1.0 112.283 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -46.86 -25.44 0.77 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.874 -1.141 . . . . 1.0 113.482 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.85 -33.0 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 119.403 1.002 . . . . 1.0 111.916 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 152.87 93.12 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 128.406 2.682 . . . . 1.0 109.013 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.06 173.15 10.76 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.742 . . . . 1.0 111.598 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.31 113.58 7.61 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.627 -1.249 . . . . 1.0 107.627 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.69 123.94 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.008 -1.479 . . . . 1.0 107.008 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -79.33 -33.41 43.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.257 -1.338 . . . . 1.0 110.737 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.84 172.66 42.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.74 -8.55 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.024 2.483 . . . . 1.0 114.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.55 -179.5 5.29 Favored 'General case' 0 N--CA 1.461 0.095 0 O-C-N 120.952 -1.093 . . . . 1.0 113.57 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.27 3.81 4.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.307 1.443 . . . . 1.0 113.576 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.79 157.12 29.48 Favored Glycine 0 CA--C 1.533 1.214 1 N-CA-C 101.301 -4.72 . . . . 1.0 101.301 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -131.44 117.88 19.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 121.333 2.567 . . . . 1.0 108.869 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.16 113.94 29.46 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 129.323 3.049 . . . . 1.0 107.77 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.55 125.44 13.33 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.559 2.839 . . . . 1.0 111.203 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -131.56 -179.99 5.7 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.403 1.081 . . . . 1.0 109.846 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 55.1 m95 -117.35 141.4 48.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.797 0.839 . . . . 1.0 108.751 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.86 148.44 48.64 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.87 143.69 29.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.666 0.746 . . . . 1.0 109.01 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 113.28 39.35 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 105.498 -2.038 . . . . 1.0 105.498 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.41 -32.41 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.747 1.631 . . . . 1.0 110.656 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.01 -17.1 64.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.793 0.837 . . . . 1.0 112.299 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.96 -4.29 16.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 1.0 110.546 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.78 35.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.64 3.176 . . . . 1.0 108.45 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -162.75 170.88 17.64 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 121.139 -0.976 . . . . 1.0 110.185 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -100.85 145.08 29.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.938 1.695 . . . . 1.0 111.738 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -138.48 153.6 72.77 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.887 0.875 . . . . 1.0 110.689 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.48 163.32 24.29 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.492 2.128 . . . . 1.0 110.483 173.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.0 168.26 27.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.19 113.72 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -99.36 163.82 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.561 1.944 . . . . 1.0 105.809 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.77 1.48 41.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 116.459 1.344 . . . . 1.0 116.459 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.5 1.96 67.13 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 118.963 1.382 . . . . 1.0 115.456 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.2 p -125.53 -172.65 2.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.699 2.4 . . . . 1.0 108.074 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -33.26 133.52 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.827 2.051 . . . . 1.0 112.839 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.2 42.27 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -93.81 -174.11 3.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.172 0.987 . . . . 1.0 109.773 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.4 -7.61 88.09 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 127.764 2.602 . . . . 1.0 113.591 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -86.3 53.16 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.442 2.121 . . . . 1.0 106.911 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -131.47 112.73 12.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 101.902 -3.37 . . . . 1.0 101.902 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -108.85 156.15 19.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.12 -13.46 28.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.461 -2.154 . . . . 1.0 112.137 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -166.48 169.33 13.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.694 1.198 . . . . 1.0 109.131 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -64.5 -42.93 95.54 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -48.97 -66.34 0.42 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.689 2.796 . . . . 1.0 111.318 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.8 p -58.47 -36.07 73.14 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.95 0.781 . . . . 1.0 111.495 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 39.1 t -66.61 -52.99 39.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.5 0.72 . . . . 1.0 112.35 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.39 -33.41 72.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.471 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.42 -29.48 61.52 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.663 1.119 . . . . 1.0 111.563 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -61.64 1.69 Allowed 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.372 0.987 . . . . 1.0 110.15 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.0 m -118.89 99.7 51.05 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.693 1.197 . . . . 1.0 108.336 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -93.11 -163.68 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.482 3.455 . . . . 1.0 112.952 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.41 HG12 ' H ' ' A' ' 63' ' ' VAL . 6.5 t -105.16 -152.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.637 2 C-N-CA 138.401 6.68 . . . . 1.0 95.178 172.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -47.04 130.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 104.31 -2.478 . . . . 1.0 104.31 172.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' CG ' ' HD1' ' A' ' 66' ' ' HIS . 25.8 t70 -68.76 135.55 51.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.601 0.963 . . . . 1.0 113.601 -172.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -66.68 -4.6 9.22 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.611 1.964 . . . . 1.0 113.49 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.4 ' HD1' ' CG ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -140.3 -85.29 0.21 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.553 1.07 . . . . 1.0 108.808 -176.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.2 p80 173.17 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.863 3.265 . . . . 1.0 110.647 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -85.52 160.52 19.65 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.536 -1.352 . . . . 1.0 108.941 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -55.76 147.58 18.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.149 0.58 . . . . 1.0 109.729 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.174 0 N-CA-C 102.4 -3.185 . . . . 1.0 102.4 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 108.809 -0.811 . . . . 1.0 108.809 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.14 129.8 41.06 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 149.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -136.96 -23.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 117.757 2.503 . . . . 1.0 117.757 -172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.15 -173.32 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.218 1.372 . . . . 1.0 111.407 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -59.13 -25.7 64.09 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.362 1.465 . . . . 1.0 111.273 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.74 94.39 0.12 Allowed 'General case' 0 C--N 1.342 0.262 0 N-CA-C 106.731 -1.581 . . . . 1.0 106.731 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -82.09 94.06 7.14 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -174.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.98 157.63 27.72 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.56 23.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.258 -0.877 . . . . 1.0 111.774 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -21.0 66.01 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.302 1.41 . . . . 1.0 111.566 -174.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.3 t -74.2 -36.71 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.931 -1.105 . . . . 1.0 110.252 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 tp -70.29 129.98 89.89 Favored Pre-proline 0 N--CA 1.455 -0.176 0 C-N-CA 127.229 2.212 . . . . 1.0 113.199 -175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.01 153.73 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.008 2.472 . . . . 1.0 111.403 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.97 166.82 16.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.315 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.93 146.3 30.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.403 -2.073 . . . . 1.0 105.403 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -97.53 -24.37 15.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.259 1.024 . . . . 1.0 112.242 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.08 45.82 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.999 1.761 . . . . 1.0 112.014 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.81 -3.43 13.85 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.609 3.539 . . . . 1.0 115.032 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.3 m -61.05 178.56 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.712 1.605 . . . . 1.0 113.298 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 3.65 3.98 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.233 1.413 . . . . 1.0 113.201 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.04 153.39 20.55 Favored Glycine 0 CA--C 1.529 0.945 1 N-CA-C 101.974 -4.45 . . . . 1.0 101.974 172.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -130.06 105.79 8.19 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.245 1.523 . . . . 1.0 111.324 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.01 114.84 64.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 129.153 2.981 . . . . 1.0 106.638 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.73 122.18 8.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.395 2.73 . . . . 1.0 109.549 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -123.28 179.57 4.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.593 0.757 . . . . 1.0 108.976 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.477 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -125.13 144.35 50.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.506 1.122 . . . . 1.0 108.436 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.57 141.33 35.22 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -77.14 137.73 39.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -117.3 113.66 38.89 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 117.463 -1.256 . . . . 1.0 108.006 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.26 -33.72 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.953 1.769 . . . . 1.0 110.805 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.66 -20.32 66.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.048 0.939 . . . . 1.0 112.37 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.66 -4.06 22.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.842 1.257 . . . . 1.0 110.479 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.65 16.85 2.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 128.416 2.686 . . . . 1.0 111.721 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -164.13 172.17 14.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.979 1.263 . . . . 1.0 110.525 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -87.75 148.82 24.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -133.9 155.9 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.989 1.316 . . . . 1.0 109.953 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.38 165.88 31.06 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.982 1.788 . . . . 1.0 109.237 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -158.6 165.69 33.87 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.7 t -89.05 129.96 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.793 -1.558 . . . . 1.0 106.793 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -132.46 170.13 15.57 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.492 1.517 . . . . 1.0 107.163 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.26 -3.18 8.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.946 1.538 . . . . 1.0 116.946 -173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.56 -29.92 6.42 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.826 1.813 . . . . 1.0 111.838 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -73.34 -173.2 1.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.383 1.873 . . . . 1.0 109.649 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -34.14 134.04 0.2 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.52 2.728 . . . . 1.0 112.983 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.93 175.86 41.44 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.271 -1.932 . . . . 1.0 108.271 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -93.62 177.55 5.98 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.89 76.15 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.511 -0.768 . . . . 1.0 112.825 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -78.99 70.2 5.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.372 1.086 . . . . 1.0 108.4 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -144.42 113.07 6.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -119.76 162.03 19.75 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.227 1.411 . . . . 1.0 108.785 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -93.33 -14.16 27.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.591 -1.186 . . . . 1.0 112.032 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -166.24 170.7 12.97 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.54 0.686 . . . . 1.0 109.222 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -62.81 -46.32 88.49 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -66.87 0.32 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 128.796 2.838 . . . . 1.0 111.079 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -54.57 -33.26 59.94 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.7 t -72.62 -49.42 32.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.448 -0.782 . . . . 1.0 112.793 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.19 -33.74 76.48 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 118.515 -0.755 . . . . 1.0 109.883 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.87 -41.41 97.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.813 0.845 . . . . 1.0 110.113 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.25 -42.01 76.18 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 118.709 0.686 . . . . 1.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.9 m -122.15 78.09 42.79 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 123.619 0.768 . . . . 1.0 110.855 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.04 159.96 48.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.215 2.61 . . . . 1.0 110.003 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.67 160.99 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 122.247 1.022 . . . . 1.0 108.411 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.62 -177.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 127.518 2.327 . . . . 1.0 106.784 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.415 ' CG ' ' HD1' ' A' ' 66' ' ' HIS . 1.9 t70 -49.54 137.14 15.65 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -65.03 -7.01 10.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.415 ' HD1' ' CG ' ' A' ' 64' ' ' ASP . 49.3 m80 -78.29 -9.86 59.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.993 1.724 . . . . 1.0 109.297 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -56.78 89.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.631 2.372 . . . . 1.0 112.155 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -64.65 133.71 52.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.426 -2.435 . . . . 1.0 104.426 173.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -80.39 -144.6 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 105.376 -2.083 . . . . 1.0 105.376 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.142 0 N-CA-C 106.407 -1.701 . . . . 1.0 106.407 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.2 -155.42 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.39 1.876 . . . . 1.0 106.653 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -52.65 -23.69 7.05 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.849 1.66 . . . . 1.0 110.41 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.91 135.8 53.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.171 -2.159 . . . . 1.0 105.171 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.9 -66.91 0.31 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.028 1.331 . . . . 1.0 111.36 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -84.98 93.56 8.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.24 -1.393 . . . . 1.0 107.24 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -160.36 152.43 20.31 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.06 2.544 . . . . 1.0 104.79 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -70.47 147.46 49.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 122.101 -0.374 . . . . 1.0 110.779 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.57 -39.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.679 1.592 . . . . 1.0 111.813 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -22.67 61.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.528 1.513 . . . . 1.0 112.746 -173.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.47 -37.87 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.11 0.868 . . . . 1.0 110.754 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 147.09 87.03 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.746 2.018 . . . . 1.0 112.832 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.09 158.08 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.063 3.175 . . . . 1.0 113.019 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.89 113.39 13.32 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.343 -1.473 . . . . 1.0 108.053 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.88 129.35 44.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -79.12 -35.12 42.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.938 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.51 171.98 37.95 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.95 -40.72 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.259 1.973 . . . . 1.0 112.849 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.5 m -68.12 159.32 31.2 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 121.34 -0.85 . . . . 1.0 111.877 -174.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 3.92 24.84 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.978 2.111 . . . . 1.0 114.279 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.41 165.48 46.8 Favored Glycine 0 CA--C 1.544 1.901 1 N-CA-C 102.49 -4.244 . . . . 1.0 102.49 172.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -136.95 135.88 38.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 123.444 3.622 . . . . 1.0 110.943 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -135.91 121.05 13.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 131.221 3.808 . . . . 1.0 107.237 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 128.15 16.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.377 2.718 . . . . 1.0 109.582 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -130.67 -179.01 5.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.428 1.091 . . . . 1.0 108.506 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.524 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.0 m95 -129.83 145.31 51.58 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 127.29 2.236 . . . . 1.0 106.613 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.08 145.64 30.62 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -80.72 138.48 36.33 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.548 0.689 . . . . 1.0 109.628 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -117.31 113.68 38.85 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 116.723 -1.608 . . . . 1.0 106.798 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.67 -33.28 28.44 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.855 1.704 . . . . 1.0 110.077 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.82 -15.62 62.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.761 1.224 . . . . 1.0 112.568 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.2 mt -112.35 -4.0 14.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.414 1.486 . . . . 1.0 110.498 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.64 26.94 2.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.333 3.053 . . . . 1.0 111.843 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -164.85 167.89 18.29 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.05 -1.031 . . . . 1.0 110.134 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.4 m -84.39 144.95 28.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.751 0.786 . . . . 1.0 112.396 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.46 155.12 81.9 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.058 1.343 . . . . 1.0 109.62 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.92 167.37 27.5 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.745 1.63 . . . . 1.0 108.739 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -161.84 166.32 26.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.36 113.47 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.239 -2.134 . . . . 1.0 105.239 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.441 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 14.0 t80 -98.9 156.33 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.559 1.944 . . . . 1.0 107.005 175.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.19 1.27 73.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 115.351 0.9 . . . . 1.0 115.351 -173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.441 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 80.44 -38.22 2.26 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.51 1.529 . . . . 1.0 114.21 174.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.6 p -80.91 -173.2 4.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 1.0 109.432 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.82 133.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.317 2.647 . . . . 1.0 113.261 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.88 -179.68 39.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.881 -1.688 . . . . 1.0 108.881 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.64 -175.05 3.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.711 0.767 . . . . 1.0 110.486 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.22 -19.76 79.47 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.742 -1.588 . . . . 1.0 115.498 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -79.99 70.87 6.65 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.605 2.203 . . . . 1.0 108.227 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -149.4 113.3 5.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 -173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -125.53 156.07 39.61 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.127 1.771 . . . . 1.0 107.689 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -93.58 -10.12 35.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 1.0 111.969 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.76 158.09 43.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 120.162 1.346 . . . . 1.0 111.319 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.524 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -61.72 -45.99 91.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.39 -1.277 . . . . 1.0 109.426 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.36 -66.57 0.38 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.042 2.537 . . . . 1.0 112.369 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.4 p -57.99 -41.27 82.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.011 0.819 . . . . 1.0 110.861 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.55 -48.32 72.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.946 0.898 . . . . 1.0 112.137 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.52 -34.04 77.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 117.503 -1.237 . . . . 1.0 110.886 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.76 -29.75 70.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.406 1.912 . . . . 1.0 111.1 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -63.5 1.05 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-N 119.49 1.041 . . . . 1.0 108.398 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -131.05 105.5 15.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 1.0 110.216 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -101.68 -162.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 1 C-N-CA 127.595 5.53 . . . . 1.0 112.266 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 63' ' ' VAL . 46.5 t -92.98 -152.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 2 C-N-CA 134.922 5.289 . . . . 1.0 97.178 172.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' HG13 ' A' ' 62' ' ' VAL . 2.4 t -42.26 124.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 119.106 -2.247 . . . . 1.0 105.952 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -84.74 148.82 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 118.983 2.957 . . . . 1.0 118.983 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -64.24 -57.54 9.16 Favored 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 132.936 4.494 . . . . 1.0 106.046 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -69.39 154.34 42.18 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -141.64 163.66 32.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 119.569 -1.957 . . . . 1.0 108.696 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -50.33 116.26 1.8 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.559 1.144 . . . . 1.0 110.434 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.29 127.36 29.0 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.982 0 O-C-N 125.297 1.623 . . . . 1.0 109.808 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 2.7 mp0 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 1' ' ' GLU . . . -57.15 -3.6 0.15 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.035 2.134 . . . . 1.0 115.036 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.81 -26.79 68.79 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.226 0.921 . . . . 1.0 109.968 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.47 172.71 7.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.714 1.606 . . . . 1.0 110.516 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -58.26 -32.63 68.56 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.4 1.48 . . . . 1.0 111.923 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -156.04 172.96 17.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.722 1.609 . . . . 1.0 107.982 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 m -149.33 105.96 3.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.849 -1.537 . . . . 1.0 106.849 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.93 162.33 29.52 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.837 -1.912 . . . . 1.0 105.837 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.74 42.36 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.89 0.768 . . . . 1.0 109.799 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.15 68.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.976 0.807 . . . . 1.0 112.291 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.08 -34.55 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.039 0.936 . . . . 1.0 109.843 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tp -64.68 129.24 94.23 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 125.672 1.589 . . . . 1.0 113.169 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.6 159.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.597 2.865 . . . . 1.0 111.859 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.17 113.72 25.76 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.118 -0.989 . . . . 1.0 109.599 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.77 145.88 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.3 -23.96 18.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.066 1.347 . . . . 1.0 111.59 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.12 168.86 34.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.085 1.326 . . . . 1.0 115.189 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.17 -28.23 2.05 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.844 3.029 . . . . 1.0 113.221 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 m -72.7 165.38 24.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.035 0.834 . . . . 1.0 110.728 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -111.85 3.78 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.11 1.152 . . . . 1.0 114.11 -174.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 154.27 37.47 Favored Glycine 0 CA--C 1.534 1.25 1 N-CA-C 101.892 -4.483 . . . . 1.0 101.892 172.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -136.16 129.77 32.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.711 2.255 . . . . 1.0 108.379 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' CD ' HH12 ' A' ' 25' ' ' ARG . 5.7 tp10 -131.08 113.98 16.16 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 129.679 3.192 . . . . 1.0 105.744 -174.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.93 129.34 20.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.287 2.658 . . . . 1.0 109.925 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.413 HH12 ' CD ' ' A' ' 23' ' ' GLU . 87.3 mmt-85 -130.46 176.19 8.35 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.736 -1.12 . . . . 1.0 108.639 173.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.569 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 62.8 m95 -129.83 139.15 51.27 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.972 -1.862 . . . . 1.0 105.972 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.91 145.31 41.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -81.69 139.09 35.12 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.728 0.775 . . . . 1.0 110.811 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -117.44 113.59 38.64 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.114 -1.422 . . . . 1.0 107.328 172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.82 -34.33 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.977 1.785 . . . . 1.0 110.832 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.6 -20.67 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.142 0.977 . . . . 1.0 112.42 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -103.1 -5.39 23.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.731 1.212 . . . . 1.0 110.61 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 48.95 29.88 2.54 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 130.74 3.616 . . . . 1.0 110.065 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -165.47 168.33 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.378 -0.826 . . . . 1.0 109.187 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.5 m -90.79 147.72 23.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -126.43 156.06 73.39 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.743 1.217 . . . . 1.0 109.47 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -72.85 168.67 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.589 1.526 . . . . 1.0 109.252 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -159.54 165.34 33.13 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.64 113.93 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.053 -2.202 . . . . 1.0 105.053 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -106.55 145.92 31.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.458 -1.682 . . . . 1.0 106.458 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.07 3.31 85.75 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.109 -0.828 . . . . 1.0 114.667 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.99 -49.08 3.43 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.983 1.278 . . . . 1.0 110.058 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.6 p -72.58 -172.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.396 1.478 . . . . 1.0 108.44 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -33.05 133.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.269 2.228 . . . . 1.0 114.46 -173.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.21 177.58 44.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 128.299 2.857 . . . . 1.0 106.861 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 -93.73 177.02 6.14 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.276 1.038 . . . . 1.0 109.906 -174.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.22 82.43 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.845 -1.071 . . . . 1.0 113.504 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.34 72.11 3.07 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -135.37 112.95 10.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.94 149.69 43.93 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.51 -8.52 41.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 118.531 -0.747 . . . . 1.0 110.76 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -155.34 158.94 39.51 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.083 0.856 . . . . 1.0 112.249 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.569 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -57.19 -56.98 14.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.839 1.656 . . . . 1.0 111.661 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.16 -47.53 82.28 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.057 0.848 . . . . 1.0 111.72 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.7 p -53.68 -35.3 60.92 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.83 -48.43 21.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.55 -34.02 73.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.397 -0.811 . . . . 1.0 111.346 174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.96 -27.07 49.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.217 1.371 . . . . 1.0 110.665 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.03 1.14 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.986 1.267 . . . . 1.0 109.174 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 m -121.4 106.43 37.98 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 124.967 1.307 . . . . 1.0 107.894 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -94.28 -171.88 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.231 2.621 . . . . 1.0 113.227 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.66 -152.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.76 2 N-CA-C 96.417 -5.401 . . . . 1.0 96.417 172.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -47.87 123.53 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 N-CA-C 102.588 -3.115 . . . . 1.0 102.588 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -33.7 113.74 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 117.843 2.534 . . . . 1.0 117.843 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -34.73 65.58 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.178 0.991 . . . . 1.0 112.105 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -83.09 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.357 1.063 . . . . 1.0 111.478 -173.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 80.88 7.13 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.415 -1.428 . . . . 1.0 108.048 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -34.96 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.105 2.562 . . . . 1.0 112.09 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -62.94 150.73 41.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.986 0 N-CA-C 100.719 -3.808 . . . . 1.0 100.719 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 174.09 -140.98 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.611 1 C-N-CA 133.338 4.655 . . . . 1.0 102.134 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.54 -42.05 77.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.911 1.687 . . . . 1.0 109.707 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.28 176.28 5.17 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.45 -29.48 70.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 118.315 -1.354 . . . . 1.0 109.846 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.61 92.79 2.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.051 0.841 . . . . 1.0 109.343 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m 172.97 126.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 1 C-N-CA 132.479 4.312 . . . . 1.0 102.972 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -136.36 134.67 38.1 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.028 -2.212 . . . . 1.0 105.028 173.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.09 -29.62 2.31 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.474 1.109 . . . . 1.0 110.634 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -66.61 -14.97 63.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.934 0.893 . . . . 1.0 113.38 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.18 -28.94 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.265 1.026 . . . . 1.0 109.517 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.1 tp -71.05 131.8 86.94 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.227 2.211 . . . . 1.0 113.013 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -51.51 157.73 4.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.646 2.897 . . . . 1.0 113.139 173.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.22 164.46 24.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.663 0.785 . . . . 1.0 110.433 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.35 151.43 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.036 1.734 . . . . 1.0 106.405 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -99.38 -27.55 13.7 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.001 0.92 . . . . 1.0 113.442 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.6 171.05 46.83 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.989 -1.645 . . . . 1.0 108.989 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.85 -27.01 37.73 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.734 2.289 . . . . 1.0 112.504 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.72 155.37 38.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.085 0.954 . . . . 1.0 109.562 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.09 3.97 19.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.487 1.915 . . . . 1.0 113.962 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.03 157.48 48.85 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 103.639 -3.785 . . . . 1.0 103.639 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -132.76 108.36 8.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 121.541 2.671 . . . . 1.0 115.102 -173.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' CD ' ' HE ' ' A' ' 25' ' ' ARG . 75.7 tt0 -106.04 126.21 31.18 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -71.09 113.72 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.404 2.069 . . . . 1.0 108.142 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.495 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 25.6 mmt85 -107.92 178.87 4.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.691 -1.225 . . . . 1.0 107.691 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.503 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -133.22 143.61 49.25 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.825 1.65 . . . . 1.0 107.724 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.32 149.36 37.67 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.82 0.848 . . . . 1.0 109.063 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -83.63 141.47 31.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.195 0.998 . . . . 1.0 110.818 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.2 m -117.34 113.29 38.98 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 106.08 -1.822 . . . . 1.0 106.08 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.14 -32.18 21.71 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.631 1.554 . . . . 1.0 110.219 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.65 -15.34 61.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 1.0 112.367 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 mt -112.7 -4.57 14.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.823 1.249 . . . . 1.0 110.521 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.93 36.66 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.276 2.63 . . . . 1.0 109.821 -173.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -164.85 169.01 17.13 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.738 -0.601 . . . . 1.0 109.576 -173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -95.31 150.84 19.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.498 1.142 . . . . 1.0 112.883 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -135.04 155.66 78.94 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.725 1.21 . . . . 1.0 109.682 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.59 169.51 21.67 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.938 1.759 . . . . 1.0 110.229 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -162.56 175.22 11.66 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.538 1.935 . . . . 1.0 106.722 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.1 126.58 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.021 -1.474 . . . . 1.0 107.021 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.77 160.1 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.033 2.533 . . . . 1.0 110.015 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.72 19.32 11.37 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 118.104 2.002 . . . . 1.0 118.104 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 -46.81 3.34 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 119.807 1.803 . . . . 1.0 112.321 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 p -65.9 -173.14 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.686 1.595 . . . . 1.0 110.541 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.3 mp0 -33.54 133.85 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 129.394 3.078 . . . . 1.0 114.365 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.81 174.85 35.17 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.159 -1.976 . . . . 1.0 108.159 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.59 -177.62 4.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 -23.72 76.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.333 0.492 . . . . 1.0 112.341 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.71 69.08 4.83 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.032 0.916 . . . . 1.0 108.81 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -152.14 113.14 4.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.07 156.72 42.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.5 1.52 . . . . 1.0 109.206 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -93.46 -8.21 42.26 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.424 -0.798 . . . . 1.0 110.68 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 p -157.14 166.07 34.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.025 0.829 . . . . 1.0 109.897 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.9 tpt180 -60.28 -47.38 86.27 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 173.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -44.66 -66.56 0.38 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 128.284 2.634 . . . . 1.0 112.474 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 p -60.65 -36.04 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.626 0.579 . . . . 1.0 111.91 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.39 -47.71 63.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.283 0.633 . . . . 1.0 111.715 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.57 -32.91 74.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.176 0.991 . . . . 1.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.58 -40.18 70.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 117.737 -1.125 . . . . 1.0 110.001 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -59.18 5.09 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.819 1.19 . . . . 1.0 110.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.3 m -122.19 107.32 35.12 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.087 1.355 . . . . 1.0 108.307 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -94.37 -166.27 0.13 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.957 2.438 . . . . 1.0 113.855 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.459 HG12 ' H ' ' A' ' 63' ' ' VAL . 15.9 t -101.49 -152.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 2 C-N-CA 137.742 6.417 . . . . 1.0 95.716 172.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -44.52 125.94 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 O-C-N 119.523 -1.985 . . . . 1.0 105.864 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -62.98 133.12 54.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.596 -1.184 . . . . 1.0 112.181 -172.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -84.45 -18.32 36.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.989 2.116 . . . . 1.0 110.267 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 -131.15 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.696 2.398 . . . . 1.0 107.465 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -170.91 152.26 3.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.701 2.801 . . . . 1.0 105.61 173.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.32 53.89 1.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.181 0.992 . . . . 1.0 109.817 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.07 179.66 8.23 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 119.511 -1.993 . . . . 1.0 111.567 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.244 0.812 0 C-N-CA 130.636 3.574 . . . . 1.0 102.685 173.163 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.924 0.869 . . . . 1.0 108.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.36 29.82 0.13 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.351 2.66 . . . . 1.0 107.626 170.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -138.88 -25.08 0.89 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.09 1.356 . . . . 1.0 112.045 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.44 -8.44 11.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.361 1.864 . . . . 1.0 113.905 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -68.38 -42.33 79.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.483 1.913 . . . . 1.0 114.784 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -156.87 120.77 4.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.328 1.422 . . . . 1.0 112.618 -174.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.529 ' CG2' ' H ' ' A' ' 8' ' ' ASP . 3.6 m 173.37 -167.18 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 1 C-N-CA 133.393 4.677 . . . . 1.0 103.733 173.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.529 ' H ' ' CG2' ' A' ' 7' ' ' THR . 15.1 t70 -49.12 160.44 0.21 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.453 1.501 . . . . 1.0 109.945 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.74 -34.8 8.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.945 -1.026 . . . . 1.0 112.417 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 p -55.22 -31.51 61.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.174 1.352 . . . . 1.0 112.518 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.79 -34.3 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.307 -0.87 . . . . 1.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.7 129.14 91.2 Favored Pre-proline 0 CA--C 1.522 -0.124 0 C-N-CA 125.276 1.43 . . . . 1.0 113.045 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.93 151.36 8.58 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.316 2.678 . . . . 1.0 112.164 173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.5 23.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.576 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.48 139.98 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 104.689 -2.337 . . . . 1.0 104.689 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.61 -58.29 3.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.28 171.66 12.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.729 1.633 . . . . 1.0 109.979 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.9 -12.22 14.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.973 2.449 . . . . 1.0 112.802 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.66 176.21 6.43 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 122.34 1.067 . . . . 1.0 112.373 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.26 3.69 8.5 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.603 -1.18 . . . . 1.0 112.479 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.29 154.28 21.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 103.176 -3.97 . . . . 1.0 103.176 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -132.19 119.9 21.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.478 1.639 . . . . 1.0 108.377 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -120.2 113.75 33.82 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 129.551 3.14 . . . . 1.0 106.584 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.04 124.28 11.22 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.183 2.589 . . . . 1.0 110.835 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -129.4 178.32 6.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.958 0.903 . . . . 1.0 109.34 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.7 m95 -120.07 141.17 50.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.554 1.142 . . . . 1.0 107.994 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.25 146.7 51.67 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -84.56 136.14 33.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.6 m -117.23 113.94 38.89 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 120.35 -1.469 . . . . 1.0 109.11 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.72 -36.52 18.68 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.208 1.939 . . . . 1.0 110.634 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 mt -61.98 -23.32 66.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.793 1.237 . . . . 1.0 113.083 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 mt -102.85 -4.36 24.97 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.165 0.986 . . . . 1.0 110.801 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.08 36.13 1.91 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.985 2.914 . . . . 1.0 109.995 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.16 169.88 17.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.352 -0.842 . . . . 1.0 109.074 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.2 m -98.77 146.32 26.03 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.88 -0.512 . . . . 1.0 111.164 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -132.73 154.09 81.33 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.253 1.021 . . . . 1.0 110.194 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.17 165.9 30.94 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.482 -1.391 . . . . 1.0 108.482 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -157.68 161.59 38.58 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.366 -0.975 . . . . 1.0 108.366 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 t -86.24 113.82 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.579 -2.008 . . . . 1.0 105.579 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.41 159.06 15.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.223 -2.14 . . . . 1.0 105.223 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.44 1.25 49.83 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.854 -1.154 . . . . 1.0 115.611 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 -8.47 13.24 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.776 1.288 . . . . 1.0 115.06 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.23 -172.53 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.076 2.95 . . . . 1.0 107.252 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -33.47 133.64 0.16 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.741 2.017 . . . . 1.0 112.809 -173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -174.84 38.78 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.185 -2.366 . . . . 1.0 107.185 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -93.41 174.92 6.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.784 1.292 . . . . 1.0 108.883 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.07 84.83 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 114.574 -1.193 . . . . 1.0 112.644 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -76.54 73.12 3.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.648 -1.241 . . . . 1.0 107.648 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -138.23 112.92 8.94 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.128 -1.804 . . . . 1.0 106.128 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.06 158.26 24.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 123.618 1.675 . . . . 1.0 107.132 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -93.3 -16.47 24.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.754 -2.021 . . . . 1.0 111.602 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -166.05 164.44 18.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.976 0.893 . . . . 1.0 109.145 -173.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.1 tpt180 -60.27 -47.94 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.476 -1.238 . . . . 1.0 108.54 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.46 -66.27 0.43 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.612 2.365 . . . . 1.0 111.362 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 p -57.76 -33.4 68.46 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 123.997 0.811 . . . . 1.0 112.423 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.5 t -68.15 -54.05 20.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.146 0.978 . . . . 1.0 112.789 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.48 -33.18 75.29 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.8 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.12 -24.32 51.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.898 -1.048 . . . . 1.0 111.054 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.82 -65.03 0.73 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 120.839 1.654 . . . . 1.0 109.497 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.8 m -105.51 100.66 27.58 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.119 0.414 . . . . 1.0 112.119 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.62 173.31 14.36 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.542 2.161 . . . . 1.0 112.425 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 63' ' ' VAL . 2.4 t -153.75 -155.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.655 2 C-N-CA 134.193 4.997 . . . . 1.0 98.866 173.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.43 ' H ' HG13 ' A' ' 62' ' ' VAL . 2.4 t -56.1 135.69 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 101.964 -3.347 . . . . 1.0 101.964 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -54.05 113.54 1.27 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.626 0.973 . . . . 1.0 113.626 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -68.24 107.57 2.85 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 96.44 -5.393 . . . . 1.0 96.44 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -32.74 88.36 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 117.394 2.368 . . . . 1.0 117.394 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.729 ' CG ' ' H ' ' A' ' 68' ' ' HIS . 12.7 p-80 -149.82 -97.19 0.07 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 102.715 -3.069 . . . . 1.0 102.715 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.729 ' H ' ' CG ' ' A' ' 67' ' ' HIS . 45.3 t60 173.77 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 130.606 3.562 . . . . 1.0 103.334 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -53.46 130.3 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 104.453 -2.425 . . . . 1.0 104.453 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.397 0 CA-C-O 114.564 -2.636 . . . . 1.0 110.422 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.461 ' H1 ' ' CD ' ' A' ' 1' ' ' GLU . 3.7 mp0 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.5 -163.8 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.406 1.882 . . . . 1.0 106.092 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.58 -58.01 5.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.609 1.164 . . . . 1.0 109.215 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.82 -178.88 3.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.189 1.395 . . . . 1.0 109.732 173.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -67.67 -23.62 65.34 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.599 0.76 . . . . 1.0 109.829 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -103.22 164.77 11.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.602 1.961 . . . . 1.0 108.852 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -153.0 134.38 14.31 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.645 -1.243 . . . . 1.0 107.645 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 9' ' ' ALA . 4.4 t70 -130.88 178.14 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.539 3.136 . . . . 1.0 108.589 178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.422 ' H ' ' CG ' ' A' ' 8' ' ' ASP . . . -47.77 -26.42 1.59 Allowed 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 126.077 1.751 . . . . 1.0 111.089 173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -47.11 -34.6 6.19 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.184 1.356 . . . . 1.0 114.154 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.95 -25.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 120.683 -1.261 . . . . 1.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -67.24 127.57 93.51 Favored Pre-proline 0 CA--C 1.519 -0.243 0 C-N-CA 126.21 1.804 . . . . 1.0 112.033 173.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.9 152.24 7.45 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.993 2.462 . . . . 1.0 112.205 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.51 158.17 27.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.215 -0.902 . . . . 1.0 109.827 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -139.49 148.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.28 -69.77 0.38 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.98 175.9 14.06 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.77 -19.64 18.24 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.652 2.235 . . . . 1.0 112.651 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.38 177.85 4.95 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.059 0.944 . . . . 1.0 112.276 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.75 3.44 11.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.378 1.471 . . . . 1.0 112.1 174.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.47 153.9 32.29 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 103.704 -3.758 . . . . 1.0 103.704 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -133.62 125.79 29.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.279 1.54 . . . . 1.0 107.401 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.32 113.88 23.5 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 129.153 2.981 . . . . 1.0 106.633 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.43 129.78 15.27 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.203 2.602 . . . . 1.0 110.711 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -134.43 178.23 7.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.083 0.953 . . . . 1.0 109.614 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.3 m95 -110.84 141.71 43.85 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.191 -1.041 . . . . 1.0 108.191 174.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.5 41.76 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 118.855 0.752 . . . . 1.0 109.515 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -81.78 136.54 35.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -117.39 113.88 38.61 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 116.379 -1.772 . . . . 1.0 110.685 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.69 -34.26 32.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.726 1.618 . . . . 1.0 109.793 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.1 mt -64.78 -10.85 30.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.687 1.595 . . . . 1.0 112.716 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -120.63 -4.22 9.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.191 1.396 . . . . 1.0 110.51 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.22 36.16 6.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.746 2.418 . . . . 1.0 109.767 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.84 166.43 19.7 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.294 -0.879 . . . . 1.0 110.016 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.9 m -94.63 145.85 24.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.013 0.911 . . . . 1.0 110.607 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.37 156.46 63.96 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 118.514 -0.755 . . . . 1.0 111.304 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.63 157.28 56.41 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.12 1.88 . . . . 1.0 108.832 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -153.49 161.36 42.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.786 1.176 . . . . 1.0 108.833 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -85.76 124.41 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -116.05 163.82 15.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.98 -0.78 48.5 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.558 -1.339 . . . . 1.0 115.131 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.83 -37.07 1.04 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.41 1.481 . . . . 1.0 112.881 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.06 -172.74 4.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.211 1.804 . . . . 1.0 107.759 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.84 133.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.871 2.068 . . . . 1.0 112.88 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 -167.83 30.59 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 107.596 -2.201 . . . . 1.0 107.596 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -93.34 174.89 6.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.224 1.012 . . . . 1.0 108.827 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.02 -10.93 82.17 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.819 -1.082 . . . . 1.0 112.755 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -73.17 81.39 1.3 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.51 112.95 6.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.81 160.77 21.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 123.468 1.604 . . . . 1.0 107.894 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -93.42 -20.81 19.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 112.542 -2.117 . . . . 1.0 112.492 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -165.14 167.62 18.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -60.9 -51.31 69.84 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -45.1 -66.6 0.38 Allowed 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 128.202 2.601 . . . . 1.0 112.075 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -60.83 -33.39 72.96 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.67 0.606 . . . . 1.0 112.304 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.94 -52.23 38.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -69.92 -33.24 71.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.466 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.504 ' CG ' ' HE2' ' A' ' 67' ' ' HIS . 7.7 t70 -73.46 -28.14 61.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 117.902 -1.519 . . . . 1.0 110.448 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.2 -48.61 41.81 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-N 120.543 1.519 . . . . 1.0 110.483 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.8 m -134.17 82.72 47.03 Favored Pre-proline 0 N--CA 1.446 -0.632 0 C-N-CA 123.868 0.867 . . . . 1.0 113.328 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -87.45 -163.56 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 104.723 -2.837 . . . . 1.0 104.723 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 63' ' ' VAL . 2.5 t -92.6 -175.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 101.951 -3.352 . . . . 1.0 101.951 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 62' ' ' VAL . 2.4 t -32.98 113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 126.266 1.826 . . . . 1.0 108.318 -172.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -34.35 113.61 0.18 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 111.719 -2.491 . . . . 1.0 111.635 -172.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -76.77 77.64 3.39 Favored 'General case' 0 N--CA 1.433 -1.284 1 N-CA-C 96.557 -5.349 . . . . 1.0 96.557 173.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.31 80.0 m-70 -32.71 90.54 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 128.78 2.832 . . . . 1.0 113.831 -172.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.504 ' HE2' ' CG ' ' A' ' 58' ' ' ASP . 49.2 m80 -38.48 101.71 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.898 3.279 . . . . 1.0 106.982 -178.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -48.09 132.7 15.55 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.056 0.942 . . . . 1.0 112.021 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -134.49 -89.61 0.36 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 100.372 -3.936 . . . . 1.0 100.372 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.175 0 N-CA-C 102.519 -3.141 . . . . 1.0 102.519 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -152.53 23.96 0.61 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.231 2.212 . . . . 1.0 110.426 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 22.3 mp0 -105.37 -50.11 3.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.054 1.742 . . . . 1.0 109.836 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.28 12.62 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.055 2.142 . . . . 1.0 114.787 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 3' ' ' GLU . 8.5 mm-40 -73.95 -23.94 59.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.215 1.406 . . . . 1.0 110.354 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -130.75 -178.39 4.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 129.623 3.169 . . . . 1.0 106.552 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 m -73.25 93.73 1.91 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 173.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.9 165.39 25.21 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.41 -23.85 6.76 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.924 0.889 . . . . 1.0 111.664 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 p -52.84 -30.64 34.8 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.137 1.335 . . . . 1.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 t -78.19 -27.11 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.437 -0.789 . . . . 1.0 110.444 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 tp -69.48 130.16 90.95 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 126.391 1.876 . . . . 1.0 112.178 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -51.77 154.42 9.65 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.922 2.415 . . . . 1.0 111.579 173.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.39 160.27 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.383 0.673 . . . . 1.0 109.636 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.69 150.06 20.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 126.002 1.721 . . . . 1.0 106.567 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -72.61 -68.7 0.46 Allowed 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.75 171.36 12.82 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.441 1.496 . . . . 1.0 109.8 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.79 -12.16 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.074 2.516 . . . . 1.0 113.358 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.3 m -72.69 -174.99 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.574 1.15 . . . . 1.0 112.201 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.65 3.61 5.51 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.064 0.945 . . . . 1.0 113.167 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.83 153.61 25.97 Favored Glycine 0 CA--C 1.528 0.89 1 N-CA-C 102.292 -4.323 . . . . 1.0 102.292 172.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -134.21 123.34 24.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.482 1.641 . . . . 1.0 108.277 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.59 113.7 34.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 129.732 3.213 . . . . 1.0 106.56 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.9 130.47 14.53 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.68 . . . . 1.0 110.486 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -134.41 177.34 7.84 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.724 0.81 . . . . 1.0 109.353 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.52 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.4 m95 -111.1 141.06 45.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.27 47.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -82.68 141.35 32.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.777 0.799 . . . . 1.0 109.398 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -117.31 113.14 39.11 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 105.818 -1.919 . . . . 1.0 105.818 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -33.65 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.68 1.587 . . . . 1.0 109.584 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.29 -15.86 62.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.145 1.378 . . . . 1.0 112.601 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.6 mt -112.12 -5.32 14.25 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.262 1.025 . . . . 1.0 110.493 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.74 37.47 7.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.324 2.25 . . . . 1.0 109.47 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -160.88 166.2 28.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.2 149.57 23.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.981 0.896 . . . . 1.0 111.744 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -140.8 154.26 68.56 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.804 . . . . 1.0 110.832 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.79 162.08 33.41 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.147 1.898 . . . . 1.0 109.084 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -156.03 157.57 36.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.352 0.978 . . . . 1.0 108.416 173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.35 130.76 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.889 -2.264 . . . . 1.0 104.889 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.76 163.38 22.23 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.26 -0.11 40.83 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.53 -1.15 . . . . 1.0 115.523 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 -34.17 1.07 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.266 1.533 . . . . 1.0 113.116 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -88.85 -172.71 3.81 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.361 2.264 . . . . 1.0 107.748 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -33.8 133.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.795 2.038 . . . . 1.0 112.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.3 -172.28 40.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 107.316 -2.313 . . . . 1.0 107.316 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -93.55 175.63 6.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.326 1.06 . . . . 1.0 109.355 -174.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.99 -9.75 73.28 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.582 -1.19 . . . . 1.0 113.794 -173.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -73.89 81.15 1.65 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.447 -1.686 . . . . 1.0 106.447 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -142.36 113.04 7.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.428 -1.323 . . . . 1.0 107.428 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -118.1 161.3 20.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.009 1.385 . . . . 1.0 108.271 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.21 -19.12 21.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 112.898 -1.955 . . . . 1.0 112.288 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -165.96 168.75 15.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.89 -47.05 88.15 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 173.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -47.59 -66.58 0.38 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.844 2.858 . . . . 1.0 111.947 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 p -60.53 -33.5 72.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.602 0.564 . . . . 1.0 112.093 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.5 t -69.55 -50.7 42.4 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.714 0.806 . . . . 1.0 112.431 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.278 61.7 mt-10 -68.97 -32.9 72.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.997 -0.525 . . . . 1.0 110.085 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.56 -28.94 66.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.424 -1.275 . . . . 1.0 110.805 173.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.77 15.96 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 119.735 1.152 . . . . 1.0 111.039 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.1 m -122.44 80.41 46.23 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 123.661 0.784 . . . . 1.0 110.359 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -81.57 -163.68 0.24 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.216 3.277 . . . . 1.0 109.985 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.444 HG13 ' H ' ' A' ' 63' ' ' VAL . 2.5 t -93.6 -153.91 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 101.518 -3.512 . . . . 1.0 101.518 172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.444 ' H ' HG13 ' A' ' 62' ' ' VAL . 18.3 t -50.32 149.38 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 120.925 -1.11 . . . . 1.0 109.462 173.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -36.25 123.09 0.75 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 128.661 2.785 . . . . 1.0 112.09 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -60.46 113.79 2.61 Favored 'General case' 0 C--N 1.348 0.507 1 N-CA-C 99.126 -4.398 . . . . 1.0 99.126 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -32.98 87.29 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 117.328 2.344 . . . . 1.0 117.328 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -132.48 -115.43 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 2 C-N-CA 133.052 4.541 . . . . 1.0 98.743 173.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 173.07 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 1 C-N-CA 132.761 4.424 . . . . 1.0 104.703 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -68.19 -22.19 64.83 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.202 -0.936 . . . . 1.0 109.959 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 C--O 1.259 1.562 0 C-N-CA 129.029 2.932 . . . . 1.0 103.188 173.526 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 117.512 -1.232 . . . . 1.0 108.809 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.34 169.76 18.17 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.213 1.369 . . . . 1.0 109.447 164.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -63.63 -23.94 67.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.02 1.489 . . . . 1.0 115.02 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.09 -81.29 0.13 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -135.63 -77.82 0.43 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.782 2.033 . . . . 1.0 105.565 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -164.43 155.05 14.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 m -177.02 143.44 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.469 4.307 . . . . 1.0 102.337 173.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -147.69 174.51 11.71 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.256 2.222 . . . . 1.0 108.58 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.96 -23.97 8.38 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.583 1.153 . . . . 1.0 109.538 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -50.3 -29.5 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.957 1.303 . . . . 1.0 113.115 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.1 t -78.18 -26.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.042 . . . . 1.0 110.674 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.41 131.26 86.69 Favored Pre-proline 0 N--CA 1.453 -0.3 0 C-N-CA 127.185 2.194 . . . . 1.0 112.406 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -51.74 153.39 11.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.877 2.385 . . . . 1.0 111.59 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.9 160.74 22.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.614 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.61 148.75 21.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 125.479 1.512 . . . . 1.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.83 -68.68 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.312 1.045 . . . . 1.0 109.045 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.73 175.7 14.09 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.139 1.352 . . . . 1.0 109.772 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.92 -15.27 18.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.739 2.293 . . . . 1.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.3 m -72.97 178.85 4.04 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 124.217 1.007 . . . . 1.0 111.808 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.87 3.68 4.46 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.837 1.051 . . . . 1.0 113.837 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.54 153.71 29.01 Favored Glycine 0 CA--C 1.53 1.018 1 N-CA-C 102.037 -4.425 . . . . 1.0 102.037 172.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.18 109.6 11.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.967 1.883 . . . . 1.0 108.9 -173.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.5 113.93 61.23 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 129.021 2.928 . . . . 1.0 107.001 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.46 127.7 14.39 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.14 2.56 . . . . 1.0 110.474 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -132.71 178.7 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.996 0.919 . . . . 1.0 109.312 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.51 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.6 m95 -114.3 139.7 49.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.454 1.101 . . . . 1.0 108.177 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.81 145.38 46.43 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.898 0.772 . . . . 1.0 109.109 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -80.97 140.48 35.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.892 0.853 . . . . 1.0 109.095 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 m -117.16 113.38 39.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 106.582 -1.636 . . . . 1.0 106.582 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.78 -33.06 21.81 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.697 1.598 . . . . 1.0 110.208 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.99 -15.12 61.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.935 1.294 . . . . 1.0 112.6 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 mt -113.96 -5.57 13.17 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.533 1.133 . . . . 1.0 110.526 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.74 40.34 8.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.495 2.318 . . . . 1.0 109.072 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -163.85 165.43 22.87 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 -173.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.3 148.39 23.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.466 1.127 . . . . 1.0 111.373 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -141.78 155.44 66.26 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 114.869 -1.06 . . . . 1.0 110.942 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 160.18 35.66 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.423 2.082 . . . . 1.0 109.911 173.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.13 161.93 40.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.352 0.978 . . . . 1.0 108.409 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.64 123.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.331 -1.729 . . . . 1.0 106.331 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.4 162.89 16.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 104.857 -2.275 . . . . 1.0 104.857 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.15 4.43 31.67 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.643 -1.286 . . . . 1.0 115.511 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.27 9.8 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 118.657 1.229 . . . . 1.0 115.347 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 p -119.75 -172.63 2.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.401 2.681 . . . . 1.0 107.318 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.73 133.53 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.397 1.879 . . . . 1.0 112.619 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.24 -171.46 34.95 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.651 -2.18 . . . . 1.0 107.651 -174.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -93.44 175.18 6.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.355 1.078 . . . . 1.0 109.047 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -11.78 80.6 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.76 -1.109 . . . . 1.0 113.132 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -76.62 77.39 3.29 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -146.08 113.12 6.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.174 -1.417 . . . . 1.0 107.174 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -120.48 161.03 21.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.208 1.403 . . . . 1.0 108.388 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -93.4 -17.21 23.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.515 -1.675 . . . . 1.0 113.158 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.34 170.09 15.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -61.47 -50.12 74.03 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -66.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 128.506 2.723 . . . . 1.0 111.826 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.4 p -56.76 -33.25 66.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.812 0.671 . . . . 1.0 112.812 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.3 t -70.97 -49.7 42.5 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.637 0.775 . . . . 1.0 112.534 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.366 76.3 mt-10 -67.13 -33.06 74.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.037 -0.506 . . . . 1.0 111.237 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.7 -38.22 90.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 173.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.07 68.8 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.946 0.794 . . . . 1.0 111.808 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.8 m -139.76 102.83 7.01 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.499 1.519 . . . . 1.0 109.597 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.01 -163.19 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.535 3.49 . . . . 1.0 113.16 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.53 ' CG1' ' H ' ' A' ' 63' ' ' VAL . 37.7 t -92.83 -155.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 130.3 3.44 . . . . 1.0 102.048 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' H ' ' CG1' ' A' ' 62' ' ' VAL . 2.4 t -49.75 129.54 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 173.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -110.49 161.4 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 123.541 1.639 . . . . 1.0 113.296 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -65.99 165.86 12.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.678 2.791 . . . . 1.0 104.959 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.3 76.63 7.09 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 118.97 -2.331 . . . . 1.0 107.753 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -53.8 153.97 4.24 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.688 1.595 . . . . 1.0 107.289 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.59 167.89 16.89 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.926 1.239 . . . . 1.0 111.965 173.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -116.47 -144.15 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 1 N-CA-C 99.84 -4.133 . . . . 1.0 99.84 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 103.133 -2.914 . . . . 1.0 103.133 172.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.445 ' HA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 173.93 -17.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 130.574 3.55 . . . . 1.0 110.171 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 7.7 mp0 -67.43 -66.83 0.51 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 130.066 3.346 . . . . 1.0 107.79 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.07 57.24 4.33 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.582 1.153 . . . . 1.0 109.435 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -135.56 -87.44 0.35 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.691 1.196 . . . . 1.0 108.379 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -162.96 140.17 7.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -156.01 133.77 11.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 104.216 -2.513 . . . . 1.0 104.216 173.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.07 166.0 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.511 1.924 . . . . 1.0 107.176 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.67 -36.43 46.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.598 -0.715 . . . . 1.0 110.887 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -20.45 65.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.122 1.328 . . . . 1.0 111.544 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -81.79 -30.83 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.48 1.112 . . . . 1.0 110.761 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.4 tp -68.27 136.71 91.33 Favored Pre-proline 0 C--O 1.225 -0.209 0 C-N-CA 126.866 2.066 . . . . 1.0 110.185 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -68.56 166.2 26.64 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.71 1.607 . . . . 1.0 111.711 -176.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.71 156.63 32.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.184 -1.371 . . . . 1.0 109.614 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.54 147.24 22.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 106.901 -1.518 . . . . 1.0 106.901 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -72.0 -67.63 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.402 1.081 . . . . 1.0 109.25 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.39 177.37 14.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.53 -16.77 24.06 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.414 2.076 . . . . 1.0 112.919 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -73.49 -177.58 2.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.417 1.087 . . . . 1.0 112.402 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.91 3.8 4.9 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.895 1.278 . . . . 1.0 113.968 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.94 153.95 40.67 Favored Glycine 0 CA--C 1.531 1.054 1 N-CA-C 102.752 -4.139 . . . . 1.0 102.752 172.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -130.26 123.63 30.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.072 1.936 . . . . 1.0 107.334 -173.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -125.79 114.46 24.68 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 128.679 2.792 . . . . 1.0 107.425 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.0 126.02 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.262 2.641 . . . . 1.0 110.622 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -133.11 -179.37 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.482 1.113 . . . . 1.0 109.056 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.6 m95 -124.71 144.87 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.835 1.254 . . . . 1.0 108.578 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.27 145.61 34.21 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.272 0.629 . . . . 1.0 109.555 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -78.16 139.34 38.99 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 m -116.97 113.43 39.63 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 107.102 -1.444 . . . . 1.0 107.102 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.67 -33.75 20.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.026 1.817 . . . . 1.0 110.329 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.15 -16.28 63.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.725 1.21 . . . . 1.0 112.8 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.35 -4.47 14.28 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.789 1.236 . . . . 1.0 110.669 173.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.86 34.28 3.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.319 2.648 . . . . 1.0 110.381 -173.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.34 167.63 23.48 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -94.69 148.91 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.366 1.079 . . . . 1.0 112.274 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -140.61 156.12 69.33 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.892 -1.049 . . . . 1.0 110.972 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -69.72 163.41 38.36 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 1.0 109.509 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -158.71 165.33 34.62 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.273 -0.892 . . . . 1.0 108.721 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.63 116.58 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.784 -1.561 . . . . 1.0 106.784 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.65 162.7 12.85 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.119 -2.178 . . . . 1.0 105.119 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.81 3.48 38.95 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 115.17 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.97 -16.4 4.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.31 1.433 . . . . 1.0 115.425 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.9 p -112.85 -172.78 2.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.644 2.377 . . . . 1.0 108.188 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.76 133.49 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.403 1.881 . . . . 1.0 112.718 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.37 -169.36 31.72 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 108.194 -1.963 . . . . 1.0 108.194 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -93.29 175.4 6.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.161 0.981 . . . . 1.0 109.276 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.91 -14.08 70.58 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 114.46 -1.246 . . . . 1.0 112.575 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -80.33 75.53 7.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.116 -1.809 . . . . 1.0 106.116 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -146.15 113.24 6.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.545 -1.65 . . . . 1.0 106.545 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.02 163.09 19.98 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.272 1.429 . . . . 1.0 108.826 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -93.14 -16.91 24.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.251 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.443 ' HG ' ' CD ' ' A' ' 54' ' ' GLU . 4.0 p -164.77 173.46 11.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -173.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -59.54 -47.4 85.68 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 173.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CD ' ' HG ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -44.76 -67.1 0.31 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.975 2.91 . . . . 1.0 112.438 173.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -59.89 -33.14 71.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.534 0.683 . . . . 1.0 112.79 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.5 t -70.1 -50.16 43.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.327 63.2 mt-10 -69.43 -33.34 72.82 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.952 -1.023 . . . . 1.0 108.687 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -36.67 78.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.046 0.839 . . . . 1.0 109.116 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.37 74.62 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.405 1.002 . . . . 1.0 112.875 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.74 73.96 81.09 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 119.32 0.963 . . . . 1.0 113.029 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.59 44.45 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.492 3.461 . . . . 1.0 110.902 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.2 166.08 13.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 122.5 1.143 . . . . 1.0 110.104 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.98 155.97 3.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.477 -2.416 . . . . 1.0 104.477 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 142.37 58.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.865 1.316 . . . . 1.0 109.999 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.426 ' ND1' ' H ' ' A' ' 65' ' ' HIS . 5.4 m80 -54.85 -7.61 0.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 131.201 3.8 . . . . 1.0 112.907 -177.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 3.95 0.01 OUTLIER 'General case' 0 C--O 1.238 0.496 0 C-N-CA 131.262 3.825 . . . . 1.0 118.5 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -65.17 176.56 1.27 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.653 1.57 . . . . 1.0 108.424 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.13 -173.44 3.32 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.048 -1.032 . . . . 1.0 111.716 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -56.12 -12.53 1.55 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.76 1.224 . . . . 1.0 112.247 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 103.581 -2.748 . . . . 1.0 103.581 173.594 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.437 ' H1 ' ' CD ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 108.34 -0.985 . . . . 1.0 108.34 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -41.86 -49.8 4.46 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.903 1.816 . . . . 1.0 115.903 -161.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.52 -6.05 22.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.763 2.025 . . . . 1.0 114.498 -173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.437 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 3.2 mm-40 -69.3 -36.86 77.45 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.28 1.4 . . . . 1.0 111.213 -173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -149.69 110.98 4.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.68 -2.711 . . . . 1.0 103.68 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -144.07 177.85 8.29 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.447 0.641 . . . . 1.0 110.136 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.43 141.06 55.53 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.36 29.57 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.373 -0.822 . . . . 1.0 111.607 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 p -57.04 -29.19 63.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.891 1.223 . . . . 1.0 112.633 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.22 -30.77 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.34 -0.85 . . . . 1.0 110.685 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 tp -63.94 127.73 92.09 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 124.962 1.305 . . . . 1.0 112.23 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -50.12 154.36 5.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.385 2.724 . . . . 1.0 112.439 174.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.01 157.25 26.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.65 -0.704 . . . . 1.0 109.499 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 147.47 27.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.371 -2.085 . . . . 1.0 105.371 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.35 -63.26 1.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.55 170.53 12.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 1.0 109.528 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.9 -14.79 15.27 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.709 2.273 . . . . 1.0 113.301 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.8 m -73.85 -177.23 2.73 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.145 -0.972 . . . . 1.0 112.275 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 3.8 6.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.303 1.041 . . . . 1.0 113.125 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.19 154.0 29.81 Favored Glycine 0 CA--C 1.531 1.037 1 N-CA-C 102.344 -4.303 . . . . 1.0 102.344 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -132.52 127.91 36.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.831 1.816 . . . . 1.0 108.289 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' CD ' HH12 ' A' ' 25' ' ' ARG . 6.5 tp10 -125.91 114.32 24.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 130.158 3.383 . . . . 1.0 106.422 -173.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.72 132.03 25.79 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 123.252 2.635 . . . . 1.0 110.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.415 HH12 ' CD ' ' A' ' 23' ' ' GLU . 87.1 mmt-85 -133.98 175.49 9.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.559 173.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.407 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.4 m95 -120.96 143.42 49.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.765 2.026 . . . . 1.0 106.017 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.88 144.04 45.37 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.49 137.99 38.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.744 0.783 . . . . 1.0 109.41 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -117.21 113.53 39.13 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 124.981 1.313 . . . . 1.0 107.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.95 -36.03 24.12 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.125 1.883 . . . . 1.0 110.617 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -66.65 -17.21 64.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.298 1.039 . . . . 1.0 112.562 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.8 mt -106.26 -4.21 20.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.257 1.023 . . . . 1.0 110.293 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.28 32.56 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.172 2.589 . . . . 1.0 110.922 -174.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.23 169.2 14.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.824 0.821 . . . . 1.0 109.249 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.5 m -95.27 149.36 21.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.704 1.202 . . . . 1.0 110.619 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.49 154.31 73.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.898 . . . . 1.0 110.963 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.65 164.82 19.9 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.339 2.026 . . . . 1.0 111.63 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -162.16 164.28 27.97 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.6 t -90.14 113.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.63 159.8 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.214 -1.773 . . . . 1.0 106.214 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.16 0.94 57.39 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.232 -0.917 . . . . 1.0 114.796 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.35 -30.64 1.41 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.579 1.561 . . . . 1.0 113.965 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.89 -172.78 2.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.698 2.399 . . . . 1.0 107.566 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.75 0.17 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.253 2.221 . . . . 1.0 113.042 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.01 -169.72 35.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 107.599 -2.2 . . . . 1.0 107.599 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -93.35 174.35 7.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.491 1.145 . . . . 1.0 109.666 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.92 -11.84 83.36 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 114.694 -1.139 . . . . 1.0 113.419 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.66 74.01 5.2 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.008 -1.849 . . . . 1.0 106.008 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -139.75 113.09 8.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.23 1.012 . . . . 1.0 108.29 -173.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.05 150.96 49.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.703 1.201 . . . . 1.0 108.123 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -93.39 -6.31 47.46 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.05 -0.406 . . . . 1.0 110.709 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.24 170.36 14.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.128 1.371 . . . . 1.0 107.686 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 6.7 ttp180 -70.31 -39.86 74.54 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.324 -1.35 . . . . 1.0 108.535 173.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -39.62 -65.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.863 2.465 . . . . 1.0 111.006 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 p -57.47 -33.58 68.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.917 0.71 . . . . 1.0 112.917 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.8 t -75.12 -46.7 32.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.864 1.266 . . . . 1.0 112.577 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.12 -33.58 76.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.731 0.813 . . . . 1.0 109.288 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.55 -38.35 84.02 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.68 0.673 . . . . 1.0 109.221 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.31 -60.61 2.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.622 1.101 . . . . 1.0 110.822 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.4 m -127.26 92.46 43.72 Favored Pre-proline 0 C--O 1.234 0.285 0 C-N-CA 124.032 0.933 . . . . 1.0 110.678 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.56 -170.84 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.393 2.062 . . . . 1.0 108.584 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -93.12 177.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.734 -1.95 . . . . 1.0 105.734 174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -52.63 128.71 12.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.81 148.7 42.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.299 -1.318 . . . . 1.0 113.142 -173.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.87 -14.56 3.99 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 128.613 2.765 . . . . 1.0 110.785 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 173.29 79.84 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.5 3.12 . . . . 1.0 110.991 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -115.77 168.34 10.13 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.748 1.613 . . . . 1.0 111.642 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -142.55 45.46 1.61 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.288 1.435 . . . . 1.0 108.412 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.591 ' CD2' ' H ' ' A' ' 70' ' ' HIS . 50.9 t60 -165.03 -168.5 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.293 2.637 . . . . 1.0 104.667 -173.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.591 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 2.7 t-80 . . . . . 0 C--O 1.255 1.35 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.13 176.52 12.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.466 1.906 . . . . 1.0 107.802 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.57 -71.37 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.53 -5.91 11.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.203 1.001 . . . . 1.0 113.102 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -63.5 -50.44 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.335 1.854 . . . . 1.0 112.376 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.42 163.7 30.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 -176.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.6 m -82.79 101.09 10.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.58 142.7 43.71 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.59 32.11 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 118.283 0.492 . . . . 1.0 110.348 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -62.24 -21.2 64.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.5 0.72 . . . . 1.0 112.096 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.36 -33.05 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 O-C-N 120.961 -1.087 . . . . 1.0 110.548 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.6 tp -74.03 128.4 86.5 Favored Pre-proline 0 CA--C 1.521 -0.153 0 C-N-CA 127.407 2.283 . . . . 1.0 112.474 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.34 166.18 22.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.957 1.771 . . . . 1.0 111.816 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.89 168.43 11.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.532 1.133 . . . . 1.0 111.109 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -143.1 151.36 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.776 1.631 . . . . 1.0 107.848 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.69 -30.05 15.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.05 1.34 . . . . 1.0 113.463 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.33 177.55 51.8 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.1 -18.81 30.54 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.851 2.368 . . . . 1.0 113.601 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 m -67.83 161.74 25.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.834 -1.167 . . . . 1.0 111.048 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 3.5 15.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.966 1.706 . . . . 1.0 112.653 173.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.67 153.32 31.33 Favored Glycine 0 CA--C 1.528 0.873 1 N-CA-C 102.994 -4.042 . . . . 1.0 102.994 172.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -125.86 103.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.953 1.377 . . . . 1.0 110.461 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -95.13 113.82 62.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 127.872 2.469 . . . . 1.0 106.886 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.48 125.19 11.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.221 2.614 . . . . 1.0 110.319 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -131.26 -177.91 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.146 0.979 . . . . 1.0 108.83 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.3 m95 -125.43 143.28 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.644 1.178 . . . . 1.0 108.472 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.85 145.01 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 56.5 t80 -78.09 137.22 38.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.757 0.789 . . . . 1.0 109.361 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -117.24 113.9 38.9 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 116.801 -1.571 . . . . 1.0 108.461 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -32.25 37.19 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.519 1.479 . . . . 1.0 110.294 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.64 -15.72 61.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.087 1.355 . . . . 1.0 112.562 174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.58 -3.8 13.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 1.0 110.683 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.17 22.84 3.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 129.128 2.971 . . . . 1.0 112.229 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -166.62 170.6 12.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.188 -0.945 . . . . 1.0 110.276 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 86.2 m -84.19 146.82 27.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.101 0.953 . . . . 1.0 113.485 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -136.48 157.19 75.75 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.218 -1.355 . . . . 1.0 109.878 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -69.5 162.14 43.11 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.816 1.677 . . . . 1.0 108.758 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -155.93 163.16 40.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.063 -1.023 . . . . 1.0 108.79 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.19 125.25 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -122.41 175.26 6.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.351 2.261 . . . . 1.0 106.386 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.02 5.72 5.06 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.911 1.124 . . . . 1.0 115.911 -173.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.66 -38.21 2.8 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.842 1.821 . . . . 1.0 112.357 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.2 -173.02 1.87 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.529 1.532 . . . . 1.0 108.892 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -34.13 133.77 0.21 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.867 2.467 . . . . 1.0 113.784 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.7 176.41 41.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -93.72 177.72 5.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.77 0.785 . . . . 1.0 109.187 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.85 79.92 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.519 -0.764 . . . . 1.0 113.343 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -80.11 72.39 6.91 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -143.04 113.18 7.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.929 -1.878 . . . . 1.0 105.929 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -118.42 161.66 19.62 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 125.329 1.452 . . . . 1.0 108.85 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.27 8.2 m80 -93.18 -16.47 24.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.974 -1.466 . . . . 1.0 111.567 -172.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -165.83 172.15 11.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.2 tpt180 -61.49 -48.1 82.61 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 173.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -66.89 0.33 Allowed 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 128.765 2.826 . . . . 1.0 111.719 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -57.24 -33.07 67.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.1 t -71.96 -47.9 48.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.4 -0.812 . . . . 1.0 112.93 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.78 -33.5 76.12 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.85 -0.595 . . . . 1.0 110.248 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -44.87 93.62 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.4 -46.14 70.79 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 121.476 -0.765 . . . . 1.0 112.01 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 m -137.35 88.94 16.55 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.275 1.43 . . . . 1.0 113.917 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.94 -162.5 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 1 C-N-CA 126.929 5.086 . . . . 1.0 103.868 172.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -92.29 157.53 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 100.933 -3.728 . . . . 1.0 100.933 173.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -42.37 125.92 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.516 1.126 . . . . 1.0 112.44 -172.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 65' ' ' HIS . 14.1 t70 -65.42 176.9 1.26 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 128.234 2.614 . . . . 1.0 110.954 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 24.2 m80 -48.77 -37.58 19.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.994 1.718 . . . . 1.0 109.459 173.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.12 124.57 21.5 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 107.646 -1.242 . . . . 1.0 107.646 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.6 120.98 19.16 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -65.08 157.32 28.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -162.47 166.31 25.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.872 1.669 . . . . 1.0 106.683 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 C--O 1.252 1.22 0 N-CA-C 105.213 -2.143 . . . . 1.0 105.213 173.084 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.596 ' H2 ' ' CD ' ' A' ' 1' ' ' GLU . 3.4 mp0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 103.915 -2.624 . . . . 1.0 103.915 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 -120.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.291 -1.004 . . . . 1.0 108.291 -164.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -23.78 67.2 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.313 0.96 . . . . 1.0 111.943 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.23 166.16 12.35 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.13 1.372 . . . . 1.0 110.601 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.31 -23.82 65.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.162 2.585 . . . . 1.0 112.381 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -133.95 172.96 12.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.206 2.202 . . . . 1.0 106.46 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.9 m -143.13 94.49 2.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 119.897 -1.752 . . . . 1.0 112.114 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.77 165.29 21.72 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.62 15.01 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 118.932 0.787 . . . . 1.0 109.719 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.23 -28.26 69.91 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.807 0.731 . . . . 1.0 112.579 -173.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -73.16 -37.76 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.9 tp -62.86 122.14 72.77 Favored Pre-proline 0 N--CA 1.458 -0.07 0 C-N-CA 125.061 1.344 . . . . 1.0 113.301 -178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.84 152.85 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.717 2.945 . . . . 1.0 113.07 174.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 153.51 32.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.284 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.82 144.32 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -76.08 -53.48 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.55 175.54 15.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.344 1.45 . . . . 1.0 110.199 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.19 -28.36 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.656 2.237 . . . . 1.0 112.994 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -79.21 159.92 27.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 122.605 1.193 . . . . 1.0 112.539 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.34 3.55 38.1 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.263 1.825 . . . . 1.0 113.546 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.15 155.09 50.25 Favored Glycine 0 CA--C 1.535 1.311 1 N-CA-C 101.555 -4.618 . . . . 1.0 101.555 172.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -136.62 132.62 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 121.319 2.56 . . . . 1.0 108.476 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -135.54 118.8 12.71 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 129.265 3.026 . . . . 1.0 106.514 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.56 124.64 12.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.202 2.601 . . . . 1.0 109.675 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -128.5 179.9 5.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.407 1.083 . . . . 1.0 108.314 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.501 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.6 m95 -130.34 144.58 51.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.163 2.185 . . . . 1.0 106.759 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.95 148.27 38.35 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -82.39 138.54 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.866 0.841 . . . . 1.0 108.893 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -117.23 114.09 38.83 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 125.665 1.586 . . . . 1.0 108.32 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.79 -34.75 23.48 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.017 1.812 . . . . 1.0 110.618 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -62.44 -23.57 66.94 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.561 0.744 . . . . 1.0 112.991 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -102.72 -6.66 22.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 1.0 110.693 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 40.66 2.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.48 3.112 . . . . 1.0 108.452 -173.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.76 168.85 20.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.6 m -98.83 148.27 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.172 0.987 . . . . 1.0 111.795 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -134.62 153.29 78.9 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.315 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.96 168.96 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.971 1.78 . . . . 1.0 109.109 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -163.36 160.1 23.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.3 113.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.653 -2.351 . . . . 1.0 104.653 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' CE2' ' HA2' ' A' ' 42' ' ' GLY . 15.6 t80 -96.33 156.85 16.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.969 1.707 . . . . 1.0 106.97 174.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.13 1.95 68.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.939 0.736 . . . . 1.0 114.939 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 78.1 -38.51 1.79 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.87 1.7 . . . . 1.0 113.531 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -85.18 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.107 1.763 . . . . 1.0 108.089 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -33.68 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.575 2.35 . . . . 1.0 113.338 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.96 -167.52 28.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.522 -2.231 . . . . 1.0 107.522 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.35 174.65 7.1 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.545 1.172 . . . . 1.0 108.969 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.02 -15.17 79.5 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.784 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -76.09 78.76 2.92 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.811 -1.922 . . . . 1.0 105.811 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.17 113.17 5.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.775 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -126.12 158.0 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.452 1.901 . . . . 1.0 108.227 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -93.93 -11.02 31.88 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.867 -1.063 . . . . 1.0 112.523 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.82 160.72 42.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.901 1.228 . . . . 1.0 110.71 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.5 tpt180 -60.63 -50.77 72.17 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.519 -1.219 . . . . 1.0 109.087 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -66.75 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.343 2.657 . . . . 1.0 111.8 174.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.8 p -58.31 -33.46 69.5 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.61 -50.43 44.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.444 0.698 . . . . 1.0 112.587 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.92 -33.13 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.525 -0.75 . . . . 1.0 110.262 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.71 -26.65 62.58 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.604 -0.713 . . . . 1.0 110.538 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.28 62.13 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.108 1.322 . . . . 1.0 111.473 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.6 m -122.99 76.36 50.03 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.124 0.57 . . . . 1.0 111.693 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 179.41 6.5 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.72 2.28 . . . . 1.0 107.862 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.29 167.15 23.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 105.291 -2.115 . . . . 1.0 105.291 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.55 137.44 22.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.658 -1.608 . . . . 1.0 106.658 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.23 114.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.012 0.925 . . . . 1.0 110.191 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 -18.82 62.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.673 -0.679 . . . . 1.0 112.213 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -64.68 150.83 46.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -80.29 71.29 7.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.25 -1.532 . . . . 1.0 109.252 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.3 154.64 34.64 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.71 0.804 . . . . 1.0 109.134 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -67.75 157.9 33.62 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--O 1.251 1.158 0 N-CA-C 104.741 -2.318 . . . . 1.0 104.741 173.094 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.306 0 CA-C-O 118.805 -0.617 . . . . 1.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.58 -26.92 68.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.624 1.102 . . . . 1.0 111.449 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.17 -25.76 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.331 1.052 . . . . 1.0 109.936 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.7 tp -76.47 130.19 77.68 Favored Pre-proline 0 C--O 1.226 -0.137 0 C-N-CA 127.065 2.146 . . . . 1.0 112.944 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -52.37 153.33 13.63 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.954 2.436 . . . . 1.0 111.51 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.66 13.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.031 0.532 . . . . 1.0 110.16 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.66 148.6 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 125.119 1.368 . . . . 1.0 107.514 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.49 -56.77 4.32 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.622 1.169 . . . . 1.0 110.937 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.62 174.73 19.88 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.061 1.315 . . . . 1.0 109.971 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.19 -6.41 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.065 2.51 . . . . 1.0 113.505 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -73.32 175.62 6.72 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 122.364 1.078 . . . . 1.0 112.593 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.4 3.51 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.479 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.4 153.82 21.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 103.511 -3.836 . . . . 1.0 103.511 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -126.63 106.14 9.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.109 1.455 . . . . 1.0 109.52 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -102.12 113.83 65.71 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 128.748 2.819 . . . . 1.0 107.07 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.36 126.51 13.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.276 2.651 . . . . 1.0 110.284 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -132.37 -179.86 5.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.222 1.009 . . . . 1.0 109.005 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 48.2 m95 -119.55 143.87 47.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.667 1.187 . . . . 1.0 108.217 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.2 39.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -80.84 138.57 36.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.922 0.868 . . . . 1.0 108.976 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m -117.29 113.7 38.88 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.242 -1.361 . . . . 1.0 108.177 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.6 -33.61 21.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.788 1.659 . . . . 1.0 110.371 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -63.25 -20.54 65.54 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.0 112.711 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -108.24 -5.34 16.89 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.518 1.127 . . . . 1.0 110.769 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.63 37.93 3.64 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.543 2.737 . . . . 1.0 109.997 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -162.76 168.06 22.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.93 150.65 21.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.24 1.019 . . . . 1.0 112.156 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -140.74 154.61 69.07 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.944 -1.025 . . . . 1.0 111.28 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.59 162.71 35.78 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.178 1.918 . . . . 1.0 109.0 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.98 163.19 36.68 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.395 0.998 . . . . 1.0 108.575 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.97 127.13 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.39 -1.707 . . . . 1.0 106.39 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -119.2 168.9 10.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.848 2.059 . . . . 1.0 105.533 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.88 1.35 15.13 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 120.692 -1.255 . . . . 1.0 116.106 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.65 -7.24 58.96 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.277 1.538 . . . . 1.0 115.058 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 32.0 p -118.73 -172.75 2.34 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.723 2.409 . . . . 1.0 108.128 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.6 0.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.679 1.992 . . . . 1.0 112.853 -173.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.79 -176.76 38.1 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.555 -2.218 . . . . 1.0 107.555 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -93.5 174.93 6.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.179 0.989 . . . . 1.0 108.616 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.8 -11.76 85.11 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.228 -0.896 . . . . 1.0 112.93 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -78.02 74.17 4.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.435 1.118 . . . . 1.0 108.199 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.53 113.08 6.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -121.12 161.02 22.5 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.82 1.248 . . . . 1.0 108.624 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -93.27 -15.05 26.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.981 -1.463 . . . . 1.0 112.336 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -166.54 171.11 12.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.402 0.681 . . . . 1.0 109.295 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.9 tpt180 -62.29 -47.3 84.91 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -66.93 0.31 Allowed 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 128.466 2.706 . . . . 1.0 111.261 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -54.93 -33.17 61.94 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.0 t -72.04 -50.72 26.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.821 0.848 . . . . 1.0 112.899 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.348 76.2 mt-10 -67.29 -33.13 74.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 118.432 -0.795 . . . . 1.0 109.948 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.35 -38.9 85.26 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.376 0.989 . . . . 1.0 109.007 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 -43.66 72.84 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.33 0.968 . . . . 1.0 112.781 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.237 0.418 0 C-N-CA 123.662 0.785 . . . . 1.0 109.856 178.404 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.3 p -47.58 -28.45 2.31 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.588 -1.32 . . . . 1.0 113.603 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.55 -28.29 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 119.56 1.073 . . . . 1.0 112.301 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -75.46 156.14 85.36 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 127.929 2.491 . . . . 1.0 109.594 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 12' ' ' LEU . 14.8 Cg_endo -67.5 168.54 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.825 1.684 . . . . 1.0 111.856 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 113.54 8.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.931 -1.137 . . . . 1.0 107.931 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.2 t -91.94 124.14 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -80.07 -33.07 39.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.693 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.17 173.32 42.03 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.409 -1.077 . . . . 1.0 110.409 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.54 -8.16 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.261 2.641 . . . . 1.0 114.409 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -73.6 -179.05 3.36 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 3.86 5.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.66 1.584 . . . . 1.0 113.105 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.17 155.18 26.04 Favored Glycine 0 CA--C 1.533 1.161 1 N-CA-C 101.157 -4.777 . . . . 1.0 101.157 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -132.58 120.32 21.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.931 2.366 . . . . 1.0 108.829 -173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.95 113.79 28.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 129.377 3.071 . . . . 1.0 107.801 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.32 125.23 12.62 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.441 2.76 . . . . 1.0 111.214 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -131.81 178.31 6.86 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.295 1.038 . . . . 1.0 109.729 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.456 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 68.6 m95 -113.2 143.34 44.56 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.1 144.02 42.85 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.773 1.17 . . . . 1.0 108.243 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -79.5 139.21 37.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.808 0.813 . . . . 1.0 109.43 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -117.17 113.86 39.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.274 1.83 . . . . 1.0 107.806 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.79 -34.34 24.65 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.946 1.764 . . . . 1.0 111.06 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.59 -13.99 55.75 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.369 1.067 . . . . 1.0 112.754 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -115.9 -4.0 12.11 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.963 1.305 . . . . 1.0 110.723 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.65 37.97 1.76 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.893 2.877 . . . . 1.0 109.974 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.67 169.32 23.08 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.9 m -106.78 136.0 47.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.573 0.749 . . . . 1.0 110.681 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -122.89 159.48 53.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.295 1.038 . . . . 1.0 109.325 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -71.12 164.81 34.46 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 120.233 1.119 . . . . 1.0 109.588 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.22 168.89 25.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.09 113.7 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -99.46 162.08 13.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.02 55.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 116.185 1.234 . . . . 1.0 116.185 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.96 2.05 57.11 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 118.943 1.371 . . . . 1.0 115.062 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 p -125.46 -172.64 2.64 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.263 2.625 . . . . 1.0 107.846 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -33.3 133.64 0.15 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.801 2.04 . . . . 1.0 112.514 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.93 174.68 43.49 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.169 -1.973 . . . . 1.0 108.169 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.62 -174.76 3.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.195 0.997 . . . . 1.0 108.603 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.77 -4.26 82.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 126.983 2.23 . . . . 1.0 113.934 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -80.07 65.7 5.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.929 2.864 . . . . 1.0 107.107 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -144.04 112.9 6.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -115.27 161.25 18.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.399 -1.704 . . . . 1.0 106.399 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.294 6.4 m80 -92.75 -20.68 20.52 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.614 -2.539 . . . . 1.0 108.477 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -170.47 165.52 8.54 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.906 0.882 . . . . 1.0 108.641 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 14.9 ttp85 -65.75 -42.3 91.11 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.678 -1.23 . . . . 1.0 107.678 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -46.55 -66.1 0.46 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.369 2.268 . . . . 1.0 110.276 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 p -57.77 -34.28 69.4 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.689 0.618 . . . . 1.0 111.954 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.1 t -71.66 -48.52 47.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.285 1.034 . . . . 1.0 112.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.09 -33.53 73.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.53 0.681 . . . . 1.0 109.733 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.64 -23.36 39.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.13 -62.78 1.48 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.935 0.789 . . . . 1.0 111.847 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -173.114 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 p -49.3 -33.38 13.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.422 1.465 . . . . 1.0 112.766 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -76.63 -21.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 O-C-N 120.788 -1.195 . . . . 1.0 111.076 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -73.72 131.03 82.52 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 127.313 2.245 . . . . 1.0 112.193 174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.1 Cg_exo -49.76 154.22 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.227 2.618 . . . . 1.0 112.825 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.51 161.52 24.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.017 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.8 t -137.89 145.47 28.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 105.74 -1.948 . . . . 1.0 105.74 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -96.48 -23.99 16.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.668 0.787 . . . . 1.0 112.086 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.34 170.43 46.24 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.587 1.565 . . . . 1.0 111.307 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.13 -3.39 13.73 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.388 3.392 . . . . 1.0 114.691 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.3 176.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.655 1.582 . . . . 1.0 112.984 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 3.65 3.82 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.411 1.485 . . . . 1.0 112.946 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.15 153.44 20.27 Favored Glycine 0 CA--C 1.528 0.896 1 N-CA-C 101.63 -4.588 . . . . 1.0 101.63 172.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -128.69 104.68 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.974 1.387 . . . . 1.0 110.889 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -94.16 113.67 61.3 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.138 2.975 . . . . 1.0 106.992 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.21 127.75 14.66 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.37 2.714 . . . . 1.0 110.478 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.52 179.4 5.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.82 0.848 . . . . 1.0 108.935 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.2 m95 -119.74 136.31 54.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.883 -1.525 . . . . 1.0 106.883 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.62 143.51 48.66 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 79.6 t80 -77.45 139.18 39.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.705 0.764 . . . . 1.0 110.299 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -117.15 113.57 39.22 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 117.064 -1.446 . . . . 1.0 107.537 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.09 -33.38 31.88 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.09 1.86 . . . . 1.0 110.601 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.04 -16.88 63.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.568 1.147 . . . . 1.0 112.804 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -111.56 -4.35 14.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.38 1.472 . . . . 1.0 110.557 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 51.99 20.2 1.19 Allowed 'General case' 0 N--CA 1.431 -1.421 1 C-N-CA 132.35 4.26 . . . . 1.0 110.324 -173.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -157.72 167.98 28.52 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.416 -1.427 . . . . 1.0 108.988 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 75.8 m -84.23 152.89 23.92 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -138.43 156.05 73.58 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.933 -1.485 . . . . 1.0 109.527 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.57 160.27 32.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.135 1.89 . . . . 1.0 109.666 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -156.75 163.83 38.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.39 0.995 . . . . 1.0 108.603 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.0 t -87.2 122.85 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -124.08 173.27 8.39 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.899 1.68 . . . . 1.0 106.637 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.32 -7.66 5.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 116.414 1.326 . . . . 1.0 116.414 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.86 -28.76 8.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 119.472 1.636 . . . . 1.0 111.586 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -75.11 -173.26 1.92 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.979 1.712 . . . . 1.0 109.331 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 2.6 mp0 -34.41 134.2 0.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.759 2.824 . . . . 1.0 112.764 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.77 178.71 39.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.965 -2.054 . . . . 1.0 107.965 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -93.61 178.59 5.64 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.3 -18.51 71.46 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.582 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.54 70.97 1.82 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.996 0.919 . . . . 1.0 108.797 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.14 112.71 7.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.78 -1.563 . . . . 1.0 106.78 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.34 162.96 16.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.513 1.525 . . . . 1.0 107.072 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -106.55 -9.39 16.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.341 -1.299 . . . . 1.0 114.459 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 p -162.45 161.76 27.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.396 0.617 . . . . 1.0 109.964 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 23.0 tpt85 -60.95 -40.35 92.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.528 0.731 . . . . 1.0 110.464 174.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -66.8 0.41 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.932 2.493 . . . . 1.0 110.655 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 p -56.54 -33.87 66.51 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.647 0.592 . . . . 1.0 111.702 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.81 -51.92 23.79 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.281 13.9 mt-10 -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 116.052 -2.259 . . . . 1.0 112.825 173.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.258 8.2 t70 -65.95 -23.17 66.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 118.986 -1.086 . . . . 1.0 109.004 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.11 2.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.152 -1.593 . . . . 1.0 106.855 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.7 m . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.604 . . . . 1.0 110.901 -178.834 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 119.213 -0.422 . . . . 1.0 110.283 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -23.84 67.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.186 0.903 . . . . 1.0 112.696 -174.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.31 -30.93 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.147 0.979 . . . . 1.0 109.87 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.0 tp -66.07 130.69 94.38 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 125.256 1.423 . . . . 1.0 112.732 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 12' ' ' LEU . 77.5 Cg_exo -49.88 153.62 5.88 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.499 2.799 . . . . 1.0 113.183 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.72 143.73 29.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.846 -1.07 . . . . 1.0 108.663 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.93 147.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -78.04 -53.42 7.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.259 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 176.49 15.7 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.085 1.326 . . . . 1.0 110.095 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.71 -35.24 4.72 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.923 2.415 . . . . 1.0 111.865 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.0 m -71.93 160.91 31.73 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 121.901 0.858 . . . . 1.0 111.006 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.94 3.77 19.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.854 1.662 . . . . 1.0 114.218 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.64 157.21 53.52 Favored Glycine 0 CA--C 1.538 1.476 1 N-CA-C 102.347 -4.301 . . . . 1.0 102.347 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -130.3 125.59 35.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.315 2.557 . . . . 1.0 108.742 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.33 113.99 15.85 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 129.187 2.995 . . . . 1.0 107.076 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.62 133.59 32.51 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.734 2.956 . . . . 1.0 110.502 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -133.09 177.29 7.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.608 -1.178 . . . . 1.0 108.85 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.4 m95 -126.11 143.48 51.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.526 2.33 . . . . 1.0 105.591 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.74 144.08 41.5 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.722 1.209 . . . . 1.0 107.838 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -81.24 137.59 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.78 0.8 . . . . 1.0 109.14 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 m -117.44 113.66 38.62 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 126.136 1.774 . . . . 1.0 107.578 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.86 -33.7 19.71 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.888 1.725 . . . . 1.0 110.88 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.78 -14.38 58.78 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.725 1.21 . . . . 1.0 112.348 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -113.4 -4.31 13.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.978 1.311 . . . . 1.0 110.549 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.09 36.83 2.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.163 2.585 . . . . 1.0 110.043 -173.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.68 172.13 14.68 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.373 -0.829 . . . . 1.0 108.918 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -104.94 143.01 33.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.4 0.68 . . . . 1.0 110.111 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -123.77 153.72 66.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.727 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -70.74 168.65 22.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.525 1.483 . . . . 1.0 110.027 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -163.11 163.91 25.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.66 113.5 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.927 -1.879 . . . . 1.0 105.927 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -99.85 163.22 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.622 1.969 . . . . 1.0 106.829 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.17 4.5 52.04 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.326 0.89 . . . . 1.0 115.326 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.59 -36.86 2.05 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.597 1.57 . . . . 1.0 113.832 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.7 p -87.99 -172.87 4.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.716 1.606 . . . . 1.0 107.927 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.62 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.649 2.38 . . . . 1.0 113.158 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.71 29.74 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.918 -2.073 . . . . 1.0 107.918 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' ND2' HD11 ' A' ' 12' ' ' LEU . 4.5 m-20 -93.37 174.66 7.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.336 1.068 . . . . 1.0 109.712 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 -15.69 80.51 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.55 1.071 . . . . 1.0 114.179 -173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -78.41 70.24 4.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -138.1 113.12 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.616 1.166 . . . . 1.0 108.306 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.24 151.94 48.68 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.682 1.193 . . . . 1.0 108.28 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -93.15 -7.94 43.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.408 -0.807 . . . . 1.0 110.026 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -158.71 162.61 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.889 0.768 . . . . 1.0 111.108 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 26.1 ttp85 -65.26 -49.43 69.61 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.391 -0.822 . . . . 1.0 112.256 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -58.95 -48.27 82.13 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.56 0.537 . . . . 1.0 110.718 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 p -51.1 -38.85 54.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.7 t -73.99 -48.43 30.37 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.88 1.272 . . . . 1.0 110.067 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.34 -33.47 71.19 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.16 -31.69 62.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.385 -1.447 . . . . 1.0 109.407 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.89 -59.15 3.51 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.971 0.794 . . . . 1.0 110.658 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 1.0 108.397 175.447 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 119.265 -0.398 . . . . 1.0 111.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 p -48.53 -29.76 4.54 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.256 0.935 . . . . 1.0 113.479 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.08 -27.06 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.178 0.899 . . . . 1.0 111.332 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.51 152.91 61.3 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 127.682 2.393 . . . . 1.0 110.938 -176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.83 161.31 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.721 2.947 . . . . 1.0 113.158 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.99 113.61 11.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.01 115.15 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 107.436 -1.32 . . . . 1.0 107.436 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.74 -24.44 44.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.951 -1.477 . . . . 1.0 110.952 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.55 173.96 50.06 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.201 0.905 . . . . 1.0 111.263 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.06 -5.94 7.55 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.396 2.731 . . . . 1.0 114.631 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.3 m -73.74 -178.21 3.08 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 3.7 4.65 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.827 1.651 . . . . 1.0 113.423 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.88 154.32 22.46 Favored Glycine 0 CA--C 1.533 1.184 1 N-CA-C 100.652 -4.979 . . . . 1.0 100.652 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -132.55 122.59 25.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 120.968 2.384 . . . . 1.0 108.795 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -125.14 113.82 26.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.908 3.283 . . . . 1.0 106.847 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.13 126.82 14.95 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.521 2.814 . . . . 1.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -131.72 178.4 6.78 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.036 0.934 . . . . 1.0 109.361 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -117.59 144.43 45.15 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.443 1.097 . . . . 1.0 108.144 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.12 148.04 37.69 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.079 -0.711 . . . . 1.0 109.079 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -82.83 139.38 33.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 174.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m -117.11 113.42 39.37 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 117.213 -1.375 . . . . 1.0 107.619 173.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.43 -32.26 25.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.75 1.634 . . . . 1.0 110.239 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.3 -15.01 59.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.923 1.289 . . . . 1.0 112.471 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 mt -115.23 -4.2 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.094 1.358 . . . . 1.0 110.805 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.0 35.44 3.35 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.388 2.675 . . . . 1.0 110.042 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -162.51 168.68 21.54 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.563 -0.71 . . . . 1.0 109.707 -173.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -95.6 149.58 21.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.963 0.887 . . . . 1.0 112.114 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -139.85 154.5 70.82 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.624 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -69.78 161.82 44.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 107.971 -1.588 . . . . 1.0 107.971 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -159.04 170.7 21.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.081 0.855 . . . . 1.0 109.031 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.43 113.8 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 106.609 -1.626 . . . . 1.0 106.609 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.63 158.02 16.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.43 0.39 58.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 116.677 1.431 . . . . 1.0 116.677 -173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.65 3.41 54.51 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.224 1.512 . . . . 1.0 114.857 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 p -125.11 -172.46 2.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 128.717 2.807 . . . . 1.0 108.073 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -33.37 133.54 0.16 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.533 1.933 . . . . 1.0 113.001 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.26 168.09 40.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.814 -2.114 . . . . 1.0 107.814 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.99 -174.17 3.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.089 0.947 . . . . 1.0 109.06 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.72 -7.04 88.98 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 116.927 -2.041 . . . . 1.0 113.774 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -81.98 66.47 7.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 121.761 2.78 . . . . 1.0 107.607 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -147.08 113.66 6.0 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 130.81 3.644 . . . . 1.0 102.25 -173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -123.71 162.17 23.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.343 1.457 . . . . 1.0 107.747 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -93.07 -14.55 27.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.112 -1.403 . . . . 1.0 111.157 -173.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p -167.72 169.17 11.95 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.76 0.791 . . . . 1.0 109.996 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.0 tpt180 -61.4 -44.75 96.6 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -47.83 -66.51 0.39 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.231 2.612 . . . . 1.0 111.659 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.4 p -59.11 -33.46 70.87 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.046 0.927 . . . . 1.0 112.58 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -71.61 -49.95 35.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.044 0.938 . . . . 1.0 112.491 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.337 27.7 mt-10 -67.19 -32.94 74.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.02 -47.27 78.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 1.0 106.107 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.87 -58.44 8.59 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 118.686 0.675 . . . . 1.0 111.871 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.452 -0.363 0 O-C-N 123.737 0.648 . . . . 1.0 110.506 -174.649 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 119.036 -0.507 . . . . 1.0 111.1 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -69.02 -15.62 63.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.059 1.3 . . . . 1.0 111.747 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.02 -21.77 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.418 1.087 . . . . 1.0 111.129 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -73.32 148.67 88.62 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 127.261 2.224 . . . . 1.0 110.819 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 12' ' ' LEU . 36.6 Cg_endo -70.85 179.04 4.6 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.266 1.977 . . . . 1.0 111.034 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -120.41 161.6 20.94 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.14 152.97 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.653 1.181 . . . . 1.0 109.217 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -88.04 -31.47 19.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.343 1.457 . . . . 1.0 113.201 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 176.94 51.44 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.199 0.904 . . . . 1.0 112.404 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.88 -25.47 27.98 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.293 2.662 . . . . 1.0 112.842 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.56 158.85 25.98 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.206 -0.934 . . . . 1.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 3.53 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.685 1.594 . . . . 1.0 112.985 173.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.42 153.23 38.79 Favored Glycine 0 CA--C 1.531 1.044 1 N-CA-C 102.123 -4.391 . . . . 1.0 102.123 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.91 105.37 8.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.621 1.711 . . . . 1.0 111.022 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.02 114.01 62.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.426 2.29 . . . . 1.0 105.629 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 114.1 3.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.536 2.824 . . . . 1.0 109.747 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -114.78 176.94 4.83 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.361 0.664 . . . . 1.0 109.372 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.518 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 63.1 m95 -114.19 145.37 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.34 144.91 40.56 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.24 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.717 0.807 . . . . 1.0 110.009 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -117.43 113.36 38.78 Favored Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 120.684 -1.26 . . . . 1.0 108.034 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.09 -34.36 6.38 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.573 1.515 . . . . 1.0 109.665 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -65.03 -20.57 66.56 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 124.324 1.05 . . . . 1.0 112.355 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.34 -6.02 23.54 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.405 0.682 . . . . 1.0 110.223 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.88 38.47 6.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.278 2.631 . . . . 1.0 108.412 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.7 166.82 28.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.2 148.8 24.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.324 1.059 . . . . 1.0 110.699 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -132.35 152.18 79.61 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.592 -1.186 . . . . 1.0 109.577 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -68.9 166.31 26.91 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 13.6 p90 -155.59 164.09 39.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.15 123.81 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.455 -1.683 . . . . 1.0 106.455 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -122.49 168.84 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.409 1.884 . . . . 1.0 106.331 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.63 8.11 6.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.899 -0.945 . . . . 1.0 115.027 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.97 -48.31 4.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.29 1.545 . . . . 1.0 110.289 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 p -69.05 -173.39 0.5 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.635 1.174 . . . . 1.0 109.4 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -34.77 133.57 0.27 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.697 1.999 . . . . 1.0 114.261 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.7 173.49 39.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.756 -2.538 . . . . 1.0 106.756 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -93.65 171.24 9.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.63 -6.82 63.58 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.44 1.019 . . . . 1.0 114.356 -173.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -80.13 68.15 6.18 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -135.96 113.05 10.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.152 -1.796 . . . . 1.0 106.152 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.34 161.5 18.42 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 123.211 1.482 . . . . 1.0 108.382 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.1 -21.03 19.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.016 -2.356 . . . . 1.0 109.732 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -164.51 165.23 21.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.624 0.726 . . . . 1.0 109.117 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.56 -49.22 78.4 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.839 -1.073 . . . . 1.0 108.833 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.89 -66.85 0.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 128.004 2.521 . . . . 1.0 111.638 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -57.13 -33.27 67.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 t -67.51 -53.61 27.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.99 0.916 . . . . 1.0 112.908 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -33.27 75.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.526 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.84 -24.2 55.78 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.259 -0.877 . . . . 1.0 110.692 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.96 70.15 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 120.564 1.529 . . . . 1.0 111.634 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.239 0.541 0 CA-C-N 118.702 0.683 . . . . 1.0 112.8 173.708 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 119.194 -0.432 . . . . 1.0 110.205 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 p -62.81 -28.93 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.476 0.711 . . . . 1.0 111.924 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.32 -28.08 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.49 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.2 tp -69.2 125.43 91.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 126.946 2.098 . . . . 1.0 112.412 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 12' ' ' LEU . 51.3 Cg_exo -49.91 154.71 4.83 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.579 2.852 . . . . 1.0 112.764 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.71 160.98 27.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.844 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -135.01 148.78 28.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 126.307 1.843 . . . . 1.0 106.226 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -74.0 -56.39 4.99 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.08 171.7 15.44 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.891 2.186 . . . . 1.0 108.682 -173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.11 -35.69 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.425 2.083 . . . . 1.0 111.375 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.5 158.64 23.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.952 0.882 . . . . 1.0 110.788 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 3.94 22.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.807 2.043 . . . . 1.0 113.701 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.7 154.13 50.96 Favored Glycine 0 CA--C 1.535 1.331 1 N-CA-C 102.85 -4.1 . . . . 1.0 102.85 172.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -125.2 104.86 8.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 120.526 2.163 . . . . 1.0 110.864 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -99.27 119.21 61.04 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 127.468 2.307 . . . . 1.0 107.168 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.59 125.65 10.24 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.11 2.54 . . . . 1.0 109.933 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -130.27 177.11 7.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.36 -0.837 . . . . 1.0 109.533 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -112.66 141.2 46.72 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.93 0.892 . . . . 1.0 108.619 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.37 147.52 45.57 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.07 133.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.792 0.682 . . . . 1.0 110.145 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -117.59 113.42 38.45 Favored Pre-proline 0 N--CA 1.445 -0.702 0 O-C-N 119.854 -1.779 . . . . 1.0 109.075 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.14 -35.11 20.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.752 1.635 . . . . 1.0 109.982 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.83 -19.71 65.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.62 1.168 . . . . 1.0 112.151 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -103.04 -4.15 24.98 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.364 1.066 . . . . 1.0 110.078 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.63 29.98 8.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.493 2.717 . . . . 1.0 110.749 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -165.04 166.66 19.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.96 0.8 . . . . 1.0 109.861 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.01 147.36 22.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.029 0.918 . . . . 1.0 109.459 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -142.7 153.74 61.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.625 0.77 . . . . 1.0 111.132 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.43 160.08 44.5 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.815 1.677 . . . . 1.0 108.534 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 40' ' ' TYR . 19.8 p90 -153.59 160.34 42.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.622 1.101 . . . . 1.0 108.776 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.12 113.62 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.942 -1.874 . . . . 1.0 105.942 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.402 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 26.1 t80 -107.63 167.68 9.78 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.229 2.212 . . . . 1.0 106.457 173.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.77 9.39 10.59 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.15 0.82 . . . . 1.0 115.15 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.26 -39.66 2.3 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.276 1.417 . . . . 1.0 113.241 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.17 -172.98 3.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.584 1.154 . . . . 1.0 108.41 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.7 mp0 -33.99 133.94 0.19 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.047 2.539 . . . . 1.0 112.838 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.23 -167.22 23.33 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 107.453 -2.259 . . . . 1.0 107.453 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.31 173.56 7.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.462 1.131 . . . . 1.0 108.172 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.87 -15.19 81.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.359 -0.837 . . . . 1.0 112.547 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -74.92 79.73 2.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.872 0.869 . . . . 1.0 108.675 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -146.57 113.09 5.96 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.915 -1.883 . . . . 1.0 105.915 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.32 162.33 19.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.499 1.52 . . . . 1.0 108.351 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -93.49 -19.43 21.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.145 -1.388 . . . . 1.0 112.381 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 p -162.73 169.34 20.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 1.0 109.561 -173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.7 tpt180 -61.81 -49.32 76.77 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.06 -0.973 . . . . 1.0 108.507 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.12 -66.61 0.38 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.508 2.723 . . . . 1.0 112.123 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 p -60.35 -33.25 72.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.734 0.646 . . . . 1.0 112.229 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.41 -51.84 39.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 112.694 0.627 . . . . 1.0 112.694 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.286 71.5 mt-10 -69.76 -33.28 72.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.144 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.06 -35.28 80.1 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.48 -50.74 34.83 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 120.164 1.347 . . . . 1.0 111.674 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 116.087 1.884 . . . . 1.0 116.087 -173.136 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.521 0 N-CA-C 112.283 0.475 . . . . 1.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -46.86 -25.44 0.77 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.874 -1.141 . . . . 1.0 113.482 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.85 -33.0 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 119.403 1.002 . . . . 1.0 111.916 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 152.87 93.12 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 128.406 2.682 . . . . 1.0 109.013 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.06 173.15 10.76 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.742 . . . . 1.0 111.598 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.31 113.58 7.61 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.627 -1.249 . . . . 1.0 107.627 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.69 123.94 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.008 -1.479 . . . . 1.0 107.008 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -79.33 -33.41 43.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.257 -1.338 . . . . 1.0 110.737 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.84 172.66 42.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.74 -8.55 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.024 2.483 . . . . 1.0 114.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.55 -179.5 5.29 Favored 'General case' 0 N--CA 1.461 0.095 0 O-C-N 120.952 -1.093 . . . . 1.0 113.57 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.27 3.81 4.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.307 1.443 . . . . 1.0 113.576 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.79 157.12 29.48 Favored Glycine 0 CA--C 1.533 1.214 1 N-CA-C 101.301 -4.72 . . . . 1.0 101.301 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -131.44 117.88 19.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 121.333 2.567 . . . . 1.0 108.869 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.16 113.94 29.46 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 129.323 3.049 . . . . 1.0 107.77 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.55 125.44 13.33 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.559 2.839 . . . . 1.0 111.203 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -131.56 -179.99 5.7 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.403 1.081 . . . . 1.0 109.846 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.529 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 55.1 m95 -117.35 141.4 48.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.797 0.839 . . . . 1.0 108.751 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.86 148.44 48.64 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.87 143.69 29.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.666 0.746 . . . . 1.0 109.01 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 113.28 39.35 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 105.498 -2.038 . . . . 1.0 105.498 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.41 -32.41 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.747 1.631 . . . . 1.0 110.656 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.01 -17.1 64.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.793 0.837 . . . . 1.0 112.299 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.96 -4.29 16.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 1.0 110.546 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? 44.78 35.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.64 3.176 . . . . 1.0 108.45 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -162.75 170.88 17.64 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 121.139 -0.976 . . . . 1.0 110.185 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -100.85 145.08 29.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.938 1.695 . . . . 1.0 111.738 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -138.48 153.6 72.77 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.887 0.875 . . . . 1.0 110.689 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.48 163.32 24.29 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.492 2.128 . . . . 1.0 110.483 173.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.0 168.26 27.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.19 113.72 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -99.36 163.82 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.561 1.944 . . . . 1.0 105.809 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.77 1.48 41.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 116.459 1.344 . . . . 1.0 116.459 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.5 1.96 67.13 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 118.963 1.382 . . . . 1.0 115.456 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.2 p -125.53 -172.65 2.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.699 2.4 . . . . 1.0 108.074 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -33.26 133.52 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.827 2.051 . . . . 1.0 112.839 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.2 42.27 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -93.81 -174.11 3.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.172 0.987 . . . . 1.0 109.773 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.4 -7.61 88.09 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 127.764 2.602 . . . . 1.0 113.591 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -86.3 53.16 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.442 2.121 . . . . 1.0 106.911 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -131.47 112.73 12.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 101.902 -3.37 . . . . 1.0 101.902 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -108.85 156.15 19.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.12 -13.46 28.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.461 -2.154 . . . . 1.0 112.137 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -166.48 169.33 13.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.694 1.198 . . . . 1.0 109.131 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -64.5 -42.93 95.54 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -48.97 -66.34 0.42 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.689 2.796 . . . . 1.0 111.318 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.8 p -58.47 -36.07 73.14 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.95 0.781 . . . . 1.0 111.495 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 39.1 t -66.61 -52.99 39.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.5 0.72 . . . . 1.0 112.35 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.39 -33.41 72.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.471 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.42 -29.48 61.52 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.663 1.119 . . . . 1.0 111.563 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -61.64 1.69 Allowed 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.372 0.987 . . . . 1.0 110.15 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 124.693 1.197 . . . . 1.0 108.336 177.655 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 118.258 -0.877 . . . . 1.0 111.774 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -21.0 66.01 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.302 1.41 . . . . 1.0 111.566 -174.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.3 t -74.2 -36.71 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.931 -1.105 . . . . 1.0 110.252 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -70.29 129.98 89.89 Favored Pre-proline 0 N--CA 1.455 -0.176 0 C-N-CA 127.229 2.212 . . . . 1.0 113.199 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.4 Cg_exo -52.01 153.73 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.008 2.472 . . . . 1.0 111.403 173.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.97 166.82 16.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.315 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.93 146.3 30.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.403 -2.073 . . . . 1.0 105.403 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -97.53 -24.37 15.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.259 1.024 . . . . 1.0 112.242 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.08 45.82 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.999 1.761 . . . . 1.0 112.014 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.81 -3.43 13.85 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.609 3.539 . . . . 1.0 115.032 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.3 m -61.05 178.56 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.712 1.605 . . . . 1.0 113.298 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 3.65 3.98 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.233 1.413 . . . . 1.0 113.201 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.04 153.39 20.55 Favored Glycine 0 CA--C 1.529 0.945 1 N-CA-C 101.974 -4.45 . . . . 1.0 101.974 172.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -130.06 105.79 8.19 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.245 1.523 . . . . 1.0 111.324 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.01 114.84 64.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 129.153 2.981 . . . . 1.0 106.638 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.73 122.18 8.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.395 2.73 . . . . 1.0 109.549 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -123.28 179.57 4.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.593 0.757 . . . . 1.0 108.976 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -125.13 144.35 50.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.506 1.122 . . . . 1.0 108.436 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.57 141.33 35.22 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -77.14 137.73 39.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -117.3 113.66 38.89 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 117.463 -1.256 . . . . 1.0 108.006 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.26 -33.72 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.953 1.769 . . . . 1.0 110.805 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.66 -20.32 66.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.048 0.939 . . . . 1.0 112.37 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.66 -4.06 22.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.842 1.257 . . . . 1.0 110.479 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.65 16.85 2.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 128.416 2.686 . . . . 1.0 111.721 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -164.13 172.17 14.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.979 1.263 . . . . 1.0 110.525 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -87.75 148.82 24.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -133.9 155.9 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.989 1.316 . . . . 1.0 109.953 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.38 165.88 31.06 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.982 1.788 . . . . 1.0 109.237 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -158.6 165.69 33.87 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.7 t -89.05 129.96 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.793 -1.558 . . . . 1.0 106.793 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -132.46 170.13 15.57 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.492 1.517 . . . . 1.0 107.163 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.26 -3.18 8.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.946 1.538 . . . . 1.0 116.946 -173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.56 -29.92 6.42 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.826 1.813 . . . . 1.0 111.838 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -73.34 -173.2 1.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.383 1.873 . . . . 1.0 109.649 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -34.14 134.04 0.2 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.52 2.728 . . . . 1.0 112.983 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.93 175.86 41.44 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.271 -1.932 . . . . 1.0 108.271 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -93.62 177.55 5.98 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.89 76.15 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.511 -0.768 . . . . 1.0 112.825 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -78.99 70.2 5.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.372 1.086 . . . . 1.0 108.4 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -144.42 113.07 6.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -119.76 162.03 19.75 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.227 1.411 . . . . 1.0 108.785 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -93.33 -14.16 27.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.591 -1.186 . . . . 1.0 112.032 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -166.24 170.7 12.97 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.54 0.686 . . . . 1.0 109.222 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -62.81 -46.32 88.49 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -66.87 0.32 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 128.796 2.838 . . . . 1.0 111.079 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -54.57 -33.26 59.94 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.7 t -72.62 -49.42 32.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.448 -0.782 . . . . 1.0 112.793 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.19 -33.74 76.48 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 118.515 -0.755 . . . . 1.0 109.883 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.87 -41.41 97.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.813 0.845 . . . . 1.0 110.113 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.25 -42.01 76.18 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 118.709 0.686 . . . . 1.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.238 0.477 0 C-N-CA 123.619 0.768 . . . . 1.0 110.855 174.659 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 118.63 -0.7 . . . . 1.0 111.813 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -22.67 61.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.528 1.513 . . . . 1.0 112.746 -173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.47 -37.87 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.11 0.868 . . . . 1.0 110.754 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 147.09 87.03 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.746 2.018 . . . . 1.0 112.832 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.09 158.08 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.063 3.175 . . . . 1.0 113.019 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.89 113.39 13.32 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.343 -1.473 . . . . 1.0 108.053 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.88 129.35 44.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -79.12 -35.12 42.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.938 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.51 171.98 37.95 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.95 -40.72 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.259 1.973 . . . . 1.0 112.849 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.5 m -68.12 159.32 31.2 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 121.34 -0.85 . . . . 1.0 111.877 -174.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 3.92 24.84 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.978 2.111 . . . . 1.0 114.279 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -68.41 165.48 46.8 Favored Glycine 0 CA--C 1.544 1.901 1 N-CA-C 102.49 -4.244 . . . . 1.0 102.49 172.446 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -136.95 135.88 38.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 123.444 3.622 . . . . 1.0 110.943 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -135.91 121.05 13.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 131.221 3.808 . . . . 1.0 107.237 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 128.15 16.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.377 2.718 . . . . 1.0 109.582 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -130.67 -179.01 5.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.428 1.091 . . . . 1.0 108.506 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.0 m95 -129.83 145.31 51.58 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 127.29 2.236 . . . . 1.0 106.613 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.08 145.64 30.62 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.7 t80 -80.72 138.48 36.33 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.548 0.689 . . . . 1.0 109.628 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -117.31 113.68 38.85 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 116.723 -1.608 . . . . 1.0 106.798 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.67 -33.28 28.44 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.855 1.704 . . . . 1.0 110.077 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.82 -15.62 62.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.761 1.224 . . . . 1.0 112.568 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.2 mt -112.35 -4.0 14.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.414 1.486 . . . . 1.0 110.498 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.64 26.94 2.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.333 3.053 . . . . 1.0 111.843 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -164.85 167.89 18.29 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.05 -1.031 . . . . 1.0 110.134 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 93.4 m -84.39 144.95 28.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.751 0.786 . . . . 1.0 112.396 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.46 155.12 81.9 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.058 1.343 . . . . 1.0 109.62 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.92 167.37 27.5 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.745 1.63 . . . . 1.0 108.739 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -161.84 166.32 26.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.36 113.47 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.239 -2.134 . . . . 1.0 105.239 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -98.9 156.33 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.559 1.944 . . . . 1.0 107.005 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -92.19 1.27 73.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 115.351 0.9 . . . . 1.0 115.351 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.44 -38.22 2.26 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.51 1.529 . . . . 1.0 114.21 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.6 p -80.91 -173.2 4.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 1.0 109.432 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.82 133.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.317 2.647 . . . . 1.0 113.261 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.88 -179.68 39.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.881 -1.688 . . . . 1.0 108.881 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.64 -175.05 3.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.711 0.767 . . . . 1.0 110.486 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.22 -19.76 79.47 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.742 -1.588 . . . . 1.0 115.498 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -79.99 70.87 6.65 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.605 2.203 . . . . 1.0 108.227 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -149.4 113.3 5.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 -173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -125.53 156.07 39.61 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.127 1.771 . . . . 1.0 107.689 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -93.58 -10.12 35.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 1.0 111.969 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.76 158.09 43.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 120.162 1.346 . . . . 1.0 111.319 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -61.72 -45.99 91.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.39 -1.277 . . . . 1.0 109.426 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.36 -66.57 0.38 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.042 2.537 . . . . 1.0 112.369 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.4 p -57.99 -41.27 82.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.011 0.819 . . . . 1.0 110.861 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.55 -48.32 72.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.946 0.898 . . . . 1.0 112.137 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.52 -34.04 77.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 117.503 -1.237 . . . . 1.0 110.886 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.76 -29.75 70.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.406 1.912 . . . . 1.0 111.1 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -63.5 1.05 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-N 119.49 1.041 . . . . 1.0 108.398 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 1.0 110.216 -178.079 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.419 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.15 68.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.976 0.807 . . . . 1.0 112.291 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.08 -34.55 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.039 0.936 . . . . 1.0 109.843 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.5 tp -64.68 129.24 94.23 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 125.672 1.589 . . . . 1.0 113.169 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.0 Cg_exo -51.6 159.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.597 2.865 . . . . 1.0 111.859 173.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.17 113.72 25.76 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.118 -0.989 . . . . 1.0 109.599 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.77 145.88 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.3 -23.96 18.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.066 1.347 . . . . 1.0 111.59 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.12 168.86 34.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.085 1.326 . . . . 1.0 115.189 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.17 -28.23 2.05 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.844 3.029 . . . . 1.0 113.221 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 m -72.7 165.38 24.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.035 0.834 . . . . 1.0 110.728 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -111.85 3.78 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.11 1.152 . . . . 1.0 114.11 -174.019 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 154.27 37.47 Favored Glycine 0 CA--C 1.534 1.25 1 N-CA-C 101.892 -4.483 . . . . 1.0 101.892 172.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -136.16 129.77 32.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.711 2.255 . . . . 1.0 108.379 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.08 113.98 16.16 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 129.679 3.192 . . . . 1.0 105.744 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.93 129.34 20.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.287 2.658 . . . . 1.0 109.925 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -130.46 176.19 8.35 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.736 -1.12 . . . . 1.0 108.639 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.591 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 62.8 m95 -129.83 139.15 51.27 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.972 -1.862 . . . . 1.0 105.972 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.91 145.31 41.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -81.69 139.09 35.12 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.728 0.775 . . . . 1.0 110.811 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -117.44 113.59 38.64 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.114 -1.422 . . . . 1.0 107.328 172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.82 -34.33 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.977 1.785 . . . . 1.0 110.832 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.6 -20.67 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.142 0.977 . . . . 1.0 112.42 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -103.1 -5.39 23.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.731 1.212 . . . . 1.0 110.61 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 48.95 29.88 2.54 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 130.74 3.616 . . . . 1.0 110.065 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -165.47 168.33 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.378 -0.826 . . . . 1.0 109.187 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.5 m -90.79 147.72 23.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -126.43 156.06 73.39 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.743 1.217 . . . . 1.0 109.47 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -72.85 168.67 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.589 1.526 . . . . 1.0 109.252 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -159.54 165.34 33.13 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.64 113.93 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.053 -2.202 . . . . 1.0 105.053 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -106.55 145.92 31.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.458 -1.682 . . . . 1.0 106.458 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.07 3.31 85.75 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.109 -0.828 . . . . 1.0 114.667 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.99 -49.08 3.43 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.983 1.278 . . . . 1.0 110.058 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.6 p -72.58 -172.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.396 1.478 . . . . 1.0 108.44 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.05 133.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.269 2.228 . . . . 1.0 114.46 -173.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.21 177.58 44.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 128.299 2.857 . . . . 1.0 106.861 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.484 ' ND2' HD11 ' A' ' 12' ' ' LEU . 12.7 m-20 -93.73 177.02 6.14 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.276 1.038 . . . . 1.0 109.906 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.22 82.43 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.845 -1.071 . . . . 1.0 113.504 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.34 72.11 3.07 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -135.37 112.95 10.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.94 149.69 43.93 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.51 -8.52 41.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 118.531 -0.747 . . . . 1.0 110.76 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -155.34 158.94 39.51 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.083 0.856 . . . . 1.0 112.249 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.591 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -57.19 -56.98 14.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.839 1.656 . . . . 1.0 111.661 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.16 -47.53 82.28 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.057 0.848 . . . . 1.0 111.72 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.7 p -53.68 -35.3 60.92 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.83 -48.43 21.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.55 -34.02 73.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.397 -0.811 . . . . 1.0 111.346 174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.96 -27.07 49.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.217 1.371 . . . . 1.0 110.665 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.03 1.14 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.986 1.267 . . . . 1.0 109.174 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 124.967 1.307 . . . . 1.0 107.894 176.418 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.375 0 N-CA-C 110.634 -0.136 . . . . 1.0 110.634 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -66.61 -14.97 63.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.934 0.893 . . . . 1.0 113.38 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.18 -28.94 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.265 1.026 . . . . 1.0 109.517 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.1 tp -71.05 131.8 86.94 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.227 2.211 . . . . 1.0 113.013 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 12' ' ' LEU . 73.3 Cg_exo -51.51 157.73 4.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.646 2.897 . . . . 1.0 113.139 173.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.22 164.46 24.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.663 0.785 . . . . 1.0 110.433 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.35 151.43 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.036 1.734 . . . . 1.0 106.405 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -99.38 -27.55 13.7 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.001 0.92 . . . . 1.0 113.442 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.6 171.05 46.83 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.989 -1.645 . . . . 1.0 108.989 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.85 -27.01 37.73 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.734 2.289 . . . . 1.0 112.504 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.72 155.37 38.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.085 0.954 . . . . 1.0 109.562 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.09 3.97 19.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.487 1.915 . . . . 1.0 113.962 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.03 157.48 48.85 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 103.639 -3.785 . . . . 1.0 103.639 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -132.76 108.36 8.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 121.541 2.671 . . . . 1.0 115.102 -173.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 25' ' ' ARG . 75.7 tt0 -106.04 126.21 31.18 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -71.09 113.72 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.404 2.069 . . . . 1.0 108.142 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 25.6 mmt85 -107.92 178.87 4.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.691 -1.225 . . . . 1.0 107.691 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.502 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -133.22 143.61 49.25 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.825 1.65 . . . . 1.0 107.724 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.32 149.36 37.67 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.82 0.848 . . . . 1.0 109.063 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -83.63 141.47 31.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.195 0.998 . . . . 1.0 110.818 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.2 m -117.34 113.29 38.98 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 106.08 -1.822 . . . . 1.0 106.08 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.14 -32.18 21.71 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.631 1.554 . . . . 1.0 110.219 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.65 -15.34 61.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 1.0 112.367 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 mt -112.7 -4.57 14.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.823 1.249 . . . . 1.0 110.521 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.93 36.66 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.276 2.63 . . . . 1.0 109.821 -173.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -164.85 169.01 17.13 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.738 -0.601 . . . . 1.0 109.576 -173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -95.31 150.84 19.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.498 1.142 . . . . 1.0 112.883 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -135.04 155.66 78.94 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.725 1.21 . . . . 1.0 109.682 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.59 169.51 21.67 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.938 1.759 . . . . 1.0 110.229 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -162.56 175.22 11.66 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.538 1.935 . . . . 1.0 106.722 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.1 126.58 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.021 -1.474 . . . . 1.0 107.021 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.77 160.1 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.033 2.533 . . . . 1.0 110.015 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.72 19.32 11.37 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 118.104 2.002 . . . . 1.0 118.104 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 -46.81 3.34 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 119.807 1.803 . . . . 1.0 112.321 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 p -65.9 -173.14 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.686 1.595 . . . . 1.0 110.541 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.3 mp0 -33.54 133.85 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 129.394 3.078 . . . . 1.0 114.365 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.81 174.85 35.17 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.159 -1.976 . . . . 1.0 108.159 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.59 -177.62 4.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 -23.72 76.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.333 0.492 . . . . 1.0 112.341 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.71 69.08 4.83 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.032 0.916 . . . . 1.0 108.81 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -152.14 113.14 4.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.07 156.72 42.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.5 1.52 . . . . 1.0 109.206 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -93.46 -8.21 42.26 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.424 -0.798 . . . . 1.0 110.68 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 p -157.14 166.07 34.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.025 0.829 . . . . 1.0 109.897 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.9 tpt180 -60.28 -47.38 86.27 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 173.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -44.66 -66.56 0.38 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 128.284 2.634 . . . . 1.0 112.474 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 p -60.65 -36.04 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.626 0.579 . . . . 1.0 111.91 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.39 -47.71 63.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.283 0.633 . . . . 1.0 111.715 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.57 -32.91 74.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.176 0.991 . . . . 1.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.58 -40.18 70.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 117.737 -1.125 . . . . 1.0 110.001 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -59.18 5.09 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.819 1.19 . . . . 1.0 110.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 125.087 1.355 . . . . 1.0 108.307 173.83 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 117.945 -1.026 . . . . 1.0 112.417 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 p -55.22 -31.51 61.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.174 1.352 . . . . 1.0 112.518 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.79 -34.3 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.307 -0.87 . . . . 1.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.5 tp -61.7 129.14 91.2 Favored Pre-proline 0 CA--C 1.522 -0.124 0 C-N-CA 125.276 1.43 . . . . 1.0 113.045 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -49.93 151.36 8.58 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.316 2.678 . . . . 1.0 112.164 173.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.5 23.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.576 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.48 139.98 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 104.689 -2.337 . . . . 1.0 104.689 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.61 -58.29 3.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.28 171.66 12.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.729 1.633 . . . . 1.0 109.979 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.9 -12.22 14.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.973 2.449 . . . . 1.0 112.802 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.66 176.21 6.43 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 122.34 1.067 . . . . 1.0 112.373 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.26 3.69 8.5 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.603 -1.18 . . . . 1.0 112.479 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.29 154.28 21.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 103.176 -3.97 . . . . 1.0 103.176 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -132.19 119.9 21.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.478 1.639 . . . . 1.0 108.377 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -120.2 113.75 33.82 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 129.551 3.14 . . . . 1.0 106.584 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.04 124.28 11.22 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.183 2.589 . . . . 1.0 110.835 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -129.4 178.32 6.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.958 0.903 . . . . 1.0 109.34 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.7 m95 -120.07 141.17 50.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.554 1.142 . . . . 1.0 107.994 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.25 146.7 51.67 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -84.56 136.14 33.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.6 m -117.23 113.94 38.89 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 120.35 -1.469 . . . . 1.0 109.11 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.72 -36.52 18.68 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.208 1.939 . . . . 1.0 110.634 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 mt -61.98 -23.32 66.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.793 1.237 . . . . 1.0 113.083 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 mt -102.85 -4.36 24.97 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.165 0.986 . . . . 1.0 110.801 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.08 36.13 1.91 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.985 2.914 . . . . 1.0 109.995 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.16 169.88 17.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.352 -0.842 . . . . 1.0 109.074 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.2 m -98.77 146.32 26.03 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.88 -0.512 . . . . 1.0 111.164 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -132.73 154.09 81.33 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.253 1.021 . . . . 1.0 110.194 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.17 165.9 30.94 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.482 -1.391 . . . . 1.0 108.482 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -157.68 161.59 38.58 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.366 -0.975 . . . . 1.0 108.366 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 t -86.24 113.82 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.579 -2.008 . . . . 1.0 105.579 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.41 159.06 15.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.223 -2.14 . . . . 1.0 105.223 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.44 1.25 49.83 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.854 -1.154 . . . . 1.0 115.611 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 -8.47 13.24 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.776 1.288 . . . . 1.0 115.06 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.23 -172.53 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.076 2.95 . . . . 1.0 107.252 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 2.8 mp0 -33.47 133.64 0.16 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.741 2.017 . . . . 1.0 112.809 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -174.84 38.78 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.185 -2.366 . . . . 1.0 107.185 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -93.41 174.92 6.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.784 1.292 . . . . 1.0 108.883 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.07 84.83 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 114.574 -1.193 . . . . 1.0 112.644 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -76.54 73.12 3.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.648 -1.241 . . . . 1.0 107.648 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -138.23 112.92 8.94 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.128 -1.804 . . . . 1.0 106.128 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.06 158.26 24.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 123.618 1.675 . . . . 1.0 107.132 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -93.3 -16.47 24.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.754 -2.021 . . . . 1.0 111.602 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -166.05 164.44 18.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.976 0.893 . . . . 1.0 109.145 -173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.1 tpt180 -60.27 -47.94 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.476 -1.238 . . . . 1.0 108.54 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.46 -66.27 0.43 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.612 2.365 . . . . 1.0 111.362 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 p -57.76 -33.4 68.46 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 123.997 0.811 . . . . 1.0 112.423 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.5 t -68.15 -54.05 20.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.146 0.978 . . . . 1.0 112.789 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.48 -33.18 75.29 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.8 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.12 -24.32 51.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.898 -1.048 . . . . 1.0 111.054 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.82 -65.03 0.73 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 120.839 1.654 . . . . 1.0 109.497 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.119 0.414 . . . . 1.0 112.119 -173.77 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.627 -0.702 . . . . 1.0 111.089 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -47.11 -34.6 6.19 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.184 1.356 . . . . 1.0 114.154 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.95 -25.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 120.683 -1.261 . . . . 1.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.54 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -67.24 127.57 93.51 Favored Pre-proline 0 CA--C 1.519 -0.243 0 C-N-CA 126.21 1.804 . . . . 1.0 112.033 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.54 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.2 Cg_exo -49.9 152.24 7.45 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.993 2.462 . . . . 1.0 112.205 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.51 158.17 27.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.215 -0.902 . . . . 1.0 109.827 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -139.49 148.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.28 -69.77 0.38 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.98 175.9 14.06 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.77 -19.64 18.24 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.652 2.235 . . . . 1.0 112.651 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.38 177.85 4.95 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.059 0.944 . . . . 1.0 112.276 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.75 3.44 11.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.378 1.471 . . . . 1.0 112.1 174.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.47 153.9 32.29 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 103.704 -3.758 . . . . 1.0 103.704 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -133.62 125.79 29.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.279 1.54 . . . . 1.0 107.401 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.32 113.88 23.5 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 129.153 2.981 . . . . 1.0 106.633 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.43 129.78 15.27 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.203 2.602 . . . . 1.0 110.711 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -134.43 178.23 7.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.083 0.953 . . . . 1.0 109.614 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.3 m95 -110.84 141.71 43.85 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.191 -1.041 . . . . 1.0 108.191 174.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.5 41.76 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 118.855 0.752 . . . . 1.0 109.515 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -81.78 136.54 35.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -117.39 113.88 38.61 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 116.379 -1.772 . . . . 1.0 110.685 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.69 -34.26 32.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.726 1.618 . . . . 1.0 109.793 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.1 mt -64.78 -10.85 30.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.687 1.595 . . . . 1.0 112.716 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -120.63 -4.22 9.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.191 1.396 . . . . 1.0 110.51 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.22 36.16 6.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.746 2.418 . . . . 1.0 109.767 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.84 166.43 19.7 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.294 -0.879 . . . . 1.0 110.016 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.9 m -94.63 145.85 24.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.013 0.911 . . . . 1.0 110.607 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.37 156.46 63.96 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 118.514 -0.755 . . . . 1.0 111.304 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.63 157.28 56.41 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.12 1.88 . . . . 1.0 108.832 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -153.49 161.36 42.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.786 1.176 . . . . 1.0 108.833 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -85.76 124.41 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 173.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -116.05 163.82 15.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.98 -0.78 48.5 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.558 -1.339 . . . . 1.0 115.131 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.83 -37.07 1.04 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.41 1.481 . . . . 1.0 112.881 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.06 -172.74 4.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.211 1.804 . . . . 1.0 107.759 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.84 133.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.871 2.068 . . . . 1.0 112.88 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 -167.83 30.59 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 107.596 -2.201 . . . . 1.0 107.596 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -93.34 174.89 6.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.224 1.012 . . . . 1.0 108.827 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.02 -10.93 82.17 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.819 -1.082 . . . . 1.0 112.755 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -73.17 81.39 1.3 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.51 112.95 6.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.81 160.77 21.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 123.468 1.604 . . . . 1.0 107.894 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -93.42 -20.81 19.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 112.542 -2.117 . . . . 1.0 112.492 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -165.14 167.62 18.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -60.9 -51.31 69.84 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -45.1 -66.6 0.38 Allowed 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 128.202 2.601 . . . . 1.0 112.075 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -60.83 -33.39 72.96 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.67 0.606 . . . . 1.0 112.304 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.94 -52.23 38.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -69.92 -33.24 71.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.466 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.46 -28.14 61.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 117.902 -1.519 . . . . 1.0 110.448 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.2 -48.61 41.81 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-N 120.543 1.519 . . . . 1.0 110.483 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.446 -0.632 0 C-N-CA 123.868 0.867 . . . . 1.0 113.328 -174.261 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 118.585 -0.721 . . . . 1.0 111.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 p -52.84 -30.64 34.8 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.137 1.335 . . . . 1.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 t -78.19 -27.11 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.437 -0.789 . . . . 1.0 110.444 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -69.48 130.16 90.95 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 126.391 1.876 . . . . 1.0 112.178 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.1 Cg_exo -51.77 154.42 9.65 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.922 2.415 . . . . 1.0 111.579 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.39 160.27 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.383 0.673 . . . . 1.0 109.636 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.69 150.06 20.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 126.002 1.721 . . . . 1.0 106.567 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -72.61 -68.7 0.46 Allowed 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.75 171.36 12.82 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.441 1.496 . . . . 1.0 109.8 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.79 -12.16 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.074 2.516 . . . . 1.0 113.358 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.3 m -72.69 -174.99 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.574 1.15 . . . . 1.0 112.201 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.65 3.61 5.51 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.064 0.945 . . . . 1.0 113.167 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.83 153.61 25.97 Favored Glycine 0 CA--C 1.528 0.89 1 N-CA-C 102.292 -4.323 . . . . 1.0 102.292 172.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -134.21 123.34 24.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.482 1.641 . . . . 1.0 108.277 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.59 113.7 34.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 129.732 3.213 . . . . 1.0 106.56 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.9 130.47 14.53 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.68 . . . . 1.0 110.486 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -134.41 177.34 7.84 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.724 0.81 . . . . 1.0 109.353 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.52 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.4 m95 -111.1 141.06 45.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.27 47.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -82.68 141.35 32.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.777 0.799 . . . . 1.0 109.398 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -117.31 113.14 39.11 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 105.818 -1.919 . . . . 1.0 105.818 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -33.65 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.68 1.587 . . . . 1.0 109.584 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.29 -15.86 62.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.145 1.378 . . . . 1.0 112.601 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.6 mt -112.12 -5.32 14.25 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.262 1.025 . . . . 1.0 110.493 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.74 37.47 7.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.324 2.25 . . . . 1.0 109.47 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -160.88 166.2 28.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.2 149.57 23.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.981 0.896 . . . . 1.0 111.744 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -140.8 154.26 68.56 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.804 . . . . 1.0 110.832 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.79 162.08 33.41 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.147 1.898 . . . . 1.0 109.084 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -156.03 157.57 36.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.352 0.978 . . . . 1.0 108.416 173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.35 130.76 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.889 -2.264 . . . . 1.0 104.889 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.76 163.38 22.23 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.26 -0.11 40.83 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.53 -1.15 . . . . 1.0 115.523 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 -34.17 1.07 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.266 1.533 . . . . 1.0 113.116 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -88.85 -172.71 3.81 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.361 2.264 . . . . 1.0 107.748 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -33.8 133.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.795 2.038 . . . . 1.0 112.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.3 -172.28 40.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 107.316 -2.313 . . . . 1.0 107.316 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' ND2' HD11 ' A' ' 12' ' ' LEU . 6.2 m-20 -93.55 175.63 6.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.326 1.06 . . . . 1.0 109.355 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.99 -9.75 73.28 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.582 -1.19 . . . . 1.0 113.794 -173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -73.89 81.15 1.65 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.447 -1.686 . . . . 1.0 106.447 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -142.36 113.04 7.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.428 -1.323 . . . . 1.0 107.428 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -118.1 161.3 20.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.009 1.385 . . . . 1.0 108.271 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.21 -19.12 21.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 112.898 -1.955 . . . . 1.0 112.288 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -165.96 168.75 15.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.89 -47.05 88.15 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 173.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -47.59 -66.58 0.38 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.844 2.858 . . . . 1.0 111.947 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 p -60.53 -33.5 72.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.602 0.564 . . . . 1.0 112.093 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.5 t -69.55 -50.7 42.4 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.714 0.806 . . . . 1.0 112.431 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.278 61.7 mt-10 -68.97 -32.9 72.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.997 -0.525 . . . . 1.0 110.085 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.56 -28.94 66.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.424 -1.275 . . . . 1.0 110.805 173.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.77 15.96 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 119.735 1.152 . . . . 1.0 111.039 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.452 -0.34 0 C-N-CA 123.661 0.784 . . . . 1.0 110.359 -179.92 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.893 -0.575 . . . . 1.0 109.538 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -50.3 -29.5 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.957 1.303 . . . . 1.0 113.115 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.1 t -78.18 -26.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.042 . . . . 1.0 110.674 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -71.41 131.26 86.69 Favored Pre-proline 0 N--CA 1.453 -0.3 0 C-N-CA 127.185 2.194 . . . . 1.0 112.406 174.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.2 Cg_exo -51.74 153.39 11.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.877 2.385 . . . . 1.0 111.59 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.9 160.74 22.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.614 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.61 148.75 21.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 125.479 1.512 . . . . 1.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.83 -68.68 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.312 1.045 . . . . 1.0 109.045 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.73 175.7 14.09 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.139 1.352 . . . . 1.0 109.772 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.92 -15.27 18.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.739 2.293 . . . . 1.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.3 m -72.97 178.85 4.04 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 124.217 1.007 . . . . 1.0 111.808 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.87 3.68 4.46 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.837 1.051 . . . . 1.0 113.837 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.54 153.71 29.01 Favored Glycine 0 CA--C 1.53 1.018 1 N-CA-C 102.037 -4.425 . . . . 1.0 102.037 172.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.18 109.6 11.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.967 1.883 . . . . 1.0 108.9 -173.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.5 113.93 61.23 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 129.021 2.928 . . . . 1.0 107.001 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.46 127.7 14.39 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.14 2.56 . . . . 1.0 110.474 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -132.71 178.7 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.996 0.919 . . . . 1.0 109.312 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.506 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.6 m95 -114.3 139.7 49.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.454 1.101 . . . . 1.0 108.177 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.81 145.38 46.43 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.898 0.772 . . . . 1.0 109.109 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -80.97 140.48 35.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.892 0.853 . . . . 1.0 109.095 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 m -117.16 113.38 39.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 106.582 -1.636 . . . . 1.0 106.582 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.78 -33.06 21.81 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.697 1.598 . . . . 1.0 110.208 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.99 -15.12 61.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.935 1.294 . . . . 1.0 112.6 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 mt -113.96 -5.57 13.17 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.533 1.133 . . . . 1.0 110.526 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.74 40.34 8.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.495 2.318 . . . . 1.0 109.072 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -163.85 165.43 22.87 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 -173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.3 148.39 23.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.466 1.127 . . . . 1.0 111.373 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -141.78 155.44 66.26 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 114.869 -1.06 . . . . 1.0 110.942 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 160.18 35.66 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.423 2.082 . . . . 1.0 109.911 173.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.13 161.93 40.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.352 0.978 . . . . 1.0 108.409 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.64 123.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.331 -1.729 . . . . 1.0 106.331 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.4 162.89 16.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 104.857 -2.275 . . . . 1.0 104.857 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.15 4.43 31.67 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.643 -1.286 . . . . 1.0 115.511 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.27 9.8 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 118.657 1.229 . . . . 1.0 115.347 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 p -119.75 -172.63 2.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.401 2.681 . . . . 1.0 107.318 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.73 133.53 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.397 1.879 . . . . 1.0 112.619 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.24 -171.46 34.95 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.651 -2.18 . . . . 1.0 107.651 -174.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -93.44 175.18 6.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.355 1.078 . . . . 1.0 109.047 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -11.78 80.6 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.76 -1.109 . . . . 1.0 113.132 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -76.62 77.39 3.29 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -146.08 113.12 6.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.174 -1.417 . . . . 1.0 107.174 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -120.48 161.03 21.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.208 1.403 . . . . 1.0 108.388 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -93.4 -17.21 23.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.515 -1.675 . . . . 1.0 113.158 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.34 170.09 15.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -61.47 -50.12 74.03 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -66.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 128.506 2.723 . . . . 1.0 111.826 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.4 p -56.76 -33.25 66.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.812 0.671 . . . . 1.0 112.812 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.3 t -70.97 -49.7 42.5 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.637 0.775 . . . . 1.0 112.534 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.366 76.3 mt-10 -67.13 -33.06 74.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.037 -0.506 . . . . 1.0 111.237 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.7 -38.22 90.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.07 68.8 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.946 0.794 . . . . 1.0 111.808 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 125.499 1.519 . . . . 1.0 109.597 179.291 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.356 0 CA-C-O 118.598 -0.715 . . . . 1.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -20.45 65.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.122 1.328 . . . . 1.0 111.544 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -81.79 -30.83 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.48 1.112 . . . . 1.0 110.761 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 13' ' ' PRO . 1.4 tp -68.27 136.71 91.33 Favored Pre-proline 0 C--O 1.225 -0.209 0 C-N-CA 126.866 2.066 . . . . 1.0 110.185 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 12' ' ' LEU . 29.3 Cg_endo -68.56 166.2 26.64 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.71 1.607 . . . . 1.0 111.711 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.71 156.63 32.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.184 -1.371 . . . . 1.0 109.614 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.54 147.24 22.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 106.901 -1.518 . . . . 1.0 106.901 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -72.0 -67.63 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.402 1.081 . . . . 1.0 109.25 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.39 177.37 14.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.53 -16.77 24.06 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.414 2.076 . . . . 1.0 112.919 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -73.49 -177.58 2.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.417 1.087 . . . . 1.0 112.402 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.91 3.8 4.9 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.895 1.278 . . . . 1.0 113.968 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.94 153.95 40.67 Favored Glycine 0 CA--C 1.531 1.054 1 N-CA-C 102.752 -4.139 . . . . 1.0 102.752 172.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -130.26 123.63 30.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.072 1.936 . . . . 1.0 107.334 -173.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -125.79 114.46 24.68 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 128.679 2.792 . . . . 1.0 107.425 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.0 126.02 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.262 2.641 . . . . 1.0 110.622 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -133.11 -179.37 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.482 1.113 . . . . 1.0 109.056 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.6 m95 -124.71 144.87 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.835 1.254 . . . . 1.0 108.578 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.27 145.61 34.21 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.272 0.629 . . . . 1.0 109.555 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -78.16 139.34 38.99 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 m -116.97 113.43 39.63 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 107.102 -1.444 . . . . 1.0 107.102 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.67 -33.75 20.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.026 1.817 . . . . 1.0 110.329 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.15 -16.28 63.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.725 1.21 . . . . 1.0 112.8 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.35 -4.47 14.28 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.789 1.236 . . . . 1.0 110.669 173.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.86 34.28 3.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.319 2.648 . . . . 1.0 110.381 -173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.34 167.63 23.48 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -94.69 148.91 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.366 1.079 . . . . 1.0 112.274 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -140.61 156.12 69.33 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.892 -1.049 . . . . 1.0 110.972 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -69.72 163.41 38.36 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 1.0 109.509 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -158.71 165.33 34.62 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.273 -0.892 . . . . 1.0 108.721 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.63 116.58 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.784 -1.561 . . . . 1.0 106.784 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.65 162.7 12.85 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.119 -2.178 . . . . 1.0 105.119 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.81 3.48 38.95 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 115.17 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.97 -16.4 4.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.31 1.433 . . . . 1.0 115.425 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.9 p -112.85 -172.78 2.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.644 2.377 . . . . 1.0 108.188 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.76 133.49 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.403 1.881 . . . . 1.0 112.718 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.37 -169.36 31.72 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 108.194 -1.963 . . . . 1.0 108.194 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -93.29 175.4 6.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.161 0.981 . . . . 1.0 109.276 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.91 -14.08 70.58 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 114.46 -1.246 . . . . 1.0 112.575 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -80.33 75.53 7.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.116 -1.809 . . . . 1.0 106.116 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -146.15 113.24 6.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.545 -1.65 . . . . 1.0 106.545 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.02 163.09 19.98 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.272 1.429 . . . . 1.0 108.826 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -93.14 -16.91 24.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.251 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -164.77 173.46 11.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -59.54 -47.4 85.68 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 173.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -44.76 -67.1 0.31 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.975 2.91 . . . . 1.0 112.438 173.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -59.89 -33.14 71.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.534 0.683 . . . . 1.0 112.79 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.5 t -70.1 -50.16 43.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.327 63.2 mt-10 -69.43 -33.34 72.82 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.952 -1.023 . . . . 1.0 108.687 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -36.67 78.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.046 0.839 . . . . 1.0 109.116 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.37 74.62 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.405 1.002 . . . . 1.0 112.875 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.0 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-N 119.32 0.963 . . . . 1.0 113.029 177.09 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 118.373 -0.822 . . . . 1.0 111.607 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 p -57.04 -29.19 63.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.891 1.223 . . . . 1.0 112.633 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.22 -30.77 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.34 -0.85 . . . . 1.0 110.685 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -63.94 127.73 92.09 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 124.962 1.305 . . . . 1.0 112.23 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 12' ' ' LEU . 53.4 Cg_exo -50.12 154.36 5.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.385 2.724 . . . . 1.0 112.439 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.01 157.25 26.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.65 -0.704 . . . . 1.0 109.499 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 147.47 27.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.371 -2.085 . . . . 1.0 105.371 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.35 -63.26 1.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.55 170.53 12.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 1.0 109.528 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.9 -14.79 15.27 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.709 2.273 . . . . 1.0 113.301 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.8 m -73.85 -177.23 2.73 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.145 -0.972 . . . . 1.0 112.275 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 3.8 6.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.303 1.041 . . . . 1.0 113.125 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.19 154.0 29.81 Favored Glycine 0 CA--C 1.531 1.037 1 N-CA-C 102.344 -4.303 . . . . 1.0 102.344 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -132.52 127.91 36.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.831 1.816 . . . . 1.0 108.289 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -125.91 114.32 24.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 130.158 3.383 . . . . 1.0 106.422 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.72 132.03 25.79 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 123.252 2.635 . . . . 1.0 110.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -133.98 175.49 9.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.559 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -120.96 143.42 49.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.765 2.026 . . . . 1.0 106.017 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.88 144.04 45.37 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.49 137.99 38.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.744 0.783 . . . . 1.0 109.41 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -117.21 113.53 39.13 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 124.981 1.313 . . . . 1.0 107.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.95 -36.03 24.12 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.125 1.883 . . . . 1.0 110.617 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -66.65 -17.21 64.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.298 1.039 . . . . 1.0 112.562 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.8 mt -106.26 -4.21 20.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.257 1.023 . . . . 1.0 110.293 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.28 32.56 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.172 2.589 . . . . 1.0 110.922 -174.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.23 169.2 14.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.824 0.821 . . . . 1.0 109.249 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.5 m -95.27 149.36 21.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.704 1.202 . . . . 1.0 110.619 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.49 154.31 73.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.898 . . . . 1.0 110.963 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.65 164.82 19.9 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.339 2.026 . . . . 1.0 111.63 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -162.16 164.28 27.97 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.6 t -90.14 113.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.63 159.8 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.214 -1.773 . . . . 1.0 106.214 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.16 0.94 57.39 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.232 -0.917 . . . . 1.0 114.796 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.35 -30.64 1.41 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.579 1.561 . . . . 1.0 113.965 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.89 -172.78 2.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.698 2.399 . . . . 1.0 107.566 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.1 mp0 -33.62 133.75 0.17 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.253 2.221 . . . . 1.0 113.042 -174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.01 -169.72 35.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 107.599 -2.2 . . . . 1.0 107.599 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' HD11 ' A' ' 12' ' ' LEU . 7.0 m-20 -93.35 174.35 7.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.491 1.145 . . . . 1.0 109.666 -174.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.92 -11.84 83.36 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 114.694 -1.139 . . . . 1.0 113.419 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.66 74.01 5.2 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.008 -1.849 . . . . 1.0 106.008 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -139.75 113.09 8.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.23 1.012 . . . . 1.0 108.29 -173.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.05 150.96 49.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.703 1.201 . . . . 1.0 108.123 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -93.39 -6.31 47.46 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.05 -0.406 . . . . 1.0 110.709 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.24 170.36 14.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.128 1.371 . . . . 1.0 107.686 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -70.31 -39.86 74.54 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.324 -1.35 . . . . 1.0 108.535 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -39.62 -65.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.863 2.465 . . . . 1.0 111.006 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 p -57.47 -33.58 68.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.917 0.71 . . . . 1.0 112.917 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.8 t -75.12 -46.7 32.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.864 1.266 . . . . 1.0 112.577 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.12 -33.58 76.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.731 0.813 . . . . 1.0 109.288 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.55 -38.35 84.02 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.68 0.673 . . . . 1.0 109.221 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.31 -60.61 2.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.622 1.101 . . . . 1.0 110.822 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.234 0.285 0 C-N-CA 124.032 0.933 . . . . 1.0 110.678 -177.112 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.343 0 CA-C-O 119.413 -0.327 . . . . 1.0 110.348 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -62.24 -21.2 64.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.5 0.72 . . . . 1.0 112.096 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.36 -33.05 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 O-C-N 120.961 -1.087 . . . . 1.0 110.548 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -74.03 128.4 86.5 Favored Pre-proline 0 CA--C 1.521 -0.153 0 C-N-CA 127.407 2.283 . . . . 1.0 112.474 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 12' ' ' LEU . 19.5 Cg_endo -66.34 166.18 22.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.957 1.771 . . . . 1.0 111.816 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -92.89 168.43 11.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.532 1.133 . . . . 1.0 111.109 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -143.1 151.36 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.776 1.631 . . . . 1.0 107.848 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.69 -30.05 15.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.05 1.34 . . . . 1.0 113.463 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.33 177.55 51.8 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.1 -18.81 30.54 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.851 2.368 . . . . 1.0 113.601 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 m -67.83 161.74 25.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.834 -1.167 . . . . 1.0 111.048 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 3.5 15.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.966 1.706 . . . . 1.0 112.653 173.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.67 153.32 31.33 Favored Glycine 0 CA--C 1.528 0.873 1 N-CA-C 102.994 -4.042 . . . . 1.0 102.994 172.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -125.86 103.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.953 1.377 . . . . 1.0 110.461 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -95.13 113.82 62.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 127.872 2.469 . . . . 1.0 106.886 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.48 125.19 11.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.221 2.614 . . . . 1.0 110.319 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -131.26 -177.91 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.146 0.979 . . . . 1.0 108.83 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.3 m95 -125.43 143.28 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.644 1.178 . . . . 1.0 108.472 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.85 145.01 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 56.5 t80 -78.09 137.22 38.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.757 0.789 . . . . 1.0 109.361 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -117.24 113.9 38.9 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 116.801 -1.571 . . . . 1.0 108.461 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -32.25 37.19 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.519 1.479 . . . . 1.0 110.294 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.64 -15.72 61.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.087 1.355 . . . . 1.0 112.562 174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.58 -3.8 13.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 1.0 110.683 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.17 22.84 3.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 129.128 2.971 . . . . 1.0 112.229 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -166.62 170.6 12.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.188 -0.945 . . . . 1.0 110.276 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 86.2 m -84.19 146.82 27.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.101 0.953 . . . . 1.0 113.485 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -136.48 157.19 75.75 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.218 -1.355 . . . . 1.0 109.878 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -69.5 162.14 43.11 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.816 1.677 . . . . 1.0 108.758 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.407 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 14.9 p90 -155.93 163.16 40.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.063 -1.023 . . . . 1.0 108.79 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.19 125.25 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -122.41 175.26 6.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.351 2.261 . . . . 1.0 106.386 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.02 5.72 5.06 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.911 1.124 . . . . 1.0 115.911 -173.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.66 -38.21 2.8 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.842 1.821 . . . . 1.0 112.357 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.2 -173.02 1.87 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.529 1.532 . . . . 1.0 108.892 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -34.13 133.77 0.21 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.867 2.467 . . . . 1.0 113.784 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.7 176.41 41.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -93.72 177.72 5.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.77 0.785 . . . . 1.0 109.187 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.85 79.92 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.519 -0.764 . . . . 1.0 113.343 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -80.11 72.39 6.91 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -143.04 113.18 7.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.929 -1.878 . . . . 1.0 105.929 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -118.42 161.66 19.62 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 125.329 1.452 . . . . 1.0 108.85 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.27 8.2 m80 -93.18 -16.47 24.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.974 -1.466 . . . . 1.0 111.567 -172.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -165.83 172.15 11.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.2 tpt180 -61.49 -48.1 82.61 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 173.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -66.89 0.33 Allowed 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 128.765 2.826 . . . . 1.0 111.719 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -57.24 -33.07 67.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.1 t -71.96 -47.9 48.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.4 -0.812 . . . . 1.0 112.93 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.78 -33.5 76.12 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.85 -0.595 . . . . 1.0 110.248 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -44.87 93.62 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.4 -46.14 70.79 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 121.476 -0.765 . . . . 1.0 112.01 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 125.275 1.43 . . . . 1.0 113.917 -178.409 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.355 0 CA-C-O 119.06 -0.495 . . . . 1.0 109.719 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.23 -28.26 69.91 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.807 0.731 . . . . 1.0 112.579 -173.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -73.16 -37.76 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -62.86 122.14 72.77 Favored Pre-proline 0 N--CA 1.458 -0.07 0 C-N-CA 125.061 1.344 . . . . 1.0 113.301 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.7 Cg_exo -48.84 152.85 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.717 2.945 . . . . 1.0 113.07 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 153.51 32.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.284 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.82 144.32 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -76.08 -53.48 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.55 175.54 15.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.344 1.45 . . . . 1.0 110.199 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.19 -28.36 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.656 2.237 . . . . 1.0 112.994 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -79.21 159.92 27.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 122.605 1.193 . . . . 1.0 112.539 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.34 3.55 38.1 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.263 1.825 . . . . 1.0 113.546 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.15 155.09 50.25 Favored Glycine 0 CA--C 1.535 1.311 1 N-CA-C 101.555 -4.618 . . . . 1.0 101.555 172.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -136.62 132.62 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 121.319 2.56 . . . . 1.0 108.476 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -135.54 118.8 12.71 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 129.265 3.026 . . . . 1.0 106.514 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.56 124.64 12.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.202 2.601 . . . . 1.0 109.675 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -128.5 179.9 5.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.407 1.083 . . . . 1.0 108.314 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.6 m95 -130.34 144.58 51.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.163 2.185 . . . . 1.0 106.759 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.95 148.27 38.35 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -82.39 138.54 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.866 0.841 . . . . 1.0 108.893 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -117.23 114.09 38.83 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 125.665 1.586 . . . . 1.0 108.32 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.79 -34.75 23.48 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.017 1.812 . . . . 1.0 110.618 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -62.44 -23.57 66.94 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.561 0.744 . . . . 1.0 112.991 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -102.72 -6.66 22.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 1.0 110.693 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 40.66 2.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.48 3.112 . . . . 1.0 108.452 -173.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.76 168.85 20.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.6 m -98.83 148.27 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.172 0.987 . . . . 1.0 111.795 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -134.62 153.29 78.9 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.315 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.96 168.96 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.971 1.78 . . . . 1.0 109.109 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -163.36 160.1 23.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.3 113.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.653 -2.351 . . . . 1.0 104.653 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -96.33 156.85 16.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.969 1.707 . . . . 1.0 106.97 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.13 1.95 68.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.939 0.736 . . . . 1.0 114.939 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.1 -38.51 1.79 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.87 1.7 . . . . 1.0 113.531 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -85.18 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.107 1.763 . . . . 1.0 108.089 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.68 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.575 2.35 . . . . 1.0 113.338 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.96 -167.52 28.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.522 -2.231 . . . . 1.0 107.522 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.35 174.65 7.1 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.545 1.172 . . . . 1.0 108.969 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.02 -15.17 79.5 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.784 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -76.09 78.76 2.92 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.811 -1.922 . . . . 1.0 105.811 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.17 113.17 5.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.775 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -126.12 158.0 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.452 1.901 . . . . 1.0 108.227 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -93.93 -11.02 31.88 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.867 -1.063 . . . . 1.0 112.523 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.82 160.72 42.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.901 1.228 . . . . 1.0 110.71 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.5 tpt180 -60.63 -50.77 72.17 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.519 -1.219 . . . . 1.0 109.087 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -66.75 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.343 2.657 . . . . 1.0 111.8 174.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.8 p -58.31 -33.46 69.5 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.61 -50.43 44.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.444 0.698 . . . . 1.0 112.587 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.92 -33.13 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.525 -0.75 . . . . 1.0 110.262 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.71 -26.65 62.58 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.604 -0.713 . . . . 1.0 110.538 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.28 62.13 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.108 1.322 . . . . 1.0 111.473 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.238 0.484 0 C-N-CA 123.124 0.57 . . . . 1.0 111.693 174.086 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 107.872 -1.159 . . . . 1.0 107.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.41 178.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.402 0.546 . . . . 1.0 109.671 157.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -74.4 -23.56 58.98 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.579 -1.326 . . . . 1.0 110.056 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.62 107.36 15.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.081 -2.562 . . . . 1.0 104.081 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -118.43 -23.89 7.03 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.662 0.785 . . . . 1.0 111.423 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.75 135.12 48.0 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -78.4 93.48 4.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.579 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.91 169.21 16.28 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 104.282 -2.488 . . . . 1.0 104.282 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.29 -34.08 31.55 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 120.729 -1.232 . . . . 1.0 110.535 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.58 -26.92 68.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.624 1.102 . . . . 1.0 111.449 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.17 -25.76 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.331 1.052 . . . . 1.0 109.936 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.7 tp -76.47 130.19 77.68 Favored Pre-proline 0 C--O 1.226 -0.137 0 C-N-CA 127.065 2.146 . . . . 1.0 112.944 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -52.37 153.33 13.63 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.954 2.436 . . . . 1.0 111.51 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.66 13.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.031 0.532 . . . . 1.0 110.16 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.66 148.6 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 125.119 1.368 . . . . 1.0 107.514 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.49 -56.77 4.32 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.622 1.169 . . . . 1.0 110.937 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.62 174.73 19.88 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.061 1.315 . . . . 1.0 109.971 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.19 -6.41 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.065 2.51 . . . . 1.0 113.505 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -73.32 175.62 6.72 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 122.364 1.078 . . . . 1.0 112.593 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.4 3.51 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.479 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.4 153.82 21.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 103.511 -3.836 . . . . 1.0 103.511 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -126.63 106.14 9.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.109 1.455 . . . . 1.0 109.52 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -102.12 113.83 65.71 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 128.748 2.819 . . . . 1.0 107.07 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.36 126.51 13.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.276 2.651 . . . . 1.0 110.284 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -132.37 -179.86 5.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.222 1.009 . . . . 1.0 109.005 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 48.2 m95 -119.55 143.87 47.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.667 1.187 . . . . 1.0 108.217 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.2 39.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -80.84 138.57 36.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.922 0.868 . . . . 1.0 108.976 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m -117.29 113.7 38.88 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.242 -1.361 . . . . 1.0 108.177 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.6 -33.61 21.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.788 1.659 . . . . 1.0 110.371 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -63.25 -20.54 65.54 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.0 112.711 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -108.24 -5.34 16.89 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.518 1.127 . . . . 1.0 110.769 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.63 37.93 3.64 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.543 2.737 . . . . 1.0 109.997 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -162.76 168.06 22.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.93 150.65 21.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.24 1.019 . . . . 1.0 112.156 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -140.74 154.61 69.07 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.944 -1.025 . . . . 1.0 111.28 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.59 162.71 35.78 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.178 1.918 . . . . 1.0 109.0 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.98 163.19 36.68 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.395 0.998 . . . . 1.0 108.575 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.97 127.13 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.39 -1.707 . . . . 1.0 106.39 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -119.2 168.9 10.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.848 2.059 . . . . 1.0 105.533 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.88 1.35 15.13 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 120.692 -1.255 . . . . 1.0 116.106 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.65 -7.24 58.96 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.277 1.538 . . . . 1.0 115.058 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 32.0 p -118.73 -172.75 2.34 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.723 2.409 . . . . 1.0 108.128 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.6 0.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.679 1.992 . . . . 1.0 112.853 -173.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.79 -176.76 38.1 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.555 -2.218 . . . . 1.0 107.555 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -93.5 174.93 6.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.179 0.989 . . . . 1.0 108.616 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.8 -11.76 85.11 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.228 -0.896 . . . . 1.0 112.93 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -78.02 74.17 4.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.435 1.118 . . . . 1.0 108.199 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.53 113.08 6.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -121.12 161.02 22.5 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.82 1.248 . . . . 1.0 108.624 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -93.27 -15.05 26.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.981 -1.463 . . . . 1.0 112.336 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -166.54 171.11 12.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.402 0.681 . . . . 1.0 109.295 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.9 tpt180 -62.29 -47.3 84.91 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -66.93 0.31 Allowed 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 128.466 2.706 . . . . 1.0 111.261 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -54.93 -33.17 61.94 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.0 t -72.04 -50.72 26.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.821 0.848 . . . . 1.0 112.899 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.348 76.2 mt-10 -67.29 -33.13 74.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 118.432 -0.795 . . . . 1.0 109.948 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.35 -38.9 85.26 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.376 0.989 . . . . 1.0 109.007 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 -43.66 72.84 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.33 0.968 . . . . 1.0 112.781 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.2 m -128.33 80.43 72.39 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.662 0.785 . . . . 1.0 109.856 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.66 162.43 24.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.749 2.299 . . . . 1.0 112.395 -173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -98.25 140.76 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 103.681 -2.711 . . . . 1.0 103.681 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.2 164.71 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 126.379 1.872 . . . . 1.0 106.664 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.87 139.03 57.01 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.711 -2.329 . . . . 1.0 104.711 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.55 70.81 0.93 Allowed 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.483 1.113 . . . . 1.0 112.947 -173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -73.07 73.37 1.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 103.232 -2.877 . . . . 1.0 103.232 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -51.35 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.669 1.588 . . . . 1.0 115.239 -173.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -73.11 -31.6 64.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -74.18 168.94 18.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.326 1.85 . . . . 1.0 109.641 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.163 1.785 . . . . 1.0 109.038 173.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.88 160.31 43.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.706 1.139 . . . . 1.0 108.391 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.21 -71.34 0.42 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.495 1.518 . . . . 1.0 107.26 174.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.49 168.09 20.42 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -46.07 -44.22 15.24 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.262 2.225 . . . . 1.0 111.833 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -147.66 93.24 2.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 m -171.65 115.55 0.38 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.429 2.292 . . . . 1.0 104.952 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.01 129.14 37.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.113 -2.18 . . . . 1.0 105.113 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -43.95 -23.8 0.11 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 127.154 2.181 . . . . 1.0 112.642 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.3 p -47.58 -28.45 2.31 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.588 -1.32 . . . . 1.0 113.603 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.55 -28.29 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 119.56 1.073 . . . . 1.0 112.301 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -75.46 156.14 85.36 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 127.929 2.491 . . . . 1.0 109.594 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 12' ' ' LEU . 14.8 Cg_endo -67.5 168.54 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.825 1.684 . . . . 1.0 111.856 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 113.54 8.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.931 -1.137 . . . . 1.0 107.931 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.2 t -91.94 124.14 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -80.07 -33.07 39.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.693 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.17 173.32 42.03 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.409 -1.077 . . . . 1.0 110.409 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.54 -8.16 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.261 2.641 . . . . 1.0 114.409 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -73.6 -179.05 3.36 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 3.86 5.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.66 1.584 . . . . 1.0 113.105 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.17 155.18 26.04 Favored Glycine 0 CA--C 1.533 1.161 1 N-CA-C 101.157 -4.777 . . . . 1.0 101.157 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -132.58 120.32 21.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.931 2.366 . . . . 1.0 108.829 -173.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.95 113.79 28.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 129.377 3.071 . . . . 1.0 107.801 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.32 125.23 12.62 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.441 2.76 . . . . 1.0 111.214 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -131.81 178.31 6.86 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.295 1.038 . . . . 1.0 109.729 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.456 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 68.6 m95 -113.2 143.34 44.56 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.1 144.02 42.85 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.773 1.17 . . . . 1.0 108.243 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -79.5 139.21 37.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.808 0.813 . . . . 1.0 109.43 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -117.17 113.86 39.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.274 1.83 . . . . 1.0 107.806 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.79 -34.34 24.65 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.946 1.764 . . . . 1.0 111.06 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.59 -13.99 55.75 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.369 1.067 . . . . 1.0 112.754 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -115.9 -4.0 12.11 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.963 1.305 . . . . 1.0 110.723 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.65 37.97 1.76 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.893 2.877 . . . . 1.0 109.974 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.67 169.32 23.08 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.9 m -106.78 136.0 47.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.573 0.749 . . . . 1.0 110.681 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -122.89 159.48 53.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.295 1.038 . . . . 1.0 109.325 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -71.12 164.81 34.46 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 120.233 1.119 . . . . 1.0 109.588 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.22 168.89 25.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.09 113.7 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -99.46 162.08 13.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.02 55.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 116.185 1.234 . . . . 1.0 116.185 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.96 2.05 57.11 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 118.943 1.371 . . . . 1.0 115.062 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 p -125.46 -172.64 2.64 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.263 2.625 . . . . 1.0 107.846 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -33.3 133.64 0.15 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.801 2.04 . . . . 1.0 112.514 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.93 174.68 43.49 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.169 -1.973 . . . . 1.0 108.169 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.62 -174.76 3.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.195 0.997 . . . . 1.0 108.603 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.77 -4.26 82.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 126.983 2.23 . . . . 1.0 113.934 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -80.07 65.7 5.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.929 2.864 . . . . 1.0 107.107 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -144.04 112.9 6.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -115.27 161.25 18.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.399 -1.704 . . . . 1.0 106.399 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.294 6.4 m80 -92.75 -20.68 20.52 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.614 -2.539 . . . . 1.0 108.477 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -170.47 165.52 8.54 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.906 0.882 . . . . 1.0 108.641 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 14.9 ttp85 -65.75 -42.3 91.11 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.678 -1.23 . . . . 1.0 107.678 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -46.55 -66.1 0.46 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.369 2.268 . . . . 1.0 110.276 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 p -57.77 -34.28 69.4 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.689 0.618 . . . . 1.0 111.954 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.1 t -71.66 -48.52 47.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.285 1.034 . . . . 1.0 112.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.09 -33.53 73.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.53 0.681 . . . . 1.0 109.733 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.64 -23.36 39.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -175.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.13 -62.78 1.48 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.935 0.789 . . . . 1.0 111.847 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 20.3 m -99.75 165.92 13.76 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.28 108.72 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.312 2.008 . . . . 1.0 112.086 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 63' ' ' VAL . 3.7 t -146.29 -174.72 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 130.695 3.598 . . . . 1.0 102.825 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -62.28 127.33 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 103.294 -2.854 . . . . 1.0 103.294 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.41 ' CG ' ' HD1' ' A' ' 67' ' ' HIS . 26.6 t0 -97.16 135.13 39.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.961 -173.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -64.9 -66.8 0.5 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 102.99 -2.967 . . . . 1.0 102.99 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.6 m80 172.93 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 1 C-N-CA 134.224 5.01 . . . . 1.0 102.533 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.41 ' HD1' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -34.85 99.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.978 2.111 . . . . 1.0 111.675 -173.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -82.99 44.88 0.96 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.168 1.387 . . . . 1.0 111.989 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -72.22 -170.71 0.65 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.618 1.167 . . . . 1.0 109.966 173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.254 1.324 1 N-CA-C 99.555 -4.239 . . . . 1.0 99.555 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 4.8 tt0 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.33 86.02 0.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 105.775 -1.935 . . . . 1.0 105.775 158.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.64 -24.32 16.62 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.38 92.3 3.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -37.75 -22.71 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.018 3.727 . . . . 1.0 118.327 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -40.63 142.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.907 1.283 . . . . 1.0 112.477 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -68.38 94.5 0.55 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.372 1.469 . . . . 1.0 112.536 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.51 164.51 23.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 1.0 109.915 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -23.96 1.28 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 126.667 1.987 . . . . 1.0 111.272 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 p -49.3 -33.38 13.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.422 1.465 . . . . 1.0 112.766 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -76.63 -21.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 O-C-N 120.788 -1.195 . . . . 1.0 111.076 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -73.72 131.03 82.52 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 127.313 2.245 . . . . 1.0 112.193 174.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.1 Cg_exo -49.76 154.22 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.227 2.618 . . . . 1.0 112.825 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.51 161.52 24.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.017 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.8 t -137.89 145.47 28.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 105.74 -1.948 . . . . 1.0 105.74 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -96.48 -23.99 16.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.668 0.787 . . . . 1.0 112.086 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.34 170.43 46.24 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.587 1.565 . . . . 1.0 111.307 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.13 -3.39 13.73 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.388 3.392 . . . . 1.0 114.691 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.3 176.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.655 1.582 . . . . 1.0 112.984 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 3.65 3.82 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.411 1.485 . . . . 1.0 112.946 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.15 153.44 20.27 Favored Glycine 0 CA--C 1.528 0.896 1 N-CA-C 101.63 -4.588 . . . . 1.0 101.63 172.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -128.69 104.68 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.974 1.387 . . . . 1.0 110.889 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -94.16 113.67 61.3 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.138 2.975 . . . . 1.0 106.992 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.21 127.75 14.66 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.37 2.714 . . . . 1.0 110.478 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.52 179.4 5.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.82 0.848 . . . . 1.0 108.935 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.2 m95 -119.74 136.31 54.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.883 -1.525 . . . . 1.0 106.883 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.62 143.51 48.66 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 79.6 t80 -77.45 139.18 39.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.705 0.764 . . . . 1.0 110.299 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -117.15 113.57 39.22 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 117.064 -1.446 . . . . 1.0 107.537 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.09 -33.38 31.88 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.09 1.86 . . . . 1.0 110.601 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.04 -16.88 63.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.568 1.147 . . . . 1.0 112.804 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -111.56 -4.35 14.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.38 1.472 . . . . 1.0 110.557 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 51.99 20.2 1.19 Allowed 'General case' 0 N--CA 1.431 -1.421 1 C-N-CA 132.35 4.26 . . . . 1.0 110.324 -173.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -157.72 167.98 28.52 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.416 -1.427 . . . . 1.0 108.988 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 75.8 m -84.23 152.89 23.92 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -138.43 156.05 73.58 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.933 -1.485 . . . . 1.0 109.527 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.57 160.27 32.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.135 1.89 . . . . 1.0 109.666 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -156.75 163.83 38.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.39 0.995 . . . . 1.0 108.603 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.0 t -87.2 122.85 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -124.08 173.27 8.39 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.899 1.68 . . . . 1.0 106.637 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.32 -7.66 5.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 116.414 1.326 . . . . 1.0 116.414 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.86 -28.76 8.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 119.472 1.636 . . . . 1.0 111.586 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -75.11 -173.26 1.92 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.979 1.712 . . . . 1.0 109.331 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 2.6 mp0 -34.41 134.2 0.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.759 2.824 . . . . 1.0 112.764 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.77 178.71 39.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.965 -2.054 . . . . 1.0 107.965 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -93.61 178.59 5.64 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.3 -18.51 71.46 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.582 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.54 70.97 1.82 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.996 0.919 . . . . 1.0 108.797 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.14 112.71 7.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.78 -1.563 . . . . 1.0 106.78 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.34 162.96 16.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.513 1.525 . . . . 1.0 107.072 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -106.55 -9.39 16.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.341 -1.299 . . . . 1.0 114.459 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 p -162.45 161.76 27.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.396 0.617 . . . . 1.0 109.964 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 23.0 tpt85 -60.95 -40.35 92.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.528 0.731 . . . . 1.0 110.464 174.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -66.8 0.41 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.932 2.493 . . . . 1.0 110.655 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 p -56.54 -33.87 66.51 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.647 0.592 . . . . 1.0 111.702 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.81 -51.92 23.79 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.281 13.9 mt-10 -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 116.052 -2.259 . . . . 1.0 112.825 173.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 1' ' ' GLU 0.258 8.2 t70 -65.95 -23.17 66.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 118.986 -1.086 . . . . 1.0 109.004 175.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.11 2.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.152 -1.593 . . . . 1.0 106.855 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.7 m -140.1 114.4 7.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.604 . . . . 1.0 110.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -98.5 -165.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.742 3.628 . . . . 1.0 113.104 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.667 HG12 ' H ' ' A' ' 63' ' ' VAL . 48.0 t -93.17 -157.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 101.003 -3.703 . . . . 1.0 101.003 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.667 ' H ' HG12 ' A' ' 62' ' ' VAL . 4.5 t -45.44 138.47 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.197 -1.564 . . . . 1.0 108.858 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -33.65 113.86 0.17 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 131.491 3.916 . . . . 1.0 113.687 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.25 -63.87 1.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.96 1.304 . . . . 1.0 109.437 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -70.76 73.64 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 104.206 -2.516 . . . . 1.0 104.206 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.335 2.2 m-70 -33.72 90.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 117.55 2.426 . . . . 1.0 117.55 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -84.02 -22.72 31.23 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.361 1.865 . . . . 1.0 109.781 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -134.04 -173.95 3.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.93 1.692 . . . . 1.0 108.639 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.248 0.997 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 173.496 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 106.497 -1.668 . . . . 1.0 106.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.03 168.4 26.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.894 0.877 . . . . 1.0 108.967 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.08 -23.93 66.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.03 0.932 . . . . 1.0 110.824 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.92 -2.63 40.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.302 1.441 . . . . 1.0 113.22 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.09 -78.81 0.58 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -163.24 139.1 6.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.521 3.128 . . . . 1.0 105.486 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -157.05 114.61 3.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.985 -1.858 . . . . 1.0 105.985 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.65 159.34 32.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.764 -1.569 . . . . 1.0 106.764 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.89 -46.07 31.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 119.213 -0.422 . . . . 1.0 110.283 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -23.84 67.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.186 0.903 . . . . 1.0 112.696 -174.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.31 -30.93 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.147 0.979 . . . . 1.0 109.87 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.0 tp -66.07 130.69 94.38 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 125.256 1.423 . . . . 1.0 112.732 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 12' ' ' LEU . 77.5 Cg_exo -49.88 153.62 5.88 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.499 2.799 . . . . 1.0 113.183 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.72 143.73 29.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.846 -1.07 . . . . 1.0 108.663 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.93 147.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -78.04 -53.42 7.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.259 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 176.49 15.7 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.085 1.326 . . . . 1.0 110.095 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.71 -35.24 4.72 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.923 2.415 . . . . 1.0 111.865 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.0 m -71.93 160.91 31.73 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 121.901 0.858 . . . . 1.0 111.006 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.94 3.77 19.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.854 1.662 . . . . 1.0 114.218 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.64 157.21 53.52 Favored Glycine 0 CA--C 1.538 1.476 1 N-CA-C 102.347 -4.301 . . . . 1.0 102.347 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -130.3 125.59 35.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.315 2.557 . . . . 1.0 108.742 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.33 113.99 15.85 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 129.187 2.995 . . . . 1.0 107.076 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.62 133.59 32.51 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.734 2.956 . . . . 1.0 110.502 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -133.09 177.29 7.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.608 -1.178 . . . . 1.0 108.85 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.4 m95 -126.11 143.48 51.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.526 2.33 . . . . 1.0 105.591 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.74 144.08 41.5 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.722 1.209 . . . . 1.0 107.838 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -81.24 137.59 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.78 0.8 . . . . 1.0 109.14 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 m -117.44 113.66 38.62 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 126.136 1.774 . . . . 1.0 107.578 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.86 -33.7 19.71 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.888 1.725 . . . . 1.0 110.88 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.78 -14.38 58.78 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.725 1.21 . . . . 1.0 112.348 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -113.4 -4.31 13.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.978 1.311 . . . . 1.0 110.549 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.09 36.83 2.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.163 2.585 . . . . 1.0 110.043 -173.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.68 172.13 14.68 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.373 -0.829 . . . . 1.0 108.918 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -104.94 143.01 33.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.4 0.68 . . . . 1.0 110.111 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -123.77 153.72 66.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.727 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -70.74 168.65 22.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.525 1.483 . . . . 1.0 110.027 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -163.11 163.91 25.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.66 113.5 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.927 -1.879 . . . . 1.0 105.927 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -99.85 163.22 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.622 1.969 . . . . 1.0 106.829 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.17 4.5 52.04 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.326 0.89 . . . . 1.0 115.326 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.59 -36.86 2.05 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.597 1.57 . . . . 1.0 113.832 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.7 p -87.99 -172.87 4.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.716 1.606 . . . . 1.0 107.927 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.62 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.649 2.38 . . . . 1.0 113.158 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.71 29.74 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.918 -2.073 . . . . 1.0 107.918 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' ND2' HD11 ' A' ' 12' ' ' LEU . 4.5 m-20 -93.37 174.66 7.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.336 1.068 . . . . 1.0 109.712 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 -15.69 80.51 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.55 1.071 . . . . 1.0 114.179 -173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -78.41 70.24 4.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -138.1 113.12 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.616 1.166 . . . . 1.0 108.306 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.24 151.94 48.68 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.682 1.193 . . . . 1.0 108.28 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -93.15 -7.94 43.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.408 -0.807 . . . . 1.0 110.026 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -158.71 162.61 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.889 0.768 . . . . 1.0 111.108 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 26.1 ttp85 -65.26 -49.43 69.61 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.391 -0.822 . . . . 1.0 112.256 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -58.95 -48.27 82.13 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.56 0.537 . . . . 1.0 110.718 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 p -51.1 -38.85 54.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.7 t -73.99 -48.43 30.37 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.88 1.272 . . . . 1.0 110.067 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.34 -33.47 71.19 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.16 -31.69 62.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.385 -1.447 . . . . 1.0 109.407 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.89 -59.15 3.51 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.971 0.794 . . . . 1.0 110.658 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.4 m -110.11 98.78 36.62 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 1.0 108.397 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.68 176.46 10.01 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.971 2.447 . . . . 1.0 116.399 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 63' ' ' VAL . 3.5 t -131.43 -153.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 2 C-N-CA 135.201 5.4 . . . . 1.0 99.575 173.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.5 t -49.12 131.81 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 105.834 -1.913 . . . . 1.0 105.834 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -56.29 120.69 8.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -49.82 -64.0 0.94 Allowed 'General case' 0 C--N 1.347 0.484 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.254 0.9 OUTLIER 173.05 56.44 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.787 3.235 . . . . 1.0 109.592 173.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -70.28 68.92 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.207 -1.558 . . . . 1.0 108.328 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -144.58 151.41 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.646 -1.284 . . . . 1.0 109.83 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -123.84 -8.26 7.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.04 1.736 . . . . 1.0 108.62 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.256 1.406 2 C-N-CA 141.98 8.112 . . . . 1.0 97.723 173.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 9' ' ' ALA . . . -126.25 168.06 14.62 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.253 1.421 . . . . 1.0 107.768 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.19 -62.98 1.38 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 177.42 4.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.818 1.647 . . . . 1.0 109.713 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -52.61 -32.98 44.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.187 0.995 . . . . 1.0 111.187 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -138.92 92.99 2.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m 173.48 93.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 1 C-N-CA 132.099 4.16 . . . . 1.0 101.248 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.7 120.17 20.72 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 174.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' H ' ' HA ' ' A' ' 2' ' ' ALA . . . -49.39 -23.19 1.37 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.15 1.78 . . . . 1.0 111.882 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 p -48.53 -29.76 4.54 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.256 0.935 . . . . 1.0 113.479 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.08 -27.06 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.178 0.899 . . . . 1.0 111.332 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.51 152.91 61.3 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 127.682 2.393 . . . . 1.0 110.938 -176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.83 161.31 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.721 2.947 . . . . 1.0 113.158 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.99 113.61 11.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.01 115.15 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 107.436 -1.32 . . . . 1.0 107.436 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.74 -24.44 44.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.951 -1.477 . . . . 1.0 110.952 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.55 173.96 50.06 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.201 0.905 . . . . 1.0 111.263 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.06 -5.94 7.55 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.396 2.731 . . . . 1.0 114.631 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.3 m -73.74 -178.21 3.08 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 3.7 4.65 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.827 1.651 . . . . 1.0 113.423 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.88 154.32 22.46 Favored Glycine 0 CA--C 1.533 1.184 1 N-CA-C 100.652 -4.979 . . . . 1.0 100.652 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -132.55 122.59 25.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 120.968 2.384 . . . . 1.0 108.795 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -125.14 113.82 26.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.908 3.283 . . . . 1.0 106.847 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.13 126.82 14.95 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.521 2.814 . . . . 1.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -131.72 178.4 6.78 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.036 0.934 . . . . 1.0 109.361 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -117.59 144.43 45.15 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.443 1.097 . . . . 1.0 108.144 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.12 148.04 37.69 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.079 -0.711 . . . . 1.0 109.079 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -82.83 139.38 33.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 174.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m -117.11 113.42 39.37 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 117.213 -1.375 . . . . 1.0 107.619 173.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.43 -32.26 25.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.75 1.634 . . . . 1.0 110.239 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.3 -15.01 59.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.923 1.289 . . . . 1.0 112.471 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 mt -115.23 -4.2 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.094 1.358 . . . . 1.0 110.805 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.0 35.44 3.35 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.388 2.675 . . . . 1.0 110.042 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -162.51 168.68 21.54 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.563 -0.71 . . . . 1.0 109.707 -173.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -95.6 149.58 21.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.963 0.887 . . . . 1.0 112.114 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -139.85 154.5 70.82 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.624 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -69.78 161.82 44.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 107.971 -1.588 . . . . 1.0 107.971 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -159.04 170.7 21.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.081 0.855 . . . . 1.0 109.031 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.43 113.8 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 106.609 -1.626 . . . . 1.0 106.609 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.63 158.02 16.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.43 0.39 58.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 116.677 1.431 . . . . 1.0 116.677 -173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.65 3.41 54.51 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.224 1.512 . . . . 1.0 114.857 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 p -125.11 -172.46 2.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 128.717 2.807 . . . . 1.0 108.073 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -33.37 133.54 0.16 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.533 1.933 . . . . 1.0 113.001 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.26 168.09 40.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.814 -2.114 . . . . 1.0 107.814 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.99 -174.17 3.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.089 0.947 . . . . 1.0 109.06 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.72 -7.04 88.98 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 116.927 -2.041 . . . . 1.0 113.774 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -81.98 66.47 7.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 121.761 2.78 . . . . 1.0 107.607 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -147.08 113.66 6.0 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 130.81 3.644 . . . . 1.0 102.25 -173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -123.71 162.17 23.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.343 1.457 . . . . 1.0 107.747 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -93.07 -14.55 27.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.112 -1.403 . . . . 1.0 111.157 -173.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p -167.72 169.17 11.95 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.76 0.791 . . . . 1.0 109.996 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.0 tpt180 -61.4 -44.75 96.6 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -47.83 -66.51 0.39 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.231 2.612 . . . . 1.0 111.659 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.4 p -59.11 -33.46 70.87 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.046 0.927 . . . . 1.0 112.58 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -71.61 -49.95 35.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.044 0.938 . . . . 1.0 112.491 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.337 27.7 mt-10 -67.19 -32.94 74.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.02 -47.27 78.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 1.0 106.107 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 69' ' ' HIS . . . -58.87 -58.44 8.59 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 118.686 0.675 . . . . 1.0 111.871 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 66.9 m -129.27 86.17 57.35 Favored Pre-proline 0 N--CA 1.452 -0.363 0 O-C-N 123.737 0.648 . . . . 1.0 110.506 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -85.31 -177.06 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.642 2.895 . . . . 1.0 110.088 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.54 172.8 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 102.87 -3.011 . . . . 1.0 102.87 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.94 125.38 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 120.339 -1.476 . . . . 1.0 107.579 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -126.39 167.79 15.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.172 1.789 . . . . 1.0 108.633 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -103.06 9.29 38.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.236 3.014 . . . . 1.0 111.803 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.47 -57.79 0.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.614 1.097 . . . . 1.0 111.248 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -65.09 148.5 51.54 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.467 1.107 . . . . 1.0 111.502 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.23 169.05 23.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.008 2.923 . . . . 1.0 105.313 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 9.0 t60 -138.39 -85.85 0.27 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 102.542 -3.133 . . . . 1.0 102.542 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 . . . . . 0 C--O 1.259 1.56 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 172.905 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.89 20.99 1.0 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.642 1.977 . . . . 1.0 109.502 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -77.62 -25.33 49.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.013 1.325 . . . . 1.0 111.345 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.57 168.08 10.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.384 1.873 . . . . 1.0 108.115 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.17 -38.81 71.41 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.091 0.957 . . . . 1.0 110.833 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.36 158.2 36.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.094 1.357 . . . . 1.0 108.2 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 m -161.27 110.11 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -73.73 97.78 2.77 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.814 -1.55 . . . . 1.0 106.814 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.7 -35.38 63.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 119.036 -0.507 . . . . 1.0 111.1 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -69.02 -15.62 63.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.059 1.3 . . . . 1.0 111.747 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.02 -21.77 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.418 1.087 . . . . 1.0 111.129 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -73.32 148.67 88.62 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 127.261 2.224 . . . . 1.0 110.819 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 12' ' ' LEU . 36.6 Cg_endo -70.85 179.04 4.6 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.266 1.977 . . . . 1.0 111.034 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -120.41 161.6 20.94 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.14 152.97 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.653 1.181 . . . . 1.0 109.217 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -88.04 -31.47 19.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.343 1.457 . . . . 1.0 113.201 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 176.94 51.44 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.199 0.904 . . . . 1.0 112.404 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.88 -25.47 27.98 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.293 2.662 . . . . 1.0 112.842 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.56 158.85 25.98 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.206 -0.934 . . . . 1.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 3.53 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.685 1.594 . . . . 1.0 112.985 173.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.42 153.23 38.79 Favored Glycine 0 CA--C 1.531 1.044 1 N-CA-C 102.123 -4.391 . . . . 1.0 102.123 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.91 105.37 8.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.621 1.711 . . . . 1.0 111.022 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.02 114.01 62.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.426 2.29 . . . . 1.0 105.629 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 114.1 3.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.536 2.824 . . . . 1.0 109.747 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -114.78 176.94 4.83 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.361 0.664 . . . . 1.0 109.372 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.518 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 63.1 m95 -114.19 145.37 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.34 144.91 40.56 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.24 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.717 0.807 . . . . 1.0 110.009 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -117.43 113.36 38.78 Favored Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 120.684 -1.26 . . . . 1.0 108.034 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.09 -34.36 6.38 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.573 1.515 . . . . 1.0 109.665 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -65.03 -20.57 66.56 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 124.324 1.05 . . . . 1.0 112.355 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.34 -6.02 23.54 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.405 0.682 . . . . 1.0 110.223 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.88 38.47 6.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.278 2.631 . . . . 1.0 108.412 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.7 166.82 28.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.2 148.8 24.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.324 1.059 . . . . 1.0 110.699 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -132.35 152.18 79.61 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.592 -1.186 . . . . 1.0 109.577 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -68.9 166.31 26.91 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 13.6 p90 -155.59 164.09 39.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.15 123.81 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.455 -1.683 . . . . 1.0 106.455 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -122.49 168.84 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.409 1.884 . . . . 1.0 106.331 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.63 8.11 6.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.899 -0.945 . . . . 1.0 115.027 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.97 -48.31 4.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.29 1.545 . . . . 1.0 110.289 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 p -69.05 -173.39 0.5 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.635 1.174 . . . . 1.0 109.4 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -34.77 133.57 0.27 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.697 1.999 . . . . 1.0 114.261 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.7 173.49 39.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.756 -2.538 . . . . 1.0 106.756 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -93.65 171.24 9.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.63 -6.82 63.58 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.44 1.019 . . . . 1.0 114.356 -173.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -80.13 68.15 6.18 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -135.96 113.05 10.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.152 -1.796 . . . . 1.0 106.152 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.34 161.5 18.42 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 123.211 1.482 . . . . 1.0 108.382 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.1 -21.03 19.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.016 -2.356 . . . . 1.0 109.732 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -164.51 165.23 21.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.624 0.726 . . . . 1.0 109.117 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.56 -49.22 78.4 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.839 -1.073 . . . . 1.0 108.833 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.89 -66.85 0.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 128.004 2.521 . . . . 1.0 111.638 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -57.13 -33.27 67.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 t -67.51 -53.61 27.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.99 0.916 . . . . 1.0 112.908 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -33.27 75.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.526 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.84 -24.2 55.78 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.259 -0.877 . . . . 1.0 110.692 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.96 70.15 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 120.564 1.529 . . . . 1.0 111.634 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 m -116.41 75.64 6.61 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 118.702 0.683 . . . . 1.0 112.8 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.87 -178.89 4.11 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.397 2.065 . . . . 1.0 108.237 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.26 178.67 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.643 -1.984 . . . . 1.0 105.643 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.93 137.24 4.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.439 -1.689 . . . . 1.0 106.439 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -43.33 113.1 0.45 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.251 1.024 . . . . 1.0 113.55 -172.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.78 -27.17 60.21 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.309 -0.87 . . . . 1.0 110.276 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -70.98 8.43 0.92 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.517 1.127 . . . . 1.0 111.753 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -33.67 109.99 0.08 Allowed 'General case' 0 C--N 1.347 0.479 0 C-N-CA 127.13 2.172 . . . . 1.0 112.871 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -73.05 30.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.848 1.259 . . . . 1.0 112.473 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -144.58 177.67 8.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.577 1.951 . . . . 1.0 107.473 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.1 m170 . . . . . 0 C--O 1.244 0.796 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 173.646 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.456 ' H1 ' ' CD ' ' A' ' 1' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.77 -55.53 0.06 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.628 1.171 . . . . 1.0 108.184 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -76.42 -53.41 8.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.937 1.295 . . . . 1.0 107.677 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.73 177.92 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.623 1.569 . . . . 1.0 110.287 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.53 -23.49 26.68 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.174 2.59 . . . . 1.0 113.009 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -145.54 164.65 30.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.095 2.558 . . . . 1.0 105.385 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -122.9 93.7 4.04 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.12 170.65 16.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 105.957 -1.868 . . . . 1.0 105.957 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.62 -42.1 15.69 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 121.195 -0.941 . . . . 1.0 110.205 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 p -62.81 -28.93 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.476 0.711 . . . . 1.0 111.924 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.32 -28.08 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.49 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.2 tp -69.2 125.43 91.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 126.946 2.098 . . . . 1.0 112.412 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 12' ' ' LEU . 51.3 Cg_exo -49.91 154.71 4.83 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.579 2.852 . . . . 1.0 112.764 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.71 160.98 27.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.844 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -135.01 148.78 28.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 126.307 1.843 . . . . 1.0 106.226 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -74.0 -56.39 4.99 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.08 171.7 15.44 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.891 2.186 . . . . 1.0 108.682 -173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.11 -35.69 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.425 2.083 . . . . 1.0 111.375 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.5 158.64 23.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.952 0.882 . . . . 1.0 110.788 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 3.94 22.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.807 2.043 . . . . 1.0 113.701 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.7 154.13 50.96 Favored Glycine 0 CA--C 1.535 1.331 1 N-CA-C 102.85 -4.1 . . . . 1.0 102.85 172.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -125.2 104.86 8.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 120.526 2.163 . . . . 1.0 110.864 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -99.27 119.21 61.04 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 127.468 2.307 . . . . 1.0 107.168 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.59 125.65 10.24 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.11 2.54 . . . . 1.0 109.933 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -130.27 177.11 7.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.36 -0.837 . . . . 1.0 109.533 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -112.66 141.2 46.72 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.93 0.892 . . . . 1.0 108.619 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.37 147.52 45.57 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.07 133.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.792 0.682 . . . . 1.0 110.145 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -117.59 113.42 38.45 Favored Pre-proline 0 N--CA 1.445 -0.702 0 O-C-N 119.854 -1.779 . . . . 1.0 109.075 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.14 -35.11 20.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.752 1.635 . . . . 1.0 109.982 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.83 -19.71 65.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.62 1.168 . . . . 1.0 112.151 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -103.04 -4.15 24.98 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.364 1.066 . . . . 1.0 110.078 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.63 29.98 8.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.493 2.717 . . . . 1.0 110.749 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -165.04 166.66 19.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.96 0.8 . . . . 1.0 109.861 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.01 147.36 22.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.029 0.918 . . . . 1.0 109.459 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -142.7 153.74 61.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.625 0.77 . . . . 1.0 111.132 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.43 160.08 44.5 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.815 1.677 . . . . 1.0 108.534 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 40' ' ' TYR . 19.8 p90 -153.59 160.34 42.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.622 1.101 . . . . 1.0 108.776 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.12 113.62 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.942 -1.874 . . . . 1.0 105.942 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.402 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 26.1 t80 -107.63 167.68 9.78 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.229 2.212 . . . . 1.0 106.457 173.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.77 9.39 10.59 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.15 0.82 . . . . 1.0 115.15 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.26 -39.66 2.3 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.276 1.417 . . . . 1.0 113.241 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.17 -172.98 3.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.584 1.154 . . . . 1.0 108.41 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.7 mp0 -33.99 133.94 0.19 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.047 2.539 . . . . 1.0 112.838 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.23 -167.22 23.33 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 107.453 -2.259 . . . . 1.0 107.453 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.31 173.56 7.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.462 1.131 . . . . 1.0 108.172 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.87 -15.19 81.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.359 -0.837 . . . . 1.0 112.547 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -74.92 79.73 2.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.872 0.869 . . . . 1.0 108.675 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -146.57 113.09 5.96 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.915 -1.883 . . . . 1.0 105.915 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.32 162.33 19.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.499 1.52 . . . . 1.0 108.351 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -93.49 -19.43 21.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.145 -1.388 . . . . 1.0 112.381 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 p -162.73 169.34 20.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 1.0 109.561 -173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.7 tpt180 -61.81 -49.32 76.77 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.06 -0.973 . . . . 1.0 108.507 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.12 -66.61 0.38 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.508 2.723 . . . . 1.0 112.123 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 p -60.35 -33.25 72.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.734 0.646 . . . . 1.0 112.229 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.41 -51.84 39.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 112.694 0.627 . . . . 1.0 112.694 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.286 71.5 mt-10 -69.76 -33.28 72.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.144 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.06 -35.28 80.1 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.48 -50.74 34.83 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 120.164 1.347 . . . . 1.0 111.674 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.79 113.47 20.63 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.087 1.884 . . . . 1.0 116.087 -173.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -78.37 -163.17 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.946 1 C-N-CA 125.453 4.102 . . . . 1.0 109.714 173.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 63' ' ' VAL . 34.6 t -92.56 -168.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 104.708 -2.33 . . . . 1.0 104.708 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -46.43 123.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 102.198 -3.26 . . . . 1.0 102.198 173.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.09 113.27 8.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 117.562 2.43 . . . . 1.0 117.562 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -86.54 79.49 8.92 Favored 'General case' 0 N--CA 1.425 -1.689 1 N-CA-C 97.032 -5.174 . . . . 1.0 97.032 172.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -33.02 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.947 2.899 . . . . 1.0 116.295 -172.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.437 ' CD2' ' H ' ' A' ' 67' ' ' HIS . 4.4 p80 -78.82 96.95 5.77 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 127.187 2.195 . . . . 1.0 107.922 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -62.76 87.75 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.489 0.716 . . . . 1.0 110.055 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.2 t60 173.71 -168.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 136.133 5.773 . . . . 1.0 100.993 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.243 0.728 0 N-CA-C 102.093 -3.299 . . . . 1.0 102.093 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.39 145.33 54.23 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.598 -0.689 . . . . 1.0 110.915 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.93 -29.68 2.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.098 1.359 . . . . 1.0 110.397 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.45 167.48 11.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.553 1.141 . . . . 1.0 108.226 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.72 -44.22 58.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.324 1.449 . . . . 1.0 111.592 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.35 92.73 2.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.119 -1.437 . . . . 1.0 107.119 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m 173.54 137.26 0.04 OUTLIER 'General case' 0 C--O 1.235 0.317 0 C-N-CA 130.422 3.489 . . . . 1.0 104.979 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.53 146.83 25.39 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.601 -1.629 . . . . 1.0 106.601 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -23.6 0.42 Allowed 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 127.476 2.31 . . . . 1.0 112.283 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -46.86 -25.44 0.77 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.874 -1.141 . . . . 1.0 113.482 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.85 -33.0 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 119.403 1.002 . . . . 1.0 111.916 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 152.87 93.12 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 128.406 2.682 . . . . 1.0 109.013 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.06 173.15 10.76 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.742 . . . . 1.0 111.598 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.31 113.58 7.61 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.627 -1.249 . . . . 1.0 107.627 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.69 123.94 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.008 -1.479 . . . . 1.0 107.008 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -79.33 -33.41 43.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.257 -1.338 . . . . 1.0 110.737 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.84 172.66 42.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.74 -8.55 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.024 2.483 . . . . 1.0 114.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.55 -179.5 5.29 Favored 'General case' 0 N--CA 1.461 0.095 0 O-C-N 120.952 -1.093 . . . . 1.0 113.57 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.27 3.81 4.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.307 1.443 . . . . 1.0 113.576 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.79 157.12 29.48 Favored Glycine 0 CA--C 1.533 1.214 1 N-CA-C 101.301 -4.72 . . . . 1.0 101.301 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -131.44 117.88 19.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 121.333 2.567 . . . . 1.0 108.869 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.16 113.94 29.46 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 129.323 3.049 . . . . 1.0 107.77 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.55 125.44 13.33 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.559 2.839 . . . . 1.0 111.203 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -131.56 -179.99 5.7 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.403 1.081 . . . . 1.0 109.846 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.529 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 55.1 m95 -117.35 141.4 48.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.797 0.839 . . . . 1.0 108.751 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.86 148.44 48.64 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.87 143.69 29.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.666 0.746 . . . . 1.0 109.01 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 113.28 39.35 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 105.498 -2.038 . . . . 1.0 105.498 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.41 -32.41 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.747 1.631 . . . . 1.0 110.656 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.01 -17.1 64.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.793 0.837 . . . . 1.0 112.299 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.96 -4.29 16.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 1.0 110.546 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.78 35.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.64 3.176 . . . . 1.0 108.45 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -162.75 170.88 17.64 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 121.139 -0.976 . . . . 1.0 110.185 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -100.85 145.08 29.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.938 1.695 . . . . 1.0 111.738 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -138.48 153.6 72.77 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.887 0.875 . . . . 1.0 110.689 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.48 163.32 24.29 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.492 2.128 . . . . 1.0 110.483 173.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.0 168.26 27.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.19 113.72 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -99.36 163.82 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.561 1.944 . . . . 1.0 105.809 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.77 1.48 41.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 116.459 1.344 . . . . 1.0 116.459 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.5 1.96 67.13 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 118.963 1.382 . . . . 1.0 115.456 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.2 p -125.53 -172.65 2.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.699 2.4 . . . . 1.0 108.074 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -33.26 133.52 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.827 2.051 . . . . 1.0 112.839 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.2 42.27 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -93.81 -174.11 3.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.172 0.987 . . . . 1.0 109.773 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.4 -7.61 88.09 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 127.764 2.602 . . . . 1.0 113.591 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -86.3 53.16 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.442 2.121 . . . . 1.0 106.911 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -131.47 112.73 12.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 101.902 -3.37 . . . . 1.0 101.902 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -108.85 156.15 19.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.12 -13.46 28.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.461 -2.154 . . . . 1.0 112.137 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -166.48 169.33 13.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.694 1.198 . . . . 1.0 109.131 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -64.5 -42.93 95.54 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -48.97 -66.34 0.42 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.689 2.796 . . . . 1.0 111.318 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.8 p -58.47 -36.07 73.14 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.95 0.781 . . . . 1.0 111.495 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 39.1 t -66.61 -52.99 39.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.5 0.72 . . . . 1.0 112.35 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.39 -33.41 72.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.471 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.42 -29.48 61.52 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.663 1.119 . . . . 1.0 111.563 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -61.64 1.69 Allowed 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.372 0.987 . . . . 1.0 110.15 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.0 m -118.89 99.7 51.05 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.693 1.197 . . . . 1.0 108.336 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -93.11 -163.68 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.482 3.455 . . . . 1.0 112.952 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.16 -152.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.637 2 C-N-CA 138.401 6.68 . . . . 1.0 95.178 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -47.04 130.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 104.31 -2.478 . . . . 1.0 104.31 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.76 135.55 51.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.601 0.963 . . . . 1.0 113.601 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -66.68 -4.6 9.22 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.611 1.964 . . . . 1.0 113.49 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 -85.29 0.21 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.553 1.07 . . . . 1.0 108.808 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.2 p80 173.17 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.863 3.265 . . . . 1.0 110.647 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -85.52 160.52 19.65 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.536 -1.352 . . . . 1.0 108.941 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -55.76 147.58 18.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.149 0.58 . . . . 1.0 109.729 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.174 0 N-CA-C 102.4 -3.185 . . . . 1.0 102.4 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 108.809 -0.811 . . . . 1.0 108.809 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.14 129.8 41.06 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 149.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -136.96 -23.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 117.757 2.503 . . . . 1.0 117.757 -172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.15 -173.32 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.218 1.372 . . . . 1.0 111.407 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -59.13 -25.7 64.09 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.362 1.465 . . . . 1.0 111.273 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.74 94.39 0.12 Allowed 'General case' 0 C--N 1.342 0.262 0 N-CA-C 106.731 -1.581 . . . . 1.0 106.731 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -82.09 94.06 7.14 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -174.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.98 157.63 27.72 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.56 23.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.258 -0.877 . . . . 1.0 111.774 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -21.0 66.01 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.302 1.41 . . . . 1.0 111.566 -174.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.3 t -74.2 -36.71 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.931 -1.105 . . . . 1.0 110.252 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -70.29 129.98 89.89 Favored Pre-proline 0 N--CA 1.455 -0.176 0 C-N-CA 127.229 2.212 . . . . 1.0 113.199 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.4 Cg_exo -52.01 153.73 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.008 2.472 . . . . 1.0 111.403 173.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.97 166.82 16.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.315 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.93 146.3 30.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.403 -2.073 . . . . 1.0 105.403 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -97.53 -24.37 15.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.259 1.024 . . . . 1.0 112.242 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.08 45.82 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.999 1.761 . . . . 1.0 112.014 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.81 -3.43 13.85 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.609 3.539 . . . . 1.0 115.032 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.3 m -61.05 178.56 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.712 1.605 . . . . 1.0 113.298 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 3.65 3.98 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.233 1.413 . . . . 1.0 113.201 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.04 153.39 20.55 Favored Glycine 0 CA--C 1.529 0.945 1 N-CA-C 101.974 -4.45 . . . . 1.0 101.974 172.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -130.06 105.79 8.19 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.245 1.523 . . . . 1.0 111.324 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.01 114.84 64.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 129.153 2.981 . . . . 1.0 106.638 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.73 122.18 8.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.395 2.73 . . . . 1.0 109.549 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -123.28 179.57 4.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.593 0.757 . . . . 1.0 108.976 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -125.13 144.35 50.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.506 1.122 . . . . 1.0 108.436 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.57 141.33 35.22 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -77.14 137.73 39.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -117.3 113.66 38.89 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 117.463 -1.256 . . . . 1.0 108.006 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.26 -33.72 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.953 1.769 . . . . 1.0 110.805 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.66 -20.32 66.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.048 0.939 . . . . 1.0 112.37 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.66 -4.06 22.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.842 1.257 . . . . 1.0 110.479 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.65 16.85 2.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 128.416 2.686 . . . . 1.0 111.721 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -164.13 172.17 14.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.979 1.263 . . . . 1.0 110.525 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -87.75 148.82 24.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -133.9 155.9 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.989 1.316 . . . . 1.0 109.953 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.38 165.88 31.06 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.982 1.788 . . . . 1.0 109.237 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -158.6 165.69 33.87 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.7 t -89.05 129.96 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.793 -1.558 . . . . 1.0 106.793 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -132.46 170.13 15.57 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.492 1.517 . . . . 1.0 107.163 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.26 -3.18 8.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.946 1.538 . . . . 1.0 116.946 -173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.56 -29.92 6.42 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.826 1.813 . . . . 1.0 111.838 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -73.34 -173.2 1.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.383 1.873 . . . . 1.0 109.649 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -34.14 134.04 0.2 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.52 2.728 . . . . 1.0 112.983 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.93 175.86 41.44 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.271 -1.932 . . . . 1.0 108.271 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -93.62 177.55 5.98 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.89 76.15 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.511 -0.768 . . . . 1.0 112.825 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -78.99 70.2 5.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.372 1.086 . . . . 1.0 108.4 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -144.42 113.07 6.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -119.76 162.03 19.75 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.227 1.411 . . . . 1.0 108.785 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -93.33 -14.16 27.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.591 -1.186 . . . . 1.0 112.032 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -166.24 170.7 12.97 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.54 0.686 . . . . 1.0 109.222 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -62.81 -46.32 88.49 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -66.87 0.32 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 128.796 2.838 . . . . 1.0 111.079 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -54.57 -33.26 59.94 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.7 t -72.62 -49.42 32.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.448 -0.782 . . . . 1.0 112.793 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.19 -33.74 76.48 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 118.515 -0.755 . . . . 1.0 109.883 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.87 -41.41 97.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.813 0.845 . . . . 1.0 110.113 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.25 -42.01 76.18 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 118.709 0.686 . . . . 1.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.9 m -122.15 78.09 42.79 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 123.619 0.768 . . . . 1.0 110.855 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.04 159.96 48.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.215 2.61 . . . . 1.0 110.003 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.67 160.99 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 122.247 1.022 . . . . 1.0 108.411 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 64' ' ' ASP . 4.4 t -126.62 -177.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 127.518 2.327 . . . . 1.0 106.784 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t70 -49.54 137.14 15.65 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -65.03 -7.01 10.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.406 ' HD1' ' CG ' ' A' ' 64' ' ' ASP . 49.3 m80 -78.29 -9.86 59.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.993 1.724 . . . . 1.0 109.297 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -56.78 89.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.631 2.372 . . . . 1.0 112.155 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -64.65 133.71 52.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.426 -2.435 . . . . 1.0 104.426 173.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -80.39 -144.6 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 105.376 -2.083 . . . . 1.0 105.376 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.142 0 N-CA-C 106.407 -1.701 . . . . 1.0 106.407 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.2 -155.42 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.39 1.876 . . . . 1.0 106.653 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -52.65 -23.69 7.05 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.849 1.66 . . . . 1.0 110.41 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.91 135.8 53.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.171 -2.159 . . . . 1.0 105.171 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.9 -66.91 0.31 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.028 1.331 . . . . 1.0 111.36 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -84.98 93.56 8.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.24 -1.393 . . . . 1.0 107.24 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -160.36 152.43 20.31 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.06 2.544 . . . . 1.0 104.79 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -70.47 147.46 49.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 122.101 -0.374 . . . . 1.0 110.779 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.57 -39.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.679 1.592 . . . . 1.0 111.813 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -22.67 61.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.528 1.513 . . . . 1.0 112.746 -173.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.47 -37.87 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.11 0.868 . . . . 1.0 110.754 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 147.09 87.03 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.746 2.018 . . . . 1.0 112.832 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.09 158.08 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.063 3.175 . . . . 1.0 113.019 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.89 113.39 13.32 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.343 -1.473 . . . . 1.0 108.053 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.88 129.35 44.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -79.12 -35.12 42.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.938 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.51 171.98 37.95 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.95 -40.72 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.259 1.973 . . . . 1.0 112.849 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.5 m -68.12 159.32 31.2 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 121.34 -0.85 . . . . 1.0 111.877 -174.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 3.92 24.84 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.978 2.111 . . . . 1.0 114.279 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -68.41 165.48 46.8 Favored Glycine 0 CA--C 1.544 1.901 1 N-CA-C 102.49 -4.244 . . . . 1.0 102.49 172.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -136.95 135.88 38.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 123.444 3.622 . . . . 1.0 110.943 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -135.91 121.05 13.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 131.221 3.808 . . . . 1.0 107.237 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 128.15 16.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.377 2.718 . . . . 1.0 109.582 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -130.67 -179.01 5.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.428 1.091 . . . . 1.0 108.506 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.0 m95 -129.83 145.31 51.58 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 127.29 2.236 . . . . 1.0 106.613 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.08 145.64 30.62 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.7 t80 -80.72 138.48 36.33 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.548 0.689 . . . . 1.0 109.628 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -117.31 113.68 38.85 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 116.723 -1.608 . . . . 1.0 106.798 172.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.67 -33.28 28.44 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.855 1.704 . . . . 1.0 110.077 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.82 -15.62 62.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.761 1.224 . . . . 1.0 112.568 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.2 mt -112.35 -4.0 14.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.414 1.486 . . . . 1.0 110.498 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 50.64 26.94 2.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.333 3.053 . . . . 1.0 111.843 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -164.85 167.89 18.29 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.05 -1.031 . . . . 1.0 110.134 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 93.4 m -84.39 144.95 28.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.751 0.786 . . . . 1.0 112.396 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -131.46 155.12 81.9 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.058 1.343 . . . . 1.0 109.62 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.92 167.37 27.5 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.745 1.63 . . . . 1.0 108.739 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -161.84 166.32 26.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.36 113.47 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.239 -2.134 . . . . 1.0 105.239 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -98.9 156.33 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.559 1.944 . . . . 1.0 107.005 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -92.19 1.27 73.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 115.351 0.9 . . . . 1.0 115.351 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.44 -38.22 2.26 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.51 1.529 . . . . 1.0 114.21 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.6 p -80.91 -173.2 4.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 1.0 109.432 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.493 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.82 133.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.317 2.647 . . . . 1.0 113.261 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.88 -179.68 39.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.881 -1.688 . . . . 1.0 108.881 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.64 -175.05 3.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.711 0.767 . . . . 1.0 110.486 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.22 -19.76 79.47 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.742 -1.588 . . . . 1.0 115.498 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -79.99 70.87 6.65 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.605 2.203 . . . . 1.0 108.227 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -149.4 113.3 5.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 -173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -125.53 156.07 39.61 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.127 1.771 . . . . 1.0 107.689 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -93.58 -10.12 35.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 1.0 111.969 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.76 158.09 43.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 120.162 1.346 . . . . 1.0 111.319 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -61.72 -45.99 91.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.39 -1.277 . . . . 1.0 109.426 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.36 -66.57 0.38 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.042 2.537 . . . . 1.0 112.369 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.4 p -57.99 -41.27 82.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.011 0.819 . . . . 1.0 110.861 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.55 -48.32 72.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.946 0.898 . . . . 1.0 112.137 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.52 -34.04 77.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 117.503 -1.237 . . . . 1.0 110.886 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.76 -29.75 70.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.406 1.912 . . . . 1.0 111.1 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -63.5 1.05 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-N 119.49 1.041 . . . . 1.0 108.398 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -131.05 105.5 15.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 1.0 110.216 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -101.68 -162.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 1 C-N-CA 127.595 5.53 . . . . 1.0 112.266 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 63' ' ' VAL . 46.5 t -92.98 -152.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 2 C-N-CA 134.922 5.289 . . . . 1.0 97.178 172.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.582 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -42.26 124.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 119.106 -2.247 . . . . 1.0 105.952 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -84.74 148.82 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 118.983 2.957 . . . . 1.0 118.983 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -64.24 -57.54 9.16 Favored 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 132.936 4.494 . . . . 1.0 106.046 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -69.39 154.34 42.18 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -141.64 163.66 32.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 119.569 -1.957 . . . . 1.0 108.696 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -50.33 116.26 1.8 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.559 1.144 . . . . 1.0 110.434 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.29 127.36 29.0 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.982 0 O-C-N 125.297 1.623 . . . . 1.0 109.808 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 2.7 mp0 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 1' ' ' GLU . . . -57.15 -3.6 0.15 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.035 2.134 . . . . 1.0 115.036 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 2.1 mp0 -63.81 -26.79 68.79 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.226 0.921 . . . . 1.0 109.968 173.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.47 172.71 7.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.714 1.606 . . . . 1.0 110.516 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -58.26 -32.63 68.56 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.4 1.48 . . . . 1.0 111.923 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -156.04 172.96 17.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.722 1.609 . . . . 1.0 107.982 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 m -149.33 105.96 3.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.849 -1.537 . . . . 1.0 106.849 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.93 162.33 29.52 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.837 -1.912 . . . . 1.0 105.837 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.74 42.36 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.89 0.768 . . . . 1.0 109.799 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.15 68.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.976 0.807 . . . . 1.0 112.291 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.08 -34.55 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.039 0.936 . . . . 1.0 109.843 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.5 tp -64.68 129.24 94.23 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 125.672 1.589 . . . . 1.0 113.169 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.0 Cg_exo -51.6 159.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.597 2.865 . . . . 1.0 111.859 173.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.17 113.72 25.76 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.118 -0.989 . . . . 1.0 109.599 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.77 145.88 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.3 -23.96 18.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.066 1.347 . . . . 1.0 111.59 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.12 168.86 34.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.085 1.326 . . . . 1.0 115.189 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.17 -28.23 2.05 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.844 3.029 . . . . 1.0 113.221 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 m -72.7 165.38 24.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.035 0.834 . . . . 1.0 110.728 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HA ' ' HE ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -111.85 3.78 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.11 1.152 . . . . 1.0 114.11 -174.019 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 154.27 37.47 Favored Glycine 0 CA--C 1.534 1.25 1 N-CA-C 101.892 -4.483 . . . . 1.0 101.892 172.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -136.16 129.77 32.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.711 2.255 . . . . 1.0 108.379 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.08 113.98 16.16 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 129.679 3.192 . . . . 1.0 105.744 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.93 129.34 20.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.287 2.658 . . . . 1.0 109.925 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -130.46 176.19 8.35 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.736 -1.12 . . . . 1.0 108.639 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.591 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 62.8 m95 -129.83 139.15 51.27 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.972 -1.862 . . . . 1.0 105.972 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.91 145.31 41.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -81.69 139.09 35.12 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.728 0.775 . . . . 1.0 110.811 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -117.44 113.59 38.64 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.114 -1.422 . . . . 1.0 107.328 172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.82 -34.33 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.977 1.785 . . . . 1.0 110.832 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.6 -20.67 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.142 0.977 . . . . 1.0 112.42 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -103.1 -5.39 23.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.731 1.212 . . . . 1.0 110.61 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 48.95 29.88 2.54 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 130.74 3.616 . . . . 1.0 110.065 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -165.47 168.33 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.378 -0.826 . . . . 1.0 109.187 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.5 m -90.79 147.72 23.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -126.43 156.06 73.39 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.743 1.217 . . . . 1.0 109.47 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -72.85 168.67 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.589 1.526 . . . . 1.0 109.252 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -159.54 165.34 33.13 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.64 113.93 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.053 -2.202 . . . . 1.0 105.053 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -106.55 145.92 31.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.458 -1.682 . . . . 1.0 106.458 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.07 3.31 85.75 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.109 -0.828 . . . . 1.0 114.667 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.99 -49.08 3.43 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.983 1.278 . . . . 1.0 110.058 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.6 p -72.58 -172.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.396 1.478 . . . . 1.0 108.44 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.05 133.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.269 2.228 . . . . 1.0 114.46 -173.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.21 177.58 44.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 128.299 2.857 . . . . 1.0 106.861 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.484 ' ND2' HD11 ' A' ' 12' ' ' LEU . 12.7 m-20 -93.73 177.02 6.14 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.276 1.038 . . . . 1.0 109.906 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.22 82.43 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.845 -1.071 . . . . 1.0 113.504 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.34 72.11 3.07 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -135.37 112.95 10.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.94 149.69 43.93 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.51 -8.52 41.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 118.531 -0.747 . . . . 1.0 110.76 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -155.34 158.94 39.51 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.083 0.856 . . . . 1.0 112.249 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.591 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -57.19 -56.98 14.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.839 1.656 . . . . 1.0 111.661 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.16 -47.53 82.28 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.057 0.848 . . . . 1.0 111.72 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.7 p -53.68 -35.3 60.92 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.83 -48.43 21.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.55 -34.02 73.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.397 -0.811 . . . . 1.0 111.346 174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.96 -27.07 49.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.217 1.371 . . . . 1.0 110.665 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.03 1.14 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.986 1.267 . . . . 1.0 109.174 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 m -121.4 106.43 37.98 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 124.967 1.307 . . . . 1.0 107.894 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -94.28 -171.88 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.231 2.621 . . . . 1.0 113.227 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.66 -152.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.76 2 N-CA-C 96.417 -5.401 . . . . 1.0 96.417 172.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -47.87 123.53 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 N-CA-C 102.588 -3.115 . . . . 1.0 102.588 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -33.7 113.74 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 117.843 2.534 . . . . 1.0 117.843 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -34.73 65.58 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.178 0.991 . . . . 1.0 112.105 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -83.09 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.357 1.063 . . . . 1.0 111.478 -173.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 80.88 7.13 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.415 -1.428 . . . . 1.0 108.048 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -34.96 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.105 2.562 . . . . 1.0 112.09 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -62.94 150.73 41.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.986 0 N-CA-C 100.719 -3.808 . . . . 1.0 100.719 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 174.09 -140.98 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.611 1 C-N-CA 133.338 4.655 . . . . 1.0 102.134 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.54 -42.05 77.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.911 1.687 . . . . 1.0 109.707 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.28 176.28 5.17 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.45 -29.48 70.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 118.315 -1.354 . . . . 1.0 109.846 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.61 92.79 2.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.051 0.841 . . . . 1.0 109.343 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m 172.97 126.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 1 C-N-CA 132.479 4.312 . . . . 1.0 102.972 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -136.36 134.67 38.1 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.028 -2.212 . . . . 1.0 105.028 173.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.09 -29.62 2.31 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.474 1.109 . . . . 1.0 110.634 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -66.61 -14.97 63.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.934 0.893 . . . . 1.0 113.38 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.18 -28.94 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.265 1.026 . . . . 1.0 109.517 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.1 tp -71.05 131.8 86.94 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.227 2.211 . . . . 1.0 113.013 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 12' ' ' LEU . 73.3 Cg_exo -51.51 157.73 4.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.646 2.897 . . . . 1.0 113.139 173.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.22 164.46 24.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.663 0.785 . . . . 1.0 110.433 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.35 151.43 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.036 1.734 . . . . 1.0 106.405 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -99.38 -27.55 13.7 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.001 0.92 . . . . 1.0 113.442 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.6 171.05 46.83 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.989 -1.645 . . . . 1.0 108.989 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.85 -27.01 37.73 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.734 2.289 . . . . 1.0 112.504 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.72 155.37 38.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.085 0.954 . . . . 1.0 109.562 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.09 3.97 19.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.487 1.915 . . . . 1.0 113.962 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.03 157.48 48.85 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 103.639 -3.785 . . . . 1.0 103.639 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -132.76 108.36 8.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 121.541 2.671 . . . . 1.0 115.102 -173.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 25' ' ' ARG . 75.7 tt0 -106.04 126.21 31.18 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -71.09 113.72 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.404 2.069 . . . . 1.0 108.142 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 25.6 mmt85 -107.92 178.87 4.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.691 -1.225 . . . . 1.0 107.691 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.502 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -133.22 143.61 49.25 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.825 1.65 . . . . 1.0 107.724 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.32 149.36 37.67 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.82 0.848 . . . . 1.0 109.063 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -83.63 141.47 31.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.195 0.998 . . . . 1.0 110.818 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.2 m -117.34 113.29 38.98 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 106.08 -1.822 . . . . 1.0 106.08 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.14 -32.18 21.71 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.631 1.554 . . . . 1.0 110.219 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.65 -15.34 61.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 1.0 112.367 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 mt -112.7 -4.57 14.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.823 1.249 . . . . 1.0 110.521 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.93 36.66 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.276 2.63 . . . . 1.0 109.821 -173.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -164.85 169.01 17.13 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.738 -0.601 . . . . 1.0 109.576 -173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -95.31 150.84 19.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.498 1.142 . . . . 1.0 112.883 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -135.04 155.66 78.94 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.725 1.21 . . . . 1.0 109.682 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.59 169.51 21.67 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.938 1.759 . . . . 1.0 110.229 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -162.56 175.22 11.66 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.538 1.935 . . . . 1.0 106.722 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.1 126.58 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.021 -1.474 . . . . 1.0 107.021 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.77 160.1 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.033 2.533 . . . . 1.0 110.015 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.72 19.32 11.37 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 118.104 2.002 . . . . 1.0 118.104 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 -46.81 3.34 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 119.807 1.803 . . . . 1.0 112.321 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 p -65.9 -173.14 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.686 1.595 . . . . 1.0 110.541 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.3 mp0 -33.54 133.85 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 129.394 3.078 . . . . 1.0 114.365 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.81 174.85 35.17 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.159 -1.976 . . . . 1.0 108.159 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.59 -177.62 4.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 -23.72 76.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.333 0.492 . . . . 1.0 112.341 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.71 69.08 4.83 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.032 0.916 . . . . 1.0 108.81 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -152.14 113.14 4.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.07 156.72 42.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.5 1.52 . . . . 1.0 109.206 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -93.46 -8.21 42.26 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.424 -0.798 . . . . 1.0 110.68 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 p -157.14 166.07 34.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.025 0.829 . . . . 1.0 109.897 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.9 tpt180 -60.28 -47.38 86.27 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 173.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -44.66 -66.56 0.38 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 128.284 2.634 . . . . 1.0 112.474 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 p -60.65 -36.04 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.626 0.579 . . . . 1.0 111.91 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.39 -47.71 63.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.283 0.633 . . . . 1.0 111.715 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.57 -32.91 74.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.176 0.991 . . . . 1.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.58 -40.18 70.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 117.737 -1.125 . . . . 1.0 110.001 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -59.18 5.09 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.819 1.19 . . . . 1.0 110.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.3 m -122.19 107.32 35.12 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.087 1.355 . . . . 1.0 108.307 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -94.37 -166.27 0.13 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.957 2.438 . . . . 1.0 113.855 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 63' ' ' VAL . 15.9 t -101.49 -152.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 2 C-N-CA 137.742 6.417 . . . . 1.0 95.716 172.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -44.52 125.94 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 O-C-N 119.523 -1.985 . . . . 1.0 105.864 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -62.98 133.12 54.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.596 -1.184 . . . . 1.0 112.181 -172.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -84.45 -18.32 36.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.989 2.116 . . . . 1.0 110.267 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 -131.15 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.696 2.398 . . . . 1.0 107.465 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -170.91 152.26 3.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.701 2.801 . . . . 1.0 105.61 173.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.32 53.89 1.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.181 0.992 . . . . 1.0 109.817 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.07 179.66 8.23 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 119.511 -1.993 . . . . 1.0 111.567 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.244 0.812 0 C-N-CA 130.636 3.574 . . . . 1.0 102.685 173.163 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.924 0.869 . . . . 1.0 108.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -161.36 29.82 0.13 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.351 2.66 . . . . 1.0 107.626 170.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 7.7 mp0 -138.88 -25.08 0.89 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.09 1.356 . . . . 1.0 112.045 -173.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.44 -8.44 11.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.361 1.864 . . . . 1.0 113.905 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -68.38 -42.33 79.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.483 1.913 . . . . 1.0 114.784 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -156.87 120.77 4.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.328 1.422 . . . . 1.0 112.618 -174.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.428 ' CG2' ' H ' ' A' ' 8' ' ' ASP . 3.6 m 173.37 -167.18 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 1 C-N-CA 133.393 4.677 . . . . 1.0 103.733 173.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' H ' ' CG2' ' A' ' 7' ' ' THR . 15.1 t70 -49.12 160.44 0.21 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.453 1.501 . . . . 1.0 109.945 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.74 -34.8 8.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.945 -1.026 . . . . 1.0 112.417 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 p -55.22 -31.51 61.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.174 1.352 . . . . 1.0 112.518 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.79 -34.3 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.307 -0.87 . . . . 1.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.5 tp -61.7 129.14 91.2 Favored Pre-proline 0 CA--C 1.522 -0.124 0 C-N-CA 125.276 1.43 . . . . 1.0 113.045 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -49.93 151.36 8.58 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.316 2.678 . . . . 1.0 112.164 173.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.5 23.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.576 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.48 139.98 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 104.689 -2.337 . . . . 1.0 104.689 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.61 -58.29 3.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.28 171.66 12.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.729 1.633 . . . . 1.0 109.979 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.9 -12.22 14.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.973 2.449 . . . . 1.0 112.802 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.66 176.21 6.43 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 122.34 1.067 . . . . 1.0 112.373 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.26 3.69 8.5 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.603 -1.18 . . . . 1.0 112.479 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.29 154.28 21.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 103.176 -3.97 . . . . 1.0 103.176 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -132.19 119.9 21.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.478 1.639 . . . . 1.0 108.377 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -120.2 113.75 33.82 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 129.551 3.14 . . . . 1.0 106.584 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.04 124.28 11.22 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.183 2.589 . . . . 1.0 110.835 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -129.4 178.32 6.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.958 0.903 . . . . 1.0 109.34 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.7 m95 -120.07 141.17 50.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.554 1.142 . . . . 1.0 107.994 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.25 146.7 51.67 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -84.56 136.14 33.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.6 m -117.23 113.94 38.89 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 120.35 -1.469 . . . . 1.0 109.11 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.72 -36.52 18.68 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.208 1.939 . . . . 1.0 110.634 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 mt -61.98 -23.32 66.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.793 1.237 . . . . 1.0 113.083 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 mt -102.85 -4.36 24.97 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.165 0.986 . . . . 1.0 110.801 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.08 36.13 1.91 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.985 2.914 . . . . 1.0 109.995 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.16 169.88 17.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.352 -0.842 . . . . 1.0 109.074 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.2 m -98.77 146.32 26.03 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.88 -0.512 . . . . 1.0 111.164 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -132.73 154.09 81.33 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.253 1.021 . . . . 1.0 110.194 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.17 165.9 30.94 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.482 -1.391 . . . . 1.0 108.482 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -157.68 161.59 38.58 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.366 -0.975 . . . . 1.0 108.366 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 t -86.24 113.82 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.579 -2.008 . . . . 1.0 105.579 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.41 159.06 15.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.223 -2.14 . . . . 1.0 105.223 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.44 1.25 49.83 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.854 -1.154 . . . . 1.0 115.611 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 -8.47 13.24 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.776 1.288 . . . . 1.0 115.06 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.23 -172.53 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.076 2.95 . . . . 1.0 107.252 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 2.8 mp0 -33.47 133.64 0.16 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.741 2.017 . . . . 1.0 112.809 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -174.84 38.78 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.185 -2.366 . . . . 1.0 107.185 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -93.41 174.92 6.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.784 1.292 . . . . 1.0 108.883 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.07 84.83 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 114.574 -1.193 . . . . 1.0 112.644 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -76.54 73.12 3.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.648 -1.241 . . . . 1.0 107.648 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -138.23 112.92 8.94 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.128 -1.804 . . . . 1.0 106.128 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.06 158.26 24.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 123.618 1.675 . . . . 1.0 107.132 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -93.3 -16.47 24.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.754 -2.021 . . . . 1.0 111.602 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -166.05 164.44 18.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.976 0.893 . . . . 1.0 109.145 -173.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.1 tpt180 -60.27 -47.94 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.476 -1.238 . . . . 1.0 108.54 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.46 -66.27 0.43 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.612 2.365 . . . . 1.0 111.362 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 p -57.76 -33.4 68.46 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 123.997 0.811 . . . . 1.0 112.423 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.5 t -68.15 -54.05 20.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.146 0.978 . . . . 1.0 112.789 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.48 -33.18 75.29 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.8 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.12 -24.32 51.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.898 -1.048 . . . . 1.0 111.054 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.82 -65.03 0.73 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 120.839 1.654 . . . . 1.0 109.497 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.8 m -105.51 100.66 27.58 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.119 0.414 . . . . 1.0 112.119 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.62 173.31 14.36 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.542 2.161 . . . . 1.0 112.425 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 63' ' ' VAL . 2.4 t -153.75 -155.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.655 2 C-N-CA 134.193 4.997 . . . . 1.0 98.866 173.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -56.1 135.69 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 101.964 -3.347 . . . . 1.0 101.964 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -54.05 113.54 1.27 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.626 0.973 . . . . 1.0 113.626 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -68.24 107.57 2.85 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 96.44 -5.393 . . . . 1.0 96.44 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -32.74 88.36 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 117.394 2.368 . . . . 1.0 117.394 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.722 ' CG ' ' H ' ' A' ' 68' ' ' HIS . 12.7 p-80 -149.82 -97.19 0.07 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 102.715 -3.069 . . . . 1.0 102.715 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.722 ' H ' ' CG ' ' A' ' 67' ' ' HIS . 45.3 t60 173.77 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 130.606 3.562 . . . . 1.0 103.334 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -53.46 130.3 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 104.453 -2.425 . . . . 1.0 104.453 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.397 0 CA-C-O 114.564 -2.636 . . . . 1.0 110.422 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.5 -163.8 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.406 1.882 . . . . 1.0 106.092 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.58 -58.01 5.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.609 1.164 . . . . 1.0 109.215 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . . . -116.82 -178.88 3.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.189 1.395 . . . . 1.0 109.732 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -67.67 -23.62 65.34 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.599 0.76 . . . . 1.0 109.829 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -103.22 164.77 11.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.602 1.961 . . . . 1.0 108.852 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -153.0 134.38 14.31 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.645 -1.243 . . . . 1.0 107.645 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -130.88 178.14 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.539 3.136 . . . . 1.0 108.589 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.77 -26.42 1.59 Allowed 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 126.077 1.751 . . . . 1.0 111.089 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -47.11 -34.6 6.19 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.184 1.356 . . . . 1.0 114.154 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.95 -25.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 120.683 -1.261 . . . . 1.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -67.24 127.57 93.51 Favored Pre-proline 0 CA--C 1.519 -0.243 0 C-N-CA 126.21 1.804 . . . . 1.0 112.033 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.2 Cg_exo -49.9 152.24 7.45 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.993 2.462 . . . . 1.0 112.205 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.51 158.17 27.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.215 -0.902 . . . . 1.0 109.827 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -139.49 148.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.28 -69.77 0.38 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.98 175.9 14.06 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.77 -19.64 18.24 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.652 2.235 . . . . 1.0 112.651 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.38 177.85 4.95 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.059 0.944 . . . . 1.0 112.276 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.75 3.44 11.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.378 1.471 . . . . 1.0 112.1 174.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.47 153.9 32.29 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 103.704 -3.758 . . . . 1.0 103.704 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -133.62 125.79 29.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.279 1.54 . . . . 1.0 107.401 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.32 113.88 23.5 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 129.153 2.981 . . . . 1.0 106.633 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.43 129.78 15.27 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.203 2.602 . . . . 1.0 110.711 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -134.43 178.23 7.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.083 0.953 . . . . 1.0 109.614 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.3 m95 -110.84 141.71 43.85 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.191 -1.041 . . . . 1.0 108.191 174.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.5 41.76 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 118.855 0.752 . . . . 1.0 109.515 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -81.78 136.54 35.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -117.39 113.88 38.61 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 116.379 -1.772 . . . . 1.0 110.685 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.69 -34.26 32.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.726 1.618 . . . . 1.0 109.793 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.1 mt -64.78 -10.85 30.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.687 1.595 . . . . 1.0 112.716 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -120.63 -4.22 9.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.191 1.396 . . . . 1.0 110.51 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.22 36.16 6.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.746 2.418 . . . . 1.0 109.767 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.84 166.43 19.7 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.294 -0.879 . . . . 1.0 110.016 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.9 m -94.63 145.85 24.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.013 0.911 . . . . 1.0 110.607 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.37 156.46 63.96 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 118.514 -0.755 . . . . 1.0 111.304 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.63 157.28 56.41 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.12 1.88 . . . . 1.0 108.832 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -153.49 161.36 42.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.786 1.176 . . . . 1.0 108.833 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -85.76 124.41 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 173.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -116.05 163.82 15.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.98 -0.78 48.5 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.558 -1.339 . . . . 1.0 115.131 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.83 -37.07 1.04 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.41 1.481 . . . . 1.0 112.881 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.06 -172.74 4.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.211 1.804 . . . . 1.0 107.759 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.84 133.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.871 2.068 . . . . 1.0 112.88 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 -167.83 30.59 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 107.596 -2.201 . . . . 1.0 107.596 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -93.34 174.89 6.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.224 1.012 . . . . 1.0 108.827 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.02 -10.93 82.17 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.819 -1.082 . . . . 1.0 112.755 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -73.17 81.39 1.3 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.51 112.95 6.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.81 160.77 21.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 123.468 1.604 . . . . 1.0 107.894 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -93.42 -20.81 19.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 112.542 -2.117 . . . . 1.0 112.492 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -165.14 167.62 18.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -60.9 -51.31 69.84 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -45.1 -66.6 0.38 Allowed 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 128.202 2.601 . . . . 1.0 112.075 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -60.83 -33.39 72.96 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.67 0.606 . . . . 1.0 112.304 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.94 -52.23 38.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -69.92 -33.24 71.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.466 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.46 -28.14 61.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 117.902 -1.519 . . . . 1.0 110.448 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.2 -48.61 41.81 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-N 120.543 1.519 . . . . 1.0 110.483 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.8 m -134.17 82.72 47.03 Favored Pre-proline 0 N--CA 1.446 -0.632 0 C-N-CA 123.868 0.867 . . . . 1.0 113.328 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -87.45 -163.56 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 104.723 -2.837 . . . . 1.0 104.723 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 63' ' ' VAL . 2.5 t -92.6 -175.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 101.951 -3.352 . . . . 1.0 101.951 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 2.4 t -32.98 113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 126.266 1.826 . . . . 1.0 108.318 -172.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -34.35 113.61 0.18 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 111.719 -2.491 . . . . 1.0 111.635 -172.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -76.77 77.64 3.39 Favored 'General case' 0 N--CA 1.433 -1.284 1 N-CA-C 96.557 -5.349 . . . . 1.0 96.557 173.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.31 80.0 m-70 -32.71 90.54 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 128.78 2.832 . . . . 1.0 113.831 -172.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -38.48 101.71 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.898 3.279 . . . . 1.0 106.982 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -48.09 132.7 15.55 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.056 0.942 . . . . 1.0 112.021 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -134.49 -89.61 0.36 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 100.372 -3.936 . . . . 1.0 100.372 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.175 0 N-CA-C 102.519 -3.141 . . . . 1.0 102.519 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -152.53 23.96 0.61 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.231 2.212 . . . . 1.0 110.426 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 22.3 mp0 -105.37 -50.11 3.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.054 1.742 . . . . 1.0 109.836 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.28 12.62 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.055 2.142 . . . . 1.0 114.787 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.95 -23.94 59.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.215 1.406 . . . . 1.0 110.354 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -130.75 -178.39 4.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 129.623 3.169 . . . . 1.0 106.552 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 m -73.25 93.73 1.91 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 173.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.9 165.39 25.21 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.41 -23.85 6.76 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.924 0.889 . . . . 1.0 111.664 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 p -52.84 -30.64 34.8 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.137 1.335 . . . . 1.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 t -78.19 -27.11 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.437 -0.789 . . . . 1.0 110.444 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -69.48 130.16 90.95 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 126.391 1.876 . . . . 1.0 112.178 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.1 Cg_exo -51.77 154.42 9.65 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.922 2.415 . . . . 1.0 111.579 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.39 160.27 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.383 0.673 . . . . 1.0 109.636 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.69 150.06 20.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 126.002 1.721 . . . . 1.0 106.567 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -72.61 -68.7 0.46 Allowed 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.75 171.36 12.82 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.441 1.496 . . . . 1.0 109.8 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.79 -12.16 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.074 2.516 . . . . 1.0 113.358 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.3 m -72.69 -174.99 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.574 1.15 . . . . 1.0 112.201 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.65 3.61 5.51 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.064 0.945 . . . . 1.0 113.167 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.83 153.61 25.97 Favored Glycine 0 CA--C 1.528 0.89 1 N-CA-C 102.292 -4.323 . . . . 1.0 102.292 172.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -134.21 123.34 24.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.482 1.641 . . . . 1.0 108.277 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.59 113.7 34.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 129.732 3.213 . . . . 1.0 106.56 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.9 130.47 14.53 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.68 . . . . 1.0 110.486 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -134.41 177.34 7.84 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.724 0.81 . . . . 1.0 109.353 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.52 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.4 m95 -111.1 141.06 45.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.27 47.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -82.68 141.35 32.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.777 0.799 . . . . 1.0 109.398 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -117.31 113.14 39.11 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 105.818 -1.919 . . . . 1.0 105.818 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -33.65 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.68 1.587 . . . . 1.0 109.584 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.29 -15.86 62.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.145 1.378 . . . . 1.0 112.601 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.6 mt -112.12 -5.32 14.25 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.262 1.025 . . . . 1.0 110.493 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.74 37.47 7.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.324 2.25 . . . . 1.0 109.47 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -160.88 166.2 28.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.2 149.57 23.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.981 0.896 . . . . 1.0 111.744 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -140.8 154.26 68.56 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.804 . . . . 1.0 110.832 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.79 162.08 33.41 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.147 1.898 . . . . 1.0 109.084 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -156.03 157.57 36.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.352 0.978 . . . . 1.0 108.416 173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.35 130.76 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.889 -2.264 . . . . 1.0 104.889 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.76 163.38 22.23 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.26 -0.11 40.83 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.53 -1.15 . . . . 1.0 115.523 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 -34.17 1.07 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.266 1.533 . . . . 1.0 113.116 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -88.85 -172.71 3.81 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.361 2.264 . . . . 1.0 107.748 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -33.8 133.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.795 2.038 . . . . 1.0 112.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.3 -172.28 40.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 107.316 -2.313 . . . . 1.0 107.316 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' ND2' HD11 ' A' ' 12' ' ' LEU . 6.2 m-20 -93.55 175.63 6.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.326 1.06 . . . . 1.0 109.355 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.99 -9.75 73.28 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.582 -1.19 . . . . 1.0 113.794 -173.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -73.89 81.15 1.65 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.447 -1.686 . . . . 1.0 106.447 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -142.36 113.04 7.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.428 -1.323 . . . . 1.0 107.428 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -118.1 161.3 20.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.009 1.385 . . . . 1.0 108.271 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.21 -19.12 21.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 112.898 -1.955 . . . . 1.0 112.288 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -165.96 168.75 15.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.89 -47.05 88.15 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 173.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -47.59 -66.58 0.38 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.844 2.858 . . . . 1.0 111.947 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 p -60.53 -33.5 72.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.602 0.564 . . . . 1.0 112.093 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.5 t -69.55 -50.7 42.4 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.714 0.806 . . . . 1.0 112.431 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.278 61.7 mt-10 -68.97 -32.9 72.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.997 -0.525 . . . . 1.0 110.085 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.56 -28.94 66.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.424 -1.275 . . . . 1.0 110.805 173.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.77 15.96 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 119.735 1.152 . . . . 1.0 111.039 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.1 m -122.44 80.41 46.23 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 123.661 0.784 . . . . 1.0 110.359 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -81.57 -163.68 0.24 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.216 3.277 . . . . 1.0 109.985 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 63' ' ' VAL . 2.5 t -93.6 -153.91 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 101.518 -3.512 . . . . 1.0 101.518 172.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 62' ' ' VAL . 18.3 t -50.32 149.38 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 120.925 -1.11 . . . . 1.0 109.462 173.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -36.25 123.09 0.75 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 128.661 2.785 . . . . 1.0 112.09 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -60.46 113.79 2.61 Favored 'General case' 0 C--N 1.348 0.507 1 N-CA-C 99.126 -4.398 . . . . 1.0 99.126 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -32.98 87.29 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 117.328 2.344 . . . . 1.0 117.328 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -132.48 -115.43 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 2 C-N-CA 133.052 4.541 . . . . 1.0 98.743 173.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 173.07 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 1 C-N-CA 132.761 4.424 . . . . 1.0 104.703 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -68.19 -22.19 64.83 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.202 -0.936 . . . . 1.0 109.959 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 C--O 1.259 1.562 0 C-N-CA 129.029 2.932 . . . . 1.0 103.188 173.526 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 117.512 -1.232 . . . . 1.0 108.809 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.34 169.76 18.17 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.213 1.369 . . . . 1.0 109.447 164.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -63.63 -23.94 67.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.02 1.489 . . . . 1.0 115.02 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.09 -81.29 0.13 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -135.63 -77.82 0.43 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.782 2.033 . . . . 1.0 105.565 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -164.43 155.05 14.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 m -177.02 143.44 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.469 4.307 . . . . 1.0 102.337 173.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -147.69 174.51 11.71 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.256 2.222 . . . . 1.0 108.58 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.96 -23.97 8.38 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.583 1.153 . . . . 1.0 109.538 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -50.3 -29.5 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.957 1.303 . . . . 1.0 113.115 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.1 t -78.18 -26.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.042 . . . . 1.0 110.674 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -71.41 131.26 86.69 Favored Pre-proline 0 N--CA 1.453 -0.3 0 C-N-CA 127.185 2.194 . . . . 1.0 112.406 174.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.2 Cg_exo -51.74 153.39 11.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.877 2.385 . . . . 1.0 111.59 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.9 160.74 22.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.614 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.61 148.75 21.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 125.479 1.512 . . . . 1.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.83 -68.68 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.312 1.045 . . . . 1.0 109.045 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.73 175.7 14.09 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.139 1.352 . . . . 1.0 109.772 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.92 -15.27 18.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.739 2.293 . . . . 1.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.3 m -72.97 178.85 4.04 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 124.217 1.007 . . . . 1.0 111.808 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.87 3.68 4.46 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.837 1.051 . . . . 1.0 113.837 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.54 153.71 29.01 Favored Glycine 0 CA--C 1.53 1.018 1 N-CA-C 102.037 -4.425 . . . . 1.0 102.037 172.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.18 109.6 11.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.967 1.883 . . . . 1.0 108.9 -173.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.5 113.93 61.23 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 129.021 2.928 . . . . 1.0 107.001 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.46 127.7 14.39 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.14 2.56 . . . . 1.0 110.474 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -132.71 178.7 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.996 0.919 . . . . 1.0 109.312 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.506 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.6 m95 -114.3 139.7 49.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.454 1.101 . . . . 1.0 108.177 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.81 145.38 46.43 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.898 0.772 . . . . 1.0 109.109 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -80.97 140.48 35.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.892 0.853 . . . . 1.0 109.095 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.9 m -117.16 113.38 39.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 106.582 -1.636 . . . . 1.0 106.582 173.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.78 -33.06 21.81 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.697 1.598 . . . . 1.0 110.208 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.99 -15.12 61.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.935 1.294 . . . . 1.0 112.6 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 mt -113.96 -5.57 13.17 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.533 1.133 . . . . 1.0 110.526 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 46.74 40.34 8.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.495 2.318 . . . . 1.0 109.072 -173.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -163.85 165.43 22.87 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 -173.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.3 148.39 23.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.466 1.127 . . . . 1.0 111.373 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -141.78 155.44 66.26 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 114.869 -1.06 . . . . 1.0 110.942 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 160.18 35.66 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.423 2.082 . . . . 1.0 109.911 173.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.13 161.93 40.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.352 0.978 . . . . 1.0 108.409 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.64 123.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.331 -1.729 . . . . 1.0 106.331 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.4 162.89 16.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 104.857 -2.275 . . . . 1.0 104.857 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.15 4.43 31.67 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.643 -1.286 . . . . 1.0 115.511 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.27 9.8 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 118.657 1.229 . . . . 1.0 115.347 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 p -119.75 -172.63 2.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.401 2.681 . . . . 1.0 107.318 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.73 133.53 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.397 1.879 . . . . 1.0 112.619 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.24 -171.46 34.95 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.651 -2.18 . . . . 1.0 107.651 -174.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -93.44 175.18 6.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.355 1.078 . . . . 1.0 109.047 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -11.78 80.6 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.76 -1.109 . . . . 1.0 113.132 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -76.62 77.39 3.29 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -146.08 113.12 6.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.174 -1.417 . . . . 1.0 107.174 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -120.48 161.03 21.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.208 1.403 . . . . 1.0 108.388 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -93.4 -17.21 23.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.515 -1.675 . . . . 1.0 113.158 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.34 170.09 15.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -61.47 -50.12 74.03 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -66.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 128.506 2.723 . . . . 1.0 111.826 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.4 p -56.76 -33.25 66.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.812 0.671 . . . . 1.0 112.812 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.3 t -70.97 -49.7 42.5 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.637 0.775 . . . . 1.0 112.534 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.366 76.3 mt-10 -67.13 -33.06 74.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.037 -0.506 . . . . 1.0 111.237 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.7 -38.22 90.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 173.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.07 68.8 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.946 0.794 . . . . 1.0 111.808 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.8 m -139.76 102.83 7.01 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.499 1.519 . . . . 1.0 109.597 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.01 -163.19 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.535 3.49 . . . . 1.0 113.16 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 63' ' ' VAL . 37.7 t -92.83 -155.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 130.3 3.44 . . . . 1.0 102.048 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.568 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -49.75 129.54 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 173.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -110.49 161.4 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 123.541 1.639 . . . . 1.0 113.296 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -65.99 165.86 12.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.678 2.791 . . . . 1.0 104.959 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.3 76.63 7.09 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 118.97 -2.331 . . . . 1.0 107.753 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -53.8 153.97 4.24 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.688 1.595 . . . . 1.0 107.289 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.59 167.89 16.89 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.926 1.239 . . . . 1.0 111.965 173.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -116.47 -144.15 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 1 N-CA-C 99.84 -4.133 . . . . 1.0 99.84 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 103.133 -2.914 . . . . 1.0 103.133 172.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' GLU . . . 173.93 -17.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 130.574 3.55 . . . . 1.0 110.171 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 7.7 mp0 -67.43 -66.83 0.51 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 130.066 3.346 . . . . 1.0 107.79 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.07 57.24 4.33 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.582 1.153 . . . . 1.0 109.435 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -135.56 -87.44 0.35 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.691 1.196 . . . . 1.0 108.379 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -162.96 140.17 7.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -156.01 133.77 11.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 104.216 -2.513 . . . . 1.0 104.216 173.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.07 166.0 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.511 1.924 . . . . 1.0 107.176 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.67 -36.43 46.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.598 -0.715 . . . . 1.0 110.887 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -20.45 65.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.122 1.328 . . . . 1.0 111.544 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -81.79 -30.83 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.48 1.112 . . . . 1.0 110.761 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 13' ' ' PRO . 1.4 tp -68.27 136.71 91.33 Favored Pre-proline 0 C--O 1.225 -0.209 0 C-N-CA 126.866 2.066 . . . . 1.0 110.185 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 12' ' ' LEU . 29.3 Cg_endo -68.56 166.2 26.64 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.71 1.607 . . . . 1.0 111.711 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.71 156.63 32.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.184 -1.371 . . . . 1.0 109.614 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.54 147.24 22.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 106.901 -1.518 . . . . 1.0 106.901 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -72.0 -67.63 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.402 1.081 . . . . 1.0 109.25 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.39 177.37 14.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.53 -16.77 24.06 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.414 2.076 . . . . 1.0 112.919 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -73.49 -177.58 2.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.417 1.087 . . . . 1.0 112.402 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.91 3.8 4.9 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.895 1.278 . . . . 1.0 113.968 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.94 153.95 40.67 Favored Glycine 0 CA--C 1.531 1.054 1 N-CA-C 102.752 -4.139 . . . . 1.0 102.752 172.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -130.26 123.63 30.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.072 1.936 . . . . 1.0 107.334 -173.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -125.79 114.46 24.68 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 128.679 2.792 . . . . 1.0 107.425 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.0 126.02 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.262 2.641 . . . . 1.0 110.622 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -133.11 -179.37 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.482 1.113 . . . . 1.0 109.056 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.6 m95 -124.71 144.87 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.835 1.254 . . . . 1.0 108.578 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.27 145.61 34.21 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.272 0.629 . . . . 1.0 109.555 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -78.16 139.34 38.99 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 m -116.97 113.43 39.63 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 107.102 -1.444 . . . . 1.0 107.102 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.67 -33.75 20.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.026 1.817 . . . . 1.0 110.329 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.15 -16.28 63.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.725 1.21 . . . . 1.0 112.8 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.35 -4.47 14.28 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.789 1.236 . . . . 1.0 110.669 173.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.86 34.28 3.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.319 2.648 . . . . 1.0 110.381 -173.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.34 167.63 23.48 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -94.69 148.91 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.366 1.079 . . . . 1.0 112.274 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -140.61 156.12 69.33 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.892 -1.049 . . . . 1.0 110.972 175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -69.72 163.41 38.36 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 1.0 109.509 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -158.71 165.33 34.62 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.273 -0.892 . . . . 1.0 108.721 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.63 116.58 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.784 -1.561 . . . . 1.0 106.784 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.65 162.7 12.85 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.119 -2.178 . . . . 1.0 105.119 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.81 3.48 38.95 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 115.17 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.97 -16.4 4.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.31 1.433 . . . . 1.0 115.425 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.9 p -112.85 -172.78 2.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.644 2.377 . . . . 1.0 108.188 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.76 133.49 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.403 1.881 . . . . 1.0 112.718 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.37 -169.36 31.72 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 108.194 -1.963 . . . . 1.0 108.194 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -93.29 175.4 6.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.161 0.981 . . . . 1.0 109.276 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.91 -14.08 70.58 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 114.46 -1.246 . . . . 1.0 112.575 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -80.33 75.53 7.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.116 -1.809 . . . . 1.0 106.116 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -146.15 113.24 6.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.545 -1.65 . . . . 1.0 106.545 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.02 163.09 19.98 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.272 1.429 . . . . 1.0 108.826 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -93.14 -16.91 24.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.251 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -164.77 173.46 11.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -59.54 -47.4 85.68 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 173.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -44.76 -67.1 0.31 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.975 2.91 . . . . 1.0 112.438 173.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -59.89 -33.14 71.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.534 0.683 . . . . 1.0 112.79 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.5 t -70.1 -50.16 43.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.327 63.2 mt-10 -69.43 -33.34 72.82 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.952 -1.023 . . . . 1.0 108.687 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -36.67 78.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.046 0.839 . . . . 1.0 109.116 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.37 74.62 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.405 1.002 . . . . 1.0 112.875 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.74 73.96 81.09 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 119.32 0.963 . . . . 1.0 113.029 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.59 44.45 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.492 3.461 . . . . 1.0 110.902 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.2 166.08 13.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 122.5 1.143 . . . . 1.0 110.104 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.98 155.97 3.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.477 -2.416 . . . . 1.0 104.477 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 142.37 58.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.865 1.316 . . . . 1.0 109.999 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -54.85 -7.61 0.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 131.201 3.8 . . . . 1.0 112.907 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 3.95 0.01 OUTLIER 'General case' 0 C--O 1.238 0.496 0 C-N-CA 131.262 3.825 . . . . 1.0 118.5 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -65.17 176.56 1.27 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.653 1.57 . . . . 1.0 108.424 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.13 -173.44 3.32 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.048 -1.032 . . . . 1.0 111.716 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -56.12 -12.53 1.55 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.76 1.224 . . . . 1.0 112.247 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 103.581 -2.748 . . . . 1.0 103.581 173.594 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 108.34 -0.985 . . . . 1.0 108.34 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -41.86 -49.8 4.46 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.903 1.816 . . . . 1.0 115.903 -161.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.52 -6.05 22.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.763 2.025 . . . . 1.0 114.498 -173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.3 -36.86 77.45 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.28 1.4 . . . . 1.0 111.213 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -149.69 110.98 4.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.68 -2.711 . . . . 1.0 103.68 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -144.07 177.85 8.29 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.447 0.641 . . . . 1.0 110.136 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.43 141.06 55.53 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.36 29.57 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.373 -0.822 . . . . 1.0 111.607 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 p -57.04 -29.19 63.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.891 1.223 . . . . 1.0 112.633 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.22 -30.77 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.34 -0.85 . . . . 1.0 110.685 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -63.94 127.73 92.09 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 124.962 1.305 . . . . 1.0 112.23 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 12' ' ' LEU . 53.4 Cg_exo -50.12 154.36 5.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.385 2.724 . . . . 1.0 112.439 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.01 157.25 26.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.65 -0.704 . . . . 1.0 109.499 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 147.47 27.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.371 -2.085 . . . . 1.0 105.371 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.35 -63.26 1.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.55 170.53 12.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 1.0 109.528 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.9 -14.79 15.27 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.709 2.273 . . . . 1.0 113.301 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.8 m -73.85 -177.23 2.73 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.145 -0.972 . . . . 1.0 112.275 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 3.8 6.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.303 1.041 . . . . 1.0 113.125 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.19 154.0 29.81 Favored Glycine 0 CA--C 1.531 1.037 1 N-CA-C 102.344 -4.303 . . . . 1.0 102.344 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -132.52 127.91 36.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.831 1.816 . . . . 1.0 108.289 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -125.91 114.32 24.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 130.158 3.383 . . . . 1.0 106.422 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.72 132.03 25.79 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 123.252 2.635 . . . . 1.0 110.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -133.98 175.49 9.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.559 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -120.96 143.42 49.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.765 2.026 . . . . 1.0 106.017 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.88 144.04 45.37 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.49 137.99 38.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.744 0.783 . . . . 1.0 109.41 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.4 m -117.21 113.53 39.13 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 124.981 1.313 . . . . 1.0 107.58 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.95 -36.03 24.12 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.125 1.883 . . . . 1.0 110.617 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -66.65 -17.21 64.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.298 1.039 . . . . 1.0 112.562 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.8 mt -106.26 -4.21 20.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.257 1.023 . . . . 1.0 110.293 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.28 32.56 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.172 2.589 . . . . 1.0 110.922 -174.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.23 169.2 14.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.824 0.821 . . . . 1.0 109.249 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.5 m -95.27 149.36 21.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.704 1.202 . . . . 1.0 110.619 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -138.49 154.31 73.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.898 . . . . 1.0 110.963 175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.65 164.82 19.9 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.339 2.026 . . . . 1.0 111.63 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -162.16 164.28 27.97 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.6 t -90.14 113.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.63 159.8 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.214 -1.773 . . . . 1.0 106.214 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.16 0.94 57.39 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.232 -0.917 . . . . 1.0 114.796 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.35 -30.64 1.41 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.579 1.561 . . . . 1.0 113.965 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.89 -172.78 2.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.698 2.399 . . . . 1.0 107.566 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.1 mp0 -33.62 133.75 0.17 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.253 2.221 . . . . 1.0 113.042 -174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.01 -169.72 35.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 107.599 -2.2 . . . . 1.0 107.599 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' HD11 ' A' ' 12' ' ' LEU . 7.0 m-20 -93.35 174.35 7.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.491 1.145 . . . . 1.0 109.666 -174.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.92 -11.84 83.36 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 114.694 -1.139 . . . . 1.0 113.419 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.66 74.01 5.2 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.008 -1.849 . . . . 1.0 106.008 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -139.75 113.09 8.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.23 1.012 . . . . 1.0 108.29 -173.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.05 150.96 49.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.703 1.201 . . . . 1.0 108.123 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -93.39 -6.31 47.46 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.05 -0.406 . . . . 1.0 110.709 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.24 170.36 14.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.128 1.371 . . . . 1.0 107.686 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -70.31 -39.86 74.54 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.324 -1.35 . . . . 1.0 108.535 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -39.62 -65.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.863 2.465 . . . . 1.0 111.006 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 p -57.47 -33.58 68.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.917 0.71 . . . . 1.0 112.917 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.8 t -75.12 -46.7 32.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.864 1.266 . . . . 1.0 112.577 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.12 -33.58 76.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.731 0.813 . . . . 1.0 109.288 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.55 -38.35 84.02 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.68 0.673 . . . . 1.0 109.221 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.31 -60.61 2.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.622 1.101 . . . . 1.0 110.822 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.4 m -127.26 92.46 43.72 Favored Pre-proline 0 C--O 1.234 0.285 0 C-N-CA 124.032 0.933 . . . . 1.0 110.678 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.56 -170.84 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.393 2.062 . . . . 1.0 108.584 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 63' ' ' VAL . 3.8 t -93.12 177.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.734 -1.95 . . . . 1.0 105.734 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -52.63 128.71 12.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.81 148.7 42.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.299 -1.318 . . . . 1.0 113.142 -173.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.87 -14.56 3.99 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 128.613 2.765 . . . . 1.0 110.785 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 173.29 79.84 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.5 3.12 . . . . 1.0 110.991 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -115.77 168.34 10.13 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.748 1.613 . . . . 1.0 111.642 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -142.55 45.46 1.61 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.288 1.435 . . . . 1.0 108.412 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 70' ' ' HIS . 50.9 t60 -165.03 -168.5 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.293 2.637 . . . . 1.0 104.667 -173.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 2.7 t-80 . . . . . 0 C--O 1.255 1.35 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.13 176.52 12.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.466 1.906 . . . . 1.0 107.802 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.57 -71.37 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.53 -5.91 11.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.203 1.001 . . . . 1.0 113.102 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -63.5 -50.44 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.335 1.854 . . . . 1.0 112.376 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.42 163.7 30.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 -176.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.6 m -82.79 101.09 10.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.58 142.7 43.71 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.59 32.11 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 118.283 0.492 . . . . 1.0 110.348 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -62.24 -21.2 64.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.5 0.72 . . . . 1.0 112.096 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.36 -33.05 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 O-C-N 120.961 -1.087 . . . . 1.0 110.548 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -74.03 128.4 86.5 Favored Pre-proline 0 CA--C 1.521 -0.153 0 C-N-CA 127.407 2.283 . . . . 1.0 112.474 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 12' ' ' LEU . 19.5 Cg_endo -66.34 166.18 22.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.957 1.771 . . . . 1.0 111.816 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -92.89 168.43 11.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.532 1.133 . . . . 1.0 111.109 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -143.1 151.36 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.776 1.631 . . . . 1.0 107.848 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.69 -30.05 15.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.05 1.34 . . . . 1.0 113.463 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.33 177.55 51.8 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.1 -18.81 30.54 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.851 2.368 . . . . 1.0 113.601 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 m -67.83 161.74 25.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.834 -1.167 . . . . 1.0 111.048 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 3.5 15.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.966 1.706 . . . . 1.0 112.653 173.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.67 153.32 31.33 Favored Glycine 0 CA--C 1.528 0.873 1 N-CA-C 102.994 -4.042 . . . . 1.0 102.994 172.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -125.86 103.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.953 1.377 . . . . 1.0 110.461 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -95.13 113.82 62.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 127.872 2.469 . . . . 1.0 106.886 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.48 125.19 11.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.221 2.614 . . . . 1.0 110.319 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -131.26 -177.91 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.146 0.979 . . . . 1.0 108.83 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.3 m95 -125.43 143.28 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.644 1.178 . . . . 1.0 108.472 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.85 145.01 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 56.5 t80 -78.09 137.22 38.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.757 0.789 . . . . 1.0 109.361 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -117.24 113.9 38.9 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 116.801 -1.571 . . . . 1.0 108.461 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -32.25 37.19 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.519 1.479 . . . . 1.0 110.294 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.64 -15.72 61.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.087 1.355 . . . . 1.0 112.562 174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.58 -3.8 13.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 1.0 110.683 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.17 22.84 3.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 129.128 2.971 . . . . 1.0 112.229 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -166.62 170.6 12.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.188 -0.945 . . . . 1.0 110.276 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 86.2 m -84.19 146.82 27.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.101 0.953 . . . . 1.0 113.485 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -136.48 157.19 75.75 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.218 -1.355 . . . . 1.0 109.878 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -69.5 162.14 43.11 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.816 1.677 . . . . 1.0 108.758 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.407 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 14.9 p90 -155.93 163.16 40.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.063 -1.023 . . . . 1.0 108.79 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.19 125.25 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -122.41 175.26 6.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.351 2.261 . . . . 1.0 106.386 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.02 5.72 5.06 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.911 1.124 . . . . 1.0 115.911 -173.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.66 -38.21 2.8 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.842 1.821 . . . . 1.0 112.357 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.2 -173.02 1.87 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.529 1.532 . . . . 1.0 108.892 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -34.13 133.77 0.21 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.867 2.467 . . . . 1.0 113.784 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.7 176.41 41.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -93.72 177.72 5.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.77 0.785 . . . . 1.0 109.187 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.85 79.92 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.519 -0.764 . . . . 1.0 113.343 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -80.11 72.39 6.91 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -143.04 113.18 7.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.929 -1.878 . . . . 1.0 105.929 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -118.42 161.66 19.62 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 125.329 1.452 . . . . 1.0 108.85 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.27 8.2 m80 -93.18 -16.47 24.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.974 -1.466 . . . . 1.0 111.567 -172.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -165.83 172.15 11.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.2 tpt180 -61.49 -48.1 82.61 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 173.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -66.89 0.33 Allowed 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 128.765 2.826 . . . . 1.0 111.719 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -57.24 -33.07 67.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.1 t -71.96 -47.9 48.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.4 -0.812 . . . . 1.0 112.93 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.78 -33.5 76.12 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.85 -0.595 . . . . 1.0 110.248 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -44.87 93.62 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.4 -46.14 70.79 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 121.476 -0.765 . . . . 1.0 112.01 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 m -137.35 88.94 16.55 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.275 1.43 . . . . 1.0 113.917 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.94 -162.5 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 1 C-N-CA 126.929 5.086 . . . . 1.0 103.868 172.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -92.29 157.53 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 100.933 -3.728 . . . . 1.0 100.933 173.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -42.37 125.92 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.516 1.126 . . . . 1.0 112.44 -172.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.42 176.9 1.26 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 128.234 2.614 . . . . 1.0 110.954 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -48.77 -37.58 19.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.994 1.718 . . . . 1.0 109.459 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.12 124.57 21.5 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 107.646 -1.242 . . . . 1.0 107.646 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.6 120.98 19.16 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -65.08 157.32 28.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -162.47 166.31 25.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.872 1.669 . . . . 1.0 106.683 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 C--O 1.252 1.22 0 N-CA-C 105.213 -2.143 . . . . 1.0 105.213 173.084 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.5 ' H1 ' ' CD ' ' A' ' 1' ' ' GLU . 3.4 mp0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 103.915 -2.624 . . . . 1.0 103.915 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 -120.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.291 -1.004 . . . . 1.0 108.291 -164.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -23.78 67.2 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.313 0.96 . . . . 1.0 111.943 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.23 166.16 12.35 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.13 1.372 . . . . 1.0 110.601 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.31 -23.82 65.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.162 2.585 . . . . 1.0 112.381 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -133.95 172.96 12.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.206 2.202 . . . . 1.0 106.46 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.9 m -143.13 94.49 2.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 119.897 -1.752 . . . . 1.0 112.114 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.77 165.29 21.72 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.62 15.01 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 118.932 0.787 . . . . 1.0 109.719 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.23 -28.26 69.91 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.807 0.731 . . . . 1.0 112.579 -173.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -73.16 -37.76 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -62.86 122.14 72.77 Favored Pre-proline 0 N--CA 1.458 -0.07 0 C-N-CA 125.061 1.344 . . . . 1.0 113.301 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.7 Cg_exo -48.84 152.85 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.717 2.945 . . . . 1.0 113.07 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 153.51 32.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.284 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.82 144.32 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -76.08 -53.48 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.55 175.54 15.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.344 1.45 . . . . 1.0 110.199 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.19 -28.36 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.656 2.237 . . . . 1.0 112.994 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -79.21 159.92 27.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 122.605 1.193 . . . . 1.0 112.539 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.34 3.55 38.1 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.263 1.825 . . . . 1.0 113.546 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.15 155.09 50.25 Favored Glycine 0 CA--C 1.535 1.311 1 N-CA-C 101.555 -4.618 . . . . 1.0 101.555 172.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -136.62 132.62 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 121.319 2.56 . . . . 1.0 108.476 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -135.54 118.8 12.71 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 129.265 3.026 . . . . 1.0 106.514 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.56 124.64 12.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.202 2.601 . . . . 1.0 109.675 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -128.5 179.9 5.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.407 1.083 . . . . 1.0 108.314 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.6 m95 -130.34 144.58 51.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.163 2.185 . . . . 1.0 106.759 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.95 148.27 38.35 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -82.39 138.54 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.866 0.841 . . . . 1.0 108.893 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -117.23 114.09 38.83 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 125.665 1.586 . . . . 1.0 108.32 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.79 -34.75 23.48 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.017 1.812 . . . . 1.0 110.618 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -62.44 -23.57 66.94 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.561 0.744 . . . . 1.0 112.991 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -102.72 -6.66 22.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 1.0 110.693 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 40.66 2.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.48 3.112 . . . . 1.0 108.452 -173.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.76 168.85 20.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.6 m -98.83 148.27 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.172 0.987 . . . . 1.0 111.795 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -134.62 153.29 78.9 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.315 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.96 168.96 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.971 1.78 . . . . 1.0 109.109 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -163.36 160.1 23.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.3 113.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.653 -2.351 . . . . 1.0 104.653 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -96.33 156.85 16.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.969 1.707 . . . . 1.0 106.97 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.13 1.95 68.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.939 0.736 . . . . 1.0 114.939 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.1 -38.51 1.79 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.87 1.7 . . . . 1.0 113.531 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -85.18 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.107 1.763 . . . . 1.0 108.089 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.68 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.575 2.35 . . . . 1.0 113.338 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.96 -167.52 28.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.522 -2.231 . . . . 1.0 107.522 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.35 174.65 7.1 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.545 1.172 . . . . 1.0 108.969 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.02 -15.17 79.5 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.784 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -76.09 78.76 2.92 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.811 -1.922 . . . . 1.0 105.811 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.17 113.17 5.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.775 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -126.12 158.0 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.452 1.901 . . . . 1.0 108.227 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -93.93 -11.02 31.88 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.867 -1.063 . . . . 1.0 112.523 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.82 160.72 42.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.901 1.228 . . . . 1.0 110.71 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.5 tpt180 -60.63 -50.77 72.17 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.519 -1.219 . . . . 1.0 109.087 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -66.75 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.343 2.657 . . . . 1.0 111.8 174.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.8 p -58.31 -33.46 69.5 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.61 -50.43 44.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.444 0.698 . . . . 1.0 112.587 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.92 -33.13 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.525 -0.75 . . . . 1.0 110.262 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.71 -26.65 62.58 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.604 -0.713 . . . . 1.0 110.538 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.28 62.13 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.108 1.322 . . . . 1.0 111.473 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.6 m -122.99 76.36 50.03 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.124 0.57 . . . . 1.0 111.693 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 179.41 6.5 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.72 2.28 . . . . 1.0 107.862 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.29 167.15 23.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 105.291 -2.115 . . . . 1.0 105.291 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.55 137.44 22.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.658 -1.608 . . . . 1.0 106.658 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.23 114.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.012 0.925 . . . . 1.0 110.191 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 -18.82 62.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.673 -0.679 . . . . 1.0 112.213 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -64.68 150.83 46.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -80.29 71.29 7.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.25 -1.532 . . . . 1.0 109.252 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.3 154.64 34.64 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.71 0.804 . . . . 1.0 109.134 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -67.75 157.9 33.62 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--O 1.251 1.158 0 N-CA-C 104.741 -2.318 . . . . 1.0 104.741 173.094 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.306 0 CA-C-O 118.805 -0.617 . . . . 1.0 110.535 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.58 -26.92 68.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.624 1.102 . . . . 1.0 111.449 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.17 -25.76 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.331 1.052 . . . . 1.0 109.936 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.7 tp -76.47 130.19 77.68 Favored Pre-proline 0 C--O 1.226 -0.137 0 C-N-CA 127.065 2.146 . . . . 1.0 112.944 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -52.37 153.33 13.63 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.954 2.436 . . . . 1.0 111.51 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.66 13.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.031 0.532 . . . . 1.0 110.16 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.66 148.6 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 125.119 1.368 . . . . 1.0 107.514 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.49 -56.77 4.32 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.622 1.169 . . . . 1.0 110.937 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.62 174.73 19.88 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.061 1.315 . . . . 1.0 109.971 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.19 -6.41 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.065 2.51 . . . . 1.0 113.505 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -73.32 175.62 6.72 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 122.364 1.078 . . . . 1.0 112.593 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.4 3.51 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.479 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.4 153.82 21.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 103.511 -3.836 . . . . 1.0 103.511 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -126.63 106.14 9.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.109 1.455 . . . . 1.0 109.52 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -102.12 113.83 65.71 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 128.748 2.819 . . . . 1.0 107.07 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.36 126.51 13.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.276 2.651 . . . . 1.0 110.284 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -132.37 -179.86 5.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.222 1.009 . . . . 1.0 109.005 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 48.2 m95 -119.55 143.87 47.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.667 1.187 . . . . 1.0 108.217 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.2 39.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -80.84 138.57 36.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.922 0.868 . . . . 1.0 108.976 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m -117.29 113.7 38.88 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.242 -1.361 . . . . 1.0 108.177 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.6 -33.61 21.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.788 1.659 . . . . 1.0 110.371 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -63.25 -20.54 65.54 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.0 112.711 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -108.24 -5.34 16.89 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.518 1.127 . . . . 1.0 110.769 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.63 37.93 3.64 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.543 2.737 . . . . 1.0 109.997 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -162.76 168.06 22.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.93 150.65 21.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.24 1.019 . . . . 1.0 112.156 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -140.74 154.61 69.07 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.944 -1.025 . . . . 1.0 111.28 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.59 162.71 35.78 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.178 1.918 . . . . 1.0 109.0 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.98 163.19 36.68 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.395 0.998 . . . . 1.0 108.575 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.97 127.13 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.39 -1.707 . . . . 1.0 106.39 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -119.2 168.9 10.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.848 2.059 . . . . 1.0 105.533 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.88 1.35 15.13 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 120.692 -1.255 . . . . 1.0 116.106 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.65 -7.24 58.96 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.277 1.538 . . . . 1.0 115.058 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 32.0 p -118.73 -172.75 2.34 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.723 2.409 . . . . 1.0 108.128 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.6 0.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.679 1.992 . . . . 1.0 112.853 -173.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.79 -176.76 38.1 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.555 -2.218 . . . . 1.0 107.555 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -93.5 174.93 6.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.179 0.989 . . . . 1.0 108.616 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.8 -11.76 85.11 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.228 -0.896 . . . . 1.0 112.93 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -78.02 74.17 4.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.435 1.118 . . . . 1.0 108.199 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.53 113.08 6.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -121.12 161.02 22.5 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.82 1.248 . . . . 1.0 108.624 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -93.27 -15.05 26.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.981 -1.463 . . . . 1.0 112.336 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -166.54 171.11 12.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.402 0.681 . . . . 1.0 109.295 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.9 tpt180 -62.29 -47.3 84.91 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -66.93 0.31 Allowed 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 128.466 2.706 . . . . 1.0 111.261 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -54.93 -33.17 61.94 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.0 t -72.04 -50.72 26.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.821 0.848 . . . . 1.0 112.899 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.348 76.2 mt-10 -67.29 -33.13 74.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 118.432 -0.795 . . . . 1.0 109.948 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.35 -38.9 85.26 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.376 0.989 . . . . 1.0 109.007 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 -43.66 72.84 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.33 0.968 . . . . 1.0 112.781 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.237 0.418 0 C-N-CA 123.662 0.785 . . . . 1.0 109.856 178.404 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.3 p -47.58 -28.45 2.31 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.588 -1.32 . . . . 1.0 113.603 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.55 -28.29 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 119.56 1.073 . . . . 1.0 112.301 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -75.46 156.14 85.36 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 127.929 2.491 . . . . 1.0 109.594 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 12' ' ' LEU . 14.8 Cg_endo -67.5 168.54 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.825 1.684 . . . . 1.0 111.856 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 113.54 8.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.931 -1.137 . . . . 1.0 107.931 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.2 t -91.94 124.14 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -80.07 -33.07 39.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.693 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.17 173.32 42.03 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.409 -1.077 . . . . 1.0 110.409 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.54 -8.16 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.261 2.641 . . . . 1.0 114.409 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -73.6 -179.05 3.36 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 3.86 5.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.66 1.584 . . . . 1.0 113.105 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.17 155.18 26.04 Favored Glycine 0 CA--C 1.533 1.161 1 N-CA-C 101.157 -4.777 . . . . 1.0 101.157 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -132.58 120.32 21.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.931 2.366 . . . . 1.0 108.829 -173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.95 113.79 28.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 129.377 3.071 . . . . 1.0 107.801 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.32 125.23 12.62 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.441 2.76 . . . . 1.0 111.214 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -131.81 178.31 6.86 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.295 1.038 . . . . 1.0 109.729 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.456 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 68.6 m95 -113.2 143.34 44.56 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.1 144.02 42.85 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.773 1.17 . . . . 1.0 108.243 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -79.5 139.21 37.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.808 0.813 . . . . 1.0 109.43 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -117.17 113.86 39.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.274 1.83 . . . . 1.0 107.806 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.79 -34.34 24.65 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.946 1.764 . . . . 1.0 111.06 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.59 -13.99 55.75 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.369 1.067 . . . . 1.0 112.754 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -115.9 -4.0 12.11 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.963 1.305 . . . . 1.0 110.723 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.65 37.97 1.76 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.893 2.877 . . . . 1.0 109.974 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.67 169.32 23.08 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.9 m -106.78 136.0 47.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.573 0.749 . . . . 1.0 110.681 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -122.89 159.48 53.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.295 1.038 . . . . 1.0 109.325 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -71.12 164.81 34.46 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 120.233 1.119 . . . . 1.0 109.588 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.22 168.89 25.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.09 113.7 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -99.46 162.08 13.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.02 55.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 116.185 1.234 . . . . 1.0 116.185 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.96 2.05 57.11 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 118.943 1.371 . . . . 1.0 115.062 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 p -125.46 -172.64 2.64 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.263 2.625 . . . . 1.0 107.846 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -33.3 133.64 0.15 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.801 2.04 . . . . 1.0 112.514 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.93 174.68 43.49 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.169 -1.973 . . . . 1.0 108.169 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.62 -174.76 3.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.195 0.997 . . . . 1.0 108.603 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.77 -4.26 82.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 126.983 2.23 . . . . 1.0 113.934 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -80.07 65.7 5.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.929 2.864 . . . . 1.0 107.107 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -144.04 112.9 6.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -115.27 161.25 18.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.399 -1.704 . . . . 1.0 106.399 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.294 6.4 m80 -92.75 -20.68 20.52 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.614 -2.539 . . . . 1.0 108.477 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -170.47 165.52 8.54 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.906 0.882 . . . . 1.0 108.641 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 14.9 ttp85 -65.75 -42.3 91.11 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.678 -1.23 . . . . 1.0 107.678 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -46.55 -66.1 0.46 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.369 2.268 . . . . 1.0 110.276 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 p -57.77 -34.28 69.4 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.689 0.618 . . . . 1.0 111.954 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.1 t -71.66 -48.52 47.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.285 1.034 . . . . 1.0 112.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.09 -33.53 73.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.53 0.681 . . . . 1.0 109.733 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.64 -23.36 39.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.13 -62.78 1.48 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.935 0.789 . . . . 1.0 111.847 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.531 0.228 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -173.114 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.401 0 CA-C-O 118.479 -0.772 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 p -49.3 -33.38 13.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.422 1.465 . . . . 1.0 112.766 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -76.63 -21.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 O-C-N 120.788 -1.195 . . . . 1.0 111.076 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -73.72 131.03 82.52 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 127.313 2.245 . . . . 1.0 112.193 174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.1 Cg_exo -49.76 154.22 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.227 2.618 . . . . 1.0 112.825 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.51 161.52 24.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.017 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.8 t -137.89 145.47 28.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 105.74 -1.948 . . . . 1.0 105.74 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -96.48 -23.99 16.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.668 0.787 . . . . 1.0 112.086 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.34 170.43 46.24 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.587 1.565 . . . . 1.0 111.307 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.13 -3.39 13.73 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.388 3.392 . . . . 1.0 114.691 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.3 176.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.655 1.582 . . . . 1.0 112.984 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 3.65 3.82 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.411 1.485 . . . . 1.0 112.946 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.15 153.44 20.27 Favored Glycine 0 CA--C 1.528 0.896 1 N-CA-C 101.63 -4.588 . . . . 1.0 101.63 172.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -128.69 104.68 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.974 1.387 . . . . 1.0 110.889 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -94.16 113.67 61.3 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.138 2.975 . . . . 1.0 106.992 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.21 127.75 14.66 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.37 2.714 . . . . 1.0 110.478 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.52 179.4 5.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.82 0.848 . . . . 1.0 108.935 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.2 m95 -119.74 136.31 54.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.883 -1.525 . . . . 1.0 106.883 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.62 143.51 48.66 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 79.6 t80 -77.45 139.18 39.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.705 0.764 . . . . 1.0 110.299 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -117.15 113.57 39.22 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 117.064 -1.446 . . . . 1.0 107.537 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.09 -33.38 31.88 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.09 1.86 . . . . 1.0 110.601 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.04 -16.88 63.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.568 1.147 . . . . 1.0 112.804 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -111.56 -4.35 14.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.38 1.472 . . . . 1.0 110.557 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 51.99 20.2 1.19 Allowed 'General case' 0 N--CA 1.431 -1.421 1 C-N-CA 132.35 4.26 . . . . 1.0 110.324 -173.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -157.72 167.98 28.52 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.416 -1.427 . . . . 1.0 108.988 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 75.8 m -84.23 152.89 23.92 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -138.43 156.05 73.58 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.933 -1.485 . . . . 1.0 109.527 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.57 160.27 32.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.135 1.89 . . . . 1.0 109.666 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -156.75 163.83 38.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.39 0.995 . . . . 1.0 108.603 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.0 t -87.2 122.85 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -124.08 173.27 8.39 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.899 1.68 . . . . 1.0 106.637 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.32 -7.66 5.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 116.414 1.326 . . . . 1.0 116.414 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.86 -28.76 8.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 119.472 1.636 . . . . 1.0 111.586 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -75.11 -173.26 1.92 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.979 1.712 . . . . 1.0 109.331 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 2.6 mp0 -34.41 134.2 0.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.759 2.824 . . . . 1.0 112.764 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.77 178.71 39.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.965 -2.054 . . . . 1.0 107.965 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -93.61 178.59 5.64 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.3 -18.51 71.46 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.582 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.54 70.97 1.82 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.996 0.919 . . . . 1.0 108.797 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.14 112.71 7.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.78 -1.563 . . . . 1.0 106.78 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.34 162.96 16.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.513 1.525 . . . . 1.0 107.072 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -106.55 -9.39 16.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.341 -1.299 . . . . 1.0 114.459 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 p -162.45 161.76 27.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.396 0.617 . . . . 1.0 109.964 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 23.0 tpt85 -60.95 -40.35 92.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.528 0.731 . . . . 1.0 110.464 174.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -66.8 0.41 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.932 2.493 . . . . 1.0 110.655 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 p -56.54 -33.87 66.51 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.647 0.592 . . . . 1.0 111.702 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.81 -51.92 23.79 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.281 13.9 mt-10 -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 116.052 -2.259 . . . . 1.0 112.825 173.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.258 8.2 t70 -65.95 -23.17 66.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 118.986 -1.086 . . . . 1.0 109.004 175.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.11 2.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.152 -1.593 . . . . 1.0 106.855 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.7 m . . . . . 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.604 . . . . 1.0 110.901 -178.834 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 119.213 -0.422 . . . . 1.0 110.283 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -23.84 67.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.186 0.903 . . . . 1.0 112.696 -174.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.31 -30.93 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.147 0.979 . . . . 1.0 109.87 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.0 tp -66.07 130.69 94.38 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 125.256 1.423 . . . . 1.0 112.732 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 12' ' ' LEU . 77.5 Cg_exo -49.88 153.62 5.88 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.499 2.799 . . . . 1.0 113.183 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.72 143.73 29.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.846 -1.07 . . . . 1.0 108.663 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.93 147.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -78.04 -53.42 7.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.259 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 176.49 15.7 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.085 1.326 . . . . 1.0 110.095 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.71 -35.24 4.72 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.923 2.415 . . . . 1.0 111.865 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.0 m -71.93 160.91 31.73 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 121.901 0.858 . . . . 1.0 111.006 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.94 3.77 19.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.854 1.662 . . . . 1.0 114.218 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.64 157.21 53.52 Favored Glycine 0 CA--C 1.538 1.476 1 N-CA-C 102.347 -4.301 . . . . 1.0 102.347 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -130.3 125.59 35.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.315 2.557 . . . . 1.0 108.742 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.33 113.99 15.85 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 129.187 2.995 . . . . 1.0 107.076 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.62 133.59 32.51 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.734 2.956 . . . . 1.0 110.502 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -133.09 177.29 7.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.608 -1.178 . . . . 1.0 108.85 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.4 m95 -126.11 143.48 51.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.526 2.33 . . . . 1.0 105.591 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.74 144.08 41.5 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.722 1.209 . . . . 1.0 107.838 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -81.24 137.59 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.78 0.8 . . . . 1.0 109.14 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 m -117.44 113.66 38.62 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 126.136 1.774 . . . . 1.0 107.578 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.86 -33.7 19.71 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.888 1.725 . . . . 1.0 110.88 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.78 -14.38 58.78 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.725 1.21 . . . . 1.0 112.348 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -113.4 -4.31 13.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.978 1.311 . . . . 1.0 110.549 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.09 36.83 2.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.163 2.585 . . . . 1.0 110.043 -173.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.68 172.13 14.68 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.373 -0.829 . . . . 1.0 108.918 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -104.94 143.01 33.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.4 0.68 . . . . 1.0 110.111 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -123.77 153.72 66.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.727 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -70.74 168.65 22.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.525 1.483 . . . . 1.0 110.027 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -163.11 163.91 25.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.66 113.5 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.927 -1.879 . . . . 1.0 105.927 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -99.85 163.22 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.622 1.969 . . . . 1.0 106.829 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.17 4.5 52.04 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.326 0.89 . . . . 1.0 115.326 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.59 -36.86 2.05 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.597 1.57 . . . . 1.0 113.832 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.7 p -87.99 -172.87 4.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.716 1.606 . . . . 1.0 107.927 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.62 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.649 2.38 . . . . 1.0 113.158 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.71 29.74 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.918 -2.073 . . . . 1.0 107.918 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' ND2' HD11 ' A' ' 12' ' ' LEU . 4.5 m-20 -93.37 174.66 7.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.336 1.068 . . . . 1.0 109.712 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 -15.69 80.51 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.55 1.071 . . . . 1.0 114.179 -173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -78.41 70.24 4.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -138.1 113.12 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.616 1.166 . . . . 1.0 108.306 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.24 151.94 48.68 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.682 1.193 . . . . 1.0 108.28 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -93.15 -7.94 43.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.408 -0.807 . . . . 1.0 110.026 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -158.71 162.61 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.889 0.768 . . . . 1.0 111.108 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 26.1 ttp85 -65.26 -49.43 69.61 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.391 -0.822 . . . . 1.0 112.256 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -58.95 -48.27 82.13 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.56 0.537 . . . . 1.0 110.718 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 p -51.1 -38.85 54.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.7 t -73.99 -48.43 30.37 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.88 1.272 . . . . 1.0 110.067 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.34 -33.47 71.19 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.16 -31.69 62.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.385 -1.447 . . . . 1.0 109.407 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.89 -59.15 3.51 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.971 0.794 . . . . 1.0 110.658 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.4 m . . . . . 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 1.0 108.397 175.447 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 119.265 -0.398 . . . . 1.0 111.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 p -48.53 -29.76 4.54 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.256 0.935 . . . . 1.0 113.479 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.08 -27.06 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.178 0.899 . . . . 1.0 111.332 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.51 152.91 61.3 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 127.682 2.393 . . . . 1.0 110.938 -176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.83 161.31 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.721 2.947 . . . . 1.0 113.158 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.99 113.61 11.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.01 115.15 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 107.436 -1.32 . . . . 1.0 107.436 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.74 -24.44 44.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.951 -1.477 . . . . 1.0 110.952 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.55 173.96 50.06 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.201 0.905 . . . . 1.0 111.263 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.06 -5.94 7.55 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.396 2.731 . . . . 1.0 114.631 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.3 m -73.74 -178.21 3.08 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 3.7 4.65 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.827 1.651 . . . . 1.0 113.423 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.88 154.32 22.46 Favored Glycine 0 CA--C 1.533 1.184 1 N-CA-C 100.652 -4.979 . . . . 1.0 100.652 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -132.55 122.59 25.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 120.968 2.384 . . . . 1.0 108.795 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -125.14 113.82 26.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.908 3.283 . . . . 1.0 106.847 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.13 126.82 14.95 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.521 2.814 . . . . 1.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -131.72 178.4 6.78 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.036 0.934 . . . . 1.0 109.361 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -117.59 144.43 45.15 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.443 1.097 . . . . 1.0 108.144 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.12 148.04 37.69 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.079 -0.711 . . . . 1.0 109.079 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -82.83 139.38 33.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 174.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.469 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 18.3 m -117.11 113.42 39.37 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 117.213 -1.375 . . . . 1.0 107.619 173.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.43 -32.26 25.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.75 1.634 . . . . 1.0 110.239 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.3 -15.01 59.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.923 1.289 . . . . 1.0 112.471 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 mt -115.23 -4.2 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.094 1.358 . . . . 1.0 110.805 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.0 35.44 3.35 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.388 2.675 . . . . 1.0 110.042 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -162.51 168.68 21.54 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.563 -0.71 . . . . 1.0 109.707 -173.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -95.6 149.58 21.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.963 0.887 . . . . 1.0 112.114 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.469 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 33.1 p80 -139.85 154.5 70.82 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.624 175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -69.78 161.82 44.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 107.971 -1.588 . . . . 1.0 107.971 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -159.04 170.7 21.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.081 0.855 . . . . 1.0 109.031 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.43 113.8 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 106.609 -1.626 . . . . 1.0 106.609 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.63 158.02 16.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.43 0.39 58.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 116.677 1.431 . . . . 1.0 116.677 -173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.65 3.41 54.51 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.224 1.512 . . . . 1.0 114.857 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 p -125.11 -172.46 2.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 128.717 2.807 . . . . 1.0 108.073 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -33.37 133.54 0.16 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.533 1.933 . . . . 1.0 113.001 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.26 168.09 40.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.814 -2.114 . . . . 1.0 107.814 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.99 -174.17 3.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.089 0.947 . . . . 1.0 109.06 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.72 -7.04 88.98 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 116.927 -2.041 . . . . 1.0 113.774 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -81.98 66.47 7.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 121.761 2.78 . . . . 1.0 107.607 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -147.08 113.66 6.0 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 130.81 3.644 . . . . 1.0 102.25 -173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -123.71 162.17 23.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.343 1.457 . . . . 1.0 107.747 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -93.07 -14.55 27.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.112 -1.403 . . . . 1.0 111.157 -173.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p -167.72 169.17 11.95 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.76 0.791 . . . . 1.0 109.996 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.0 tpt180 -61.4 -44.75 96.6 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -47.83 -66.51 0.39 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.231 2.612 . . . . 1.0 111.659 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.4 p -59.11 -33.46 70.87 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.046 0.927 . . . . 1.0 112.58 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -71.61 -49.95 35.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.044 0.938 . . . . 1.0 112.491 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.337 27.7 mt-10 -67.19 -32.94 74.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.02 -47.27 78.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 1.0 106.107 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.87 -58.44 8.59 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 118.686 0.675 . . . . 1.0 111.871 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.452 -0.363 0 O-C-N 123.737 0.648 . . . . 1.0 110.506 -174.649 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 119.036 -0.507 . . . . 1.0 111.1 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -69.02 -15.62 63.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.059 1.3 . . . . 1.0 111.747 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.02 -21.77 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.418 1.087 . . . . 1.0 111.129 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -73.32 148.67 88.62 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 127.261 2.224 . . . . 1.0 110.819 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 12' ' ' LEU . 36.6 Cg_endo -70.85 179.04 4.6 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.266 1.977 . . . . 1.0 111.034 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -120.41 161.6 20.94 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.14 152.97 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.653 1.181 . . . . 1.0 109.217 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -88.04 -31.47 19.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.343 1.457 . . . . 1.0 113.201 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 176.94 51.44 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.199 0.904 . . . . 1.0 112.404 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.88 -25.47 27.98 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.293 2.662 . . . . 1.0 112.842 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.56 158.85 25.98 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.206 -0.934 . . . . 1.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 3.53 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.685 1.594 . . . . 1.0 112.985 173.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.42 153.23 38.79 Favored Glycine 0 CA--C 1.531 1.044 1 N-CA-C 102.123 -4.391 . . . . 1.0 102.123 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.91 105.37 8.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.621 1.711 . . . . 1.0 111.022 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.02 114.01 62.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.426 2.29 . . . . 1.0 105.629 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 114.1 3.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.536 2.824 . . . . 1.0 109.747 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -114.78 176.94 4.83 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.361 0.664 . . . . 1.0 109.372 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.518 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 63.1 m95 -114.19 145.37 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.34 144.91 40.56 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.24 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.717 0.807 . . . . 1.0 110.009 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -117.43 113.36 38.78 Favored Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 120.684 -1.26 . . . . 1.0 108.034 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.09 -34.36 6.38 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.573 1.515 . . . . 1.0 109.665 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -65.03 -20.57 66.56 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 124.324 1.05 . . . . 1.0 112.355 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.34 -6.02 23.54 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.405 0.682 . . . . 1.0 110.223 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.88 38.47 6.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.278 2.631 . . . . 1.0 108.412 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.7 166.82 28.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.2 148.8 24.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.324 1.059 . . . . 1.0 110.699 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -132.35 152.18 79.61 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.592 -1.186 . . . . 1.0 109.577 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -68.9 166.31 26.91 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 13.6 p90 -155.59 164.09 39.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.15 123.81 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.455 -1.683 . . . . 1.0 106.455 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -122.49 168.84 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.409 1.884 . . . . 1.0 106.331 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.63 8.11 6.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.899 -0.945 . . . . 1.0 115.027 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.97 -48.31 4.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.29 1.545 . . . . 1.0 110.289 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 p -69.05 -173.39 0.5 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.635 1.174 . . . . 1.0 109.4 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -34.77 133.57 0.27 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.697 1.999 . . . . 1.0 114.261 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.7 173.49 39.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.756 -2.538 . . . . 1.0 106.756 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -93.65 171.24 9.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.63 -6.82 63.58 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.44 1.019 . . . . 1.0 114.356 -173.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -80.13 68.15 6.18 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -135.96 113.05 10.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.152 -1.796 . . . . 1.0 106.152 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.34 161.5 18.42 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 123.211 1.482 . . . . 1.0 108.382 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.1 -21.03 19.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.016 -2.356 . . . . 1.0 109.732 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -164.51 165.23 21.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.624 0.726 . . . . 1.0 109.117 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.56 -49.22 78.4 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.839 -1.073 . . . . 1.0 108.833 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.89 -66.85 0.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 128.004 2.521 . . . . 1.0 111.638 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -57.13 -33.27 67.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 t -67.51 -53.61 27.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.99 0.916 . . . . 1.0 112.908 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -33.27 75.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.526 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.84 -24.2 55.78 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.259 -0.877 . . . . 1.0 110.692 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.96 70.15 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 120.564 1.529 . . . . 1.0 111.634 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.239 0.541 0 CA-C-N 118.702 0.683 . . . . 1.0 112.8 173.708 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 119.194 -0.432 . . . . 1.0 110.205 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 p -62.81 -28.93 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.476 0.711 . . . . 1.0 111.924 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.32 -28.08 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.49 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.2 tp -69.2 125.43 91.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 126.946 2.098 . . . . 1.0 112.412 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 12' ' ' LEU . 51.3 Cg_exo -49.91 154.71 4.83 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.579 2.852 . . . . 1.0 112.764 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.71 160.98 27.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.844 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -135.01 148.78 28.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 126.307 1.843 . . . . 1.0 106.226 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -74.0 -56.39 4.99 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.08 171.7 15.44 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.891 2.186 . . . . 1.0 108.682 -173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.11 -35.69 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.425 2.083 . . . . 1.0 111.375 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.5 158.64 23.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.952 0.882 . . . . 1.0 110.788 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 3.94 22.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.807 2.043 . . . . 1.0 113.701 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.7 154.13 50.96 Favored Glycine 0 CA--C 1.535 1.331 1 N-CA-C 102.85 -4.1 . . . . 1.0 102.85 172.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -125.2 104.86 8.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 120.526 2.163 . . . . 1.0 110.864 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -99.27 119.21 61.04 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 127.468 2.307 . . . . 1.0 107.168 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.59 125.65 10.24 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.11 2.54 . . . . 1.0 109.933 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -130.27 177.11 7.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.36 -0.837 . . . . 1.0 109.533 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -112.66 141.2 46.72 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.93 0.892 . . . . 1.0 108.619 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.37 147.52 45.57 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.07 133.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.792 0.682 . . . . 1.0 110.145 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -117.59 113.42 38.45 Favored Pre-proline 0 N--CA 1.445 -0.702 0 O-C-N 119.854 -1.779 . . . . 1.0 109.075 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.14 -35.11 20.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.752 1.635 . . . . 1.0 109.982 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.83 -19.71 65.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.62 1.168 . . . . 1.0 112.151 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -103.04 -4.15 24.98 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.364 1.066 . . . . 1.0 110.078 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.63 29.98 8.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.493 2.717 . . . . 1.0 110.749 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -165.04 166.66 19.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.96 0.8 . . . . 1.0 109.861 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.01 147.36 22.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.029 0.918 . . . . 1.0 109.459 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -142.7 153.74 61.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.625 0.77 . . . . 1.0 111.132 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.43 160.08 44.5 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.815 1.677 . . . . 1.0 108.534 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 40' ' ' TYR . 19.8 p90 -153.59 160.34 42.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.622 1.101 . . . . 1.0 108.776 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.12 113.62 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.942 -1.874 . . . . 1.0 105.942 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.402 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 26.1 t80 -107.63 167.68 9.78 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.229 2.212 . . . . 1.0 106.457 173.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.77 9.39 10.59 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.15 0.82 . . . . 1.0 115.15 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.26 -39.66 2.3 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.276 1.417 . . . . 1.0 113.241 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.17 -172.98 3.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.584 1.154 . . . . 1.0 108.41 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.7 mp0 -33.99 133.94 0.19 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.047 2.539 . . . . 1.0 112.838 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.23 -167.22 23.33 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 107.453 -2.259 . . . . 1.0 107.453 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.31 173.56 7.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.462 1.131 . . . . 1.0 108.172 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.87 -15.19 81.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.359 -0.837 . . . . 1.0 112.547 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -74.92 79.73 2.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.872 0.869 . . . . 1.0 108.675 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -146.57 113.09 5.96 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.915 -1.883 . . . . 1.0 105.915 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.32 162.33 19.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.499 1.52 . . . . 1.0 108.351 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -93.49 -19.43 21.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.145 -1.388 . . . . 1.0 112.381 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 p -162.73 169.34 20.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 1.0 109.561 -173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.7 tpt180 -61.81 -49.32 76.77 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.06 -0.973 . . . . 1.0 108.507 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.12 -66.61 0.38 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.508 2.723 . . . . 1.0 112.123 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 p -60.35 -33.25 72.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.734 0.646 . . . . 1.0 112.229 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.41 -51.84 39.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 112.694 0.627 . . . . 1.0 112.694 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.286 71.5 mt-10 -69.76 -33.28 72.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.144 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.06 -35.28 80.1 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.48 -50.74 34.83 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 120.164 1.347 . . . . 1.0 111.674 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 116.087 1.884 . . . . 1.0 116.087 -173.136 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.521 0 N-CA-C 112.283 0.475 . . . . 1.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -46.86 -25.44 0.77 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.874 -1.141 . . . . 1.0 113.482 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.85 -33.0 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 119.403 1.002 . . . . 1.0 111.916 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 152.87 93.12 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 128.406 2.682 . . . . 1.0 109.013 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.06 173.15 10.76 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.742 . . . . 1.0 111.598 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.31 113.58 7.61 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.627 -1.249 . . . . 1.0 107.627 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.69 123.94 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.008 -1.479 . . . . 1.0 107.008 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -79.33 -33.41 43.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.257 -1.338 . . . . 1.0 110.737 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.84 172.66 42.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.74 -8.55 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.024 2.483 . . . . 1.0 114.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.55 -179.5 5.29 Favored 'General case' 0 N--CA 1.461 0.095 0 O-C-N 120.952 -1.093 . . . . 1.0 113.57 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.27 3.81 4.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.307 1.443 . . . . 1.0 113.576 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.79 157.12 29.48 Favored Glycine 0 CA--C 1.533 1.214 1 N-CA-C 101.301 -4.72 . . . . 1.0 101.301 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -131.44 117.88 19.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 121.333 2.567 . . . . 1.0 108.869 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.16 113.94 29.46 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 129.323 3.049 . . . . 1.0 107.77 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.55 125.44 13.33 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.559 2.839 . . . . 1.0 111.203 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -131.56 -179.99 5.7 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.403 1.081 . . . . 1.0 109.846 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.529 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 55.1 m95 -117.35 141.4 48.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.797 0.839 . . . . 1.0 108.751 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.86 148.44 48.64 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.87 143.69 29.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.666 0.746 . . . . 1.0 109.01 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 113.28 39.35 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 105.498 -2.038 . . . . 1.0 105.498 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.41 -32.41 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.747 1.631 . . . . 1.0 110.656 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.01 -17.1 64.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.793 0.837 . . . . 1.0 112.299 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.96 -4.29 16.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 1.0 110.546 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.78 35.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.64 3.176 . . . . 1.0 108.45 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -162.75 170.88 17.64 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 121.139 -0.976 . . . . 1.0 110.185 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -100.85 145.08 29.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.938 1.695 . . . . 1.0 111.738 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -138.48 153.6 72.77 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.887 0.875 . . . . 1.0 110.689 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.48 163.32 24.29 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.492 2.128 . . . . 1.0 110.483 173.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.0 168.26 27.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.19 113.72 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -99.36 163.82 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.561 1.944 . . . . 1.0 105.809 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.77 1.48 41.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 116.459 1.344 . . . . 1.0 116.459 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.5 1.96 67.13 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 118.963 1.382 . . . . 1.0 115.456 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.2 p -125.53 -172.65 2.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.699 2.4 . . . . 1.0 108.074 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -33.26 133.52 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.827 2.051 . . . . 1.0 112.839 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.2 42.27 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -93.81 -174.11 3.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.172 0.987 . . . . 1.0 109.773 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.4 -7.61 88.09 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 127.764 2.602 . . . . 1.0 113.591 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -86.3 53.16 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.442 2.121 . . . . 1.0 106.911 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -131.47 112.73 12.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 101.902 -3.37 . . . . 1.0 101.902 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -108.85 156.15 19.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.12 -13.46 28.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.461 -2.154 . . . . 1.0 112.137 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -166.48 169.33 13.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.694 1.198 . . . . 1.0 109.131 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -64.5 -42.93 95.54 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -48.97 -66.34 0.42 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.689 2.796 . . . . 1.0 111.318 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.8 p -58.47 -36.07 73.14 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.95 0.781 . . . . 1.0 111.495 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 39.1 t -66.61 -52.99 39.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.5 0.72 . . . . 1.0 112.35 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.39 -33.41 72.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.471 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.42 -29.48 61.52 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.663 1.119 . . . . 1.0 111.563 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -61.64 1.69 Allowed 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.372 0.987 . . . . 1.0 110.15 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 124.693 1.197 . . . . 1.0 108.336 177.655 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 118.258 -0.877 . . . . 1.0 111.774 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -21.0 66.01 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.302 1.41 . . . . 1.0 111.566 -174.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.3 t -74.2 -36.71 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.931 -1.105 . . . . 1.0 110.252 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -70.29 129.98 89.89 Favored Pre-proline 0 N--CA 1.455 -0.176 0 C-N-CA 127.229 2.212 . . . . 1.0 113.199 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.4 Cg_exo -52.01 153.73 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.008 2.472 . . . . 1.0 111.403 173.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.97 166.82 16.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.315 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.93 146.3 30.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.403 -2.073 . . . . 1.0 105.403 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -97.53 -24.37 15.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.259 1.024 . . . . 1.0 112.242 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.08 45.82 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.999 1.761 . . . . 1.0 112.014 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.81 -3.43 13.85 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.609 3.539 . . . . 1.0 115.032 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.3 m -61.05 178.56 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.712 1.605 . . . . 1.0 113.298 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 3.65 3.98 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.233 1.413 . . . . 1.0 113.201 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.04 153.39 20.55 Favored Glycine 0 CA--C 1.529 0.945 1 N-CA-C 101.974 -4.45 . . . . 1.0 101.974 172.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -130.06 105.79 8.19 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.245 1.523 . . . . 1.0 111.324 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.01 114.84 64.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 129.153 2.981 . . . . 1.0 106.638 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.73 122.18 8.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.395 2.73 . . . . 1.0 109.549 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -123.28 179.57 4.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.593 0.757 . . . . 1.0 108.976 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -125.13 144.35 50.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.506 1.122 . . . . 1.0 108.436 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.57 141.33 35.22 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -77.14 137.73 39.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -117.3 113.66 38.89 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 117.463 -1.256 . . . . 1.0 108.006 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.26 -33.72 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.953 1.769 . . . . 1.0 110.805 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.66 -20.32 66.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.048 0.939 . . . . 1.0 112.37 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.66 -4.06 22.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.842 1.257 . . . . 1.0 110.479 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.65 16.85 2.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 128.416 2.686 . . . . 1.0 111.721 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -164.13 172.17 14.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.979 1.263 . . . . 1.0 110.525 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -87.75 148.82 24.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -133.9 155.9 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.989 1.316 . . . . 1.0 109.953 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.38 165.88 31.06 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.982 1.788 . . . . 1.0 109.237 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -158.6 165.69 33.87 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.7 t -89.05 129.96 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.793 -1.558 . . . . 1.0 106.793 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -132.46 170.13 15.57 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.492 1.517 . . . . 1.0 107.163 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.26 -3.18 8.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.946 1.538 . . . . 1.0 116.946 -173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.56 -29.92 6.42 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.826 1.813 . . . . 1.0 111.838 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -73.34 -173.2 1.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.383 1.873 . . . . 1.0 109.649 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -34.14 134.04 0.2 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.52 2.728 . . . . 1.0 112.983 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.93 175.86 41.44 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.271 -1.932 . . . . 1.0 108.271 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -93.62 177.55 5.98 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.89 76.15 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.511 -0.768 . . . . 1.0 112.825 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -78.99 70.2 5.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.372 1.086 . . . . 1.0 108.4 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -144.42 113.07 6.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -119.76 162.03 19.75 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.227 1.411 . . . . 1.0 108.785 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -93.33 -14.16 27.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.591 -1.186 . . . . 1.0 112.032 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -166.24 170.7 12.97 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.54 0.686 . . . . 1.0 109.222 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -62.81 -46.32 88.49 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -66.87 0.32 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 128.796 2.838 . . . . 1.0 111.079 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -54.57 -33.26 59.94 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.7 t -72.62 -49.42 32.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.448 -0.782 . . . . 1.0 112.793 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.19 -33.74 76.48 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 118.515 -0.755 . . . . 1.0 109.883 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.87 -41.41 97.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.813 0.845 . . . . 1.0 110.113 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.25 -42.01 76.18 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 118.709 0.686 . . . . 1.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.9 m . . . . . 0 C--O 1.238 0.477 0 C-N-CA 123.619 0.768 . . . . 1.0 110.855 174.659 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 118.63 -0.7 . . . . 1.0 111.813 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -22.67 61.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.528 1.513 . . . . 1.0 112.746 -173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.47 -37.87 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.11 0.868 . . . . 1.0 110.754 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 147.09 87.03 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.746 2.018 . . . . 1.0 112.832 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.09 158.08 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.063 3.175 . . . . 1.0 113.019 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.89 113.39 13.32 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.343 -1.473 . . . . 1.0 108.053 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.88 129.35 44.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -79.12 -35.12 42.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.938 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.51 171.98 37.95 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.95 -40.72 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.259 1.973 . . . . 1.0 112.849 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.5 m -68.12 159.32 31.2 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 121.34 -0.85 . . . . 1.0 111.877 -174.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 3.92 24.84 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.978 2.111 . . . . 1.0 114.279 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -68.41 165.48 46.8 Favored Glycine 0 CA--C 1.544 1.901 1 N-CA-C 102.49 -4.244 . . . . 1.0 102.49 172.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -136.95 135.88 38.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 123.444 3.622 . . . . 1.0 110.943 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -135.91 121.05 13.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 131.221 3.808 . . . . 1.0 107.237 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 128.15 16.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.377 2.718 . . . . 1.0 109.582 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -130.67 -179.01 5.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.428 1.091 . . . . 1.0 108.506 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.0 m95 -129.83 145.31 51.58 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 127.29 2.236 . . . . 1.0 106.613 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.08 145.64 30.62 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.7 t80 -80.72 138.48 36.33 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.548 0.689 . . . . 1.0 109.628 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.472 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 15.6 m -117.31 113.68 38.85 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 116.723 -1.608 . . . . 1.0 106.798 172.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.67 -33.28 28.44 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.855 1.704 . . . . 1.0 110.077 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.82 -15.62 62.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.761 1.224 . . . . 1.0 112.568 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.2 mt -112.35 -4.0 14.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.414 1.486 . . . . 1.0 110.498 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.64 26.94 2.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.333 3.053 . . . . 1.0 111.843 -174.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -164.85 167.89 18.29 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.05 -1.031 . . . . 1.0 110.134 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 93.4 m -84.39 144.95 28.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.751 0.786 . . . . 1.0 112.396 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.472 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 32.3 p80 -131.46 155.12 81.9 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.058 1.343 . . . . 1.0 109.62 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.92 167.37 27.5 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.745 1.63 . . . . 1.0 108.739 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -161.84 166.32 26.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.36 113.47 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.239 -2.134 . . . . 1.0 105.239 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -98.9 156.33 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.559 1.944 . . . . 1.0 107.005 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -92.19 1.27 73.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 115.351 0.9 . . . . 1.0 115.351 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.44 -38.22 2.26 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.51 1.529 . . . . 1.0 114.21 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.6 p -80.91 -173.2 4.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 1.0 109.432 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.82 133.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.317 2.647 . . . . 1.0 113.261 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.88 -179.68 39.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.881 -1.688 . . . . 1.0 108.881 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.64 -175.05 3.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.711 0.767 . . . . 1.0 110.486 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.22 -19.76 79.47 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.742 -1.588 . . . . 1.0 115.498 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -79.99 70.87 6.65 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.605 2.203 . . . . 1.0 108.227 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -149.4 113.3 5.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 -173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -125.53 156.07 39.61 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.127 1.771 . . . . 1.0 107.689 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -93.58 -10.12 35.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 1.0 111.969 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.76 158.09 43.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 120.162 1.346 . . . . 1.0 111.319 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -61.72 -45.99 91.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.39 -1.277 . . . . 1.0 109.426 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.36 -66.57 0.38 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.042 2.537 . . . . 1.0 112.369 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.4 p -57.99 -41.27 82.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.011 0.819 . . . . 1.0 110.861 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.55 -48.32 72.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.946 0.898 . . . . 1.0 112.137 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.52 -34.04 77.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 117.503 -1.237 . . . . 1.0 110.886 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.76 -29.75 70.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.406 1.912 . . . . 1.0 111.1 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -63.5 1.05 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-N 119.49 1.041 . . . . 1.0 108.398 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 1.0 110.216 -178.079 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.419 0 N-CA-C 109.799 -0.445 . . . . 1.0 109.799 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.15 68.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.976 0.807 . . . . 1.0 112.291 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.08 -34.55 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.039 0.936 . . . . 1.0 109.843 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.5 tp -64.68 129.24 94.23 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 125.672 1.589 . . . . 1.0 113.169 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.0 Cg_exo -51.6 159.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.597 2.865 . . . . 1.0 111.859 173.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.17 113.72 25.76 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.118 -0.989 . . . . 1.0 109.599 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.77 145.88 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.3 -23.96 18.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.066 1.347 . . . . 1.0 111.59 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.12 168.86 34.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.085 1.326 . . . . 1.0 115.189 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.17 -28.23 2.05 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.844 3.029 . . . . 1.0 113.221 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 m -72.7 165.38 24.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.035 0.834 . . . . 1.0 110.728 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -111.85 3.78 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.11 1.152 . . . . 1.0 114.11 -174.019 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 154.27 37.47 Favored Glycine 0 CA--C 1.534 1.25 1 N-CA-C 101.892 -4.483 . . . . 1.0 101.892 172.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -136.16 129.77 32.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.711 2.255 . . . . 1.0 108.379 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.08 113.98 16.16 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 129.679 3.192 . . . . 1.0 105.744 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.93 129.34 20.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.287 2.658 . . . . 1.0 109.925 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -130.46 176.19 8.35 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.736 -1.12 . . . . 1.0 108.639 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.591 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 62.8 m95 -129.83 139.15 51.27 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.972 -1.862 . . . . 1.0 105.972 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.91 145.31 41.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -81.69 139.09 35.12 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.728 0.775 . . . . 1.0 110.811 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -117.44 113.59 38.64 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.114 -1.422 . . . . 1.0 107.328 172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.82 -34.33 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.977 1.785 . . . . 1.0 110.832 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.6 -20.67 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.142 0.977 . . . . 1.0 112.42 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -103.1 -5.39 23.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.731 1.212 . . . . 1.0 110.61 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 48.95 29.88 2.54 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 130.74 3.616 . . . . 1.0 110.065 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -165.47 168.33 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.378 -0.826 . . . . 1.0 109.187 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.5 m -90.79 147.72 23.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -126.43 156.06 73.39 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.743 1.217 . . . . 1.0 109.47 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -72.85 168.67 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.589 1.526 . . . . 1.0 109.252 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -159.54 165.34 33.13 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.64 113.93 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.053 -2.202 . . . . 1.0 105.053 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -106.55 145.92 31.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.458 -1.682 . . . . 1.0 106.458 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.07 3.31 85.75 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.109 -0.828 . . . . 1.0 114.667 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.99 -49.08 3.43 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.983 1.278 . . . . 1.0 110.058 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.6 p -72.58 -172.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.396 1.478 . . . . 1.0 108.44 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.05 133.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.269 2.228 . . . . 1.0 114.46 -173.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.21 177.58 44.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 128.299 2.857 . . . . 1.0 106.861 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.484 ' ND2' HD11 ' A' ' 12' ' ' LEU . 12.7 m-20 -93.73 177.02 6.14 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.276 1.038 . . . . 1.0 109.906 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.22 82.43 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.845 -1.071 . . . . 1.0 113.504 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.34 72.11 3.07 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -135.37 112.95 10.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.94 149.69 43.93 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.51 -8.52 41.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 118.531 -0.747 . . . . 1.0 110.76 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -155.34 158.94 39.51 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.083 0.856 . . . . 1.0 112.249 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.591 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -57.19 -56.98 14.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.839 1.656 . . . . 1.0 111.661 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.16 -47.53 82.28 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.057 0.848 . . . . 1.0 111.72 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.7 p -53.68 -35.3 60.92 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.83 -48.43 21.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.55 -34.02 73.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.397 -0.811 . . . . 1.0 111.346 174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.96 -27.07 49.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.217 1.371 . . . . 1.0 110.665 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.03 1.14 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.986 1.267 . . . . 1.0 109.174 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 124.967 1.307 . . . . 1.0 107.894 176.418 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.375 0 N-CA-C 110.634 -0.136 . . . . 1.0 110.634 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -66.61 -14.97 63.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.934 0.893 . . . . 1.0 113.38 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.18 -28.94 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.265 1.026 . . . . 1.0 109.517 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.1 tp -71.05 131.8 86.94 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.227 2.211 . . . . 1.0 113.013 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 12' ' ' LEU . 73.3 Cg_exo -51.51 157.73 4.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.646 2.897 . . . . 1.0 113.139 173.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.22 164.46 24.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.663 0.785 . . . . 1.0 110.433 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.35 151.43 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.036 1.734 . . . . 1.0 106.405 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -99.38 -27.55 13.7 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.001 0.92 . . . . 1.0 113.442 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.6 171.05 46.83 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.989 -1.645 . . . . 1.0 108.989 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.85 -27.01 37.73 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.734 2.289 . . . . 1.0 112.504 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.72 155.37 38.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.085 0.954 . . . . 1.0 109.562 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.09 3.97 19.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.487 1.915 . . . . 1.0 113.962 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.03 157.48 48.85 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 103.639 -3.785 . . . . 1.0 103.639 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -132.76 108.36 8.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 121.541 2.671 . . . . 1.0 115.102 -173.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 25' ' ' ARG . 75.7 tt0 -106.04 126.21 31.18 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -71.09 113.72 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.404 2.069 . . . . 1.0 108.142 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 25.6 mmt85 -107.92 178.87 4.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.691 -1.225 . . . . 1.0 107.691 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.502 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -133.22 143.61 49.25 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.825 1.65 . . . . 1.0 107.724 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.32 149.36 37.67 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.82 0.848 . . . . 1.0 109.063 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -83.63 141.47 31.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.195 0.998 . . . . 1.0 110.818 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.2 m -117.34 113.29 38.98 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 106.08 -1.822 . . . . 1.0 106.08 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.14 -32.18 21.71 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.631 1.554 . . . . 1.0 110.219 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.65 -15.34 61.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 1.0 112.367 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 mt -112.7 -4.57 14.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.823 1.249 . . . . 1.0 110.521 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.93 36.66 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.276 2.63 . . . . 1.0 109.821 -173.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -164.85 169.01 17.13 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.738 -0.601 . . . . 1.0 109.576 -173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -95.31 150.84 19.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.498 1.142 . . . . 1.0 112.883 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -135.04 155.66 78.94 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.725 1.21 . . . . 1.0 109.682 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.59 169.51 21.67 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.938 1.759 . . . . 1.0 110.229 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -162.56 175.22 11.66 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.538 1.935 . . . . 1.0 106.722 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.1 126.58 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.021 -1.474 . . . . 1.0 107.021 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.77 160.1 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.033 2.533 . . . . 1.0 110.015 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.72 19.32 11.37 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 118.104 2.002 . . . . 1.0 118.104 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 -46.81 3.34 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 119.807 1.803 . . . . 1.0 112.321 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 p -65.9 -173.14 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.686 1.595 . . . . 1.0 110.541 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.3 mp0 -33.54 133.85 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 129.394 3.078 . . . . 1.0 114.365 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.81 174.85 35.17 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.159 -1.976 . . . . 1.0 108.159 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.59 -177.62 4.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 -23.72 76.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.333 0.492 . . . . 1.0 112.341 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.71 69.08 4.83 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.032 0.916 . . . . 1.0 108.81 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -152.14 113.14 4.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.07 156.72 42.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.5 1.52 . . . . 1.0 109.206 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -93.46 -8.21 42.26 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.424 -0.798 . . . . 1.0 110.68 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 p -157.14 166.07 34.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.025 0.829 . . . . 1.0 109.897 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.9 tpt180 -60.28 -47.38 86.27 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 173.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -44.66 -66.56 0.38 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 128.284 2.634 . . . . 1.0 112.474 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 p -60.65 -36.04 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.626 0.579 . . . . 1.0 111.91 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.39 -47.71 63.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.283 0.633 . . . . 1.0 111.715 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.57 -32.91 74.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.176 0.991 . . . . 1.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.58 -40.18 70.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 117.737 -1.125 . . . . 1.0 110.001 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -59.18 5.09 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.819 1.19 . . . . 1.0 110.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 125.087 1.355 . . . . 1.0 108.307 173.83 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 117.945 -1.026 . . . . 1.0 112.417 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 p -55.22 -31.51 61.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.174 1.352 . . . . 1.0 112.518 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.79 -34.3 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.307 -0.87 . . . . 1.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.5 tp -61.7 129.14 91.2 Favored Pre-proline 0 CA--C 1.522 -0.124 0 C-N-CA 125.276 1.43 . . . . 1.0 113.045 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -49.93 151.36 8.58 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.316 2.678 . . . . 1.0 112.164 173.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.5 23.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.576 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.48 139.98 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 104.689 -2.337 . . . . 1.0 104.689 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.61 -58.29 3.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.28 171.66 12.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.729 1.633 . . . . 1.0 109.979 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.9 -12.22 14.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.973 2.449 . . . . 1.0 112.802 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.66 176.21 6.43 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 122.34 1.067 . . . . 1.0 112.373 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.26 3.69 8.5 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.603 -1.18 . . . . 1.0 112.479 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.29 154.28 21.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 103.176 -3.97 . . . . 1.0 103.176 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -132.19 119.9 21.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.478 1.639 . . . . 1.0 108.377 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -120.2 113.75 33.82 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 129.551 3.14 . . . . 1.0 106.584 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.04 124.28 11.22 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.183 2.589 . . . . 1.0 110.835 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -129.4 178.32 6.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.958 0.903 . . . . 1.0 109.34 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.7 m95 -120.07 141.17 50.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.554 1.142 . . . . 1.0 107.994 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.25 146.7 51.67 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -84.56 136.14 33.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.6 m -117.23 113.94 38.89 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 120.35 -1.469 . . . . 1.0 109.11 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.72 -36.52 18.68 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.208 1.939 . . . . 1.0 110.634 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 mt -61.98 -23.32 66.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.793 1.237 . . . . 1.0 113.083 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 mt -102.85 -4.36 24.97 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.165 0.986 . . . . 1.0 110.801 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.08 36.13 1.91 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.985 2.914 . . . . 1.0 109.995 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.16 169.88 17.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.352 -0.842 . . . . 1.0 109.074 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.2 m -98.77 146.32 26.03 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.88 -0.512 . . . . 1.0 111.164 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -132.73 154.09 81.33 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.253 1.021 . . . . 1.0 110.194 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.17 165.9 30.94 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.482 -1.391 . . . . 1.0 108.482 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -157.68 161.59 38.58 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.366 -0.975 . . . . 1.0 108.366 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 t -86.24 113.82 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.579 -2.008 . . . . 1.0 105.579 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.41 159.06 15.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.223 -2.14 . . . . 1.0 105.223 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.44 1.25 49.83 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.854 -1.154 . . . . 1.0 115.611 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 -8.47 13.24 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.776 1.288 . . . . 1.0 115.06 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.23 -172.53 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.076 2.95 . . . . 1.0 107.252 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 2.8 mp0 -33.47 133.64 0.16 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.741 2.017 . . . . 1.0 112.809 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -174.84 38.78 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.185 -2.366 . . . . 1.0 107.185 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -93.41 174.92 6.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.784 1.292 . . . . 1.0 108.883 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.07 84.83 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 114.574 -1.193 . . . . 1.0 112.644 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -76.54 73.12 3.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.648 -1.241 . . . . 1.0 107.648 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -138.23 112.92 8.94 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.128 -1.804 . . . . 1.0 106.128 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.06 158.26 24.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 123.618 1.675 . . . . 1.0 107.132 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -93.3 -16.47 24.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.754 -2.021 . . . . 1.0 111.602 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -166.05 164.44 18.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.976 0.893 . . . . 1.0 109.145 -173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.1 tpt180 -60.27 -47.94 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.476 -1.238 . . . . 1.0 108.54 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.46 -66.27 0.43 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.612 2.365 . . . . 1.0 111.362 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 p -57.76 -33.4 68.46 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 123.997 0.811 . . . . 1.0 112.423 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.5 t -68.15 -54.05 20.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.146 0.978 . . . . 1.0 112.789 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.48 -33.18 75.29 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.8 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.12 -24.32 51.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.898 -1.048 . . . . 1.0 111.054 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.82 -65.03 0.73 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 120.839 1.654 . . . . 1.0 109.497 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.8 m . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.119 0.414 . . . . 1.0 112.119 -173.77 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.627 -0.702 . . . . 1.0 111.089 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -47.11 -34.6 6.19 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.184 1.356 . . . . 1.0 114.154 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.95 -25.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 120.683 -1.261 . . . . 1.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.54 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -67.24 127.57 93.51 Favored Pre-proline 0 CA--C 1.519 -0.243 0 C-N-CA 126.21 1.804 . . . . 1.0 112.033 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.54 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.2 Cg_exo -49.9 152.24 7.45 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.993 2.462 . . . . 1.0 112.205 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.51 158.17 27.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.215 -0.902 . . . . 1.0 109.827 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -139.49 148.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.28 -69.77 0.38 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.98 175.9 14.06 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.77 -19.64 18.24 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.652 2.235 . . . . 1.0 112.651 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.38 177.85 4.95 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.059 0.944 . . . . 1.0 112.276 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.75 3.44 11.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.378 1.471 . . . . 1.0 112.1 174.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.47 153.9 32.29 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 103.704 -3.758 . . . . 1.0 103.704 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -133.62 125.79 29.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.279 1.54 . . . . 1.0 107.401 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.32 113.88 23.5 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 129.153 2.981 . . . . 1.0 106.633 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.43 129.78 15.27 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.203 2.602 . . . . 1.0 110.711 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -134.43 178.23 7.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.083 0.953 . . . . 1.0 109.614 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.3 m95 -110.84 141.71 43.85 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.191 -1.041 . . . . 1.0 108.191 174.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.5 41.76 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 118.855 0.752 . . . . 1.0 109.515 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -81.78 136.54 35.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -117.39 113.88 38.61 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 116.379 -1.772 . . . . 1.0 110.685 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.69 -34.26 32.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.726 1.618 . . . . 1.0 109.793 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.1 mt -64.78 -10.85 30.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.687 1.595 . . . . 1.0 112.716 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -120.63 -4.22 9.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.191 1.396 . . . . 1.0 110.51 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.22 36.16 6.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.746 2.418 . . . . 1.0 109.767 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.84 166.43 19.7 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.294 -0.879 . . . . 1.0 110.016 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.9 m -94.63 145.85 24.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.013 0.911 . . . . 1.0 110.607 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.37 156.46 63.96 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 118.514 -0.755 . . . . 1.0 111.304 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.63 157.28 56.41 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.12 1.88 . . . . 1.0 108.832 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -153.49 161.36 42.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.786 1.176 . . . . 1.0 108.833 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -85.76 124.41 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 173.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -116.05 163.82 15.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.98 -0.78 48.5 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.558 -1.339 . . . . 1.0 115.131 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.83 -37.07 1.04 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.41 1.481 . . . . 1.0 112.881 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.06 -172.74 4.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.211 1.804 . . . . 1.0 107.759 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.84 133.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.871 2.068 . . . . 1.0 112.88 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 -167.83 30.59 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 107.596 -2.201 . . . . 1.0 107.596 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -93.34 174.89 6.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.224 1.012 . . . . 1.0 108.827 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.02 -10.93 82.17 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.819 -1.082 . . . . 1.0 112.755 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -73.17 81.39 1.3 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.51 112.95 6.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.81 160.77 21.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 123.468 1.604 . . . . 1.0 107.894 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -93.42 -20.81 19.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 112.542 -2.117 . . . . 1.0 112.492 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -165.14 167.62 18.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -60.9 -51.31 69.84 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -45.1 -66.6 0.38 Allowed 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 128.202 2.601 . . . . 1.0 112.075 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -60.83 -33.39 72.96 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.67 0.606 . . . . 1.0 112.304 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.94 -52.23 38.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -69.92 -33.24 71.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.466 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.46 -28.14 61.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 117.902 -1.519 . . . . 1.0 110.448 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.2 -48.61 41.81 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-N 120.543 1.519 . . . . 1.0 110.483 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.8 m . . . . . 0 N--CA 1.446 -0.632 0 C-N-CA 123.868 0.867 . . . . 1.0 113.328 -174.261 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.334 0 CA-C-O 118.585 -0.721 . . . . 1.0 111.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 p -52.84 -30.64 34.8 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.137 1.335 . . . . 1.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 t -78.19 -27.11 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.437 -0.789 . . . . 1.0 110.444 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -69.48 130.16 90.95 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 126.391 1.876 . . . . 1.0 112.178 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.1 Cg_exo -51.77 154.42 9.65 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.922 2.415 . . . . 1.0 111.579 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.39 160.27 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.383 0.673 . . . . 1.0 109.636 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.69 150.06 20.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 126.002 1.721 . . . . 1.0 106.567 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -72.61 -68.7 0.46 Allowed 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.75 171.36 12.82 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.441 1.496 . . . . 1.0 109.8 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.79 -12.16 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.074 2.516 . . . . 1.0 113.358 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.3 m -72.69 -174.99 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.574 1.15 . . . . 1.0 112.201 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.65 3.61 5.51 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.064 0.945 . . . . 1.0 113.167 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.83 153.61 25.97 Favored Glycine 0 CA--C 1.528 0.89 1 N-CA-C 102.292 -4.323 . . . . 1.0 102.292 172.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -134.21 123.34 24.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.482 1.641 . . . . 1.0 108.277 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.59 113.7 34.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 129.732 3.213 . . . . 1.0 106.56 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.9 130.47 14.53 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.68 . . . . 1.0 110.486 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -134.41 177.34 7.84 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.724 0.81 . . . . 1.0 109.353 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.52 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.4 m95 -111.1 141.06 45.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.27 47.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -82.68 141.35 32.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.777 0.799 . . . . 1.0 109.398 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -117.31 113.14 39.11 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 105.818 -1.919 . . . . 1.0 105.818 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -33.65 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.68 1.587 . . . . 1.0 109.584 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.29 -15.86 62.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.145 1.378 . . . . 1.0 112.601 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.6 mt -112.12 -5.32 14.25 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.262 1.025 . . . . 1.0 110.493 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.74 37.47 7.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.324 2.25 . . . . 1.0 109.47 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -160.88 166.2 28.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.2 149.57 23.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.981 0.896 . . . . 1.0 111.744 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -140.8 154.26 68.56 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.804 . . . . 1.0 110.832 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.79 162.08 33.41 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.147 1.898 . . . . 1.0 109.084 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -156.03 157.57 36.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.352 0.978 . . . . 1.0 108.416 173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.35 130.76 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.889 -2.264 . . . . 1.0 104.889 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.76 163.38 22.23 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.26 -0.11 40.83 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.53 -1.15 . . . . 1.0 115.523 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 -34.17 1.07 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.266 1.533 . . . . 1.0 113.116 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -88.85 -172.71 3.81 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.361 2.264 . . . . 1.0 107.748 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -33.8 133.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.795 2.038 . . . . 1.0 112.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.3 -172.28 40.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 107.316 -2.313 . . . . 1.0 107.316 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.413 ' ND2' HD11 ' A' ' 12' ' ' LEU . 6.2 m-20 -93.55 175.63 6.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.326 1.06 . . . . 1.0 109.355 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.99 -9.75 73.28 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.582 -1.19 . . . . 1.0 113.794 -173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -73.89 81.15 1.65 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.447 -1.686 . . . . 1.0 106.447 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -142.36 113.04 7.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.428 -1.323 . . . . 1.0 107.428 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -118.1 161.3 20.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.009 1.385 . . . . 1.0 108.271 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.21 -19.12 21.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 112.898 -1.955 . . . . 1.0 112.288 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -165.96 168.75 15.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.89 -47.05 88.15 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 173.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -47.59 -66.58 0.38 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.844 2.858 . . . . 1.0 111.947 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 p -60.53 -33.5 72.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.602 0.564 . . . . 1.0 112.093 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.5 t -69.55 -50.7 42.4 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.714 0.806 . . . . 1.0 112.431 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.278 61.7 mt-10 -68.97 -32.9 72.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.997 -0.525 . . . . 1.0 110.085 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.56 -28.94 66.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.424 -1.275 . . . . 1.0 110.805 173.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.77 15.96 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 119.735 1.152 . . . . 1.0 111.039 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.452 -0.34 0 C-N-CA 123.661 0.784 . . . . 1.0 110.359 -179.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.893 -0.575 . . . . 1.0 109.538 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -50.3 -29.5 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.957 1.303 . . . . 1.0 113.115 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.1 t -78.18 -26.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.042 . . . . 1.0 110.674 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -71.41 131.26 86.69 Favored Pre-proline 0 N--CA 1.453 -0.3 0 C-N-CA 127.185 2.194 . . . . 1.0 112.406 174.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.2 Cg_exo -51.74 153.39 11.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.877 2.385 . . . . 1.0 111.59 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.9 160.74 22.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.614 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.61 148.75 21.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 125.479 1.512 . . . . 1.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.83 -68.68 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.312 1.045 . . . . 1.0 109.045 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.73 175.7 14.09 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.139 1.352 . . . . 1.0 109.772 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.92 -15.27 18.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.739 2.293 . . . . 1.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.3 m -72.97 178.85 4.04 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 124.217 1.007 . . . . 1.0 111.808 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.87 3.68 4.46 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.837 1.051 . . . . 1.0 113.837 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.54 153.71 29.01 Favored Glycine 0 CA--C 1.53 1.018 1 N-CA-C 102.037 -4.425 . . . . 1.0 102.037 172.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.18 109.6 11.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.967 1.883 . . . . 1.0 108.9 -173.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.5 113.93 61.23 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 129.021 2.928 . . . . 1.0 107.001 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.46 127.7 14.39 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.14 2.56 . . . . 1.0 110.474 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -132.71 178.7 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.996 0.919 . . . . 1.0 109.312 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.506 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.6 m95 -114.3 139.7 49.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.454 1.101 . . . . 1.0 108.177 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.81 145.38 46.43 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.898 0.772 . . . . 1.0 109.109 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -80.97 140.48 35.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.892 0.853 . . . . 1.0 109.095 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.441 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 21.9 m -117.16 113.38 39.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 106.582 -1.636 . . . . 1.0 106.582 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.78 -33.06 21.81 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.697 1.598 . . . . 1.0 110.208 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.99 -15.12 61.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.935 1.294 . . . . 1.0 112.6 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 mt -113.96 -5.57 13.17 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.533 1.133 . . . . 1.0 110.526 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.74 40.34 8.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.495 2.318 . . . . 1.0 109.072 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -163.85 165.43 22.87 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 -173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.3 148.39 23.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.466 1.127 . . . . 1.0 111.373 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 31.4 p80 -141.78 155.44 66.26 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 114.869 -1.06 . . . . 1.0 110.942 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 160.18 35.66 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.423 2.082 . . . . 1.0 109.911 173.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.13 161.93 40.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.352 0.978 . . . . 1.0 108.409 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.64 123.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.331 -1.729 . . . . 1.0 106.331 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.4 162.89 16.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 104.857 -2.275 . . . . 1.0 104.857 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.15 4.43 31.67 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.643 -1.286 . . . . 1.0 115.511 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.27 9.8 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 118.657 1.229 . . . . 1.0 115.347 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 p -119.75 -172.63 2.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.401 2.681 . . . . 1.0 107.318 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.73 133.53 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.397 1.879 . . . . 1.0 112.619 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.24 -171.46 34.95 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.651 -2.18 . . . . 1.0 107.651 -174.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -93.44 175.18 6.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.355 1.078 . . . . 1.0 109.047 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -11.78 80.6 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.76 -1.109 . . . . 1.0 113.132 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -76.62 77.39 3.29 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -146.08 113.12 6.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.174 -1.417 . . . . 1.0 107.174 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -120.48 161.03 21.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.208 1.403 . . . . 1.0 108.388 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -93.4 -17.21 23.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.515 -1.675 . . . . 1.0 113.158 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.34 170.09 15.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -61.47 -50.12 74.03 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -66.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 128.506 2.723 . . . . 1.0 111.826 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.4 p -56.76 -33.25 66.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.812 0.671 . . . . 1.0 112.812 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.3 t -70.97 -49.7 42.5 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.637 0.775 . . . . 1.0 112.534 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.366 76.3 mt-10 -67.13 -33.06 74.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.037 -0.506 . . . . 1.0 111.237 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.7 -38.22 90.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.07 68.8 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.946 0.794 . . . . 1.0 111.808 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 125.499 1.519 . . . . 1.0 109.597 179.291 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.356 0 CA-C-O 118.598 -0.715 . . . . 1.0 110.887 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -20.45 65.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.122 1.328 . . . . 1.0 111.544 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -81.79 -30.83 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.48 1.112 . . . . 1.0 110.761 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 13' ' ' PRO . 1.4 tp -68.27 136.71 91.33 Favored Pre-proline 0 C--O 1.225 -0.209 0 C-N-CA 126.866 2.066 . . . . 1.0 110.185 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 12' ' ' LEU . 29.3 Cg_endo -68.56 166.2 26.64 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.71 1.607 . . . . 1.0 111.711 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.71 156.63 32.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.184 -1.371 . . . . 1.0 109.614 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.54 147.24 22.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 106.901 -1.518 . . . . 1.0 106.901 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -72.0 -67.63 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.402 1.081 . . . . 1.0 109.25 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.39 177.37 14.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.53 -16.77 24.06 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.414 2.076 . . . . 1.0 112.919 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -73.49 -177.58 2.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.417 1.087 . . . . 1.0 112.402 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.91 3.8 4.9 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.895 1.278 . . . . 1.0 113.968 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.94 153.95 40.67 Favored Glycine 0 CA--C 1.531 1.054 1 N-CA-C 102.752 -4.139 . . . . 1.0 102.752 172.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -130.26 123.63 30.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.072 1.936 . . . . 1.0 107.334 -173.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -125.79 114.46 24.68 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 128.679 2.792 . . . . 1.0 107.425 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.0 126.02 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.262 2.641 . . . . 1.0 110.622 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -133.11 -179.37 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.482 1.113 . . . . 1.0 109.056 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.6 m95 -124.71 144.87 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.835 1.254 . . . . 1.0 108.578 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.27 145.61 34.21 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.272 0.629 . . . . 1.0 109.555 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -78.16 139.34 38.99 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.451 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 19.0 m -116.97 113.43 39.63 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 107.102 -1.444 . . . . 1.0 107.102 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.67 -33.75 20.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.026 1.817 . . . . 1.0 110.329 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.15 -16.28 63.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.725 1.21 . . . . 1.0 112.8 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.35 -4.47 14.28 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.789 1.236 . . . . 1.0 110.669 173.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.86 34.28 3.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.319 2.648 . . . . 1.0 110.381 -173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.34 167.63 23.48 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -94.69 148.91 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.366 1.079 . . . . 1.0 112.274 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.451 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 31.5 p80 -140.61 156.12 69.33 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.892 -1.049 . . . . 1.0 110.972 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -69.72 163.41 38.36 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 1.0 109.509 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -158.71 165.33 34.62 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.273 -0.892 . . . . 1.0 108.721 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.63 116.58 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.784 -1.561 . . . . 1.0 106.784 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.65 162.7 12.85 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.119 -2.178 . . . . 1.0 105.119 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.81 3.48 38.95 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 115.17 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.97 -16.4 4.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.31 1.433 . . . . 1.0 115.425 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.9 p -112.85 -172.78 2.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.644 2.377 . . . . 1.0 108.188 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.76 133.49 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.403 1.881 . . . . 1.0 112.718 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.37 -169.36 31.72 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 108.194 -1.963 . . . . 1.0 108.194 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -93.29 175.4 6.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.161 0.981 . . . . 1.0 109.276 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.91 -14.08 70.58 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 114.46 -1.246 . . . . 1.0 112.575 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -80.33 75.53 7.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.116 -1.809 . . . . 1.0 106.116 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -146.15 113.24 6.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.545 -1.65 . . . . 1.0 106.545 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.02 163.09 19.98 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.272 1.429 . . . . 1.0 108.826 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -93.14 -16.91 24.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.251 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -164.77 173.46 11.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -59.54 -47.4 85.68 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 173.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -44.76 -67.1 0.31 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.975 2.91 . . . . 1.0 112.438 173.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -59.89 -33.14 71.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.534 0.683 . . . . 1.0 112.79 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.5 t -70.1 -50.16 43.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.327 63.2 mt-10 -69.43 -33.34 72.82 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.952 -1.023 . . . . 1.0 108.687 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -36.67 78.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.046 0.839 . . . . 1.0 109.116 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.37 74.62 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.405 1.002 . . . . 1.0 112.875 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.0 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-N 119.32 0.963 . . . . 1.0 113.029 177.09 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 118.373 -0.822 . . . . 1.0 111.607 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 p -57.04 -29.19 63.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.891 1.223 . . . . 1.0 112.633 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.22 -30.77 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.34 -0.85 . . . . 1.0 110.685 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -63.94 127.73 92.09 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 124.962 1.305 . . . . 1.0 112.23 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 12' ' ' LEU . 53.4 Cg_exo -50.12 154.36 5.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.385 2.724 . . . . 1.0 112.439 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.01 157.25 26.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.65 -0.704 . . . . 1.0 109.499 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 147.47 27.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.371 -2.085 . . . . 1.0 105.371 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.35 -63.26 1.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.55 170.53 12.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 1.0 109.528 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.9 -14.79 15.27 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.709 2.273 . . . . 1.0 113.301 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.8 m -73.85 -177.23 2.73 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.145 -0.972 . . . . 1.0 112.275 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 3.8 6.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.303 1.041 . . . . 1.0 113.125 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.19 154.0 29.81 Favored Glycine 0 CA--C 1.531 1.037 1 N-CA-C 102.344 -4.303 . . . . 1.0 102.344 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -132.52 127.91 36.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.831 1.816 . . . . 1.0 108.289 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -125.91 114.32 24.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 130.158 3.383 . . . . 1.0 106.422 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.72 132.03 25.79 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 123.252 2.635 . . . . 1.0 110.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -133.98 175.49 9.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.559 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -120.96 143.42 49.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.765 2.026 . . . . 1.0 106.017 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.88 144.04 45.37 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.49 137.99 38.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.744 0.783 . . . . 1.0 109.41 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.455 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 29.4 m -117.21 113.53 39.13 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 124.981 1.313 . . . . 1.0 107.58 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.95 -36.03 24.12 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.125 1.883 . . . . 1.0 110.617 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -66.65 -17.21 64.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.298 1.039 . . . . 1.0 112.562 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.8 mt -106.26 -4.21 20.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.257 1.023 . . . . 1.0 110.293 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.28 32.56 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.172 2.589 . . . . 1.0 110.922 -174.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.23 169.2 14.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.824 0.821 . . . . 1.0 109.249 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.5 m -95.27 149.36 21.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.704 1.202 . . . . 1.0 110.619 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.455 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 33.1 p80 -138.49 154.31 73.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.898 . . . . 1.0 110.963 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.65 164.82 19.9 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.339 2.026 . . . . 1.0 111.63 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -162.16 164.28 27.97 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.6 t -90.14 113.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.63 159.8 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.214 -1.773 . . . . 1.0 106.214 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.16 0.94 57.39 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.232 -0.917 . . . . 1.0 114.796 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.35 -30.64 1.41 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.579 1.561 . . . . 1.0 113.965 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.89 -172.78 2.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.698 2.399 . . . . 1.0 107.566 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.1 mp0 -33.62 133.75 0.17 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.253 2.221 . . . . 1.0 113.042 -174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.01 -169.72 35.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 107.599 -2.2 . . . . 1.0 107.599 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' HD11 ' A' ' 12' ' ' LEU . 7.0 m-20 -93.35 174.35 7.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.491 1.145 . . . . 1.0 109.666 -174.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.92 -11.84 83.36 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 114.694 -1.139 . . . . 1.0 113.419 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.66 74.01 5.2 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.008 -1.849 . . . . 1.0 106.008 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -139.75 113.09 8.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.23 1.012 . . . . 1.0 108.29 -173.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.05 150.96 49.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.703 1.201 . . . . 1.0 108.123 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -93.39 -6.31 47.46 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.05 -0.406 . . . . 1.0 110.709 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.24 170.36 14.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.128 1.371 . . . . 1.0 107.686 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -70.31 -39.86 74.54 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.324 -1.35 . . . . 1.0 108.535 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -39.62 -65.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.863 2.465 . . . . 1.0 111.006 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 p -57.47 -33.58 68.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.917 0.71 . . . . 1.0 112.917 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.8 t -75.12 -46.7 32.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.864 1.266 . . . . 1.0 112.577 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.12 -33.58 76.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.731 0.813 . . . . 1.0 109.288 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.55 -38.35 84.02 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.68 0.673 . . . . 1.0 109.221 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.31 -60.61 2.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.622 1.101 . . . . 1.0 110.822 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.4 m . . . . . 0 C--O 1.234 0.285 0 C-N-CA 124.032 0.933 . . . . 1.0 110.678 -177.112 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.343 0 CA-C-O 119.413 -0.327 . . . . 1.0 110.348 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -62.24 -21.2 64.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.5 0.72 . . . . 1.0 112.096 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.36 -33.05 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 O-C-N 120.961 -1.087 . . . . 1.0 110.548 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -74.03 128.4 86.5 Favored Pre-proline 0 CA--C 1.521 -0.153 0 C-N-CA 127.407 2.283 . . . . 1.0 112.474 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 12' ' ' LEU . 19.5 Cg_endo -66.34 166.18 22.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.957 1.771 . . . . 1.0 111.816 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -92.89 168.43 11.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.532 1.133 . . . . 1.0 111.109 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -143.1 151.36 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.776 1.631 . . . . 1.0 107.848 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.69 -30.05 15.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.05 1.34 . . . . 1.0 113.463 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.33 177.55 51.8 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.1 -18.81 30.54 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.851 2.368 . . . . 1.0 113.601 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 m -67.83 161.74 25.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.834 -1.167 . . . . 1.0 111.048 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 3.5 15.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.966 1.706 . . . . 1.0 112.653 173.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.67 153.32 31.33 Favored Glycine 0 CA--C 1.528 0.873 1 N-CA-C 102.994 -4.042 . . . . 1.0 102.994 172.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -125.86 103.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.953 1.377 . . . . 1.0 110.461 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -95.13 113.82 62.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 127.872 2.469 . . . . 1.0 106.886 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.48 125.19 11.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.221 2.614 . . . . 1.0 110.319 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -131.26 -177.91 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.146 0.979 . . . . 1.0 108.83 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.3 m95 -125.43 143.28 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.644 1.178 . . . . 1.0 108.472 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.85 145.01 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 56.5 t80 -78.09 137.22 38.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.757 0.789 . . . . 1.0 109.361 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -117.24 113.9 38.9 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 116.801 -1.571 . . . . 1.0 108.461 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -32.25 37.19 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.519 1.479 . . . . 1.0 110.294 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.64 -15.72 61.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.087 1.355 . . . . 1.0 112.562 174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.58 -3.8 13.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 1.0 110.683 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.17 22.84 3.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 129.128 2.971 . . . . 1.0 112.229 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -166.62 170.6 12.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.188 -0.945 . . . . 1.0 110.276 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 86.2 m -84.19 146.82 27.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.101 0.953 . . . . 1.0 113.485 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -136.48 157.19 75.75 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.218 -1.355 . . . . 1.0 109.878 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -69.5 162.14 43.11 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.816 1.677 . . . . 1.0 108.758 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.407 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 14.9 p90 -155.93 163.16 40.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.063 -1.023 . . . . 1.0 108.79 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.19 125.25 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -122.41 175.26 6.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.351 2.261 . . . . 1.0 106.386 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.02 5.72 5.06 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.911 1.124 . . . . 1.0 115.911 -173.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.66 -38.21 2.8 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.842 1.821 . . . . 1.0 112.357 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.2 -173.02 1.87 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.529 1.532 . . . . 1.0 108.892 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -34.13 133.77 0.21 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.867 2.467 . . . . 1.0 113.784 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.7 176.41 41.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -93.72 177.72 5.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.77 0.785 . . . . 1.0 109.187 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.85 79.92 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.519 -0.764 . . . . 1.0 113.343 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -80.11 72.39 6.91 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -143.04 113.18 7.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.929 -1.878 . . . . 1.0 105.929 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -118.42 161.66 19.62 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 125.329 1.452 . . . . 1.0 108.85 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.27 8.2 m80 -93.18 -16.47 24.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.974 -1.466 . . . . 1.0 111.567 -172.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -165.83 172.15 11.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.2 tpt180 -61.49 -48.1 82.61 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 173.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -66.89 0.33 Allowed 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 128.765 2.826 . . . . 1.0 111.719 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -57.24 -33.07 67.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.1 t -71.96 -47.9 48.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.4 -0.812 . . . . 1.0 112.93 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.78 -33.5 76.12 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.85 -0.595 . . . . 1.0 110.248 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -44.87 93.62 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.4 -46.14 70.79 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 121.476 -0.765 . . . . 1.0 112.01 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 125.275 1.43 . . . . 1.0 113.917 -178.409 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.355 0 CA-C-O 119.06 -0.495 . . . . 1.0 109.719 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.23 -28.26 69.91 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.807 0.731 . . . . 1.0 112.579 -173.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -73.16 -37.76 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -62.86 122.14 72.77 Favored Pre-proline 0 N--CA 1.458 -0.07 0 C-N-CA 125.061 1.344 . . . . 1.0 113.301 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.7 Cg_exo -48.84 152.85 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.717 2.945 . . . . 1.0 113.07 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 153.51 32.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.284 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.82 144.32 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -76.08 -53.48 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.55 175.54 15.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.344 1.45 . . . . 1.0 110.199 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.19 -28.36 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.656 2.237 . . . . 1.0 112.994 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -79.21 159.92 27.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 122.605 1.193 . . . . 1.0 112.539 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.34 3.55 38.1 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.263 1.825 . . . . 1.0 113.546 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.15 155.09 50.25 Favored Glycine 0 CA--C 1.535 1.311 1 N-CA-C 101.555 -4.618 . . . . 1.0 101.555 172.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -136.62 132.62 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 121.319 2.56 . . . . 1.0 108.476 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -135.54 118.8 12.71 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 129.265 3.026 . . . . 1.0 106.514 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.56 124.64 12.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.202 2.601 . . . . 1.0 109.675 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -128.5 179.9 5.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.407 1.083 . . . . 1.0 108.314 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.6 m95 -130.34 144.58 51.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.163 2.185 . . . . 1.0 106.759 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.95 148.27 38.35 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -82.39 138.54 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.866 0.841 . . . . 1.0 108.893 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -117.23 114.09 38.83 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 125.665 1.586 . . . . 1.0 108.32 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.79 -34.75 23.48 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.017 1.812 . . . . 1.0 110.618 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -62.44 -23.57 66.94 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.561 0.744 . . . . 1.0 112.991 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -102.72 -6.66 22.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 1.0 110.693 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 40.66 2.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.48 3.112 . . . . 1.0 108.452 -173.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.76 168.85 20.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.6 m -98.83 148.27 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.172 0.987 . . . . 1.0 111.795 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -134.62 153.29 78.9 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.315 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.96 168.96 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.971 1.78 . . . . 1.0 109.109 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -163.36 160.1 23.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.3 113.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.653 -2.351 . . . . 1.0 104.653 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -96.33 156.85 16.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.969 1.707 . . . . 1.0 106.97 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.13 1.95 68.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.939 0.736 . . . . 1.0 114.939 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.1 -38.51 1.79 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.87 1.7 . . . . 1.0 113.531 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -85.18 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.107 1.763 . . . . 1.0 108.089 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.68 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.575 2.35 . . . . 1.0 113.338 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.96 -167.52 28.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.522 -2.231 . . . . 1.0 107.522 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.35 174.65 7.1 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.545 1.172 . . . . 1.0 108.969 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.02 -15.17 79.5 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.784 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -76.09 78.76 2.92 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.811 -1.922 . . . . 1.0 105.811 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.17 113.17 5.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.775 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -126.12 158.0 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.452 1.901 . . . . 1.0 108.227 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -93.93 -11.02 31.88 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.867 -1.063 . . . . 1.0 112.523 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.82 160.72 42.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.901 1.228 . . . . 1.0 110.71 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.5 tpt180 -60.63 -50.77 72.17 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.519 -1.219 . . . . 1.0 109.087 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -66.75 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.343 2.657 . . . . 1.0 111.8 174.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.8 p -58.31 -33.46 69.5 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.61 -50.43 44.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.444 0.698 . . . . 1.0 112.587 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.92 -33.13 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.525 -0.75 . . . . 1.0 110.262 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.71 -26.65 62.58 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.604 -0.713 . . . . 1.0 110.538 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.28 62.13 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.108 1.322 . . . . 1.0 111.473 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.238 0.484 0 C-N-CA 123.124 0.57 . . . . 1.0 111.693 174.086 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 107.872 -1.159 . . . . 1.0 107.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.41 178.15 0.08 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.402 0.546 . . . . 1.0 109.671 157.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -74.4 -23.56 58.98 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 120.579 -1.326 . . . . 1.0 110.056 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.62 107.36 15.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 104.081 -2.562 . . . . 1.0 104.081 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -118.43 -23.89 7.03 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.662 0.785 . . . . 1.0 111.423 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.75 135.12 48.0 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 104.313 -2.477 . . . . 1.0 104.313 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.7 m -78.4 93.48 4.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.579 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.91 169.21 16.28 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 104.282 -2.488 . . . . 1.0 104.282 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.29 -34.08 31.55 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 120.729 -1.232 . . . . 1.0 110.535 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -61.58 -26.92 68.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.624 1.102 . . . . 1.0 111.449 -175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 43.4 t -79.17 -25.76 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.331 1.052 . . . . 1.0 109.936 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.7 tp -76.47 130.19 77.68 Favored Pre-proline 0 C--O 1.226 -0.137 0 C-N-CA 127.065 2.146 . . . . 1.0 112.944 177.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.658 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -52.37 153.33 13.63 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.954 2.436 . . . . 1.0 111.51 173.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -90.0 165.66 13.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.031 0.532 . . . . 1.0 110.16 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.66 148.6 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 125.119 1.368 . . . . 1.0 107.514 -175.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -76.49 -56.77 4.32 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.622 1.169 . . . . 1.0 110.937 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.62 174.73 19.88 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.061 1.315 . . . . 1.0 109.971 -174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.19 -6.41 18.39 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.065 2.51 . . . . 1.0 113.505 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -73.32 175.62 6.72 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-O 122.364 1.078 . . . . 1.0 112.593 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.4 3.51 5.12 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.644 -1.162 . . . . 1.0 112.479 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -94.4 153.82 21.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 103.511 -3.836 . . . . 1.0 103.511 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 22.0 m95 -126.63 106.14 9.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.109 1.455 . . . . 1.0 109.52 -173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -102.12 113.83 65.71 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 128.748 2.819 . . . . 1.0 107.07 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.36 126.51 13.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.276 2.651 . . . . 1.0 110.284 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.0 mmt-85 -132.37 -179.86 5.69 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.222 1.009 . . . . 1.0 109.005 174.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.516 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 48.2 m95 -119.55 143.87 47.38 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.667 1.187 . . . . 1.0 108.217 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.78 145.2 39.86 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -80.84 138.57 36.21 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.922 0.868 . . . . 1.0 108.976 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m -117.29 113.7 38.88 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 117.242 -1.361 . . . . 1.0 108.177 173.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.6 -33.61 21.61 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.788 1.659 . . . . 1.0 110.371 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -63.25 -20.54 65.54 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.573 1.149 . . . . 1.0 112.711 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.0 mt -108.24 -5.34 16.89 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.518 1.127 . . . . 1.0 110.769 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.63 37.93 3.64 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.543 2.737 . . . . 1.0 109.997 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -162.76 168.06 22.03 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.02 -0.733 . . . . 1.0 109.02 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.6 m -97.93 150.65 21.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 122.24 1.019 . . . . 1.0 112.156 174.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -140.74 154.61 69.07 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.944 -1.025 . . . . 1.0 111.28 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.59 162.71 35.78 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.178 1.918 . . . . 1.0 109.0 173.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -158.98 163.19 36.68 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 119.395 0.998 . . . . 1.0 108.575 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 91.9 t -85.97 127.13 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.39 -1.707 . . . . 1.0 106.39 173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -119.2 168.9 10.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.848 2.059 . . . . 1.0 105.533 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.88 1.35 15.13 Favored Glycine 0 CA--C 1.526 0.757 0 O-C-N 120.692 -1.255 . . . . 1.0 116.106 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.65 -7.24 58.96 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.277 1.538 . . . . 1.0 115.058 174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 32.0 p -118.73 -172.75 2.34 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.723 2.409 . . . . 1.0 108.128 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -33.62 133.6 0.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.679 1.992 . . . . 1.0 112.853 -173.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.79 -176.76 38.1 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.555 -2.218 . . . . 1.0 107.555 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -93.5 174.93 6.95 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.179 0.989 . . . . 1.0 108.616 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.8 -11.76 85.11 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.228 -0.896 . . . . 1.0 112.93 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -78.02 74.17 4.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.435 1.118 . . . . 1.0 108.199 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.53 113.08 6.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.8 -1.926 . . . . 1.0 105.8 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -121.12 161.02 22.5 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 124.82 1.248 . . . . 1.0 108.624 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -93.27 -15.05 26.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.981 -1.463 . . . . 1.0 112.336 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -166.54 171.11 12.09 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 123.402 0.681 . . . . 1.0 109.295 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.9 tpt180 -62.29 -47.3 84.91 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.139 -1.06 . . . . 1.0 108.139 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.84 -66.93 0.31 Allowed 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 128.466 2.706 . . . . 1.0 111.261 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 53.0 p -54.93 -33.17 61.94 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.441 0.904 . . . . 1.0 113.441 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.0 t -72.04 -50.72 26.1 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 123.821 0.848 . . . . 1.0 112.899 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.348 76.2 mt-10 -67.29 -33.13 74.66 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-O 118.432 -0.795 . . . . 1.0 109.948 174.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.35 -38.9 85.26 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.376 0.989 . . . . 1.0 109.007 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.45 -43.66 72.84 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 119.33 0.968 . . . . 1.0 112.781 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.2 m -128.33 80.43 72.39 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.662 0.785 . . . . 1.0 109.856 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.66 162.43 24.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.749 2.299 . . . . 1.0 112.395 -173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -98.25 140.76 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 103.681 -2.711 . . . . 1.0 103.681 173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.2 164.71 27.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 126.379 1.872 . . . . 1.0 106.664 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -58.87 139.03 57.01 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 104.711 -2.329 . . . . 1.0 104.711 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.55 70.81 0.93 Allowed 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 124.483 1.113 . . . . 1.0 112.947 -173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -73.07 73.37 1.2 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 103.232 -2.877 . . . . 1.0 103.232 173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -51.35 93.9 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.669 1.588 . . . . 1.0 115.239 -173.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -73.11 -31.6 64.43 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.247 -1.76 . . . . 1.0 106.247 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 38.0 p-80 -74.18 168.94 18.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.326 1.85 . . . . 1.0 109.641 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 126.163 1.785 . . . . 1.0 109.038 173.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.475 0.775 0 N-CA-C 108.495 -0.928 . . . . 1.0 108.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.88 160.31 43.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 119.706 1.139 . . . . 1.0 108.391 168.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -138.21 -71.34 0.42 Allowed 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.495 1.518 . . . . 1.0 107.26 174.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.49 168.09 20.42 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -46.07 -44.22 15.24 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 127.262 2.225 . . . . 1.0 111.833 -173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -147.66 93.24 2.18 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.461 -1.311 . . . . 1.0 107.461 173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 m -171.65 115.55 0.38 Allowed 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.429 2.292 . . . . 1.0 104.952 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -74.01 129.14 37.27 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 105.113 -2.18 . . . . 1.0 105.113 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -43.95 -23.8 0.11 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 127.154 2.181 . . . . 1.0 112.642 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.3 p -47.58 -28.45 2.31 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 120.588 -1.32 . . . . 1.0 113.603 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 44.3 t -74.55 -28.29 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 119.56 1.073 . . . . 1.0 112.301 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.4 OUTLIER -75.46 156.14 85.36 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 127.929 2.491 . . . . 1.0 109.594 178.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' A' ' 12' ' ' LEU . 14.8 Cg_endo -67.5 168.54 17.82 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.825 1.684 . . . . 1.0 111.856 175.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.82 113.54 8.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.931 -1.137 . . . . 1.0 107.931 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.2 t -91.94 124.14 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 174.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -80.07 -33.07 39.24 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.558 -1.201 . . . . 1.0 110.693 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.17 173.32 42.03 Favored Glycine 0 CA--C 1.536 1.359 0 N-CA-C 110.409 -1.077 . . . . 1.0 110.409 -174.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -84.54 -8.16 9.55 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.261 2.641 . . . . 1.0 114.409 -173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.9 m -73.6 -179.05 3.36 Favored 'General case' 0 C--O 1.226 -0.183 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 -173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.64 3.86 5.02 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.66 1.584 . . . . 1.0 113.105 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.17 155.18 26.04 Favored Glycine 0 CA--C 1.533 1.161 1 N-CA-C 101.157 -4.777 . . . . 1.0 101.157 172.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 28.9 m95 -132.58 120.32 21.66 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.931 2.366 . . . . 1.0 108.829 -173.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.95 113.79 28.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 129.377 3.071 . . . . 1.0 107.801 -173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.32 125.23 12.62 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.441 2.76 . . . . 1.0 111.214 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -131.81 178.31 6.86 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 124.295 1.038 . . . . 1.0 109.729 174.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.456 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 68.6 m95 -113.2 143.34 44.56 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.346 -0.983 . . . . 1.0 108.346 177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.1 144.02 42.85 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.773 1.17 . . . . 1.0 108.243 173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -79.5 139.21 37.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.808 0.813 . . . . 1.0 109.43 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.5 m -117.17 113.86 39.04 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.274 1.83 . . . . 1.0 107.806 173.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.79 -34.34 24.65 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.946 1.764 . . . . 1.0 111.06 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.4 mt -64.59 -13.99 55.75 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.369 1.067 . . . . 1.0 112.754 175.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -115.9 -4.0 12.11 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.963 1.305 . . . . 1.0 110.723 173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.65 37.97 1.76 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 128.893 2.877 . . . . 1.0 109.974 -173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -160.67 169.32 23.08 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 -173.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.9 m -106.78 136.0 47.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.573 0.749 . . . . 1.0 110.681 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -122.89 159.48 53.51 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 124.295 1.038 . . . . 1.0 109.325 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -71.12 164.81 34.46 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 120.233 1.119 . . . . 1.0 109.588 174.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.22 168.89 25.37 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.271 -1.011 . . . . 1.0 108.271 175.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 t -98.09 113.7 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.745 -1.576 . . . . 1.0 106.745 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -99.46 162.08 13.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 173.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.82 0.02 55.2 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 116.185 1.234 . . . . 1.0 116.185 -173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.96 2.05 57.11 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 118.943 1.371 . . . . 1.0 115.062 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 p -125.46 -172.64 2.64 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 128.263 2.625 . . . . 1.0 107.846 174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -33.3 133.64 0.15 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.801 2.04 . . . . 1.0 112.514 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.93 174.68 43.49 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.169 -1.973 . . . . 1.0 108.169 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -93.62 -174.76 3.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.195 0.997 . . . . 1.0 108.603 174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.77 -4.26 82.68 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 126.983 2.23 . . . . 1.0 113.934 -173.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -80.07 65.7 5.31 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 121.929 2.864 . . . . 1.0 107.107 173.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -144.04 112.9 6.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -115.27 161.25 18.74 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.399 -1.704 . . . . 1.0 106.399 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.294 6.4 m80 -92.75 -20.68 20.52 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 111.614 -2.539 . . . . 1.0 108.477 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -170.47 165.52 8.54 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.906 0.882 . . . . 1.0 108.641 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 14.9 ttp85 -65.75 -42.3 91.11 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.678 -1.23 . . . . 1.0 107.678 173.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -46.55 -66.1 0.46 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.369 2.268 . . . . 1.0 110.276 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.1 p -57.77 -34.28 69.4 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 123.689 0.618 . . . . 1.0 111.954 -174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.1 t -71.66 -48.52 47.06 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.285 1.034 . . . . 1.0 112.559 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -61.09 -33.53 73.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.53 0.681 . . . . 1.0 109.733 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -80.64 -23.36 39.76 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 -175.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.13 -62.78 1.48 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.935 0.789 . . . . 1.0 111.847 173.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 20.3 m -99.75 165.92 13.76 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.28 108.72 1.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.312 2.008 . . . . 1.0 112.086 -175.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 63' ' ' VAL . 3.7 t -146.29 -174.72 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 130.695 3.598 . . . . 1.0 102.825 173.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -62.28 127.33 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 103.294 -2.854 . . . . 1.0 103.294 173.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -97.16 135.13 39.56 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.961 -173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -64.9 -66.8 0.5 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 102.99 -2.967 . . . . 1.0 102.99 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 1.6 m80 172.93 94.77 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 1 C-N-CA 134.224 5.01 . . . . 1.0 102.533 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -34.85 99.9 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 126.978 2.111 . . . . 1.0 111.675 -173.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -82.99 44.88 0.96 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.168 1.387 . . . . 1.0 111.989 -174.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -72.22 -170.71 0.65 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.618 1.167 . . . . 1.0 109.966 173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.254 1.324 1 N-CA-C 99.555 -4.239 . . . . 1.0 99.555 172.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 4.8 tt0 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.33 86.02 0.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 105.775 -1.935 . . . . 1.0 105.775 158.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -95.64 -24.32 16.62 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 -173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.38 92.3 3.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 103.529 -2.767 . . . . 1.0 103.529 173.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -37.75 -22.71 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 131.018 3.727 . . . . 1.0 118.327 -173.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -40.63 142.1 0.48 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.907 1.283 . . . . 1.0 112.477 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 m -68.38 94.5 0.55 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.372 1.469 . . . . 1.0 112.536 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.51 164.51 23.01 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.858 0.837 . . . . 1.0 109.915 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.86 -23.96 1.28 Allowed 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 126.667 1.987 . . . . 1.0 111.272 173.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.5 p -49.3 -33.38 13.0 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 120.422 1.465 . . . . 1.0 112.766 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 56.1 t -76.63 -21.77 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.788 0 O-C-N 120.788 -1.195 . . . . 1.0 111.076 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -73.72 131.03 82.52 Favored Pre-proline 0 N--CA 1.455 -0.209 0 C-N-CA 127.313 2.245 . . . . 1.0 112.193 174.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.1 Cg_exo -49.76 154.22 5.02 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.227 2.618 . . . . 1.0 112.825 174.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.51 161.52 24.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.017 177.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.8 t -137.89 145.47 28.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 105.74 -1.948 . . . . 1.0 105.74 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -96.48 -23.99 16.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.668 0.787 . . . . 1.0 112.086 -175.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.34 170.43 46.24 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.587 1.565 . . . . 1.0 111.307 -174.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.13 -3.39 13.73 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.388 3.392 . . . . 1.0 114.691 -174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.5 m -60.3 176.9 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.655 1.582 . . . . 1.0 112.984 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.74 3.65 3.82 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.411 1.485 . . . . 1.0 112.946 173.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -97.15 153.44 20.27 Favored Glycine 0 CA--C 1.528 0.896 1 N-CA-C 101.63 -4.588 . . . . 1.0 101.63 172.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.1 m95 -128.69 104.68 7.79 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.974 1.387 . . . . 1.0 110.889 -173.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -94.16 113.67 61.3 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 129.138 2.975 . . . . 1.0 106.992 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.21 127.75 14.66 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.37 2.714 . . . . 1.0 110.478 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.9 mmt-85 -130.52 179.4 5.95 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.82 0.848 . . . . 1.0 108.935 173.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.513 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.2 m95 -119.74 136.31 54.49 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.883 -1.525 . . . . 1.0 106.883 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.62 143.51 48.66 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 79.6 t80 -77.45 139.18 39.61 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.705 0.764 . . . . 1.0 110.299 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -117.15 113.57 39.22 Favored Pre-proline 0 N--CA 1.442 -0.856 0 CA-C-O 117.064 -1.446 . . . . 1.0 107.537 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -67.09 -33.38 31.88 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.09 1.86 . . . . 1.0 110.601 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.04 -16.88 63.94 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.568 1.147 . . . . 1.0 112.804 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -111.56 -4.35 14.81 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.38 1.472 . . . . 1.0 110.557 173.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 51.99 20.2 1.19 Allowed 'General case' 0 N--CA 1.431 -1.421 1 C-N-CA 132.35 4.26 . . . . 1.0 110.324 -173.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -157.72 167.98 28.52 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.416 -1.427 . . . . 1.0 108.988 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 75.8 m -84.23 152.89 23.92 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 114.168 1.173 . . . . 1.0 114.168 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -138.43 156.05 73.58 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.933 -1.485 . . . . 1.0 109.527 173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.57 160.27 32.89 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.135 1.89 . . . . 1.0 109.666 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -156.75 163.83 38.81 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.39 0.995 . . . . 1.0 108.603 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.0 t -87.2 122.85 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -124.08 173.27 8.39 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.899 1.68 . . . . 1.0 106.637 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.32 -7.66 5.75 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 116.414 1.326 . . . . 1.0 116.414 -173.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.86 -28.76 8.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 119.472 1.636 . . . . 1.0 111.586 -174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -75.11 -173.26 1.92 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.979 1.712 . . . . 1.0 109.331 173.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 2.6 mp0 -34.41 134.2 0.21 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 128.759 2.824 . . . . 1.0 112.764 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.77 178.71 39.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 107.965 -2.054 . . . . 1.0 107.965 174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -93.61 178.59 5.64 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.3 -18.51 71.46 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.582 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -74.54 70.97 1.82 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.996 0.919 . . . . 1.0 108.797 174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -141.14 112.71 7.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.78 -1.563 . . . . 1.0 106.78 176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.34 162.96 16.73 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 125.513 1.525 . . . . 1.0 107.072 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -106.55 -9.39 16.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.341 -1.299 . . . . 1.0 114.459 -172.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.8 p -162.45 161.76 27.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.396 0.617 . . . . 1.0 109.964 -174.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 23.0 tpt85 -60.95 -40.35 92.97 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.528 0.731 . . . . 1.0 110.464 174.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -66.8 0.41 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.932 2.493 . . . . 1.0 110.655 174.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.7 p -56.54 -33.87 66.51 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.647 0.592 . . . . 1.0 111.702 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 5.3 t -70.81 -51.92 23.79 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 117.954 -1.022 . . . . 1.0 110.567 -177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.281 13.9 mt-10 -63.71 -33.78 76.41 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 116.052 -2.259 . . . . 1.0 112.825 173.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 1' ' ' GLU 0.258 8.2 t70 -65.95 -23.17 66.55 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 118.986 -1.086 . . . . 1.0 109.004 175.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.33 -59.11 2.91 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.152 -1.593 . . . . 1.0 106.855 172.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.7 m -140.1 114.4 7.67 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 125.711 1.604 . . . . 1.0 110.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -98.5 -165.61 0.08 OUTLIER 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 124.742 3.628 . . . . 1.0 113.104 -176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.667 HG12 ' H ' ' A' ' 63' ' ' VAL . 48.0 t -93.17 -157.4 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 101.003 -3.703 . . . . 1.0 101.003 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.667 ' H ' HG12 ' A' ' 62' ' ' VAL . 4.5 t -45.44 138.47 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.197 -1.564 . . . . 1.0 108.858 173.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -33.65 113.86 0.17 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 131.491 3.916 . . . . 1.0 113.687 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -95.25 -63.87 1.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.96 1.304 . . . . 1.0 109.437 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -70.76 73.64 0.57 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 104.206 -2.516 . . . . 1.0 104.206 173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.335 2.2 m-70 -33.72 90.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 117.55 2.426 . . . . 1.0 117.55 -172.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -84.02 -22.72 31.23 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 126.361 1.865 . . . . 1.0 109.781 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -134.04 -173.95 3.4 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.93 1.692 . . . . 1.0 108.639 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--O 1.248 0.997 0 N-CA-C 106.542 -1.651 . . . . 1.0 106.542 173.496 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 106.497 -1.668 . . . . 1.0 106.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.03 168.4 26.81 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.894 0.877 . . . . 1.0 108.967 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -62.08 -23.93 66.81 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.03 0.932 . . . . 1.0 110.824 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.92 -2.63 40.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.302 1.441 . . . . 1.0 113.22 174.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.09 -78.81 0.58 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -163.24 139.1 6.85 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.521 3.128 . . . . 1.0 105.486 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 m -157.05 114.61 3.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.985 -1.858 . . . . 1.0 105.985 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -68.65 159.34 32.26 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.764 -1.569 . . . . 1.0 106.764 173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.89 -46.07 31.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 119.213 -0.422 . . . . 1.0 110.283 174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -62.59 -23.84 67.24 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.186 0.903 . . . . 1.0 112.696 -174.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -85.31 -30.93 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.147 0.979 . . . . 1.0 109.87 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.675 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.0 tp -66.07 130.69 94.38 Favored Pre-proline 0 C--O 1.234 0.259 0 C-N-CA 125.256 1.423 . . . . 1.0 112.732 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.675 ' HD2' HD12 ' A' ' 12' ' ' LEU . 77.5 Cg_exo -49.88 153.62 5.88 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.499 2.799 . . . . 1.0 113.183 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -83.72 143.73 29.82 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 114.846 -1.07 . . . . 1.0 108.663 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.93 147.9 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -78.04 -53.42 7.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.735 -0.666 . . . . 1.0 110.259 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.44 176.49 15.7 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.085 1.326 . . . . 1.0 110.095 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -73.71 -35.24 4.72 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.923 2.415 . . . . 1.0 111.865 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.0 m -71.93 160.91 31.73 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 121.901 0.858 . . . . 1.0 111.006 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.94 3.77 19.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.854 1.662 . . . . 1.0 114.218 -177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.64 157.21 53.52 Favored Glycine 0 CA--C 1.538 1.476 1 N-CA-C 102.347 -4.301 . . . . 1.0 102.347 172.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -130.3 125.59 35.11 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 121.315 2.557 . . . . 1.0 108.742 -173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.33 113.99 15.85 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 129.187 2.995 . . . . 1.0 107.076 -173.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.62 133.59 32.51 Favored 'Trans proline' 0 C--O 1.238 0.496 0 C-N-CA 123.734 2.956 . . . . 1.0 110.502 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -133.09 177.29 7.78 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 114.608 -1.178 . . . . 1.0 108.85 173.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.4 m95 -126.11 143.48 51.11 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 127.526 2.33 . . . . 1.0 105.591 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.74 144.08 41.5 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.722 1.209 . . . . 1.0 107.838 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -81.24 137.59 35.83 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.78 0.8 . . . . 1.0 109.14 176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.1 m -117.44 113.66 38.62 Favored Pre-proline 0 N--CA 1.443 -0.783 0 C-N-CA 126.136 1.774 . . . . 1.0 107.578 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.86 -33.7 19.71 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.888 1.725 . . . . 1.0 110.88 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.4 mt -64.78 -14.38 58.78 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.725 1.21 . . . . 1.0 112.348 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -113.4 -4.31 13.64 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.978 1.311 . . . . 1.0 110.549 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.09 36.83 2.2 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 128.163 2.585 . . . . 1.0 110.043 -173.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -163.68 172.13 14.68 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.373 -0.829 . . . . 1.0 108.918 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -104.94 143.01 33.75 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 123.4 0.68 . . . . 1.0 110.111 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -123.77 153.72 66.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.727 176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -70.74 168.65 22.22 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.525 1.483 . . . . 1.0 110.027 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -163.11 163.91 25.58 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 86.6 t -94.66 113.5 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 105.927 -1.879 . . . . 1.0 105.927 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -99.85 163.22 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.622 1.969 . . . . 1.0 106.829 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.17 4.5 52.04 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 115.326 0.89 . . . . 1.0 115.326 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.59 -36.86 2.05 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.597 1.57 . . . . 1.0 113.832 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.7 p -87.99 -172.87 4.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.716 1.606 . . . . 1.0 107.927 173.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.62 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.649 2.38 . . . . 1.0 113.158 -174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.72 -167.71 29.74 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 107.918 -2.073 . . . . 1.0 107.918 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' ND2' HD11 ' A' ' 12' ' ' LEU . 4.5 m-20 -93.37 174.66 7.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 118.336 1.068 . . . . 1.0 109.712 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 -15.69 80.51 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.55 1.071 . . . . 1.0 114.179 -173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -78.41 70.24 4.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.134 -1.432 . . . . 1.0 107.134 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -138.1 113.12 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.616 1.166 . . . . 1.0 108.306 -173.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -128.24 151.94 48.68 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.682 1.193 . . . . 1.0 108.28 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -93.15 -7.94 43.94 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.408 -0.807 . . . . 1.0 110.026 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -158.71 162.61 37.19 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.889 0.768 . . . . 1.0 111.108 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 26.1 ttp85 -65.26 -49.43 69.61 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.391 -0.822 . . . . 1.0 112.256 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -58.95 -48.27 82.13 Favored 'General case' 0 C--O 1.213 -0.855 0 O-C-N 123.56 0.537 . . . . 1.0 110.718 -173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.9 p -51.1 -38.85 54.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 176.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 42.7 t -73.99 -48.43 30.37 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.88 1.272 . . . . 1.0 110.067 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.34 -33.47 71.19 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -74.16 -31.69 62.81 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.385 -1.447 . . . . 1.0 109.407 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.89 -59.15 3.51 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.971 0.794 . . . . 1.0 110.658 173.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.4 m -110.11 98.78 36.62 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.27 1.028 . . . . 1.0 108.397 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.68 176.46 10.01 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.971 2.447 . . . . 1.0 116.399 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 63' ' ' VAL . 3.5 t -131.43 -153.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 2 C-N-CA 135.201 5.4 . . . . 1.0 99.575 173.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.443 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.5 t -49.12 131.81 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 105.834 -1.913 . . . . 1.0 105.834 173.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -56.29 120.69 8.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.791 1.404 . . . . 1.0 114.791 -172.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -49.82 -64.0 0.94 Allowed 'General case' 0 C--N 1.347 0.484 0 N-CA-C 106.84 -1.541 . . . . 1.0 106.84 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.254 0.9 OUTLIER 173.05 56.44 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 129.787 3.235 . . . . 1.0 109.592 173.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -70.28 68.92 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.207 -1.558 . . . . 1.0 108.328 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -144.58 151.41 39.01 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.646 -1.284 . . . . 1.0 109.83 -173.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.2 m170 -123.84 -8.26 7.84 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.04 1.736 . . . . 1.0 108.62 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.256 1.406 2 C-N-CA 141.98 8.112 . . . . 1.0 97.723 173.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 108.122 -1.066 . . . . 1.0 108.122 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 9' ' ' ALA . . . -126.25 168.06 14.62 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.253 1.421 . . . . 1.0 107.768 170.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -87.19 -62.98 1.38 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.63 177.42 4.7 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.818 1.647 . . . . 1.0 109.713 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -52.61 -32.98 44.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.187 0.995 . . . . 1.0 111.187 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -138.92 92.99 2.65 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 m 173.48 93.77 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 1 C-N-CA 132.099 4.16 . . . . 1.0 101.248 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -75.7 120.17 20.72 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.233 -1.766 . . . . 1.0 106.233 174.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' H ' ' HA ' ' A' ' 2' ' ' ALA . . . -49.39 -23.19 1.37 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.15 1.78 . . . . 1.0 111.882 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 p -48.53 -29.76 4.54 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.256 0.935 . . . . 1.0 113.479 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.08 -27.06 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 119.178 0.899 . . . . 1.0 111.332 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.51 152.91 61.3 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 127.682 2.393 . . . . 1.0 110.938 -176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.83 161.31 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.721 2.947 . . . . 1.0 113.158 173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.99 113.61 11.36 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 t -93.01 115.15 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 107.436 -1.32 . . . . 1.0 107.436 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.74 -24.44 44.83 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.951 -1.477 . . . . 1.0 110.952 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.55 173.96 50.06 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.201 0.905 . . . . 1.0 111.263 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -87.06 -5.94 7.55 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.396 2.731 . . . . 1.0 114.631 -173.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.3 m -73.74 -178.21 3.08 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 114.43 1.27 . . . . 1.0 114.43 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 3.7 4.65 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.827 1.651 . . . . 1.0 113.423 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.88 154.32 22.46 Favored Glycine 0 CA--C 1.533 1.184 1 N-CA-C 100.652 -4.979 . . . . 1.0 100.652 172.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.0 m95 -132.55 122.59 25.04 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 120.968 2.384 . . . . 1.0 108.795 -173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -125.14 113.82 26.23 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.908 3.283 . . . . 1.0 106.847 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.13 126.82 14.95 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.521 2.814 . . . . 1.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -131.72 178.4 6.78 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.036 0.934 . . . . 1.0 109.361 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.528 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -117.59 144.43 45.15 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.443 1.097 . . . . 1.0 108.144 177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.12 148.04 37.69 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 109.079 -0.711 . . . . 1.0 109.079 174.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -82.83 139.38 33.53 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.579 -0.897 . . . . 1.0 108.579 174.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.469 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 18.3 m -117.11 113.42 39.37 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-O 117.213 -1.375 . . . . 1.0 107.619 173.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.43 -32.26 25.92 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.75 1.634 . . . . 1.0 110.239 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 mt -64.3 -15.01 59.4 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.923 1.289 . . . . 1.0 112.471 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.7 mt -115.23 -4.2 12.45 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.094 1.358 . . . . 1.0 110.805 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.0 35.44 3.35 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.388 2.675 . . . . 1.0 110.042 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -162.51 168.68 21.54 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.563 -0.71 . . . . 1.0 109.707 -173.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.9 m -95.6 149.58 21.29 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.963 0.887 . . . . 1.0 112.114 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.469 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 33.1 p80 -139.85 154.5 70.82 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.624 175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -69.78 161.82 44.48 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 N-CA-C 107.971 -1.588 . . . . 1.0 107.971 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -159.04 170.7 21.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 119.081 0.855 . . . . 1.0 109.031 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 46.3 t -96.43 113.8 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 106.609 -1.626 . . . . 1.0 106.609 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -104.63 158.02 16.79 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.495 -2.039 . . . . 1.0 105.495 173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.43 0.39 58.35 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 116.677 1.431 . . . . 1.0 116.677 -173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.65 3.41 54.51 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-N 119.224 1.512 . . . . 1.0 114.857 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.6 p -125.11 -172.46 2.59 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 128.717 2.807 . . . . 1.0 108.073 174.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -33.37 133.54 0.16 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.533 1.933 . . . . 1.0 113.001 -173.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.26 168.09 40.99 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 107.814 -2.114 . . . . 1.0 107.814 -174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.99 -174.17 3.33 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.089 0.947 . . . . 1.0 109.06 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.72 -7.04 88.98 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 116.927 -2.041 . . . . 1.0 113.774 -174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -81.98 66.47 7.57 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 121.761 2.78 . . . . 1.0 107.607 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -147.08 113.66 6.0 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 130.81 3.644 . . . . 1.0 102.25 -173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -123.71 162.17 23.66 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.343 1.457 . . . . 1.0 107.747 -176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -93.07 -14.55 27.17 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.112 -1.403 . . . . 1.0 111.157 -173.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 p -167.72 169.17 11.95 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.76 0.791 . . . . 1.0 109.996 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.0 tpt180 -61.4 -44.75 96.6 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 173.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -47.83 -66.51 0.39 Allowed 'General case' 0 CA--C 1.513 -0.481 0 C-N-CA 128.231 2.612 . . . . 1.0 111.659 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.4 p -59.11 -33.46 70.87 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.046 0.927 . . . . 1.0 112.58 -174.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 12.9 t -71.61 -49.95 35.4 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.044 0.938 . . . . 1.0 112.491 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.337 27.7 mt-10 -67.19 -32.94 74.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 175.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.02 -47.27 78.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.107 -1.812 . . . . 1.0 106.107 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 69' ' ' HIS . . . -58.87 -58.44 8.59 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 118.686 0.675 . . . . 1.0 111.871 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 66.9 m -129.27 86.17 57.35 Favored Pre-proline 0 N--CA 1.452 -0.363 0 O-C-N 123.737 0.648 . . . . 1.0 110.506 -174.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -85.31 -177.06 2.56 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.642 2.895 . . . . 1.0 110.088 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -93.54 172.8 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 102.87 -3.011 . . . . 1.0 102.87 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.94 125.38 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 O-C-N 120.339 -1.476 . . . . 1.0 107.579 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -126.39 167.79 15.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 126.172 1.789 . . . . 1.0 108.633 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 -103.06 9.29 38.59 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 129.236 3.014 . . . . 1.0 111.803 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.47 -57.79 0.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.614 1.097 . . . . 1.0 111.248 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -65.09 148.5 51.54 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.467 1.107 . . . . 1.0 111.502 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -153.23 169.05 23.98 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.008 2.923 . . . . 1.0 105.313 173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 9.0 t60 -138.39 -85.85 0.27 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 102.542 -3.133 . . . . 1.0 102.542 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 . . . . . 0 C--O 1.259 1.56 0 N-CA-C 105.571 -2.011 . . . . 1.0 105.571 172.905 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 . . . . . 0 N--CA 1.472 0.625 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.89 20.99 1.0 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.642 1.977 . . . . 1.0 109.502 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -77.62 -25.33 49.69 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.013 1.325 . . . . 1.0 111.345 -173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.57 168.08 10.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.384 1.873 . . . . 1.0 108.115 173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.17 -38.81 71.41 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.091 0.957 . . . . 1.0 110.833 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.36 158.2 36.98 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.094 1.357 . . . . 1.0 108.2 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 m -161.27 110.11 1.57 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.267 -2.123 . . . . 1.0 105.267 173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -73.73 97.78 2.77 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.814 -1.55 . . . . 1.0 106.814 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -54.7 -35.38 63.56 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 119.036 -0.507 . . . . 1.0 111.1 -178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 p -69.02 -15.62 63.52 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 120.059 1.3 . . . . 1.0 111.747 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.02 -21.77 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 124.418 1.087 . . . . 1.0 111.129 174.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 13' ' ' PRO . 0.9 OUTLIER -73.32 148.67 88.62 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 127.261 2.224 . . . . 1.0 110.819 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 12' ' ' LEU . 36.6 Cg_endo -70.85 179.04 4.6 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.266 1.977 . . . . 1.0 111.034 176.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -120.41 161.6 20.94 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 174.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.14 152.97 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.653 1.181 . . . . 1.0 109.217 -173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -88.04 -31.47 19.27 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.343 1.457 . . . . 1.0 113.201 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.59 176.94 51.44 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.199 0.904 . . . . 1.0 112.404 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.88 -25.47 27.98 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.293 2.662 . . . . 1.0 112.842 -175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.56 158.85 25.98 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.206 -0.934 . . . . 1.0 110.151 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.22 3.53 16.05 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.685 1.594 . . . . 1.0 112.985 173.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -78.42 153.23 38.79 Favored Glycine 0 CA--C 1.531 1.044 1 N-CA-C 102.123 -4.391 . . . . 1.0 102.123 172.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -126.91 105.37 8.58 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 119.621 1.711 . . . . 1.0 111.022 -173.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.02 114.01 62.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.426 2.29 . . . . 1.0 105.629 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.08 114.1 3.94 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.536 2.824 . . . . 1.0 109.747 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -114.78 176.94 4.83 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.361 0.664 . . . . 1.0 109.372 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.518 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 63.1 m95 -114.19 145.37 41.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.34 144.91 40.56 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.581 -0.896 . . . . 1.0 108.581 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -87.24 137.22 32.53 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.717 0.807 . . . . 1.0 110.009 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.7 m -117.43 113.36 38.78 Favored Pre-proline 0 N--CA 1.449 -0.48 0 O-C-N 120.684 -1.26 . . . . 1.0 108.034 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.09 -34.36 6.38 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.573 1.515 . . . . 1.0 109.665 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.7 mt -65.03 -20.57 66.56 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 124.324 1.05 . . . . 1.0 112.355 175.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.34 -6.02 23.54 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.405 0.682 . . . . 1.0 110.223 173.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.88 38.47 6.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.278 2.631 . . . . 1.0 108.412 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.7 166.82 28.12 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.703 -0.851 . . . . 1.0 108.703 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -102.2 148.8 24.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 122.324 1.059 . . . . 1.0 110.699 173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -132.35 152.18 79.61 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.592 -1.186 . . . . 1.0 109.577 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -68.9 166.31 26.91 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 173.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 13.6 p90 -155.59 164.09 39.09 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 173.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 57.7 t -91.15 123.81 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.455 -1.683 . . . . 1.0 106.455 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -122.49 168.84 11.63 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.409 1.884 . . . . 1.0 106.331 173.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.63 8.11 6.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 118.899 -0.945 . . . . 1.0 115.027 -173.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.97 -48.31 4.02 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 119.29 1.545 . . . . 1.0 110.289 -176.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 p -69.05 -173.39 0.5 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.635 1.174 . . . . 1.0 109.4 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -34.77 133.57 0.27 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.697 1.999 . . . . 1.0 114.261 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.7 173.49 39.79 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.756 -2.538 . . . . 1.0 106.756 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -93.65 171.24 9.01 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.63 -6.82 63.58 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 124.44 1.019 . . . . 1.0 114.356 -173.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -80.13 68.15 6.18 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -135.96 113.05 10.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.152 -1.796 . . . . 1.0 106.152 -174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -115.34 161.5 18.42 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 123.211 1.482 . . . . 1.0 108.382 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -93.1 -21.03 19.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.016 -2.356 . . . . 1.0 109.732 -172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -164.51 165.23 21.48 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.624 0.726 . . . . 1.0 109.117 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.56 -49.22 78.4 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 114.839 -1.073 . . . . 1.0 108.833 173.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.89 -66.85 0.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 128.004 2.521 . . . . 1.0 111.638 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.0 p -57.13 -33.27 67.19 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.957 0.725 . . . . 1.0 112.957 -174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 24.6 t -67.51 -53.61 27.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 123.99 0.916 . . . . 1.0 112.908 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -66.9 -33.27 75.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.526 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -75.84 -24.2 55.78 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.259 -0.877 . . . . 1.0 110.692 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.03 -41.96 70.15 Favored 'General case' 0 C--N 1.354 0.767 0 CA-C-N 120.564 1.529 . . . . 1.0 111.634 174.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 m -116.41 75.64 6.61 Favored Pre-proline 0 C--O 1.239 0.541 0 CA-C-N 118.702 0.683 . . . . 1.0 112.8 173.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.87 -178.89 4.11 Favored 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.397 2.065 . . . . 1.0 108.237 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.7 t -135.26 178.67 5.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 105.643 -1.984 . . . . 1.0 105.643 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -48.93 137.24 4.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.439 -1.689 . . . . 1.0 106.439 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -43.33 113.1 0.45 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 122.251 1.024 . . . . 1.0 113.55 -172.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.78 -27.17 60.21 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 121.309 -0.87 . . . . 1.0 110.276 176.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -70.98 8.43 0.92 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.517 1.127 . . . . 1.0 111.753 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -33.67 109.99 0.08 Allowed 'General case' 0 C--N 1.347 0.479 0 C-N-CA 127.13 2.172 . . . . 1.0 112.871 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -73.05 30.3 0.06 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.848 1.259 . . . . 1.0 112.473 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -144.58 177.67 8.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.577 1.951 . . . . 1.0 107.473 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 43.1 m170 . . . . . 0 C--O 1.244 0.796 0 N-CA-C 107.76 -1.2 . . . . 1.0 107.76 173.646 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.456 ' H1 ' ' CD ' ' A' ' 1' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 107.547 -1.279 . . . . 1.0 107.547 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.77 -55.53 0.06 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.628 1.171 . . . . 1.0 108.184 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -76.42 -53.41 8.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.937 1.295 . . . . 1.0 107.677 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.73 177.92 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.623 1.569 . . . . 1.0 110.287 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -55.53 -23.49 26.68 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.174 2.59 . . . . 1.0 113.009 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -145.54 164.65 30.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.095 2.558 . . . . 1.0 105.385 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -122.9 93.7 4.04 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 108.141 -1.059 . . . . 1.0 108.141 173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.12 170.65 16.34 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 105.957 -1.868 . . . . 1.0 105.957 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.62 -42.1 15.69 Favored 'General case' 0 C--O 1.22 -0.455 0 O-C-N 121.195 -0.941 . . . . 1.0 110.205 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.9 p -62.81 -28.93 70.34 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.476 0.711 . . . . 1.0 111.924 -173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.32 -28.08 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.49 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.2 tp -69.2 125.43 91.95 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 126.946 2.098 . . . . 1.0 112.412 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.49 ' HD2' HD12 ' A' ' 12' ' ' LEU . 51.3 Cg_exo -49.91 154.71 4.83 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 123.579 2.852 . . . . 1.0 112.764 174.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.71 160.98 27.2 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.425 -0.807 . . . . 1.0 110.844 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.2 t -135.01 148.78 28.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 126.307 1.843 . . . . 1.0 106.226 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -74.0 -56.39 4.99 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 110.074 -0.343 . . . . 1.0 110.074 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.08 171.7 15.44 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 126.891 2.186 . . . . 1.0 108.682 -173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.11 -35.69 24.31 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.425 2.083 . . . . 1.0 111.375 -175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 14.4 m -64.5 158.64 23.5 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.952 0.882 . . . . 1.0 110.788 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.0 3.94 22.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.807 2.043 . . . . 1.0 113.701 176.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.7 154.13 50.96 Favored Glycine 0 CA--C 1.535 1.331 1 N-CA-C 102.85 -4.1 . . . . 1.0 102.85 172.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -125.2 104.86 8.74 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 120.526 2.163 . . . . 1.0 110.864 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -99.27 119.21 61.04 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 127.468 2.307 . . . . 1.0 107.168 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.59 125.65 10.24 Favored 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.11 2.54 . . . . 1.0 109.933 174.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -130.27 177.11 7.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.36 -0.837 . . . . 1.0 109.533 174.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 51.2 m95 -112.66 141.2 46.72 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 123.93 0.892 . . . . 1.0 108.619 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.37 147.52 45.57 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 109.183 -0.673 . . . . 1.0 109.183 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -85.07 133.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 123.792 0.682 . . . . 1.0 110.145 174.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.6 m -117.59 113.42 38.45 Favored Pre-proline 0 N--CA 1.445 -0.702 0 O-C-N 119.854 -1.779 . . . . 1.0 109.075 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.14 -35.11 20.47 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.752 1.635 . . . . 1.0 109.982 174.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.83 -19.71 65.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.62 1.168 . . . . 1.0 112.151 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.8 mt -103.04 -4.15 24.98 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.364 1.066 . . . . 1.0 110.078 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.63 29.98 8.05 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.493 2.717 . . . . 1.0 110.749 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -165.04 166.66 19.08 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.96 0.8 . . . . 1.0 109.861 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.3 m -93.01 147.36 22.9 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 122.029 0.918 . . . . 1.0 109.459 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -142.7 153.74 61.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 123.625 0.77 . . . . 1.0 111.132 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -65.43 160.08 44.5 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.815 1.677 . . . . 1.0 108.534 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 40' ' ' TYR . 19.8 p90 -153.59 160.34 42.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 119.622 1.101 . . . . 1.0 108.776 173.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 84.8 t -89.12 113.62 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 105.942 -1.874 . . . . 1.0 105.942 175.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.402 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 26.1 t80 -107.63 167.68 9.78 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.229 2.212 . . . . 1.0 106.457 173.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.77 9.39 10.59 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 115.15 0.82 . . . . 1.0 115.15 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.26 -39.66 2.3 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 125.276 1.417 . . . . 1.0 113.241 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.17 -172.98 3.73 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.584 1.154 . . . . 1.0 108.41 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.7 mp0 -33.99 133.94 0.19 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.047 2.539 . . . . 1.0 112.838 -177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.23 -167.22 23.33 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 107.453 -2.259 . . . . 1.0 107.453 176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -93.31 173.56 7.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.462 1.131 . . . . 1.0 108.172 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.87 -15.19 81.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.359 -0.837 . . . . 1.0 112.547 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -74.92 79.73 2.15 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.872 0.869 . . . . 1.0 108.675 174.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -146.57 113.09 5.96 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.915 -1.883 . . . . 1.0 105.915 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -120.32 162.33 19.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.499 1.52 . . . . 1.0 108.351 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -93.49 -19.43 21.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.145 -1.388 . . . . 1.0 112.381 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 p -162.73 169.34 20.15 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 1.0 109.561 -173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.7 tpt180 -61.81 -49.32 76.77 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 115.06 -0.973 . . . . 1.0 108.507 173.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -46.12 -66.61 0.38 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.508 2.723 . . . . 1.0 112.123 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.4 p -60.35 -33.25 72.16 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.734 0.646 . . . . 1.0 112.229 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.1 t -68.41 -51.84 39.5 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 112.694 0.627 . . . . 1.0 112.694 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.286 71.5 mt-10 -69.76 -33.28 72.21 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.046 -0.661 . . . . 1.0 110.144 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.06 -35.28 80.1 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.304 -0.998 . . . . 1.0 108.304 173.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.48 -50.74 34.83 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 120.164 1.347 . . . . 1.0 111.674 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.4 m -127.79 113.47 20.63 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 116.087 1.884 . . . . 1.0 116.087 -173.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -78.37 -163.17 0.2 Allowed 'Trans proline' 0 CA--C 1.543 0.946 1 C-N-CA 125.453 4.102 . . . . 1.0 109.714 173.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 63' ' ' VAL . 34.6 t -92.56 -168.36 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 104.708 -2.33 . . . . 1.0 104.708 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.561 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -46.43 123.12 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 102.198 -3.26 . . . . 1.0 102.198 173.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -72.09 113.27 8.95 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 117.562 2.43 . . . . 1.0 117.562 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -86.54 79.49 8.92 Favored 'General case' 0 N--CA 1.425 -1.689 1 N-CA-C 97.032 -5.174 . . . . 1.0 97.032 172.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -33.02 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 128.947 2.899 . . . . 1.0 116.295 -172.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.437 ' H ' ' CD2' ' A' ' 67' ' ' HIS . 4.4 p80 -78.82 96.95 5.77 Favored 'General case' 0 C--O 1.222 -0.35 0 C-N-CA 127.187 2.195 . . . . 1.0 107.922 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -62.76 87.75 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.489 0.716 . . . . 1.0 110.055 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.2 t60 173.71 -168.05 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.914 1 C-N-CA 136.133 5.773 . . . . 1.0 100.993 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.243 0.728 0 N-CA-C 102.093 -3.299 . . . . 1.0 102.093 172.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.39 145.33 54.23 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.598 -0.689 . . . . 1.0 110.915 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -129.93 -29.68 2.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.098 1.359 . . . . 1.0 110.397 173.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.45 167.48 11.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.553 1.141 . . . . 1.0 108.226 173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -50.72 -44.22 58.18 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.324 1.449 . . . . 1.0 111.592 -175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.35 92.73 2.34 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.119 -1.437 . . . . 1.0 107.119 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 m 173.54 137.26 0.04 OUTLIER 'General case' 0 C--O 1.235 0.317 0 C-N-CA 130.422 3.489 . . . . 1.0 104.979 173.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -98.53 146.83 25.39 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.601 -1.629 . . . . 1.0 106.601 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -23.6 0.42 Allowed 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 127.476 2.31 . . . . 1.0 112.283 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -46.86 -25.44 0.77 Allowed 'General case' 0 CA--C 1.546 0.79 0 O-C-N 120.874 -1.141 . . . . 1.0 113.482 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.1 t -75.85 -33.0 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-N 119.403 1.002 . . . . 1.0 111.916 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.89 152.87 93.12 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 128.406 2.682 . . . . 1.0 109.013 174.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -69.06 173.15 10.76 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 121.914 1.742 . . . . 1.0 111.598 176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.31 113.58 7.61 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 107.627 -1.249 . . . . 1.0 107.627 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.6 t -89.69 123.94 42.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.008 -1.479 . . . . 1.0 107.008 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -79.33 -33.41 43.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.257 -1.338 . . . . 1.0 110.737 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.84 172.66 42.39 Favored Glycine 0 CA--C 1.535 1.326 0 N-CA-C 110.343 -1.103 . . . . 1.0 110.343 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.74 -8.55 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.024 2.483 . . . . 1.0 114.312 -173.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.55 -179.5 5.29 Favored 'General case' 0 N--CA 1.461 0.095 0 O-C-N 120.952 -1.093 . . . . 1.0 113.57 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.27 3.81 4.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.307 1.443 . . . . 1.0 113.576 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.79 157.12 29.48 Favored Glycine 0 CA--C 1.533 1.214 1 N-CA-C 101.301 -4.72 . . . . 1.0 101.301 172.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -131.44 117.88 19.45 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 121.333 2.567 . . . . 1.0 108.869 -173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -123.16 113.94 29.46 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 129.323 3.049 . . . . 1.0 107.77 -173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.55 125.44 13.33 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.559 2.839 . . . . 1.0 111.203 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -131.56 -179.99 5.7 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 124.403 1.081 . . . . 1.0 109.846 174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.529 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 55.1 m95 -117.35 141.4 48.37 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.797 0.839 . . . . 1.0 108.751 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.86 148.44 48.64 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.309 -0.997 . . . . 1.0 108.309 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -83.87 143.69 29.73 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.666 0.746 . . . . 1.0 109.01 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.4 m -117.15 113.28 39.35 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 105.498 -2.038 . . . . 1.0 105.498 173.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -70.41 -32.41 15.92 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.747 1.631 . . . . 1.0 110.656 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.01 -17.1 64.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.793 0.837 . . . . 1.0 112.299 174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.8 mt -109.96 -4.29 16.02 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.697 1.199 . . . . 1.0 110.546 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.78 35.88 1.63 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 129.64 3.176 . . . . 1.0 108.45 -173.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -162.75 170.88 17.64 Favored 'General case' 0 C--N 1.34 0.177 0 O-C-N 121.139 -0.976 . . . . 1.0 110.185 -173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -100.85 145.08 29.04 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.938 1.695 . . . . 1.0 111.738 -174.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -138.48 153.6 72.77 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.887 0.875 . . . . 1.0 110.689 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -63.48 163.32 24.29 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.492 2.128 . . . . 1.0 110.483 173.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -159.0 168.26 27.21 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.892 -1.151 . . . . 1.0 107.892 173.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.19 113.72 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 107.299 -1.371 . . . . 1.0 107.299 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -99.36 163.82 12.37 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 126.561 1.944 . . . . 1.0 105.809 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -104.77 1.48 41.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 116.459 1.344 . . . . 1.0 116.459 -173.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.5 1.96 67.13 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 118.963 1.382 . . . . 1.0 115.456 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.2 p -125.53 -172.65 2.64 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 127.699 2.4 . . . . 1.0 108.074 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -33.26 133.52 0.15 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.827 2.051 . . . . 1.0 112.839 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.4 172.2 42.27 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.5 -1.84 . . . . 1.0 108.5 -175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -93.81 -174.11 3.34 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.172 0.987 . . . . 1.0 109.773 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.4 -7.61 88.09 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 127.764 2.602 . . . . 1.0 113.591 -174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -86.3 53.16 2.7 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 120.442 2.121 . . . . 1.0 106.911 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -131.47 112.73 12.93 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 101.902 -3.37 . . . . 1.0 101.902 174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -108.85 156.15 19.98 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.457 -2.053 . . . . 1.0 105.457 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.12 -13.46 28.48 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 112.461 -2.154 . . . . 1.0 112.137 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -166.48 169.33 13.96 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 124.694 1.198 . . . . 1.0 109.131 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -64.5 -42.93 95.54 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 173.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -48.97 -66.34 0.42 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 128.689 2.796 . . . . 1.0 111.318 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.8 p -58.47 -36.07 73.14 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.95 0.781 . . . . 1.0 111.495 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 39.1 t -66.61 -52.99 39.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.5 0.72 . . . . 1.0 112.35 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -60.39 -33.41 72.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.471 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.42 -29.48 61.52 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 119.663 1.119 . . . . 1.0 111.563 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.15 -61.64 1.69 Allowed 'General case' 0 C--N 1.345 0.405 0 CA-C-N 119.372 0.987 . . . . 1.0 110.15 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 36.0 m -118.89 99.7 51.05 Favored Pre-proline 0 N--CA 1.454 -0.244 0 C-N-CA 124.693 1.197 . . . . 1.0 108.336 177.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -93.11 -163.68 0.11 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.482 3.455 . . . . 1.0 112.952 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.5 t -105.16 -152.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.637 2 C-N-CA 138.401 6.68 . . . . 1.0 95.178 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -47.04 130.38 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 N-CA-C 104.31 -2.478 . . . . 1.0 104.31 172.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -68.76 135.55 51.41 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.601 0.963 . . . . 1.0 113.601 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -66.68 -4.6 9.22 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.611 1.964 . . . . 1.0 113.49 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.3 -85.29 0.21 Allowed 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.553 1.07 . . . . 1.0 108.808 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.2 p80 173.17 37.89 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.863 3.265 . . . . 1.0 110.647 173.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -85.52 160.52 19.65 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.536 -1.352 . . . . 1.0 108.941 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -55.76 147.58 18.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.149 0.58 . . . . 1.0 109.729 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.174 0 N-CA-C 102.4 -3.185 . . . . 1.0 102.4 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 108.809 -0.811 . . . . 1.0 108.809 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.14 129.8 41.06 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 106.4 -1.704 . . . . 1.0 106.4 149.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -136.96 -23.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 117.757 2.503 . . . . 1.0 117.757 -172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.15 -173.32 2.34 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.218 1.372 . . . . 1.0 111.407 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.1 mp0 -59.13 -25.7 64.09 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.362 1.465 . . . . 1.0 111.273 175.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -64.74 94.39 0.12 Allowed 'General case' 0 C--N 1.342 0.262 0 N-CA-C 106.731 -1.581 . . . . 1.0 106.731 173.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -82.09 94.06 7.14 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.418 -1.327 . . . . 1.0 107.418 -174.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.98 157.63 27.72 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 173.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.56 23.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.258 -0.877 . . . . 1.0 111.774 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -21.0 66.01 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.302 1.41 . . . . 1.0 111.566 -174.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.3 t -74.2 -36.71 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 120.931 -1.105 . . . . 1.0 110.252 174.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.619 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -70.29 129.98 89.89 Favored Pre-proline 0 N--CA 1.455 -0.176 0 C-N-CA 127.229 2.212 . . . . 1.0 113.199 -175.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.4 Cg_exo -52.01 153.73 11.65 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.008 2.472 . . . . 1.0 111.403 173.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.97 166.82 16.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.315 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.93 146.3 30.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.403 -2.073 . . . . 1.0 105.403 174.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -97.53 -24.37 15.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.259 1.024 . . . . 1.0 112.242 -173.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.44 170.08 45.82 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 125.999 1.761 . . . . 1.0 112.014 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.81 -3.43 13.85 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.609 3.539 . . . . 1.0 115.032 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 81.3 m -61.05 178.56 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.712 1.605 . . . . 1.0 113.298 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.29 3.65 3.98 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.233 1.413 . . . . 1.0 113.201 173.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -96.04 153.39 20.55 Favored Glycine 0 CA--C 1.529 0.945 1 N-CA-C 101.974 -4.45 . . . . 1.0 101.974 172.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -130.06 105.79 8.19 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.245 1.523 . . . . 1.0 111.324 -173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -94.01 114.84 64.21 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 129.153 2.981 . . . . 1.0 106.638 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.73 122.18 8.87 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.395 2.73 . . . . 1.0 109.549 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.8 mmt85 -123.28 179.57 4.67 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 123.593 0.757 . . . . 1.0 108.976 174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.482 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -125.13 144.35 50.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.506 1.122 . . . . 1.0 108.436 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.57 141.33 35.22 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 175.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -77.14 137.73 39.07 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.023 -0.732 . . . . 1.0 109.023 174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -117.3 113.66 38.89 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 117.463 -1.256 . . . . 1.0 108.006 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.26 -33.72 23.43 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.953 1.769 . . . . 1.0 110.805 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.2 mt -64.66 -20.32 66.23 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.048 0.939 . . . . 1.0 112.37 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 mt -104.66 -4.06 22.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.842 1.257 . . . . 1.0 110.479 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.65 16.85 2.09 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 128.416 2.686 . . . . 1.0 111.721 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -164.13 172.17 14.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.979 1.263 . . . . 1.0 110.525 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.2 m -87.75 148.82 24.55 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 113.975 1.102 . . . . 1.0 113.975 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -133.9 155.9 79.81 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.989 1.316 . . . . 1.0 109.953 174.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -71.38 165.88 31.06 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.982 1.788 . . . . 1.0 109.237 173.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -158.6 165.69 33.87 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.466 -0.938 . . . . 1.0 108.466 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 68.7 t -89.05 129.96 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.793 -1.558 . . . . 1.0 106.793 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -132.46 170.13 15.57 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.492 1.517 . . . . 1.0 107.163 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.26 -3.18 8.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.946 1.538 . . . . 1.0 116.946 -173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.56 -29.92 6.42 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.826 1.813 . . . . 1.0 111.838 -174.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.6 p -73.34 -173.2 1.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.383 1.873 . . . . 1.0 109.649 173.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -34.14 134.04 0.2 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.52 2.728 . . . . 1.0 112.983 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.93 175.86 41.44 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.271 -1.932 . . . . 1.0 108.271 174.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -93.62 177.55 5.98 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.89 76.15 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.511 -0.768 . . . . 1.0 112.825 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -78.99 70.2 5.28 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 118.372 1.086 . . . . 1.0 108.4 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -144.42 113.07 6.65 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -119.76 162.03 19.75 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 125.227 1.411 . . . . 1.0 108.785 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.4 m-70 -93.33 -14.16 27.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.591 -1.186 . . . . 1.0 112.032 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -166.24 170.7 12.97 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.54 0.686 . . . . 1.0 109.222 -172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -62.81 -46.32 88.49 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.434 -0.95 . . . . 1.0 108.434 173.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -66.87 0.32 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 128.796 2.838 . . . . 1.0 111.079 175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 55.5 p -54.57 -33.26 59.94 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.7 t -72.62 -49.42 32.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.448 -0.782 . . . . 1.0 112.793 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -64.19 -33.74 76.48 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-O 118.515 -0.755 . . . . 1.0 109.883 174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -61.87 -41.41 97.82 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.813 0.845 . . . . 1.0 110.113 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.25 -42.01 76.18 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 118.709 0.686 . . . . 1.0 112.62 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.9 m -122.15 78.09 42.79 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 123.619 0.768 . . . . 1.0 110.855 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.04 159.96 48.76 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.215 2.61 . . . . 1.0 110.003 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -126.67 160.99 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-O 122.247 1.022 . . . . 1.0 108.411 -173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.482 HG12 ' H ' ' A' ' 64' ' ' ASP . 4.4 t -126.62 -177.21 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 127.518 2.327 . . . . 1.0 106.784 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' H ' HG12 ' A' ' 63' ' ' VAL . 1.9 t70 -49.54 137.14 15.65 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -65.03 -7.01 10.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.565 1.691 . . . . 1.0 115.565 -173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.406 ' HD1' ' CG ' ' A' ' 64' ' ' ASP . 49.3 m80 -78.29 -9.86 59.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 120.993 1.724 . . . . 1.0 109.297 173.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -56.78 89.31 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 127.631 2.372 . . . . 1.0 112.155 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -64.65 133.71 52.77 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.426 -2.435 . . . . 1.0 104.426 173.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -80.39 -144.6 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 105.376 -2.083 . . . . 1.0 105.376 173.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.142 0 N-CA-C 106.407 -1.701 . . . . 1.0 106.407 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.2 -155.42 0.47 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 126.39 1.876 . . . . 1.0 106.653 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -52.65 -23.69 7.05 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.849 1.66 . . . . 1.0 110.41 173.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.91 135.8 53.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.171 -2.159 . . . . 1.0 105.171 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.9 -66.91 0.31 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.028 1.331 . . . . 1.0 111.36 -173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -84.98 93.56 8.6 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.24 -1.393 . . . . 1.0 107.24 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -160.36 152.43 20.31 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.06 2.544 . . . . 1.0 104.79 174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -70.47 147.46 49.4 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 122.101 -0.374 . . . . 1.0 110.779 -176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.57 -39.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.679 1.592 . . . . 1.0 111.813 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -22.67 61.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.528 1.513 . . . . 1.0 112.746 -173.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.2 t -72.47 -37.87 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.11 0.868 . . . . 1.0 110.754 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.1 147.09 87.03 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.746 2.018 . . . . 1.0 112.832 -173.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.09 158.08 9.84 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.063 3.175 . . . . 1.0 113.019 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.89 113.39 13.32 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 120.343 -1.473 . . . . 1.0 108.053 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.88 129.35 44.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -79.12 -35.12 42.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.602 -0.726 . . . . 1.0 111.938 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.51 171.98 37.95 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 108.412 -1.875 . . . . 1.0 108.412 -173.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.95 -40.72 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.259 1.973 . . . . 1.0 112.849 -173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.5 m -68.12 159.32 31.2 Favored 'General case' 0 C--N 1.333 -0.109 0 O-C-N 121.34 -0.85 . . . . 1.0 111.877 -174.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.87 3.92 24.84 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.978 2.111 . . . . 1.0 114.279 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.416 ' O ' ' HA2' ' A' ' 41' ' ' GLY . . . -68.41 165.48 46.8 Favored Glycine 0 CA--C 1.544 1.901 1 N-CA-C 102.49 -4.244 . . . . 1.0 102.49 172.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -136.95 135.88 38.09 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 123.444 3.622 . . . . 1.0 110.943 -173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -135.91 121.05 13.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 131.221 3.808 . . . . 1.0 107.237 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 128.15 16.91 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.377 2.718 . . . . 1.0 109.582 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.5 mmt85 -130.67 -179.01 5.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 124.428 1.091 . . . . 1.0 108.506 174.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 57.0 m95 -129.83 145.31 51.58 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 127.29 2.236 . . . . 1.0 106.613 -178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.08 145.64 30.62 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.381 -0.97 . . . . 1.0 108.381 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.7 t80 -80.72 138.48 36.33 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.548 0.689 . . . . 1.0 109.628 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.472 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 15.6 m -117.31 113.68 38.85 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 116.723 -1.608 . . . . 1.0 106.798 172.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.67 -33.28 28.44 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.855 1.704 . . . . 1.0 110.077 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.0 mt -64.82 -15.62 62.03 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.761 1.224 . . . . 1.0 112.568 174.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.2 mt -112.35 -4.0 14.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.414 1.486 . . . . 1.0 110.498 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.516 HE22 HG13 ' A' ' 62' ' ' VAL . 0.0 OUTLIER 50.64 26.94 2.69 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 129.333 3.053 . . . . 1.0 111.843 -174.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -164.85 167.89 18.29 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 121.05 -1.031 . . . . 1.0 110.134 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 93.4 m -84.39 144.95 28.47 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.751 0.786 . . . . 1.0 112.396 174.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.472 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 32.3 p80 -131.46 155.12 81.9 Favored Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.058 1.343 . . . . 1.0 109.62 175.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -72.92 167.37 27.5 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.745 1.63 . . . . 1.0 108.739 173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -161.84 166.32 26.52 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 107.906 -1.146 . . . . 1.0 107.906 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.36 113.47 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 105.239 -2.134 . . . . 1.0 105.239 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -98.9 156.33 16.94 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.559 1.944 . . . . 1.0 107.005 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -92.19 1.27 73.21 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 115.351 0.9 . . . . 1.0 115.351 -173.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.44 -38.22 2.26 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 125.51 1.529 . . . . 1.0 114.21 174.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 16.6 p -80.91 -173.2 4.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.752 1.221 . . . . 1.0 109.432 173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.6 mp0 -33.82 133.74 0.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.317 2.647 . . . . 1.0 113.261 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -165.88 -179.68 39.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 108.881 -1.688 . . . . 1.0 108.881 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.64 -175.05 3.65 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.711 0.767 . . . . 1.0 110.486 -173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.22 -19.76 79.47 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.742 -1.588 . . . . 1.0 115.498 -173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -79.99 70.87 6.65 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 120.605 2.203 . . . . 1.0 108.227 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -149.4 113.3 5.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.937 -0.764 . . . . 1.0 108.937 -173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -125.53 156.07 39.61 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.127 1.771 . . . . 1.0 107.689 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -93.58 -10.12 35.81 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.807 -1.092 . . . . 1.0 111.969 174.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.76 158.09 43.91 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 120.162 1.346 . . . . 1.0 111.319 -173.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -61.72 -45.99 91.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 114.39 -1.277 . . . . 1.0 109.426 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -47.36 -66.57 0.38 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 128.042 2.537 . . . . 1.0 112.369 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.4 p -57.99 -41.27 82.64 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 124.011 0.819 . . . . 1.0 110.861 -174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.55 -48.32 72.83 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.946 0.898 . . . . 1.0 112.137 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -64.52 -34.04 77.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 117.503 -1.237 . . . . 1.0 110.886 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -65.76 -29.75 70.3 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 121.406 1.912 . . . . 1.0 111.1 174.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.6 -63.5 1.05 Allowed 'General case' 0 C--N 1.348 0.527 0 CA-C-N 119.49 1.041 . . . . 1.0 108.398 173.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.6 m -131.05 105.5 15.07 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 1.0 110.216 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -101.68 -162.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.911 1 C-N-CA 127.595 5.53 . . . . 1.0 112.266 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 63' ' ' VAL . 46.5 t -92.98 -152.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.831 2 C-N-CA 134.922 5.289 . . . . 1.0 97.178 172.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.582 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -42.26 124.75 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 119.106 -2.247 . . . . 1.0 105.952 173.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -84.74 148.82 26.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 118.983 2.957 . . . . 1.0 118.983 -172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -64.24 -57.54 9.16 Favored 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 132.936 4.494 . . . . 1.0 106.046 173.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -69.39 154.34 42.18 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 105.925 -1.88 . . . . 1.0 105.925 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -141.64 163.66 32.33 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 119.569 -1.957 . . . . 1.0 108.696 -174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -50.33 116.26 1.8 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.559 1.144 . . . . 1.0 110.434 175.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.29 127.36 29.0 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 103.483 -2.784 . . . . 1.0 103.483 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.982 0 O-C-N 125.297 1.623 . . . . 1.0 109.808 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.414 ' HB3' ' H ' ' A' ' 2' ' ' ALA . 2.7 mp0 . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 107.769 -1.197 . . . . 1.0 107.769 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 1' ' ' GLU . . . -57.15 -3.6 0.15 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.035 2.134 . . . . 1.0 115.036 -177.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 2.1 mp0 -63.81 -26.79 68.79 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.226 0.921 . . . . 1.0 109.968 173.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.47 172.71 7.03 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.714 1.606 . . . . 1.0 110.516 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -58.26 -32.63 68.56 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.4 1.48 . . . . 1.0 111.923 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -156.04 172.96 17.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.722 1.609 . . . . 1.0 107.982 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.3 m -149.33 105.96 3.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.849 -1.537 . . . . 1.0 106.849 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.93 162.33 29.52 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 105.837 -1.912 . . . . 1.0 105.837 172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.09 -44.74 42.36 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 118.89 0.768 . . . . 1.0 109.799 173.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -61.41 -27.15 68.33 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.976 0.807 . . . . 1.0 112.291 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.08 -34.55 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 124.039 0.936 . . . . 1.0 109.843 175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.603 HD12 ' HD2' ' A' ' 13' ' ' PRO . 9.5 tp -64.68 129.24 94.23 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 125.672 1.589 . . . . 1.0 113.169 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.603 ' HD2' HD12 ' A' ' 12' ' ' LEU . 58.0 Cg_exo -51.6 159.21 3.5 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.597 2.865 . . . . 1.0 111.859 173.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -113.17 113.72 25.76 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.118 -0.989 . . . . 1.0 109.599 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.77 145.88 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.74 -1.208 . . . . 1.0 107.74 173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.3 -23.96 18.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.066 1.347 . . . . 1.0 111.59 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.12 168.86 34.72 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.085 1.326 . . . . 1.0 115.189 173.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.17 -28.23 2.05 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.844 3.029 . . . . 1.0 113.221 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 26.4 m -72.7 165.38 24.89 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.035 0.834 . . . . 1.0 110.728 -175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -111.85 3.78 17.86 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.11 1.152 . . . . 1.0 114.11 -174.019 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -79.83 154.27 37.47 Favored Glycine 0 CA--C 1.534 1.25 1 N-CA-C 101.892 -4.483 . . . . 1.0 101.892 172.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -136.16 129.77 32.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.711 2.255 . . . . 1.0 108.379 -173.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -131.08 113.98 16.16 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 129.679 3.192 . . . . 1.0 105.744 -174.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.93 129.34 20.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.287 2.658 . . . . 1.0 109.925 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -130.46 176.19 8.35 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.736 -1.12 . . . . 1.0 108.639 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.591 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 62.8 m95 -129.83 139.15 51.27 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.972 -1.862 . . . . 1.0 105.972 -177.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.91 145.31 41.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.359 -0.978 . . . . 1.0 108.359 176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -81.69 139.09 35.12 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.728 0.775 . . . . 1.0 110.811 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.6 m -117.44 113.59 38.64 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-O 117.114 -1.422 . . . . 1.0 107.328 172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.82 -34.33 31.12 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 121.977 1.785 . . . . 1.0 110.832 174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.9 mt -65.6 -20.67 66.41 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.142 0.977 . . . . 1.0 112.42 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.9 mt -103.1 -5.39 23.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.731 1.212 . . . . 1.0 110.61 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 48.95 29.88 2.54 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 130.74 3.616 . . . . 1.0 110.065 -173.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -165.47 168.33 16.71 Favored 'General case' 0 C--O 1.234 0.269 0 O-C-N 121.378 -0.826 . . . . 1.0 109.187 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.5 m -90.79 147.72 23.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 112.992 0.738 . . . . 1.0 112.992 176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -126.43 156.06 73.39 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.743 1.217 . . . . 1.0 109.47 174.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -72.85 168.67 24.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.589 1.526 . . . . 1.0 109.252 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -159.54 165.34 33.13 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.0 t -94.64 113.93 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.053 -2.202 . . . . 1.0 105.053 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -106.55 145.92 31.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.458 -1.682 . . . . 1.0 106.458 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -88.07 3.31 85.75 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.109 -0.828 . . . . 1.0 114.667 -173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.99 -49.08 3.43 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.983 1.278 . . . . 1.0 110.058 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.6 p -72.58 -172.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.396 1.478 . . . . 1.0 108.44 172.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.05 133.4 0.13 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.269 2.228 . . . . 1.0 114.46 -173.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.21 177.58 44.81 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 128.299 2.857 . . . . 1.0 106.861 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.484 ' ND2' HD11 ' A' ' 12' ' ' LEU . 12.7 m-20 -93.73 177.02 6.14 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.276 1.038 . . . . 1.0 109.906 -174.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.22 82.43 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 114.845 -1.071 . . . . 1.0 113.504 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -76.34 72.11 3.07 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -135.37 112.95 10.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -122.94 149.69 43.93 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -93.51 -8.52 41.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 118.531 -0.747 . . . . 1.0 110.76 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 p -155.34 158.94 39.51 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.083 0.856 . . . . 1.0 112.249 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.591 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.5 tpt180 -57.19 -56.98 14.77 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.839 1.656 . . . . 1.0 111.661 176.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -63.16 -47.53 82.28 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.057 0.848 . . . . 1.0 111.72 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.7 p -53.68 -35.3 60.92 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.83 -48.43 21.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -60.55 -34.02 73.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.397 -0.811 . . . . 1.0 111.346 174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.96 -27.07 49.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 120.217 1.371 . . . . 1.0 110.665 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.03 1.14 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.986 1.267 . . . . 1.0 109.174 173.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 27.0 m -121.4 106.43 37.98 Favored Pre-proline 0 N--CA 1.453 -0.288 0 C-N-CA 124.967 1.307 . . . . 1.0 107.894 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -94.28 -171.88 0.27 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.231 2.621 . . . . 1.0 113.227 -173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.66 -152.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.76 2 N-CA-C 96.417 -5.401 . . . . 1.0 96.417 172.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -47.87 123.53 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 N-CA-C 102.588 -3.115 . . . . 1.0 102.588 172.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -33.7 113.74 0.17 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 117.843 2.534 . . . . 1.0 117.843 -172.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -34.73 65.58 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 124.178 0.991 . . . . 1.0 112.105 173.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -83.09 -101.72 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.357 1.063 . . . . 1.0 111.478 -173.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.74 80.88 7.13 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 120.415 -1.428 . . . . 1.0 108.048 175.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -34.96 100.86 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 128.105 2.562 . . . . 1.0 112.09 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -62.94 150.73 41.4 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.986 0 N-CA-C 100.719 -3.808 . . . . 1.0 100.719 172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 174.09 -140.98 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.611 1 C-N-CA 133.338 4.655 . . . . 1.0 102.134 177.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -56.54 -42.05 77.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.911 1.687 . . . . 1.0 109.707 173.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.28 176.28 5.17 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.45 -29.48 70.16 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 118.315 -1.354 . . . . 1.0 109.846 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -146.61 92.79 2.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 119.051 0.841 . . . . 1.0 109.343 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m 172.97 126.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.412 1 C-N-CA 132.479 4.312 . . . . 1.0 102.972 173.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -136.36 134.67 38.1 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.028 -2.212 . . . . 1.0 105.028 173.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.09 -29.62 2.31 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 124.474 1.109 . . . . 1.0 110.634 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 p -66.61 -14.97 63.09 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.934 0.893 . . . . 1.0 113.38 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.4 t -81.18 -28.94 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.265 1.026 . . . . 1.0 109.517 173.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.1 tp -71.05 131.8 86.94 Favored Pre-proline 0 N--CA 1.452 -0.327 0 C-N-CA 127.227 2.211 . . . . 1.0 113.013 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' HD12 ' A' ' 12' ' ' LEU . 73.3 Cg_exo -51.51 157.73 4.71 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.646 2.897 . . . . 1.0 113.139 173.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.22 164.46 24.15 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.663 0.785 . . . . 1.0 110.433 174.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 t -137.35 151.43 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.036 1.734 . . . . 1.0 106.405 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -99.38 -27.55 13.7 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.001 0.92 . . . . 1.0 113.442 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.6 171.05 46.83 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.989 -1.645 . . . . 1.0 108.989 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.85 -27.01 37.73 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.734 2.289 . . . . 1.0 112.504 -174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.6 m -66.72 155.37 38.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.085 0.954 . . . . 1.0 109.562 -177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.09 3.97 19.01 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.487 1.915 . . . . 1.0 113.962 175.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.03 157.48 48.85 Favored Glycine 0 CA--C 1.537 1.451 0 N-CA-C 103.639 -3.785 . . . . 1.0 103.639 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -132.76 108.36 8.95 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 121.541 2.671 . . . . 1.0 115.102 -173.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 25' ' ' ARG . 75.7 tt0 -106.04 126.21 31.18 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 104.002 -2.592 . . . . 1.0 104.002 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -71.09 113.72 3.68 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.404 2.069 . . . . 1.0 108.142 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 23' ' ' GLU . 25.6 mmt85 -107.92 178.87 4.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.691 -1.225 . . . . 1.0 107.691 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.502 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.7 m95 -133.22 143.61 49.25 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.825 1.65 . . . . 1.0 107.724 -174.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.32 149.36 37.67 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 123.82 0.848 . . . . 1.0 109.063 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -83.63 141.47 31.5 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.195 0.998 . . . . 1.0 110.818 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.2 m -117.34 113.29 38.98 Favored Pre-proline 0 N--CA 1.441 -0.914 0 N-CA-C 106.08 -1.822 . . . . 1.0 106.08 172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.14 -32.18 21.71 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.631 1.554 . . . . 1.0 110.219 174.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.65 -15.34 61.13 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.534 1.134 . . . . 1.0 112.367 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.5 mt -112.7 -4.57 14.05 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.823 1.249 . . . . 1.0 110.521 173.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 46.93 36.66 4.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.276 2.63 . . . . 1.0 109.821 -173.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -164.85 169.01 17.13 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.738 -0.601 . . . . 1.0 109.576 -173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.9 m -95.31 150.84 19.81 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 122.498 1.142 . . . . 1.0 112.883 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -135.04 155.66 78.94 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.725 1.21 . . . . 1.0 109.682 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -72.59 169.51 21.67 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.938 1.759 . . . . 1.0 110.229 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -162.56 175.22 11.66 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.538 1.935 . . . . 1.0 106.722 173.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.1 126.58 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 107.021 -1.474 . . . . 1.0 107.021 -174.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.77 160.1 36.54 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.033 2.533 . . . . 1.0 110.015 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.72 19.32 11.37 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 118.104 2.002 . . . . 1.0 118.104 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.78 -46.81 3.34 Favored Glycine 0 N--CA 1.466 0.642 0 CA-C-N 119.807 1.803 . . . . 1.0 112.321 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 p -65.9 -173.14 0.16 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.686 1.595 . . . . 1.0 110.541 173.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.3 mp0 -33.54 133.85 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 129.394 3.078 . . . . 1.0 114.365 -173.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.81 174.85 35.17 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.159 -1.976 . . . . 1.0 108.159 174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -93.59 -177.62 4.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 -23.72 76.42 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 123.333 0.492 . . . . 1.0 112.341 -179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -78.71 69.08 4.83 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.032 0.916 . . . . 1.0 108.81 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -152.14 113.14 4.22 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -128.07 156.72 42.33 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.5 1.52 . . . . 1.0 109.206 -173.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -93.46 -8.21 42.26 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.424 -0.798 . . . . 1.0 110.68 -177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.3 p -157.14 166.07 34.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 119.025 0.829 . . . . 1.0 109.897 -173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.9 tpt180 -60.28 -47.38 86.27 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 173.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -44.66 -66.56 0.38 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 128.284 2.634 . . . . 1.0 112.474 173.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 10.9 p -60.65 -36.04 77.71 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.626 0.579 . . . . 1.0 111.91 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.6 t -69.39 -47.71 63.38 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.283 0.633 . . . . 1.0 111.715 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.57 -32.91 74.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.176 0.991 . . . . 1.0 109.462 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -71.58 -40.18 70.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 117.737 -1.125 . . . . 1.0 110.001 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -59.18 5.09 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-N 119.819 1.19 . . . . 1.0 110.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.3 m -122.19 107.32 35.12 Favored Pre-proline 0 N--CA 1.449 -0.493 0 C-N-CA 125.087 1.355 . . . . 1.0 108.307 173.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -94.37 -166.27 0.13 Allowed 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 122.957 2.438 . . . . 1.0 113.855 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.404 HG12 ' H ' ' A' ' 63' ' ' VAL . 15.9 t -101.49 -152.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 2 C-N-CA 137.742 6.417 . . . . 1.0 95.716 172.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -44.52 125.94 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 O-C-N 119.523 -1.985 . . . . 1.0 105.864 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -62.98 133.12 54.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.596 -1.184 . . . . 1.0 112.181 -172.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -84.45 -18.32 36.31 Favored 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.989 2.116 . . . . 1.0 110.267 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 -131.15 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 127.696 2.398 . . . . 1.0 107.465 -173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -170.91 152.26 3.55 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.701 2.801 . . . . 1.0 105.61 173.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -78.32 53.89 1.32 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.181 0.992 . . . . 1.0 109.817 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -161.07 179.66 8.23 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 119.511 -1.993 . . . . 1.0 111.567 -173.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.244 0.812 0 C-N-CA 130.636 3.574 . . . . 1.0 102.685 173.163 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 N--CA 1.475 0.784 0 CA-C-O 121.924 0.869 . . . . 1.0 108.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.436 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -161.36 29.82 0.13 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.351 2.66 . . . . 1.0 107.626 170.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 7.7 mp0 -138.88 -25.08 0.89 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.09 1.356 . . . . 1.0 112.045 -173.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.44 -8.44 11.59 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.361 1.864 . . . . 1.0 113.905 -173.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -68.38 -42.33 79.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.483 1.913 . . . . 1.0 114.784 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -156.87 120.77 4.29 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.328 1.422 . . . . 1.0 112.618 -174.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.428 ' CG2' ' H ' ' A' ' 8' ' ' ASP . 3.6 m 173.37 -167.18 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 1 C-N-CA 133.393 4.677 . . . . 1.0 103.733 173.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' H ' ' CG2' ' A' ' 7' ' ' THR . 15.1 t70 -49.12 160.44 0.21 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.453 1.501 . . . . 1.0 109.945 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.74 -34.8 8.85 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 117.945 -1.026 . . . . 1.0 112.417 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.4 p -55.22 -31.51 61.52 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 120.174 1.352 . . . . 1.0 112.518 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.79 -34.3 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.307 -0.87 . . . . 1.0 110.896 177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.5 tp -61.7 129.14 91.2 Favored Pre-proline 0 CA--C 1.522 -0.124 0 C-N-CA 125.276 1.43 . . . . 1.0 113.045 -179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.627 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.0 Cg_exo -49.93 151.36 8.58 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.316 2.678 . . . . 1.0 112.164 173.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.45 153.5 23.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.6 -0.727 . . . . 1.0 109.576 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.48 139.98 48.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 104.689 -2.337 . . . . 1.0 104.689 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -75.61 -58.29 3.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.28 171.66 12.85 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.729 1.633 . . . . 1.0 109.979 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.9 -12.22 14.82 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.973 2.449 . . . . 1.0 112.802 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.2 m -73.66 176.21 6.43 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 122.34 1.067 . . . . 1.0 112.373 -177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.26 3.69 8.5 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.603 -1.18 . . . . 1.0 112.479 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.29 154.28 21.75 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 103.176 -3.97 . . . . 1.0 103.176 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 32.7 m95 -132.19 119.9 21.5 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.478 1.639 . . . . 1.0 108.377 -173.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -120.2 113.75 33.82 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 129.551 3.14 . . . . 1.0 106.584 -174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.04 124.28 11.22 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.183 2.589 . . . . 1.0 110.835 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -129.4 178.32 6.54 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 123.958 0.903 . . . . 1.0 109.34 173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.508 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.7 m95 -120.07 141.17 50.02 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 124.554 1.142 . . . . 1.0 107.994 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.25 146.7 51.67 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 174.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -84.56 136.14 33.92 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.6 m -117.23 113.94 38.89 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 120.35 -1.469 . . . . 1.0 109.11 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.72 -36.52 18.68 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.208 1.939 . . . . 1.0 110.634 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 14.3 mt -61.98 -23.32 66.33 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.793 1.237 . . . . 1.0 113.083 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 mt -102.85 -4.36 24.97 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.165 0.986 . . . . 1.0 110.801 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.08 36.13 1.91 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 128.985 2.914 . . . . 1.0 109.995 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -164.16 169.88 17.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 121.352 -0.842 . . . . 1.0 109.074 -173.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.2 m -98.77 146.32 26.03 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.88 -0.512 . . . . 1.0 111.164 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -132.73 154.09 81.33 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 124.253 1.021 . . . . 1.0 110.194 176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.17 165.9 30.94 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 N-CA-C 108.482 -1.391 . . . . 1.0 108.482 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -157.68 161.59 38.58 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.366 -0.975 . . . . 1.0 108.366 173.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 t -86.24 113.82 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 105.579 -2.008 . . . . 1.0 105.579 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.41 159.06 15.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 105.223 -2.14 . . . . 1.0 105.223 173.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.44 1.25 49.83 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.854 -1.154 . . . . 1.0 115.611 -173.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.36 -8.47 13.24 Favored Glycine 0 CA--C 1.533 1.167 0 CA-C-N 118.776 1.288 . . . . 1.0 115.06 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.23 -172.53 2.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 129.076 2.95 . . . . 1.0 107.252 173.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 2.8 mp0 -33.47 133.64 0.16 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.741 2.017 . . . . 1.0 112.809 -173.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -170.43 -174.84 38.78 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 107.185 -2.366 . . . . 1.0 107.185 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -93.41 174.92 6.96 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.784 1.292 . . . . 1.0 108.883 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.08 -11.07 84.83 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 114.574 -1.193 . . . . 1.0 112.644 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -76.54 73.12 3.26 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.648 -1.241 . . . . 1.0 107.648 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -138.23 112.92 8.94 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.128 -1.804 . . . . 1.0 106.128 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -117.06 158.26 24.47 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 123.618 1.675 . . . . 1.0 107.132 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -93.3 -16.47 24.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.754 -2.021 . . . . 1.0 111.602 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -166.05 164.44 18.19 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.976 0.893 . . . . 1.0 109.145 -173.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.1 tpt180 -60.27 -47.94 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.476 -1.238 . . . . 1.0 108.54 173.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -48.46 -66.27 0.43 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.612 2.365 . . . . 1.0 111.362 174.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.5 p -57.76 -33.4 68.46 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 123.997 0.811 . . . . 1.0 112.423 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.5 t -68.15 -54.05 20.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.146 0.978 . . . . 1.0 112.789 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -64.48 -33.18 75.29 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.8 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -77.12 -24.32 51.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.898 -1.048 . . . . 1.0 111.054 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.82 -65.03 0.73 Allowed 'General case' 0 C--N 1.344 0.366 0 CA-C-N 120.839 1.654 . . . . 1.0 109.497 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 21.8 m -105.51 100.66 27.58 Favored Pre-proline 0 C--O 1.235 0.299 0 N-CA-C 112.119 0.414 . . . . 1.0 112.119 -173.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.62 173.31 14.36 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.542 2.161 . . . . 1.0 112.425 176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 63' ' ' VAL . 2.4 t -153.75 -155.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.655 2 C-N-CA 134.193 4.997 . . . . 1.0 98.866 173.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.4 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -56.1 135.69 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 101.964 -3.347 . . . . 1.0 101.964 172.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -54.05 113.54 1.27 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.626 0.973 . . . . 1.0 113.626 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -68.24 107.57 2.85 Favored 'General case' 0 N--CA 1.445 -0.709 1 N-CA-C 96.44 -5.393 . . . . 1.0 96.44 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -32.74 88.36 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 117.394 2.368 . . . . 1.0 117.394 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.722 ' CG ' ' H ' ' A' ' 68' ' ' HIS . 12.7 p-80 -149.82 -97.19 0.07 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 102.715 -3.069 . . . . 1.0 102.715 173.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.722 ' H ' ' CG ' ' A' ' 67' ' ' HIS . 45.3 t60 173.77 102.88 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 130.606 3.562 . . . . 1.0 103.334 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 -53.46 130.3 35.09 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 104.453 -2.425 . . . . 1.0 104.453 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.256 1.397 0 CA-C-O 114.564 -2.636 . . . . 1.0 110.422 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.5 -163.8 1.52 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.406 1.882 . . . . 1.0 106.092 169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -48.58 -58.01 5.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.609 1.164 . . . . 1.0 109.215 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . . . -116.82 -178.88 3.53 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.189 1.395 . . . . 1.0 109.732 173.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -67.67 -23.62 65.34 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.599 0.76 . . . . 1.0 109.829 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -103.22 164.77 11.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.602 1.961 . . . . 1.0 108.852 174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.4 m -153.0 134.38 14.31 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.645 -1.243 . . . . 1.0 107.645 176.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -130.88 178.14 6.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.539 3.136 . . . . 1.0 108.589 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.77 -26.42 1.59 Allowed 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 126.077 1.751 . . . . 1.0 111.089 173.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.0 p -47.11 -34.6 6.19 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.184 1.356 . . . . 1.0 114.154 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.95 -25.71 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 120.683 -1.261 . . . . 1.0 110.662 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.54 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -67.24 127.57 93.51 Favored Pre-proline 0 CA--C 1.519 -0.243 0 C-N-CA 126.21 1.804 . . . . 1.0 112.033 173.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.54 ' HD2' HD12 ' A' ' 12' ' ' LEU . 52.2 Cg_exo -49.9 152.24 7.45 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.993 2.462 . . . . 1.0 112.205 174.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.51 158.17 27.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.215 -0.902 . . . . 1.0 109.827 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.7 t -139.49 148.95 22.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 106.548 -1.649 . . . . 1.0 106.548 174.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.28 -69.77 0.38 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 136.98 175.9 14.06 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.282 -1.527 . . . . 1.0 109.282 -176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -74.77 -19.64 18.24 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.652 2.235 . . . . 1.0 112.651 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.0 m -73.38 177.85 4.95 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.059 0.944 . . . . 1.0 112.276 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.75 3.44 11.65 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.378 1.471 . . . . 1.0 112.1 174.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.47 153.9 32.29 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 103.704 -3.758 . . . . 1.0 103.704 172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.9 m95 -133.62 125.79 29.49 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 119.279 1.54 . . . . 1.0 107.401 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -126.32 113.88 23.5 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 129.153 2.981 . . . . 1.0 106.633 -173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.43 129.78 15.27 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.203 2.602 . . . . 1.0 110.711 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.9 mmt-85 -134.43 178.23 7.15 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.083 0.953 . . . . 1.0 109.614 174.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.512 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.3 m95 -110.84 141.71 43.85 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.191 -1.041 . . . . 1.0 108.191 174.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.64 146.5 41.76 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 118.855 0.752 . . . . 1.0 109.515 174.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -81.78 136.54 35.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 173.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m -117.39 113.88 38.61 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-O 116.379 -1.772 . . . . 1.0 110.685 173.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.69 -34.26 32.55 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.726 1.618 . . . . 1.0 109.793 173.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.1 mt -64.78 -10.85 30.85 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.687 1.595 . . . . 1.0 112.716 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.5 mt -120.63 -4.22 9.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.191 1.396 . . . . 1.0 110.51 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.22 36.16 6.41 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.746 2.418 . . . . 1.0 109.767 -173.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -164.84 166.43 19.7 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.294 -0.879 . . . . 1.0 110.016 -173.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.9 m -94.63 145.85 24.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 122.013 0.911 . . . . 1.0 110.607 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -142.37 156.46 63.96 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 118.514 -0.755 . . . . 1.0 111.304 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -64.63 157.28 56.41 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.12 1.88 . . . . 1.0 108.832 173.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -153.49 161.36 42.33 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.786 1.176 . . . . 1.0 108.833 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 50.8 t -85.76 124.41 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.58 -2.007 . . . . 1.0 105.58 173.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -116.05 163.82 15.36 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 104.768 -2.308 . . . . 1.0 104.768 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.98 -0.78 48.5 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 120.558 -1.339 . . . . 1.0 115.131 -173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.83 -37.07 1.04 Allowed Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.41 1.481 . . . . 1.0 112.881 -175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.8 p -86.06 -172.74 4.23 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.211 1.804 . . . . 1.0 107.759 173.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.84 133.96 0.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.871 2.068 . . . . 1.0 112.88 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.5 -167.83 30.59 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 107.596 -2.201 . . . . 1.0 107.596 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -93.34 174.89 6.98 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 118.224 1.012 . . . . 1.0 108.827 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.02 -10.93 82.17 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 114.819 -1.082 . . . . 1.0 112.755 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -73.17 81.39 1.3 Allowed 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 174.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.51 112.95 6.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.061 -1.459 . . . . 1.0 107.061 -174.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -119.81 160.77 21.98 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 123.468 1.604 . . . . 1.0 107.894 -174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -93.42 -20.81 19.96 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 112.542 -2.117 . . . . 1.0 112.492 -172.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -165.14 167.62 18.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 -173.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -60.9 -51.31 69.84 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.533 -0.914 . . . . 1.0 108.533 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -45.1 -66.6 0.38 Allowed 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 128.202 2.601 . . . . 1.0 112.075 174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -60.83 -33.39 72.96 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.67 0.606 . . . . 1.0 112.304 -173.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 14.7 t -67.94 -52.23 38.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -69.92 -33.24 71.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 118.016 -0.992 . . . . 1.0 110.466 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.46 -28.14 61.79 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 117.902 -1.519 . . . . 1.0 110.448 173.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.2 -48.61 41.81 Favored 'General case' 0 C--N 1.357 0.933 0 CA-C-N 120.543 1.519 . . . . 1.0 110.483 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 62.8 m -134.17 82.72 47.03 Favored Pre-proline 0 N--CA 1.446 -0.632 0 C-N-CA 123.868 0.867 . . . . 1.0 113.328 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -87.45 -163.56 0.17 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 N-CA-C 104.723 -2.837 . . . . 1.0 104.723 172.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 63' ' ' VAL . 2.5 t -92.6 -175.69 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 N-CA-C 101.951 -3.352 . . . . 1.0 101.951 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 2.4 t -32.98 113.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 126.266 1.826 . . . . 1.0 108.318 -172.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -34.35 113.61 0.18 Allowed 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 111.719 -2.491 . . . . 1.0 111.635 -172.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -76.77 77.64 3.39 Favored 'General case' 0 N--CA 1.433 -1.284 1 N-CA-C 96.557 -5.349 . . . . 1.0 96.557 173.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . 0.31 80.0 m-70 -32.71 90.54 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 128.78 2.832 . . . . 1.0 113.831 -172.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -38.48 101.71 0.02 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.898 3.279 . . . . 1.0 106.982 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -48.09 132.7 15.55 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 124.056 0.942 . . . . 1.0 112.021 -173.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -134.49 -89.61 0.36 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 100.372 -3.936 . . . . 1.0 100.372 173.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.175 0 N-CA-C 102.519 -3.141 . . . . 1.0 102.519 172.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 112.495 0.554 . . . . 1.0 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -152.53 23.96 0.61 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 127.231 2.212 . . . . 1.0 110.426 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 22.3 mp0 -105.37 -50.11 3.29 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.054 1.742 . . . . 1.0 109.836 -173.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.28 12.62 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.055 2.142 . . . . 1.0 114.787 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.95 -23.94 59.57 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.215 1.406 . . . . 1.0 110.354 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -130.75 -178.39 4.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 129.623 3.169 . . . . 1.0 106.552 174.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.1 m -73.25 93.73 1.91 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 173.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -73.9 165.39 25.21 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.41 -23.85 6.76 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.924 0.889 . . . . 1.0 111.664 173.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 p -52.84 -30.64 34.8 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 120.137 1.335 . . . . 1.0 112.224 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 18.5 t -78.19 -27.11 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.437 -0.789 . . . . 1.0 110.444 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -69.48 130.16 90.95 Favored Pre-proline 0 N--CA 1.455 -0.196 0 C-N-CA 126.391 1.876 . . . . 1.0 112.178 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.576 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.1 Cg_exo -51.77 154.42 9.65 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.922 2.415 . . . . 1.0 111.579 173.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.39 160.27 18.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.383 0.673 . . . . 1.0 109.636 175.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.7 t -140.69 150.06 20.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 126.002 1.721 . . . . 1.0 106.567 175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -72.61 -68.7 0.46 Allowed 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.75 171.36 12.82 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.441 1.496 . . . . 1.0 109.8 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.79 -12.16 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.074 2.516 . . . . 1.0 113.358 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 88.3 m -72.69 -174.99 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.574 1.15 . . . . 1.0 112.201 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.65 3.61 5.51 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.064 0.945 . . . . 1.0 113.167 174.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.83 153.61 25.97 Favored Glycine 0 CA--C 1.528 0.89 1 N-CA-C 102.292 -4.323 . . . . 1.0 102.292 172.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -134.21 123.34 24.15 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.482 1.641 . . . . 1.0 108.277 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -119.59 113.7 34.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 129.732 3.213 . . . . 1.0 106.56 -174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.9 130.47 14.53 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.68 . . . . 1.0 110.486 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -134.41 177.34 7.84 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.724 0.81 . . . . 1.0 109.353 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.52 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 54.4 m95 -111.1 141.06 45.1 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 175.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.77 144.27 47.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -82.68 141.35 32.53 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.777 0.799 . . . . 1.0 109.398 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 m -117.31 113.14 39.11 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 105.818 -1.919 . . . . 1.0 105.818 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.39 -33.65 17.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.68 1.587 . . . . 1.0 109.584 174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.29 -15.86 62.96 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.145 1.378 . . . . 1.0 112.601 175.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.6 mt -112.12 -5.32 14.25 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.262 1.025 . . . . 1.0 110.493 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.74 37.47 7.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.324 2.25 . . . . 1.0 109.47 -173.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -160.88 166.2 28.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 109.011 -0.737 . . . . 1.0 109.011 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -101.2 149.57 23.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.981 0.896 . . . . 1.0 111.744 174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -140.8 154.26 68.56 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 123.711 0.804 . . . . 1.0 110.832 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.79 162.08 33.41 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.147 1.898 . . . . 1.0 109.084 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -156.03 157.57 36.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.352 0.978 . . . . 1.0 108.416 173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.6 t -83.35 130.76 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.889 -2.264 . . . . 1.0 104.889 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -124.76 163.38 22.23 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 105.518 -2.03 . . . . 1.0 105.518 173.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.26 -0.11 40.83 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.53 -1.15 . . . . 1.0 115.523 -173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 -34.17 1.07 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.266 1.533 . . . . 1.0 113.116 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 p -88.85 -172.71 3.81 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.361 2.264 . . . . 1.0 107.748 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -33.8 133.67 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.795 2.038 . . . . 1.0 112.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -176.3 -172.28 40.86 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 107.316 -2.313 . . . . 1.0 107.316 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.413 ' ND2' HD11 ' A' ' 12' ' ' LEU . 6.2 m-20 -93.55 175.63 6.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 122.326 1.06 . . . . 1.0 109.355 -174.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.99 -9.75 73.28 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.582 -1.19 . . . . 1.0 113.794 -173.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -73.89 81.15 1.65 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 106.447 -1.686 . . . . 1.0 106.447 174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -142.36 113.04 7.34 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.428 -1.323 . . . . 1.0 107.428 -173.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -118.1 161.3 20.07 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 123.009 1.385 . . . . 1.0 108.271 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -93.21 -19.12 21.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 112.898 -1.955 . . . . 1.0 112.288 -172.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.8 p -165.96 168.75 15.43 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 -173.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.2 tpt180 -60.89 -47.05 88.15 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 173.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -47.59 -66.58 0.38 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 128.844 2.858 . . . . 1.0 111.947 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.9 p -60.53 -33.5 72.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.602 0.564 . . . . 1.0 112.093 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 16.5 t -69.55 -50.7 42.4 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 123.714 0.806 . . . . 1.0 112.431 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.278 61.7 mt-10 -68.97 -32.9 72.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.997 -0.525 . . . . 1.0 110.085 178.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -69.56 -28.94 66.42 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 117.424 -1.275 . . . . 1.0 110.805 173.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.77 15.96 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 119.735 1.152 . . . . 1.0 111.039 175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 67.1 m -122.44 80.41 46.23 Favored Pre-proline 0 N--CA 1.452 -0.34 0 C-N-CA 123.661 0.784 . . . . 1.0 110.359 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -81.57 -163.68 0.24 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 124.216 3.277 . . . . 1.0 109.985 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 63' ' ' VAL . 2.5 t -93.6 -153.91 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 101.518 -3.512 . . . . 1.0 101.518 172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 62' ' ' VAL . 18.3 t -50.32 149.38 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 O-C-N 120.925 -1.11 . . . . 1.0 109.462 173.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -36.25 123.09 0.75 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 128.661 2.785 . . . . 1.0 112.09 -176.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -60.46 113.79 2.61 Favored 'General case' 0 C--N 1.348 0.507 1 N-CA-C 99.126 -4.398 . . . . 1.0 99.126 173.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -32.98 87.29 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 117.328 2.344 . . . . 1.0 117.328 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -132.48 -115.43 0.22 Allowed 'General case' 0 N--CA 1.441 -0.917 2 C-N-CA 133.052 4.541 . . . . 1.0 98.743 173.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 173.07 45.52 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.3 1 C-N-CA 132.761 4.424 . . . . 1.0 104.703 173.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -68.19 -22.19 64.83 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.202 -0.936 . . . . 1.0 109.959 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.8 t60 . . . . . 0 C--O 1.259 1.562 0 C-N-CA 129.029 2.932 . . . . 1.0 103.188 173.526 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 117.512 -1.232 . . . . 1.0 108.809 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.34 169.76 18.17 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 120.213 1.369 . . . . 1.0 109.447 164.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -63.63 -23.94 67.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 115.02 1.489 . . . . 1.0 115.02 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.09 -81.29 0.13 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -135.63 -77.82 0.43 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.782 2.033 . . . . 1.0 105.565 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -164.43 155.05 14.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.674 -0.861 . . . . 1.0 108.674 173.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.2 m -177.02 143.44 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.469 4.307 . . . . 1.0 102.337 173.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -147.69 174.51 11.71 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 127.256 2.222 . . . . 1.0 108.58 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.96 -23.97 8.38 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 124.583 1.153 . . . . 1.0 109.538 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 p -50.3 -29.5 9.87 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.957 1.303 . . . . 1.0 113.115 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.1 t -78.18 -26.86 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 O-C-N 121.032 -1.042 . . . . 1.0 110.674 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 13' ' ' PRO . 11.0 tp -71.41 131.26 86.69 Favored Pre-proline 0 N--CA 1.453 -0.3 0 C-N-CA 127.185 2.194 . . . . 1.0 112.406 174.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.2 Cg_exo -51.74 153.39 11.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.877 2.385 . . . . 1.0 111.59 173.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.9 160.74 22.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.614 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -140.61 148.75 21.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 125.479 1.512 . . . . 1.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.83 -68.68 0.44 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.312 1.045 . . . . 1.0 109.045 173.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 132.73 175.7 14.09 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.139 1.352 . . . . 1.0 109.772 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.92 -15.27 18.87 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.739 2.293 . . . . 1.0 112.592 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.3 m -72.97 178.85 4.04 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 124.217 1.007 . . . . 1.0 111.808 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.87 3.68 4.46 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.837 1.051 . . . . 1.0 113.837 -176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.54 153.71 29.01 Favored Glycine 0 CA--C 1.53 1.018 1 N-CA-C 102.037 -4.425 . . . . 1.0 102.037 172.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -128.18 109.6 11.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.967 1.883 . . . . 1.0 108.9 -173.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -107.5 113.93 61.23 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 129.021 2.928 . . . . 1.0 107.001 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.46 127.7 14.39 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.14 2.56 . . . . 1.0 110.474 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -132.71 178.7 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.996 0.919 . . . . 1.0 109.312 174.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.506 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 53.6 m95 -114.3 139.7 49.22 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.454 1.101 . . . . 1.0 108.177 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.81 145.38 46.43 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.898 0.772 . . . . 1.0 109.109 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -80.97 140.48 35.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.892 0.853 . . . . 1.0 109.095 174.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.441 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 21.9 m -117.16 113.38 39.29 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 106.582 -1.636 . . . . 1.0 106.582 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.78 -33.06 21.81 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.697 1.598 . . . . 1.0 110.208 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.99 -15.12 61.91 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.935 1.294 . . . . 1.0 112.6 174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 mt -113.96 -5.57 13.17 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.533 1.133 . . . . 1.0 110.526 173.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.535 HE22 HG13 ' A' ' 62' ' ' VAL . 0.0 OUTLIER 46.74 40.34 8.6 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.495 2.318 . . . . 1.0 109.072 -173.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -163.85 165.43 22.87 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 -173.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -98.3 148.39 23.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 122.466 1.127 . . . . 1.0 111.373 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.441 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 31.4 p80 -141.78 155.44 66.26 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 114.869 -1.06 . . . . 1.0 110.942 177.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.16 160.18 35.66 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.423 2.082 . . . . 1.0 109.911 173.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -156.13 161.93 40.3 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.352 0.978 . . . . 1.0 108.409 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -85.64 123.76 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 106.331 -1.729 . . . . 1.0 106.331 174.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -114.4 162.89 16.07 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 104.857 -2.275 . . . . 1.0 104.857 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.15 4.43 31.67 Favored Glycine 0 CA--C 1.527 0.81 0 O-C-N 120.643 -1.286 . . . . 1.0 115.511 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.99 -10.27 9.8 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-N 118.657 1.229 . . . . 1.0 115.347 174.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 p -119.75 -172.63 2.37 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.401 2.681 . . . . 1.0 107.318 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -33.73 133.53 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.397 1.879 . . . . 1.0 112.619 -173.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -169.24 -171.46 34.95 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.651 -2.18 . . . . 1.0 107.651 -174.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -93.44 175.18 6.85 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.355 1.078 . . . . 1.0 109.047 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.05 -11.78 80.6 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 114.76 -1.109 . . . . 1.0 113.132 -174.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -76.62 77.39 3.29 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.112 -1.44 . . . . 1.0 107.112 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -146.08 113.12 6.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.174 -1.417 . . . . 1.0 107.174 -174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -120.48 161.03 21.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.208 1.403 . . . . 1.0 108.388 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -93.4 -17.21 23.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 113.515 -1.675 . . . . 1.0 113.158 -172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.34 170.09 15.04 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.4 tpt180 -61.47 -50.12 74.03 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.609 -0.885 . . . . 1.0 108.609 173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.15 -66.85 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 128.506 2.723 . . . . 1.0 111.826 176.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.4 p -56.76 -33.25 66.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.812 0.671 . . . . 1.0 112.812 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 11.3 t -70.97 -49.7 42.5 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 123.637 0.775 . . . . 1.0 112.534 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.366 76.3 mt-10 -67.13 -33.06 74.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 119.037 -0.506 . . . . 1.0 111.237 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.7 -38.22 90.28 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 173.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.07 68.8 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 118.946 0.794 . . . . 1.0 111.808 176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 19.8 m -139.76 102.83 7.01 Favored Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 125.499 1.519 . . . . 1.0 109.597 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.01 -163.19 0.21 Allowed 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 124.535 3.49 . . . . 1.0 113.16 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 63' ' ' VAL . 37.7 t -92.83 -155.52 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 130.3 3.44 . . . . 1.0 102.048 173.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.568 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -49.75 129.54 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.47 -2.048 . . . . 1.0 105.47 173.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -110.49 161.4 15.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 123.541 1.639 . . . . 1.0 113.296 -172.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -65.99 165.86 12.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 128.678 2.791 . . . . 1.0 104.959 173.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -80.3 76.63 7.09 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 118.97 -2.331 . . . . 1.0 107.753 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -53.8 153.97 4.24 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.688 1.595 . . . . 1.0 107.289 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.59 167.89 16.89 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 119.926 1.239 . . . . 1.0 111.965 173.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -116.47 -144.15 0.38 Allowed 'General case' 0 C--N 1.323 -0.567 1 N-CA-C 99.84 -4.133 . . . . 1.0 99.84 172.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 C--O 1.248 0.99 0 N-CA-C 103.133 -2.914 . . . . 1.0 103.133 172.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 3' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 N-CA-C 108.319 -0.993 . . . . 1.0 108.319 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' H ' ' H ' ' A' ' 3' ' ' GLU . . . 173.93 -17.07 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 130.574 3.55 . . . . 1.0 110.171 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 7.7 mp0 -67.43 -66.83 0.51 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 130.066 3.346 . . . . 1.0 107.79 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.07 57.24 4.33 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.582 1.153 . . . . 1.0 109.435 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -135.56 -87.44 0.35 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.691 1.196 . . . . 1.0 108.379 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -162.96 140.17 7.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.03 -1.1 . . . . 1.0 108.03 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -156.01 133.77 11.12 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 104.216 -2.513 . . . . 1.0 104.216 173.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -120.07 166.0 13.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.511 1.924 . . . . 1.0 107.176 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.67 -36.43 46.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-O 118.598 -0.715 . . . . 1.0 110.887 174.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -20.45 65.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.122 1.328 . . . . 1.0 111.544 -175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 17.2 t -81.79 -30.83 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 124.48 1.112 . . . . 1.0 110.761 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 13' ' ' PRO . 1.4 tp -68.27 136.71 91.33 Favored Pre-proline 0 C--O 1.225 -0.209 0 C-N-CA 126.866 2.066 . . . . 1.0 110.185 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 12' ' ' LEU . 29.3 Cg_endo -68.56 166.2 26.64 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.71 1.607 . . . . 1.0 111.711 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.71 156.63 32.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 114.184 -1.371 . . . . 1.0 109.614 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.5 t -141.54 147.24 22.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 106.901 -1.518 . . . . 1.0 106.901 174.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -72.0 -67.63 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.402 1.081 . . . . 1.0 109.25 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.39 177.37 14.85 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 109.795 -1.322 . . . . 1.0 109.795 -175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.53 -16.77 24.06 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.414 2.076 . . . . 1.0 112.919 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 98.3 m -73.49 -177.58 2.71 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.417 1.087 . . . . 1.0 112.402 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.91 3.8 4.9 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.895 1.278 . . . . 1.0 113.968 174.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.94 153.95 40.67 Favored Glycine 0 CA--C 1.531 1.054 1 N-CA-C 102.752 -4.139 . . . . 1.0 102.752 172.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -130.26 123.63 30.55 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 120.072 1.936 . . . . 1.0 107.334 -173.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -125.79 114.46 24.68 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 128.679 2.792 . . . . 1.0 107.425 -173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.0 126.02 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.262 2.641 . . . . 1.0 110.622 176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.5 mmt-85 -133.11 -179.37 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.482 1.113 . . . . 1.0 109.056 174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 44.6 m95 -124.71 144.87 49.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.835 1.254 . . . . 1.0 108.578 -178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.27 145.61 34.21 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.272 0.629 . . . . 1.0 109.555 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -78.16 139.34 38.99 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.557 -1.275 . . . . 1.0 107.557 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.451 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 19.0 m -116.97 113.43 39.63 Favored Pre-proline 0 N--CA 1.441 -0.901 0 N-CA-C 107.102 -1.444 . . . . 1.0 107.102 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.67 -33.75 20.79 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.026 1.817 . . . . 1.0 110.329 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.2 mt -65.15 -16.28 63.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.725 1.21 . . . . 1.0 112.8 174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.5 mt -112.35 -4.47 14.28 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.789 1.236 . . . . 1.0 110.669 173.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 47.86 34.28 3.85 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.319 2.648 . . . . 1.0 110.381 -173.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.34 167.63 23.48 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 66.2 m -94.69 148.91 21.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 122.366 1.079 . . . . 1.0 112.274 175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.451 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 31.5 p80 -140.61 156.12 69.33 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 114.892 -1.049 . . . . 1.0 110.972 175.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -69.72 163.41 38.36 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 1.0 109.509 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -158.71 165.33 34.62 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 121.273 -0.892 . . . . 1.0 108.721 176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -87.63 116.58 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.784 -1.561 . . . . 1.0 106.784 174.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -103.65 162.7 12.85 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 105.119 -2.178 . . . . 1.0 105.119 173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.81 3.48 38.95 Favored Glycine 0 CA--C 1.527 0.808 0 O-C-N 120.945 -1.097 . . . . 1.0 115.17 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.97 -16.4 4.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.31 1.433 . . . . 1.0 115.425 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 13.9 p -112.85 -172.78 2.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.644 2.377 . . . . 1.0 108.188 173.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -33.76 133.49 0.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.403 1.881 . . . . 1.0 112.718 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.37 -169.36 31.72 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 108.194 -1.963 . . . . 1.0 108.194 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -93.29 175.4 6.78 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.161 0.981 . . . . 1.0 109.276 -176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.91 -14.08 70.58 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 114.46 -1.246 . . . . 1.0 112.575 -175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -80.33 75.53 7.15 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.116 -1.809 . . . . 1.0 106.116 173.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -146.15 113.24 6.16 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.545 -1.65 . . . . 1.0 106.545 -173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -122.02 163.09 19.98 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.272 1.429 . . . . 1.0 108.826 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -93.14 -16.91 24.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.122 -0.944 . . . . 1.0 111.251 -173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.0 p -164.77 173.46 11.78 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.092 -0.707 . . . . 1.0 109.092 -173.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.3 tpt180 -59.54 -47.4 85.68 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 173.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -44.76 -67.1 0.31 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.975 2.91 . . . . 1.0 112.438 173.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.0 p -59.89 -33.14 71.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.534 0.683 . . . . 1.0 112.79 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.5 t -70.1 -50.16 43.59 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.327 63.2 mt-10 -69.43 -33.34 72.82 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 117.952 -1.023 . . . . 1.0 108.687 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -36.67 78.42 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.046 0.839 . . . . 1.0 109.116 173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.37 74.62 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 119.405 1.002 . . . . 1.0 112.875 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 18.0 m -129.74 73.96 81.09 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 119.32 0.963 . . . . 1.0 113.029 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -88.59 44.45 0.85 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.492 3.461 . . . . 1.0 110.902 -174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.2 166.08 13.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 122.5 1.143 . . . . 1.0 110.104 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.98 155.97 3.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 104.477 -2.416 . . . . 1.0 104.477 173.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 142.37 58.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 122.865 1.316 . . . . 1.0 109.999 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -54.85 -7.61 0.19 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 131.201 3.8 . . . . 1.0 112.907 -177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 3.95 0.01 OUTLIER 'General case' 0 C--O 1.238 0.496 0 C-N-CA 131.262 3.825 . . . . 1.0 118.5 -174.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -65.17 176.56 1.27 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 120.653 1.57 . . . . 1.0 108.424 173.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.13 -173.44 3.32 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.048 -1.032 . . . . 1.0 111.716 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -56.12 -12.53 1.55 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.76 1.224 . . . . 1.0 112.247 174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 . . . . . 0 C--O 1.252 1.196 0 N-CA-C 103.581 -2.748 . . . . 1.0 103.581 173.594 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 108.34 -0.985 . . . . 1.0 108.34 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -41.86 -49.8 4.46 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 115.903 1.816 . . . . 1.0 115.903 -161.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.52 -6.05 22.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.763 2.025 . . . . 1.0 114.498 -173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -69.3 -36.86 77.45 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 120.28 1.4 . . . . 1.0 111.213 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -149.69 110.98 4.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.68 -2.711 . . . . 1.0 103.68 178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 m -144.07 177.85 8.29 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.447 0.641 . . . . 1.0 110.136 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -59.43 141.06 55.53 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 105.984 -1.858 . . . . 1.0 105.984 173.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.43 -28.36 29.57 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.373 -0.822 . . . . 1.0 111.607 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.0 p -57.04 -29.19 63.19 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.891 1.223 . . . . 1.0 112.633 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.22 -30.77 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 121.34 -0.85 . . . . 1.0 110.685 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.606 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -63.94 127.73 92.09 Favored Pre-proline 0 N--CA 1.458 -0.066 0 C-N-CA 124.962 1.305 . . . . 1.0 112.23 178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' HD12 ' A' ' 12' ' ' LEU . 53.4 Cg_exo -50.12 154.36 5.62 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.385 2.724 . . . . 1.0 112.439 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -80.01 157.25 26.84 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.65 -0.704 . . . . 1.0 109.499 174.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 147.47 27.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 105.371 -2.085 . . . . 1.0 105.371 174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.35 -63.26 1.19 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 108.518 -0.919 . . . . 1.0 108.518 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 126.55 170.53 12.95 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.839 1.685 . . . . 1.0 109.528 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.9 -14.79 15.27 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.709 2.273 . . . . 1.0 113.301 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.8 m -73.85 -177.23 2.73 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.145 -0.972 . . . . 1.0 112.275 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.49 3.8 6.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.303 1.041 . . . . 1.0 113.125 174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.19 154.0 29.81 Favored Glycine 0 CA--C 1.531 1.037 1 N-CA-C 102.344 -4.303 . . . . 1.0 102.344 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -132.52 127.91 36.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 119.831 1.816 . . . . 1.0 108.289 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -125.91 114.32 24.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 130.158 3.383 . . . . 1.0 106.422 -173.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -67.72 132.03 25.79 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 123.252 2.635 . . . . 1.0 110.142 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 87.1 mmt-85 -133.98 175.49 9.43 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.559 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 46.4 m95 -120.96 143.42 49.02 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.765 2.026 . . . . 1.0 106.017 174.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.88 144.04 45.37 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 174.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -78.49 137.99 38.21 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.744 0.783 . . . . 1.0 109.41 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.455 ' HG ' ' CD2' ' A' ' 36' ' ' HIS . 29.4 m -117.21 113.53 39.13 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 124.981 1.313 . . . . 1.0 107.58 173.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.95 -36.03 24.12 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.125 1.883 . . . . 1.0 110.617 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.4 mt -66.65 -17.21 64.72 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.298 1.039 . . . . 1.0 112.562 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.8 mt -106.26 -4.21 20.39 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.257 1.023 . . . . 1.0 110.293 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.28 32.56 3.21 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.172 2.589 . . . . 1.0 110.922 -174.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -166.23 169.2 14.52 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 121.824 0.821 . . . . 1.0 109.249 -173.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.5 m -95.27 149.36 21.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 124.704 1.202 . . . . 1.0 110.619 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.455 ' CD2' ' HG ' ' A' ' 29' ' ' SER . 33.1 p80 -138.49 154.31 73.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.223 -0.898 . . . . 1.0 110.963 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -63.65 164.82 19.9 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.339 2.026 . . . . 1.0 111.63 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -162.16 164.28 27.97 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 173.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 72.6 t -90.14 113.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.294 -1.743 . . . . 1.0 106.294 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -105.63 159.8 15.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.214 -1.773 . . . . 1.0 106.214 173.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.16 0.94 57.39 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.232 -0.917 . . . . 1.0 114.796 -173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.35 -30.64 1.41 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.579 1.561 . . . . 1.0 113.965 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.6 p -93.89 -172.78 2.95 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.698 2.399 . . . . 1.0 107.566 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.1 mp0 -33.62 133.75 0.17 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.253 2.221 . . . . 1.0 113.042 -174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.01 -169.72 35.85 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 107.599 -2.2 . . . . 1.0 107.599 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' HD11 ' A' ' 12' ' ' LEU . 7.0 m-20 -93.35 174.35 7.25 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.491 1.145 . . . . 1.0 109.666 -174.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.92 -11.84 83.36 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 114.694 -1.139 . . . . 1.0 113.419 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -78.66 74.01 5.2 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 106.008 -1.849 . . . . 1.0 106.008 173.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -139.75 113.09 8.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.23 1.012 . . . . 1.0 108.29 -173.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.05 150.96 49.72 Favored 'General case' 0 CA--C 1.513 -0.472 0 C-N-CA 124.703 1.201 . . . . 1.0 108.123 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -93.39 -6.31 47.46 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.05 -0.406 . . . . 1.0 110.709 -174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -165.24 170.36 14.9 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.128 1.371 . . . . 1.0 107.686 -173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -70.31 -39.86 74.54 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 118.324 -1.35 . . . . 1.0 108.535 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -39.62 -65.96 0.34 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.863 2.465 . . . . 1.0 111.006 173.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 p -57.47 -33.58 68.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.917 0.71 . . . . 1.0 112.917 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 9.8 t -75.12 -46.7 32.73 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.864 1.266 . . . . 1.0 112.577 -178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.12 -33.58 76.1 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.731 0.813 . . . . 1.0 109.288 174.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.55 -38.35 84.02 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.68 0.673 . . . . 1.0 109.221 173.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.31 -60.61 2.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.622 1.101 . . . . 1.0 110.822 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 22.4 m -127.26 92.46 43.72 Favored Pre-proline 0 C--O 1.234 0.285 0 C-N-CA 124.032 0.933 . . . . 1.0 110.678 -177.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.56 -170.84 0.96 Allowed 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.393 2.062 . . . . 1.0 108.584 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 63' ' ' VAL . 3.8 t -93.12 177.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 105.734 -1.95 . . . . 1.0 105.734 174.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' H ' HG12 ' A' ' 62' ' ' VAL . 2.4 t -52.63 128.71 12.09 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 -174.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.81 148.7 42.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.299 -1.318 . . . . 1.0 113.142 -173.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -129.87 -14.56 3.99 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 128.613 2.765 . . . . 1.0 110.785 173.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 4.8 p80 173.29 79.84 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 129.5 3.12 . . . . 1.0 110.991 173.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -115.77 168.34 10.13 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 120.748 1.613 . . . . 1.0 111.642 178.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -142.55 45.46 1.61 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.288 1.435 . . . . 1.0 108.412 174.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.419 ' CD2' ' H ' ' A' ' 70' ' ' HIS . 50.9 t60 -165.03 -168.5 1.44 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.293 2.637 . . . . 1.0 104.667 -173.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' H ' ' CD2' ' A' ' 69' ' ' HIS . 2.7 t-80 . . . . . 0 C--O 1.255 1.35 0 N-CA-C 106.302 -1.74 . . . . 1.0 106.302 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.13 176.52 12.15 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.466 1.906 . . . . 1.0 107.802 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -121.57 -71.37 0.73 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.53 -5.91 11.69 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.203 1.001 . . . . 1.0 113.102 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -63.5 -50.44 69.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.335 1.854 . . . . 1.0 112.376 -173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -161.42 163.7 30.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.807 -0.812 . . . . 1.0 108.807 -176.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 94.6 m -82.79 101.09 10.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.001 -1.851 . . . . 1.0 106.001 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.58 142.7 43.71 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.59 32.11 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 118.283 0.492 . . . . 1.0 110.348 174.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 p -62.24 -21.2 64.98 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.5 0.72 . . . . 1.0 112.096 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.36 -33.05 44.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 O-C-N 120.961 -1.087 . . . . 1.0 110.548 174.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.67 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.6 tp -74.03 128.4 86.5 Favored Pre-proline 0 CA--C 1.521 -0.153 0 C-N-CA 127.407 2.283 . . . . 1.0 112.474 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.67 ' HD2' HD12 ' A' ' 12' ' ' LEU . 19.5 Cg_endo -66.34 166.18 22.31 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 121.957 1.771 . . . . 1.0 111.816 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' ' CE2' ' A' ' 38' ' ' PHE . . . -92.89 168.43 11.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.532 1.133 . . . . 1.0 111.109 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.7 t -143.1 151.36 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.776 1.631 . . . . 1.0 107.848 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -92.69 -30.05 15.76 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.05 1.34 . . . . 1.0 113.463 178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.33 177.55 51.8 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.1 -18.81 30.54 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.851 2.368 . . . . 1.0 113.601 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 m -67.83 161.74 25.57 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.834 -1.167 . . . . 1.0 111.048 -175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 3.5 15.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.966 1.706 . . . . 1.0 112.653 173.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -82.67 153.32 31.33 Favored Glycine 0 CA--C 1.528 0.873 1 N-CA-C 102.994 -4.042 . . . . 1.0 102.994 172.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -125.86 103.05 7.57 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.953 1.377 . . . . 1.0 110.461 -173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -95.13 113.82 62.32 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 127.872 2.469 . . . . 1.0 106.886 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.48 125.19 11.51 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.221 2.614 . . . . 1.0 110.319 175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 84.2 mmt-85 -131.26 -177.91 4.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.146 0.979 . . . . 1.0 108.83 174.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.492 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 46.3 m95 -125.43 143.28 51.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.644 1.178 . . . . 1.0 108.472 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.85 145.01 32.74 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 56.5 t80 -78.09 137.22 38.11 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.757 0.789 . . . . 1.0 109.361 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.0 m -117.24 113.9 38.9 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 116.801 -1.571 . . . . 1.0 108.461 173.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.81 -32.25 37.19 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.519 1.479 . . . . 1.0 110.294 173.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 mp -64.64 -15.72 61.69 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.087 1.355 . . . . 1.0 112.562 174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.6 mt -113.58 -3.8 13.58 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.663 1.585 . . . . 1.0 110.683 174.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.17 22.84 3.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 129.128 2.971 . . . . 1.0 112.229 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -166.62 170.6 12.48 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.188 -0.945 . . . . 1.0 110.276 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 28' ' ' TYR . 86.2 m -84.19 146.82 27.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 122.101 0.953 . . . . 1.0 113.485 175.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -136.48 157.19 75.75 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 114.218 -1.355 . . . . 1.0 109.878 174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -69.5 162.14 43.11 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 121.816 1.677 . . . . 1.0 108.758 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.407 ' CE2' ' HB1' ' A' ' 14' ' ' ALA . 14.9 p90 -155.93 163.16 40.1 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.063 -1.023 . . . . 1.0 108.79 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.6 t -86.19 125.25 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 106.802 -1.555 . . . . 1.0 106.802 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -122.41 175.26 6.53 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.351 2.261 . . . . 1.0 106.386 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.02 5.72 5.06 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 115.911 1.124 . . . . 1.0 115.911 -173.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.66 -38.21 2.8 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 119.842 1.821 . . . . 1.0 112.357 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.8 p -75.2 -173.02 1.87 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.529 1.532 . . . . 1.0 108.892 173.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -34.13 133.77 0.21 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.867 2.467 . . . . 1.0 113.784 -176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.7 176.41 41.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 174.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -93.72 177.72 5.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 117.77 0.785 . . . . 1.0 109.187 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.93 -14.85 79.92 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.519 -0.764 . . . . 1.0 113.343 -174.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -80.11 72.39 6.91 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -143.04 113.18 7.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 105.929 -1.878 . . . . 1.0 105.929 -176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -118.42 161.66 19.62 Favored 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 125.329 1.452 . . . . 1.0 108.85 -173.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . 0.27 8.2 m80 -93.18 -16.47 24.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.974 -1.466 . . . . 1.0 111.567 -172.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -165.83 172.15 11.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.474 -0.565 . . . . 1.0 109.474 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 8.2 tpt180 -61.49 -48.1 82.61 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 173.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.37 -66.89 0.33 Allowed 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 128.765 2.826 . . . . 1.0 111.719 176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.6 p -57.24 -33.07 67.18 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 6.1 t -71.96 -47.9 48.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.4 -0.812 . . . . 1.0 112.93 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -64.78 -33.5 76.12 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-O 118.85 -0.595 . . . . 1.0 110.248 174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -44.87 93.62 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.976 -0.75 . . . . 1.0 108.976 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.4 -46.14 70.79 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 121.476 -0.765 . . . . 1.0 112.01 176.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.5 m -137.35 88.94 16.55 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 125.275 1.43 . . . . 1.0 113.917 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.94 -162.5 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 1 C-N-CA 126.929 5.086 . . . . 1.0 103.868 172.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -92.29 157.53 2.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 100.933 -3.728 . . . . 1.0 100.933 173.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.4 t -42.37 125.92 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.516 1.126 . . . . 1.0 112.44 -172.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.42 176.9 1.26 Allowed 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 128.234 2.614 . . . . 1.0 110.954 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -48.77 -37.58 19.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.994 1.718 . . . . 1.0 109.459 173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.12 124.57 21.5 Favored 'General case' 0 C--N 1.344 0.334 0 N-CA-C 107.646 -1.242 . . . . 1.0 107.646 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.6 120.98 19.16 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -65.08 157.32 28.84 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.48 -0.933 . . . . 1.0 108.48 174.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -162.47 166.31 25.11 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.872 1.669 . . . . 1.0 106.683 174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 C--O 1.252 1.22 0 N-CA-C 105.213 -2.143 . . . . 1.0 105.213 173.084 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.5 ' H1 ' ' CD ' ' A' ' 1' ' ' GLU . 3.4 mp0 . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 103.915 -2.624 . . . . 1.0 103.915 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 -120.96 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.291 -1.004 . . . . 1.0 108.291 -164.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -65.17 -23.78 67.2 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.313 0.96 . . . . 1.0 111.943 175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.23 166.16 12.35 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.13 1.372 . . . . 1.0 110.601 174.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -61.31 -23.82 65.99 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.162 2.585 . . . . 1.0 112.381 -176.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -133.95 172.96 12.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.206 2.202 . . . . 1.0 106.46 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.9 m -143.13 94.49 2.63 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 119.897 -1.752 . . . . 1.0 112.114 177.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.77 165.29 21.72 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 104.79 -2.3 . . . . 1.0 104.79 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.67 -47.62 15.01 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 118.932 0.787 . . . . 1.0 109.719 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.23 -28.26 69.91 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.807 0.731 . . . . 1.0 112.579 -173.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 37.8 t -73.16 -37.76 53.3 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.489 HD12 ' HD2' ' A' ' 13' ' ' PRO . 10.9 tp -62.86 122.14 72.77 Favored Pre-proline 0 N--CA 1.458 -0.07 0 C-N-CA 125.061 1.344 . . . . 1.0 113.301 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.489 ' HD2' HD12 ' A' ' 12' ' ' LEU . 50.7 Cg_exo -48.84 152.85 4.15 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.717 2.945 . . . . 1.0 113.07 174.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 153.51 32.96 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.284 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.5 t -133.82 144.32 36.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -76.08 -53.48 8.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.55 175.54 15.92 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.344 1.45 . . . . 1.0 110.199 -173.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.19 -28.36 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.656 2.237 . . . . 1.0 112.994 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 19.3 m -79.21 159.92 27.14 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 122.605 1.193 . . . . 1.0 112.539 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.34 3.55 38.1 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.263 1.825 . . . . 1.0 113.546 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.15 155.09 50.25 Favored Glycine 0 CA--C 1.535 1.311 1 N-CA-C 101.555 -4.618 . . . . 1.0 101.555 172.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -136.62 132.62 35.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 121.319 2.56 . . . . 1.0 108.476 -173.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -135.54 118.8 12.71 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 129.265 3.026 . . . . 1.0 106.514 -176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -67.56 124.64 12.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.202 2.601 . . . . 1.0 109.675 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 29.8 mmt85 -128.5 179.9 5.41 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 124.407 1.083 . . . . 1.0 108.314 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' CZ3' ' HD3' ' A' ' 53' ' ' ARG . 49.6 m95 -130.34 144.58 51.47 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 127.163 2.185 . . . . 1.0 106.759 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.95 148.27 38.35 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 174.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -82.39 138.54 34.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.866 0.841 . . . . 1.0 108.893 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -117.23 114.09 38.83 Favored Pre-proline 0 C--N 1.322 -0.617 0 C-N-CA 125.665 1.586 . . . . 1.0 108.32 173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.79 -34.75 23.48 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.017 1.812 . . . . 1.0 110.618 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.6 mt -62.44 -23.57 66.94 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.561 0.744 . . . . 1.0 112.991 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.2 mt -102.72 -6.66 22.42 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 1.0 110.693 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 43.44 40.66 2.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.48 3.112 . . . . 1.0 108.452 -173.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.76 168.85 20.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 -173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 87.6 m -98.83 148.27 24.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 122.172 0.987 . . . . 1.0 111.795 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -134.62 153.29 78.9 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.315 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -72.96 168.96 23.34 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.971 1.78 . . . . 1.0 109.109 173.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -163.36 160.1 23.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.725 -1.213 . . . . 1.0 107.725 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.8 t -90.3 113.44 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 104.653 -2.351 . . . . 1.0 104.653 173.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -96.33 156.85 16.16 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 125.969 1.707 . . . . 1.0 106.97 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.13 1.95 68.13 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 114.939 0.736 . . . . 1.0 114.939 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.1 -38.51 1.79 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.87 1.7 . . . . 1.0 113.531 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.4 p -85.18 -172.83 4.38 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.107 1.763 . . . . 1.0 108.089 173.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 44' ' ' GLU . 3.4 mp0 -33.68 133.86 0.17 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.575 2.35 . . . . 1.0 113.338 -174.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.96 -167.52 28.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.522 -2.231 . . . . 1.0 107.522 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -93.35 174.65 7.1 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.545 1.172 . . . . 1.0 108.969 -174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.02 -15.17 79.5 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.016 -0.993 . . . . 1.0 112.784 -174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -76.09 78.76 2.92 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.811 -1.922 . . . . 1.0 105.811 174.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.17 113.17 5.15 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.775 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -126.12 158.0 36.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.452 1.901 . . . . 1.0 108.227 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -93.93 -11.02 31.88 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 117.867 -1.063 . . . . 1.0 112.523 174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 p -148.82 160.72 42.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.901 1.228 . . . . 1.0 110.71 -173.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HD3' ' CZ3' ' A' ' 26' ' ' TRP . 9.5 tpt180 -60.63 -50.77 72.17 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.519 -1.219 . . . . 1.0 109.087 173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.31 -66.75 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 128.343 2.657 . . . . 1.0 111.8 174.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.8 p -58.31 -33.46 69.5 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 112.858 0.688 . . . . 1.0 112.858 -175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 t -69.61 -50.43 44.46 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.444 0.698 . . . . 1.0 112.587 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.92 -33.13 73.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 118.525 -0.75 . . . . 1.0 110.262 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.71 -26.65 62.58 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 118.604 -0.713 . . . . 1.0 110.538 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.63 -44.28 62.13 Favored 'General case' 0 C--N 1.353 0.732 0 CA-C-N 120.108 1.322 . . . . 1.0 111.473 175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 17.6 m -122.99 76.36 50.03 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 123.124 0.57 . . . . 1.0 111.693 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -79.06 179.41 6.5 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.72 2.28 . . . . 1.0 107.862 173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.29 167.15 23.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 105.291 -2.115 . . . . 1.0 105.291 173.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.5 t -60.55 137.44 22.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.658 -1.608 . . . . 1.0 106.658 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -53.23 114.49 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.012 0.925 . . . . 1.0 110.191 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.05 -18.82 62.55 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 118.673 -0.679 . . . . 1.0 112.213 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -64.68 150.83 46.42 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.244 -1.761 . . . . 1.0 106.244 173.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -80.29 71.29 7.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.25 -1.532 . . . . 1.0 109.252 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -64.3 154.64 34.64 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.71 0.804 . . . . 1.0 109.134 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -67.75 157.9 33.62 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.79 -0.819 . . . . 1.0 108.79 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--O 1.251 1.158 0 N-CA-C 104.741 -2.318 . . . . 1.0 104.741 173.094 . . . . . . . . 0 0 . 1 stop_ save_